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IThe Biomechanical and Analgesic Effects of Lumbar Mobilisations 
Abstract
A common treatment used by physiotherapists for patients with low back pain (LBP) is 
mobilisations. The aim of applying mobilisations is to increase range of movement (ROM) 
and reduce pain and stiffness. Therapists choose a specific dose of mobilisation for each 
patient, which includes a decision on the duration of applied force, commonly up to 3 
minutes. Little research has been done to determine the biomechanical and analgesic 
effects of different durations of treatment. There is tentative evidence that increased duration 
beyond 3 minutes leads to an increase in range of movement and decrease in pain. This 
research set out to establish the biomechanical and analgesic effects of longer durations  
of lumbar mobilisations than commonly used in clinical practice. Only the immediate effects 
of a single treatment dose have been assessed to date. 
Three studies were conducted. Firstly a reliability study (n=20) was undertaken to ensure 
the reliability of pressure pain thresholds (PPT), ROM, and stiffness measurements of the 
lumbar spine. Two methods of stiffness measurement were identified from the literature; 
in this study measurements were simultaneously collected using both methods to allow 
comparison. Excellent reliability PPT, good reliability for ROM and moderate reliability for 
both stiffness measurements were established. Standard error of measurement (SEM) and 
Minimal Detectable change (MDC) statistics were calculated to enable identification of 
participants who responded to treatment in the later studies. 
A single-arm trial (n=17) was conducted to determine the immediate effects of 3 and 6 
minutes of lumbar spine mobilisations on ROM, stiffness and pain (PPT) and verbal rating 
scales (VRS) of pain in participants with LBP. For verbal rating of pain on movement 
there was a significant difference between durations, with a significant reduction in pain 
immediately after 6 minutes of treatment, but not after 3 minutes of treatment. There was  
a significant increase in PPT (p<.01) immediately following both durations of treatment. 
The difference between 3 and 6 minutes of treatment on PPT failed to reach significance. 
These findings suggest that 3 minutes of mobilisation treatment were not sufficient to create 
a significant change in PPT. The changes in PPT were evident at sites suggesting both a 
local and segmental treatment effect. There was dissociation between PPT’s and VRS. There 
was no significant change in ROM (p=0.42) or stiffness (p=0.11- p=0.99) following either 
duration of treatment; therefore these measures were not included in the final study. 
Finally a randomised placebo controlled trial (n=72) was conducted to establish the 
immediate and short-term (24 hours after treatment) analgesic effects of different duration 
of lumbar mobilisation in participants with LBP. Two groups (short and long duration) 
were included in the study. Participants in the short duration treatment group received 
measurements of pain (PPT and verbal rating of pain) before and after 2 minutes of sham 
mobilisation and again after 1 minute of mobilisations. Participants in the long duration 
treatment group received measurements of pain before and after 2 minutes of mobilisation 
and again after an additional 4 minutes of mobilisations. In both treatment groups pain 
measures were also taken 24-hours after treatment. Analysis of treatment responders 
demonstrated that significantly more participants receiving longer duration of treatment 
experienced a reduction in PPT local to the site of treatment. There was no overall difference 
between treatment groups. Verbal rating of pain on movement was significantly reduced 
after treatment but the difference between treatment groups failed to reach significance. 
There was dissociation between patients rating of pain and PPT, suggesting that the 
different measures are mediated by different underlying neurobiological mechanisms. 
II
III
Clair Hebron 
The Biomechanical and Analgesic  
Effects of Lumbar Mobilisations 
Abstract  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I
Contents .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . III
  List of figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  X
  List of tables  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . XIII
  List of appendices . . . . . . . . . . . . . . . . . . . . . . . . . .   XV
  Glossary  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . XVI
  Acknowledgements .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .    XVII
  Declaration . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  XVIII
 
Chapter 1
Introduction to the thesis  . . . . . . . . . . . . . . . . . . . . . . . . . 1
Chapter 2
Mobilisations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
 2.1.  Literature search . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
 2.2. Physiotherapy treatment of low back pain. . . . . . . . . . . . . . . . 5
 2.3. The use of mobilisations in the treatment of low back pain.  . . . . . . 6
 2.4.  The biomechanical and analgesic effects of mobilisations .  .  .  .  .  .  . 8
 2.5.   The effects of mobilisation treatment on range 
  of movement in asymptomatic participants.  .  .  .  .  .  .  .  .  .  .  .  .  .  . 8
 2.6.  The effects of mobilisation treatment
  on range of movement in symptomatic participants . . . . . . . . . . 9
 2.7.  Lumbar spine stiffness in patients with LBP  . . . . . . . . . . . . . 12
 2.8.  The effects of mobilisations on lumbar stiffness  . . . . . . . . . . . 12
 2.9. The effects of mobilisations on pain measures . . . . . . . . . . . . 14
 2.9.1.  Changes in PPT following mobilisation treatment.  .  .  .  .  .  .  .  .  .  .  15 
 2.9.2.  Changes in patient reported pain measures following
   mobilisation treatment  . . . . . . . . . . . . . . . . . . . . . . . . 18
 2.10.  Mechanisms of analgesia.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  19 
 2.10.1.  The pain gate theory . . . . . . . . . . . . . . . . . . . . . . . . . 19
 2.10.2.  Descending modulation of pain. . . . . . . . . . . . . . . . . . . . 20
 2.10.3.  Opioid analgesia . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 
IV
 2.10.4.  The extent of the hypoalgesic effect of PA 
  mobilisation treatment  . . . . . . . . . . . . . . . . . . . . . . . . 21
 2.11.  The effect of different durations of mobilisation treatment. . . . . . . 22
 
Chapter 3
 Methods of measurement of pain and lumbar
spine range of movement and stiffness .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  25
 3.1.  Measurement of lumbar spine range of movement.  . . . . . . . . . 25
 3.1.1.  Reliability of ROM measurements using electromagnetic 
  tracking systems . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
 3.2. Measurement of lumbar spine stiffness.  . . . . . . . . . . . . . . . 28
 3.2.1.  The displacement method of spinal stiffness measurement . . . . . 28
 3.2.2. Three-point bending method of stiffness measurement. . . . . . . . 32
 3.2.3.  Experimental variables influencing stiffness measurements .  .  .  .  .  33
 3.2.4.  Stiffness calculations using the displacement
  method of measurement. . . . . . . . . . . . . . . . . . . . . . . . 33
 3.3.  Measurement of forces . . . . . . . . . . . . . . . . . . . . . . . . 36
 3.4. Measurement of pain . . . . . . . . . . . . . . . . . . . . . . . . . 37
 3.4.1.  Pressure algometry .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  37
 3.4.2.  Reliability of pressure pain threshold measurements .  .  .  .  .  .  .  .  .  38
 3.4.3.  Verbal Rating Scale (VRS) of pain measurements . . . . . . . . . . 41
 3.5.  Questionnaires . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
 3.5.1.  Measures to describe the pain . . . . . . . . . . . . . . . . . . . . 41
 3.5.2.  Measurement of the response to pain  . . . . . . . . . . . . . . . . 42
 3.5.3.  Measurement of the impact of the pain .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  42
 3.5.4.  Measurement of depression / anxiety.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  43
 3.5.5.  Demographic questionnaire  . . . . . . . . . . . . . . . . . . . . . 43
 3.5.6.  Nicotine and alcohol questionnaires . . . . . . . . . . . . . . . . . 43
 3.6. Summary of the literature review and overview of studies . . . . . . 43
 3.7. The research questions addressed in the studies in this thesis  . . . 44
 
Chapter 4
 Preliminary studies  . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
 
 4.1.  Study establishing the validity and reliability of Fastrak  . . . . . . . 47
 4.1.1.  Pilot study aim  . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
 4.1.2.  Equipment  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
 4.1.3.  Methods  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
 4.1.4.  Data analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
 4.1.5.  Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
V 4.1.6.  Discussion  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
 4.2.  Study to establish the synchronisation
  of force and motion measurements .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  49
 4.2.1.  Pilot study aim  . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
 4.2.2. Instrumentation and measurements  . . . . . . . . . . . . . . . . . 49
 4.2.3.  Methods  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
 4.2.4.  Data analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
 4.2.5.  Results and discussion .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  50
 4.3. Study to calibrate the algometer . . . . . . . . . . . . . . . . . . . 50
 4.4.  Study to assess the procedure and data analysis
  for ROM, stiffness and PPT measurements .  .  .  .  .  .  .  .  .  .  .  .  .  .  50 
 4.4.1.  Pilot study aim  . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
 4.4.2. Ethics approval . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
 4.4.3.  Participants .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  51
 4.4.4. Inclusion and exclusion criteria .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  52
 4.4.5.  Confidentiality.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  52
 4.4.6. Instrumentation and measurements  . . . . . . . . . . . . . . . . . 52
 4.4.7.  Procedure.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  54
 4.4.8. Range of movement measurements  . . . . . . . . . . . . . . . . . 55
 4.4.9. Stiffness measurements  . . . . . . . . . . . . . . . . . . . . . . . 56
 4.4.10.  Pressure pain threshold measurements  . . . . . . . . . . . . . . . 56 
 4.4.11.  Results and discussion .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  56
 4.5.  Development of a hand held indenter for the
  displacement method of spinal stiffness measurements . . . . . . . 61
 4.6. Key learning points from the preliminary studies .  .  .  .  .  .  .  .  .  .  .  62
 4.7. Pilot work conclusions  . . . . . . . . . . . . . . . . . . . . . . . . 62
 
 Chapter 5.
 The within- and between-day test-retest reliability of pressure  
pain threshold, range of movement and stiffness measurements  
of the lumbar spine  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
 5.1.  Introduction .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  65
 5.1.1.  Research Questions  . . . . . . . . . . . . . . . . . . . . . . . . . 66
 5.1.2.  Study aim .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  66
 5.2.  Methods  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
 5.2.1.  Study design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
 5.2.2.  Ethics approval . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66 
 5.2.3.  Participants .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  66
 5.2.4.  Inclusion criteria and exclusion criteria .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  66
 5.2.5.  Confidentiality.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  67
VI
 5.2.6. Research approach and methods . . . . . . . . . . . . . . . . . . 68
 5.2.7.  Instrumentation and measurements  . . . . . . . . . . . . . . . . . 68
 5.2.8. Procedure.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  69
 5.2.9.  Fastrak sensor placement  . . . . . . . . . . . . . . . . . . . . . . 69
 5.2.10.  Range of movement measurements  . . . . . . . . . . . . . . . . . 70
 5.2.11.  Measurement of stiffness . . . . . . . . . . . . . . . . . . . . . . . 71
 5.2.12.  Procedure and order of PPT testing  . . . . . . . . . . . . . . . . . 71
 5.3.  Data analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
 5.3.1.  Analysis of range of movement (ROM) data . . . . . . . . . . . . . 75
 5.3.2.  Analysis of stiffness data . . . . . . . . . . . . . . . . . . . . . . . 75
 5.3.3.  Analysis of pressure pain threshold data .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  75
 5.3.4.  Normality testing of data . . . . . . . . . . . . . . . . . . . . . . . 75
 5.3.5. Reliability analysis  . . . . . . . . . . . . . . . . . . . . . . . . . . 76
 5.3.6.   Analysis of the association between three-point
  bending and displacement methods of stiffness data . . . . . . . . 76
 5.4.  Results of the reliability study .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  76
 5.4.1.  Results of the reliability of ROM measurements  . . . . . . . . . . . 76
 5.4.2.  Results of the reliability stiffness of measurements .  .  .  .  .  .  .  .  .  .  79
 5.4.3.  Correlation between three-point bending and displacement
   methods of stiffness data .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  81
 5.4.4.  Results of the reliability PPT of measurements .  .  .  .  .  .  .  .  .  .  .  .  83
 5.5.  Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
 5.5.1.  Discussion of the reliability of ROM measurements.  .  .  .  .  .  .  .  .  .  85
 5.5.2.  Discussion of the reliability stiffness of measurements . . . . . . . . 87
 5.5.3.  Validity of the reliability three-point bending methods  
  of stiffness measurements . . . . . . . . . . . . . . . . . . . . . . 89
 5.5.4.  Discussion of the reliability PPT of measurements . . . . . . . . . . 91
 5.5.5.  Key learning points from the test re-test reliability study . . . . . . . 93
 5.5.6.  Overall summary of discussion .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  93
 
 Chapter 6
 A single-arm trial investigating the immediate effects 
of duration of lumbar mobilisation on pain, range of 
Movement and stiffness in patients with LBP . . . . . . . . . . . . 95
 6.1.  Introduction .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  95
 6.1.1.  Research question . . . . . . . . . . . . . . . . . . . . . . . . . . 96
 6.1.2.  Study aims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
 6.2. Methods  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  96
 6.2.1.  Study design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
 6.2.2.  Ethics approval . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
 6.2.3.  Participants .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  97
VII
 6.2.4 Inclusion and exclusion criteria .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  97
 6.2.5 Confidentiality.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  98
 6.2.6. Instrumentation and measurements  . . . . . . . . . . . . . . . . . 98
 6.2.7.  Pilot work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
 6.2.8. Procedure.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  99 
 6.2.9. Occasion one procedure . . . . . . . . . . . . . . . . . . . . . . . 99
 6.2.10.  Occasion two procedure . . . . . . . . . . . . . . . . . . . . . . . 100
 6.2.11.  Range of movement measurements  . . . . . . . . . . . . . . . . . 101
 6.2.12.  Verbal rating of pain on PA force to the symptomatic level .  .  .  .  .  . 101
 6.2.13.  Three-point bending and displacement stiffness
  measurement procedure . . . . . . . . . . . . . . . . . . . . . . . 101
 6.2.14.  Pressure pain threshold measurement procedure . . . . . . . . . . 101
 6.2.15.  Mobilisation treatment  . . . . . . . . . . . . . . . . . . . . . . . . 103
 6.3.  Data Analysis .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 103
 6.3.1.  Analysis of response to treatment  . . . . . . . . . . . . . . . . . . 104
 6.3.2.  Normality testing of data . . . . . . . . . . . . . . . . . . . . . . . 105
 6.3.3.  Analysis of variance  . . . . . . . . . . . . . . . . . . . . . . . . . 105
 6.3.4.  Correlation between measures . . . . . . . . . . . . . . . . . . . . 106
 6.4. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
 6.4.1.  Results of mobilisation treatment
  on lumbar range of movement . . . . . . . . . . . . . . . . . . . . 107
 6.4.2.  Results of mobilisation treatment on lumbar stiffness.  .  .  .  .  .  .  .  . 108
 6.4.3.  Results for pressure pain thresholds . . . . . . . . . . . . . . . . . 110
 6.4.4.  Results for verbal rating of pain.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 113
 6.4.5.  The relationship between change in PPT and change in VRS  . . . . 116
 6.4.6.  Summary of findings . . . . . . . . . . . . . . . . . . . . . . . . . 116
 6.5. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
 6.5.1.  Discussion of the effects of mobilisation
  on lumbar range of movement .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 117
 6.5.2.  Discussion of the effects of mobilisations on stiffness . . . . . . . . 117
 6.5.3.  Comparison of three-point bending and displacement 
  stiffness measurements.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 118
 6.5.4.  Discussion of pain related measures .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 121
 6.5.5. Discussion of the effects of mobilisation
  duration on verbal rating scales of pain  . . . . . . . . . . . . . . . 123
 6.5.6.  Discussion of the relationship between verbal rating 
  scales of pain and PPT . . . . . . . . . . . . . . . . . . . . . . . . 123
 6.5.7.  Discussion of prediction of responders treatment  . . . . . . . . . . 123
 6.5.8.  Study limitations  . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
 6.6.  Key learning point from the single-arm trail  . . . . . . . . . . . . . 125
 6.7.  Conclusions.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 125
VIII
 Chapter 7
 A randomised placebo-controlled study investigating 
the immediate and 24-hour effects of mobilisation treatment
duration on pain in patients with chronic LBP .  .  .  .  .  .  .  .  .  .  .  . 127
 7.1.  Introduction .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 127
 7.1.1.  Research questions.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 128
 7.1.2.  Study aims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
 7.2. Methods  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  129
 7.2.1.  Study design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
 7.2.2. Ethics approval . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
 7.2.3.  Participants .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 132
 7.2.4.  Inclusion and exclusion criteria .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 132
 7.2.5.  Confidentiality.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 133
 7.2.6.  Instrumentation and measurements  . . . . . . . . . . . . . . . . . 133
 7.2.7. Procedure.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 133
 7.2.8.   Occasion one procedure . . . . . . . . . . . . . . . . . . . . . .  134 
 7.2.9.  Occasion two procedure . . . . . . . . . . . . . . . . . . . . . . . 134
 7.2.10.  Baseline measurements of verbal rating of pain . . . . . . . . . . . 134
 7.2.11.  Baseline measurements of PPT .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 135
 7.2.12.   Treatment period 1: Placebo (2 minutes sham mobilisation) 
versus 2 minutes of mobilisation treatment .  .  .  .  .  .  .  .  .  .  .  .  .  . 136
 7.2.13.  Measurements after treatment period 1  . . . . . . . . . . . . . .  137 
 7.2.14.   Treatment period 2: One minute of mobilisation treatment 
versus six minutes of mobilisation treatment . . . . . . . . . . . . . 137
 7.2.15.  Measurements after treatment period 2.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 137
 7.2.16.  Occasion 3 – 24 hour follow-up procedure .  .  .  .  .  .  .  .  .  .  .  .  .  . 137
 7.3.  Data Analysis .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 138
 7.3.1.  Normality testing of data . . . . . . . . . . . . . . . . . . . . . . . 138
 7.3.2.  Mann-Whitney U test and independent T-test.  .  .  .  .  .  .  .  .  .  .  .  . 138
 7.3.3.  Analysis of variance  . . . . . . . . . . . . . . . . . . . . . . . . . 139
 7.3.4.  Stratified analysis .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 139
 7.3.5. Correlations .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 139
 7.3.6.   Analysis of expectations and experience  
of mobilisations questionnaire  . . . . . . . . . . . . . . . . . . . . 139
 7.3.7.  Analysis of response to treatment  . . . . . . . . . . . . . . . . . . 140
 7.4. Results  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
 7.4.1.  Results for pressure pain thresholds . . . . . . . . . . . . . . . . . 142
 7.4.2.   Results for verbal rating of pain on movement . . . . . . . . . . . . 148
 7.4.3.   Results for verbal rating of resting pain  . . . . . . . . . . . . . . . 150
 7.4.4.   Results for verbal rating scale of pain on the application 
of PA force to the symptomatic level . . . . . . . . . . . . . . . . . 151
 7.4.5.  Global rating of perceived effect . . . . . . . . . . . . . . . . . . . 152
IX
 7.4.6.  Stratified analysis of force  . . . . . . . . . . . . . . . . . . . . .  154
 7.4.7.  The relationship between PPT and participants VRS .  .  .  .  .  .  .  .  . 157
 7.4.8.   Participants’ expectation and experience of receiving  
a mobilisation treatment  . . . . . . . . . . . . . . . . . . . . . . . 161
 7.4.9.  Analysis of treatment responders and non-responders.  .  .  .  .  .  .  . 163
 7.4.10.  Profile of treatment responders .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 167
 7.4.11.  Summary of findings . . . . . . . . . . . . . . . . . . . . . . . . . 172
 7.5. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
 7.5.1.  Discussion of the immediate effects of mobilisations .  .  .  .  .  .  .  .  . 173
 7.5.2.  The effects of mobilisation treatment at 24-hour follow-up . . . . . . 175
 7.5.3.  The mediating effect of treatment force on change in pain .  .  .  .  .  . 176
 7.5.4.  The relationship between PPT and verbal rating of pain measures  . 177 
 7.5.5.  Discussion of responders’ analysis .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 178
 7.5.6.  Participants’ expectations of mobilisation treatment . . . . . . . . . 179 
 7.5.7.  Predictors of response to mobilisation treatment .  .  .  .  .  .  .  .  .  .  . 180
 7.5.8.  The extent of the analgesic effect of mobilisations . . . . . . . . . . 180
 7.5.9.  Study limitations  . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
 7.6.  Conclusions.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 184
 
 Chapter 8
 Overall discussion and summary . . . . . . . . . . . . . . . . . . . . 187
 
 8.1.  Analysis of treatment responders  . . . . . . . . . . . . . . . . . . 187
 8.2.  The effects of lumbar mobilisations on PPT.  .  .  .  .  .  .  .  .  .  .  .  .  . 187
 8.3.  The extent of the analgesic effect of mobilisations . . . . . . . . . . 189
 8.4.  The effects of lumbar mobilisations on verbal rating of pain . . . . . 189
 8.5.  The relationship between pain measures .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 189
 8.6.  The mediating effect of treatment force.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 190
 8.7.  Predictors of response to treatment  . . . . . . . . . . . . . . . . . 190
 8.8.  The effect of lumbar mobilisations on stiffness . . . . . . . . . . . . 190
 8.9.  The effects of mobilisations on range of movement  . . . . . . . . . 191
 8.10.  Summary of limitations . . . . . . . . . . . . . . . . . . . . . . . . 192
 8.11.  Research questions addressed in this thesis  . . . . . . . . . . . . 193
 8.12.  Recommendations for future work . . . . . . . . . . . . . . . . . . 195
 8.13.  Original contribution to knowledge . . . . . . . . . . . . . . . . . . 197
 8.14.  Conclusions.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 198
 
 References.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .   201
Appendices  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  219
X List of figures
 2.1. Literature search . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4 
 2.2. Posteroanterior mobilisation of the spine . . . . . . . . . . . . . . . .  6 
 3.1.  Force displacement graph of PA pressure applied to the lumbar spine.  .  34
 3.2. Flowchart depicting the sequence of studies and research 
  questions addressed in each study of this thesis.  .  .  .  .  .  .  .  .  .  .  .  .  45
 4.1. Plinth mounted of force plates and lean bar  . . . . . . . . . . . . . . . 53
 4.2. Algometer software with on screen scale to indicate rate of application . 54
 4.3. Fastrak sensor placement on base of sacrum and L1 . . . . . . . . . . 55
 4.4. Lumbar flexion and extension ROM.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  55
 4.5. Lumbar lateral flexion ROM . . . . . . . . . . . . . . . . . . . . . . . . 55
 4.6. A plot of Fastrak data for range of movement  . . . . . . . . . . . . . . 57
 4.7. Handheld indenter  . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
 5.1. Flowchart depicting the reliability procedure PPT testing sites.  .  .  .  .  .  67
 5.2. Fixation of Fastrak sensors on the base of the sacrum and L1.  .  .  .  .  .  70
 5.3. PPT testing sites .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  72
 5.4. PPT testing at T10 paravertebral muscles  . . . . . . . . . . . . . . . . 73
 5.5. PPT testing at the Deltoid muscle site.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  73
 5.6. PPT testing at L3 dermatome site .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  74
 5.7. PPT testing at S1 dermatome site .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  74
 5.8. Right lateral flexion range of movement for 
  all participants on all occasions.  . . . . . . . . . . . . . . . . . . . . . 77
 5.9. Range of flexion and extension for all 6 trials
  (3 trials on 2 different occasions) . . . . . . . . . . . . . . . . . . . . . 78
 5.10. Range of lateral flexion and extension for all 6 trials
  (3 trials on 2 different occasions) . . . . . . . . . . . . . . . . . . . . . 78
 5.11. Three-point bending measurements for all 6 trials
  (3 trials on 2 different occasions) . . . . . . . . . . . . . . . . . . . . . 80
 5.12.  Displacement measurements for all 6 trials
  (3 trials on 2 different occasions) . . . . . . . . . . . . . . . . . . . . . 80
 5.13. Graph of force, angle and displacement measurements.  .  .  .  .  .  .  .  .  82
 5.14. Correlation between three-point bending and displacement
  measurements at baseline on occasion 1  . . . . . . . . . . . . . . . . 82
 5.15. Correlation between three-point bending and displacement
  measurements at baseline on occasion 2  . . . . . . . . . . . . . . . . 83
 5.16. PPT measurements for all 6 trials (3 trials on 2 different occasions)
  at the paravertebral and Deltoid muscle sites  . . . . . . . . . . . . . . 83
XI
 5.17. PPT measurements for all 6 trials (3 trials on 2 different occasions)
  in the dermatome signature zones . . . . . . . . . . . . . . . . . . . . 84
 6.1. Flowchart of single-arm trial procedure .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .100
 6.2. Range of movement at baseline and after
  3 and 6 minutes of mobilisation treatment  . . . . . . . . . . . . . . . .107
 6.3. Stiffness at baseline and after 3 and 6 minutes of treatment . . . . . . .108
 6.4. Correlation between three-point bending and displacement
  methods of stiffness measurement . . . . . . . . . . . . . . . . . . . .109
 6.5. PPT at baseline and after 3 and 6 minutes of mobilisation treatment  . .111
 6.6. PPT at baseline and after 3 and 6 minutes of mobilisation treatment  . .111
 6.7. Cumulative proportion of responders analysis for PPT at the symptomatic
  paravertebral site following 3 and 6 minutes of treatment . . . . . . . .112
 6.8. Verbal rating of pain on movement . . . . . . . . . . . . . . . . . . . .113
 6.9. Cumulative proportion of responders analysis for verbal rating
  of pain on movement following 3 and 6 minutes of treatment  . . . . . .114
 6.10. Verbal rating of pain on application of PA force.  .  .  .  .  .  .  .  .  .  .  .  .  .115
 7.1. Participants journey through the RCT..  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .131
 7.2. Paravertebral PPT measurements.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .144
 7.3. PPT measurements . . . . . . . . . . . . . . . . . . . . . . . . . . . .144
 7.4. PPT measurements . . . . . . . . . . . . . . . . . . . . . . . . . . . .145
 7.5. PPT measurements . . . . . . . . . . . . . . . . . . . . . . . . . . . .145
 7.6. Verbal rating of pain on movement . . . . . . . . . . . . . . . . . . . .150
 7.7. Verbal rating of resting pain .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .151
 7.8. Verbal rating of pain on the application of PA force to the most
  symptomatic vertebral level .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .152
 7.9. Correlation between GRPC and change in PPT  . . . . . . . . . . . . .154
 7.10.  Correlation between GRPC and change in verbal rating
  of pain on movement . . . . . . . . . . . . . . . . . . . . . . . . . . .154
 7.11. Mediating effect of force on change in PPT
  at the symptomatic paravertebral level . . . . . . . . . . . . . . . . . .155
 7.12. Mediating effect of force on change in PPT at T10 paravertebral level  .156
 7.13. Mediating effect of force on change in verbal rating of pain
  on movement after treatment period 2 . . . . . . . . . . . . . . . . . .156
 7.14. Mediating effect of force on change in verbal rating of pain
   on movement at 24-hour follow-up . . . . . . . . . . . . . . . . . . . .157
 7.15. Correlation between change in verbal rating of pain on movement
  and resting pain at baseline.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .158
XII
 7.16. Correlation between change in verbal rating of resting pain
  and pain on PA force application .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .158
 7.17. Correlation between change in verbal rating of pain on movement
  and pain on PA force application .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .158
 7.18. Correlation between change in verbal rating pain on PA force
  application and PPT at the symptomatic paravertebral level.  .  .  .  .  .  .158
 7.19. Participants’ expectations of mobilisation treatment . . . . . . . . . . .161
 7.20. Beneficial expectations of treatment . . . . . . . . . . . . . . . . . . .161
 7.21. Participants’ experiences of pain associated
  with mobilisation treatment  . . . . . . . . . . . . . . . . . . . . . . . .162
 7.22. Cumulative proportion of responders analysis for PPT at
  the symptomatic paravertebral site after treatment period 1 .  .  .  .  .  .  .163
 7.23. Cumulative proportion of responders analysis for PPT at
  the symptomatic paravertebral site after treatment period 2 .  .  .  .  .  .  .164
 7.24. Cumulative proportion of responders analysis for PPT a
   the T10 paravertebral site after treatment period 2  . . . . . . . . . . .164
 7.25. Cumulative proportion of responders analysis for Deltoid PPT
  site after treatment period 2 .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .165
 7.26. Cumulative proportion of responders analysis for PPT at
  the symptomatic paravertebral site at 24-hour follow-up .  .  .  .  .  .  .  .  .165
 7.27. Cumulative proportion of responders analysis for verbal rating
  of pain on movement after treatment period 2 . . . . . . . . . . . . . .167
XIII
List of tables
 2.1. Components of treatment dose . . . . . . . . . . . . . . . . . . . . . . 7
 2.2. The effects of mobilisation on ROM .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  10
 2.3. The immediate effects of a single treatment dose on stiffness .  .  .  .  .  .  .  13
 2.4. The immediate effects of a single treatment dose
  on PPT and patient reported pain measures  . . . . . . . . . . . . . . . . 16
 3.1. Studies measuring of range of movement of the lumbar spine
  using three dimensional methods. . . . . . . . . . . . . . . . . . . . . . . . 27
 3.2. Differences in methodology of studies using instrumented
  measurement of lumbar spine stiffness.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 30
 3.3. Stiffness index (K) and deformation (D30) valued for the lumbar spine  35
 3.4. Reliability of pressure pain threshold measurements . . . . . . . . . . 40
 4.1. Comparison of Fastrak and goniometry measurements  . . . . . . . . 48
 4.2. Algometry testing procedure established from pilot work.  .  .  .  .  .  .  .  61
 5.1. Within-day and between-day reliability of ROM measurements.  .  .  .  .  79
 5.2. Within-day and between-day reliability of three-point bending
  and displacement stiffness measurements . . . . . . . . . . . . . . . 81
 5.3. Within-day and between-day reliability of PPT measurements . . . . . 84
 5.4. Different interpretations of intraclass correlation coefficients . . . . . . 86
 6.1. Instructions given to participants during ROM testing . . . . . . . . . 101
 6.2. PPT testing procedure  . . . . . . . . . . . . . . . . . . . . . . . . . 102
 6.3. Demographic and symptom information for participants . . . . . . . . 106
 6.4. Questionnaire results . . . . . . . . . . . . . . . . . . . . . . . . . . 106
 6.5. Survey of pain attitudes scores . . . . . . . . . . . . . . . . . . . . . 107
 6.6. Percentage change in three-point bending and displacement
  values after 3 and 6 minutes of treatment .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 109
 6.7. Percentage change in PPT after 3 and 6 minutes of treatment . . . . . 112
 6.8. Number of responders to treatment based on changes
  in symptomatic paravertebral PPT  . . . . . . . . . . . . . . . . . . . 113
 6.9. Number of responders to treatment based on verbal 
  rating of pain on movement .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 115
 7.1. Instructions given to participants during ROM testing . . . . . . . . . 135
 7.2. The order of PPT testing; participants position and landmarks
  for each PPT testing site  . . . . . . . . . . . . . . . . . . . . . . . . 136
 7.3. The questions contained in the expectations and experience
  of receiving mobilisations questionnaire  . . . . . . . . . . . . . . . 138
 7.4. Demographic, symptom and treatment details . . . . . . . . . . . . . 141
XIV
 7.5. Questionnaire results . . . . . . . . . . . . . . . . . . . . . . . . . . 142
 7.6. Survey of pain attitudes scores . . . . . . . . . . . . . . . . . . . . . 142
 7.7. The force applied in each treatment condition . . . . . . . . . . . . . 142
 7.8. Percentage change in PPT in the short and long
  duration treatment groups.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 147
 7.9. Verbal rating of pain on individual movements in the short
  and long duration treatment groups . . . . . . . . . . . . . . . . . . . 148
 7.10. Two-way mixed ANOVA results for verbal ratings of pain .  .  .  .  .  .  .  . 152
 7.11. Global rating of perceived change . . . . . . . . . . . . . . . . . . . 153
 7.12.  Correlation between changes in pain and global
  rating of perceived change . . . . . . . . . . . . . . . . . . . . . . . 153
 7.13. Correlation between PPT at the symptomatic paravertebral site
  and verbal rating of pain  . . . . . . . . . . . . . . . . . . . . . . . . 160
 7.14. Number of responders to treatment based on changes
  in symptomatic paravertebral PPT  . . . . . . . . . . . . . . . . . . . 166
 7.15. Number of responders to treatment based on changes
  in verbal rating of pain on movement . . . . . . . . . . . . . . . . . . 167 
 7.16. Short duration group responders . . . . . . . . . . . . . . . . . . . . 169
 7.17. Long duration group responders . . . . . . . . . . . . . . . . . . . . 170
 7.18. Questionnaire results of responders to mobilisations .  .  .  .  .  .  .  .  .  . 171
 7.19. Survey of pain attitudes for responders and non-responders .  .  .  .  .  . 171
XV
List of appendices 
 
 1. List of publications and conference presentations by author .  .  .  .  .   220
 2. Ethical approval for reliability study .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .   222
 3. Macro – Batch process procedure for analysis of ROM
  and stiffness data .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .   223
 4. Normality testing for the reliability study  . . . . . . . . . . . . . . .  229
 5.  Correlation between three-point bending and displacement methods  
of stiffness measurements in the reliability study . . . . . . . . . . .  232
 6. Physiotherapy diagnosis of symptomatic level . . . . . . . . . . . .  233
 7. Study questionnaires . . . . . . . . . . . . . . . . . . . . . . . . .  235
 8. Normality testing for single-arm trial  . . . . . . . . . . . . . . . . .  242
 9. ANOVA for ROM and stiffness– single-arm trial .  .  .  .  .  .  .  .  .  .  .  .   245
 10. Correlation between three-point bending and displacement  
  methods of stiffness measurements – single-arm trial  . . . . . . . .  247
 11. ANOVA and ANCOVA for PPT– single-arm trial .  .  .  .  .  .  .  .  .  .  .  .   248
 12. ANOVA and ANCOVA for verbal rating of pain on movement
  – single-arm trial  . . . . . . . . . . . . . . . . . . . . . . . . . . .  259
 13. ANOVA and ANCOVA for verbal rating of pain on the application
  of PA force– single-arm trial .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .   263
 14. Correlation between PPT and VAS– single-arm trial.  .  .  .  .  .  .  .  .  .   267
 15. Participant information sheet for RCT .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .   268
 16. Global rating of perceived change . . . . . . . . . . . . . . . . . .  271
 17. Questionnaire on participants’ expectations and experiences
  of receiving a mobilisation treatment . . . . . . . . . . . . . . . . . . . . .  272
 18. Normality testing for the RCT . . . . . . . . . . . . . . . . . . . . .  274
 19. Tests for differences between baselines measures between groups  .  277
 20. ANOVA and ANCOVA for PPT– RCT  . . . . . . . . . . . . . . . . .  283
 21. Analysis of treatment force . . . . . . . . . . . . . . . . . . . . . .  288
 22. ANOVA and ANCOVA for verbal rating of pain – RCT.  .  .  .  .  .  .  .  .   295
 23. Global rating of perceived effect analysis.  .  .  .  .  .  .  .  .  .  .  .  .  .  .   304
 24. Correlation between PPT and verbal rating of pain scores . . . . . .  312
 25. Responders analysis . . . . . . . . . . . . . . . . . . . . . . . . .  317
 26. Questionnaire analysis . . . . . . . . . . . . . . . . . . . . . . . .  322
 
XVI
Glossary of terms
 
 
 GRPC global rating of received change
 ICC Intraclass correlation coefficient
 PA posteroanterior
 PAG periaqueductal gray 
 LBP  low back pain
 MDC minimal detectable change
 MRI magnetic resonance imaging
 N Newton
 PPT pressure pain threshold
 RCT randomised controlled trial
 ROM range of movement 
 SEM standard error of measurement
 SD standard deviation
 SPS Spinal physiotherapy simulator
 SAM Stiffness assessment machine
 SPAM Spinal PosteroAnterior mobiliser
 VAS visual analogue scale
 VRS verbal rating scale
 
 
 
XVII
Acknowledgements
 
 It can take a long time to write a PhD thesis. I would here like to take a little  
more time to thank those people that have supported me throughout this  
lengthy process.
 
 I have been fortunate with my supervisors, Ann Moore, Anne Jackson, and  
Kambiz Saber-Sheikh who have provided support throughout. My sincere thanks 
to them and to Nikki Petty who has stood by me with encouragement at the  
lowest points and invaluable advice throughout.
 
 In order to undertake this thesis, it required data. I collected a lot of data. None  
of this would have been possible without the participants and I would like to 
thank them all. Whilst the data collecting process has not always run smoothly it 
has been, at times, a reminder of why I became involved with the profession 19 
years ago to improve peoples wellbeing. Thank you to Emmanuel Defever for his 
assistance with the collection of data and subsequently Liz Cheek for her patience 
and advice with the statistical analysis. 
 
 I am dedicating this thesis to my family. My children, Zak, Edward and Ella (now 
9,10 & 12 years), who have lost such significant time from their mother, but gained 
a valuable head start with statistics. Andrew, my husband has continued to support 
me, believed in me and given me the strength to carry on whilst taking care of the 
child care and cooking duties over the last 8 years. Finally to my parents, albeit 
with a sense of sadness that my mother was not able to see me complete this goal.
 
  
 
 
 
 
 
 
XVIII
Declaration
 
 
 I declare that the research contained in this thesis, unless otherwise formally 
indicated within the text, is the original work of the Author. The thesis has not been 
previously submitted to this or any other university for a degree, and does not 
incorporate any material already submitted for a degree.
 
 
 
Signed   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dated    . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 
 
 
 
1Chapter 1.
Introduction to the thesis
The overall aim of this thesis was to investigate the immediate and short-term 
effect of duration of lumbar mobilisation treatment on ROM, stiffness and pain in 
participants with non-specific chronic LBP.
LBP has been defined as pain between the costal margin and the gluteal fold, 
which may occur with or without leg pain (Krismer and van Tulder, 2007). Reports 
on the prevalence of LBP from the UK have indicated that approximately 17.3 
million people, more than one third of the adult population are affected (Savigny 
et al., 2009). It is estimated that 1-in-15 people in the UK seek advice for their 
LBP (NICE, 2009a). The overall cost of healthcare for treating people with LBP is 
estimated to exceed £500 million per year in the private sector and over £1000 
million in the National Health Service (NICE, 2009b). Healthcare professionals 
such as physiotherapists, osteopaths and chiropractors frequently use spinal 
manual therapy (SMT) to treat low back pain (Bronfort et al., 2004). Systematic 
reviews of the literature have suggested that manual therapy may be effective  
in the treatment of patients with spinal pain (Cleland et al., 2005; Bronfort et al., 
2004; Gross et al., 2002). 
Manual therapy is a term used to encompass physical techniques applied by the 
therapist to patients and includes mobilisation and manipulation. Mobilisation refers 
to low velocity repetitive oscillations of a joint, which can be passive or combined 
with active movements (Maitland et al., 2005). Manipulation refers to a high velocity 
thrust, which is applied to a joint over a short amplitude and is often associated 
with an audible crack (Maitland, 2005). One commonly used mobilisation technique 
is a posteroanterior (PA) mobilisation. When used on the spine it involves sustained, 
or repeated, oscillatory pressure that can be applied through the spinous or 
transverse process of the vertebra with the patient lying prone (Maitland, 2005).  
It is the dosage and effects of this PA mobilisation of the spine that forms the basis 
of this thesis. 
Physiotherapists often apply mobilisations aiming to increase range of movement, 
reduce stiffness and/or decrease pain (Schmidt et al., 2008). Although the literature 
discusses possible biomechanical effects of mobilisation there is limited evidence to 
demonstrate that they have an effect on spinal range of movement (ROM) or stiffness. 
Mobilisations have been found to have an immediate hypoalgesic effect in patients 
with neck pain (Sterling et al., 2001; Vicenzino et al., 1998 and 1996; Vicenzino,1995). 
Although an immediate hypoalgesic effect has also been demonstrated in response to 
2lumbar mobilisation this evidence is confined to asymptomatic participants (Pentelka 
et al., 2012; Krouwel et al., 2010; Willett et al., 2010). 
Clinically mobilisations are performed for varying amounts of time. The maximum 
duration of treatment advocated in one session would be 3 sets of 60 seconds of 
mobilisation (Maitland et al., 2005). However there is some evidence that suggests 
that a longer duration of treatment may be indicated (Pentelka et al., 2012; Sluka 
and Wright, 2001):
Pressure pain thresholds (PPT) have been used to measure the immediate 
hypoalgesic effects of mobilisations (Pentelka et al., 2012; Willett et al., 2010; 
Sterling et al., 2001; Vicenzino et al., 1998 and1996; Vicenzino, 1995). However, 
no studies have demonstrated a relationship between changes in PPT following 
mobilisations and patient reported changes in pain such as pain on movement. 
The literature pertaining to mobilisations and their effects and the influence of 
mobilisation treatment duration is considered in chapter 2. The studies in (chapter 
6) of this thesis investigated the effects of mobilisations on ROM, stiffness and 
pain. The evidence pertaining to the methods of measurements of ROM, stiffness 
and pain that were employed in this thesis are considered in chapter 3. Chapter 4 
outlines the preliminary work for this thesis and chapter 5 reports on a study which 
investigated the reliability of these measurements (n=20). 
Chapter 6 outlines a single-arm trial (n=17) which investigated the immediate 
effects of different durations of mobilisation treatment (3 and 6 minutes) on ROM, 
stiffness and pain in participants with chronic non-specific LBP. This single-arm trial 
was conducted as a preliminary investigation and served to focus a randomised 
placebo-controlled trial (n=72) which investigated the immediate and short-
term analgesic effects of different durations of lumbar mobilisation treatment in 
participants with chronic non-specific LBP (chapter 7). Chapter 8 summarises the 
overall findings of the studies in this thesis, highlights areas for future work and 
outlines the original contribution to knowledge.
The author of this thesis is a senior lecturer at the University of Brighton and a 
course leader of an MSc in neuromusculoskeletal physiotherapy. The author is an 
experienced physiotherapist in both the NHS and private sectors and an active 
member of the Musculoskeletal Association of Chartered Physiotherapists. The use 
of mobilisations has been of interest to the author since first applying mobilisation 
treatment to patients as a physiotherapy student. She has published several peer-
reviewed articles investigating the dosage of mobilisation treatment.
3Chapter Two
Mobilisations
This chapter initially describes mobilisations, their dosage and use in clinical 
practice. A review of the literature pertaining to the effects of a mobilisation on 
range of movement (ROM), stiffness and pain follows. This chapter continues by 
considering the potential analgesic mechanisms through which mobilisation may 
extol a hypoalgesic effect. Because this thesis aimed to investigate the influence  
of one component of treatment dose, duration of mobilisation treatment, this 
chapter is completed by consideration of the influence of treatment duration.
2.1. Literature Search
A literature search was conducted which consisted of an extensive search of the 
following databases: Ovid, Medline, CINAHL, Pubmed, EMBASE, Science Direct, 
ProQuest and Web of Science. The search strategy used a combination of the 
following sub headings (MeSH) and key words 
Spin* OR lumbar AND:
•		Motion	(mh)	OR	range	of	motion	(mh)	OR	movement
•		mobilis*	OR	mobiliz *
•		stiff *
•		pain	OR	hypoalgesia	
The reference lists were hand searched. Iterative supplementary searches literature 
were conducted to explore specific aspects of the literature for example pressure 
algomet* OR pressure pain threshold, verbal rating scale OR visual analogue scale, 
placebo, pain gate (see Figure 2.1). Additional literature was considered throughout 
the course of this PhD that was not included in the thesis such as that on mobilis* 
AND muscle OR proprioception and creep OR hysteresis.  
All available literature written in English was searched without restriction to human 
subjects or publication date. The reference list of retrieved article was hand 
searched. RSS feeds were set up, using the search terms detailed, to alert the 
researcher to new publications.
4LITERATURE SEARCH
Lumbar Mobilisations / Manipulation   
Mobilisations (effects of a single treatment dose)
Mobilisation    n<15 IDENTIFIED   ➔ Peripheral  ——————————  n=3 EVALUATED  ——— ➔   n=3 REFERENCED 
  ➔ Cervical  ———————————  n=6 EVALUATED   ——— ➔   n=6 REFERENCED 
   ➔ Lumbar  ———————————  n=4 EVALUATED   ——— ➔   n=4 REFERENCED 
Manipulation  n<120 IDENTIFIED   ➔ Clinical prediction rules ————   n<15 EVALUATED ——  ➔  n=3 REFERENCED 
As part of multimodal care package
Mobilisation   n<15 IDENTIFIED   ➔ Systematic reviews  ——————  n=5 EVALUATED   ——— ➔   n=0 REFERENCED 
Measurements   
Pain
 PPT  n=40 IDENTIFIED   ➔ Reliability Papers ———————   n=12 EVALUATED  ——— ➔   n=8 REFERENCED 
   ➔ Dermatome zones ———————  n=3  EVALUATED   ——— ➔   n=3 REFERENCED 
 VRS /VAS  n>10 IDENTIFIED ➔  MCID ————————————  n=10 EVALUATED ——— ➔   n=3 REFERENCED
 Questionnaires  n>35 IDENTIFIED ➔  McGill ————————————  n=8 EVALUATED  ——— ➔   n=4 REFERENCED 
   ➔  SOPA ————————————  n=6 EVALUATED  ——— ➔   n=3 REFERENCED 
   ➔  Oswestry ——————————  n=9 EVALUATED  ——— ➔   n=3 REFERENCED 
   ➔  GHQ ————————————   n=4 EVALUATED   ——— ➔   n=1 REFERENCED 
Lumbar range  n=20 IDENTIFIED ➔  3D Measurement ———————  n=10 EVALUATED   —— ➔   n=8 REFERENCED
of movement
Stiffness  n>120 IDENTIFIED ➔  Human, lumbar spine —————  n>20 EVALUATED   —— ➔   n=18 REFERENCED
Force  
 n>15 IDENTIFIED   ➔  Used in stiffness mesaurment —  n>8 EVALUATED   ——— ➔   n=6 REFERENCEDmeasurement
Analgesic mechanisms   
Descending inhibition  n>30 IDENTIFIED    ➔  Landmark/Mobilisation related    n=15 EVALUATED ➔   n=10 REFERENCED
Pain gate  n>6 IDENTIFIED      ➔  Landmark/Mobilisation related    n=6 EVALUATED ➔   n=6 REFERENCED
Opioid /serotonergic  n>30 IDENTIFIED    ➔  Landmark/Mobilisation related    n=15 EVALUATED ➔   n=2 REFERENCED
Placebo/expectations  n>30 IDENTIFIED    ➔  Landmark/Mobilisation related    n=10 EVALUATED ➔   n=4 REFERENCED
Statistics   
Reliability   n>10 IDENTIFIED   ➔ ———————————   n=10 EVALUATED  ——— ➔   n=5 REFERENCED
MDC/MCID   n>10 IDENTIFIED   ➔   ———————————   n=7 EVALUATED ———— ➔   n=3 REFERENCED
Responders analysis  n<7 IDENTIFIED   ➔  ———————————   n=5 EVALUATED ———— ➔   n=2 REFERENCED
Miscellaneous   
Creep and hysteresis  n>20 IDENTIFIED   ➔ ———————————   n=10 EVALUATED  ——— ➔   n=0 REFERENCED
Risk factors for LBP  n>30 IDENTIFIED   ➔ ———————————   n=10 EVALUATED  ——— ➔   n=0 REFERENCED
Epidemiology of LBP  n>30 IDENTIFIED   ➔ ———————————   n=10 EVALUATED  ——— ➔   n=0 REFERENCED
Treatment of LBP  n>30 IDENTIFIED   ➔ ———————————   n=20 EVALUATED  ——— ➔   n=0 REFERENCED
Figure 2.1. Literature Search — papers identified, evaluated and referenced.
Note: Those papers investigating the effects 
on muscle and proprioception not identified.
52.2. Physiotherapy treatment of low back pain
Approximately 9% of patients suffering from LBP visit a physiotherapist (Office 
of population census and surveys 1997), resulting in an estimated 1.6 million 
adults receiving physiotherapy for LBP each year. In 1998 it was estimated that 
37% (£600 million) of the total LBP healthcare cost was spent on physiotherapy 
and other allied professions (Maniadakis and Gray 2000). The National Institute 
of Clinical Excellence systematically reviewed the literature on LBP in order to 
produce national guidelines and recommendation for clinicians in the UK. The 
resulting recommendations were that patients should be offered a tailored treatment 
programme of exercise or acupuncture or mobilisations and for patients where these 
interventions have not been successful, a combined physical and psychological 
treatment programme was recommended to include a cognitive behavioral 
approach and exercise. It concluded that physiotherapy provides a cost effective 
treatment for recurrent and persistent LBP (Savigny et al., 2009).
When a patient is referred to the physiotherapy department for treatment of their 
LBP the physiotherapist takes a subjective history from the patient. This involves 
mapping the area of patients’ symptoms, understanding what aggravates or eases 
their symptoms, gaining a history of the present and past episodes of symptoms 
and gaining a thorough account of their general health and past medical history 
(Petty, 2011). The physiotherapist also asks special questions about features 
that may indicate serious pathology (if these sign and symptoms are present the 
patient would be referred to another appropriate health professional) (Greenhalgh 
and Selfe, 2006). It is also important that during the subjective history taking 
the physiotherapist gains an insight into the patient’s functional limitations and 
perceptions of the problem and physical or psychological factors that may affect 
recovery (Petty, 2011).
A physical examination follows which is tailored to the patient’s individual problem, 
based on the information gained in the subjective examination (Petty, 2011). A 
physical examination of the lumbar spine normally includes an assessment of 
lumbar physiological and accessory movement (physiological movements are those 
that the patient can perform themselves such as bending to their toes and leaning 
backwards. Accessory movements are gliding movements that occur at the joint 
during physiological movement but cannot be performed by the patient in isolation, 
requiring an external force such as that applied by a physiotherapist (Maitland et al., 
2005). Other test may be performed which preferentially assess the muscles and 
nerves that may give rise to pain in the pattern described by the patient (Petty, 2011)
Once the complete examination has been performed the therapist determines 
whether the patient is suitable for physiotherapy treatment or requires referral for 
6further investigation or alternative treatment. The therapist then devises a treatment 
plan based on the examination and the patient’s goals. Treatment options vary, 
exercise and advice are incorporated into most treatment plans, but other specific 
treatments such as electrotherapy, graded return to activity and spinal manual 
therapy may be included. 
2.3. The use of mobilisations in the treatment of low back pain
One technique commonly used in the treatment of back pain is a posteroanterior 
(PA) mobilisation. This involves the application of low velocity force, directed  
from posterior to anterior (posteroanterior (PA)), through the spinous process 
(central PA) or transverse process (unilateral PA) of the vertebra (Maitland et al., 
2005), (Figure 2.2). 
Figure 2.2: Central posteroanterior (PA) mobilisation of the spine. 
During the application of a central PA mobilisation, movement occurs throughout 
the whole thoracolumbar region (Lee et al., 1996). This is made up of rotation of the 
pelvis (Chansirinukor et al., 2001) and the thoracic cage (Chansirinukor et al., 2003), 
compression of the skin and soft tissue (Lee, 1990) and movement of the spinal 
joints (Kulig et al., 2004; Powers et al., 2003; Lee and Evans, 2000 and 1997; Lee 
and Svensson, 1993; Lee and Evans, 1991). 
ORIGINAL IN COLOUR
7Physiotherapists apply mobilisations in order to increase range of movement and/or 
reduce perceived stiffness or pain. Different treatment doses are selected based on 
perceived clinical need. Some of the factors that therapists may take into account 
when deciding on treatment include how acute the symptoms are, the nature of the 
condition, the severity and irritability of the symptoms and the relationship between 
pain and stiffness as assessed on clinical examination (Maitland, 2005). 
Treatment dose describes the variation in different components of treatment applied 
and is designed to create the optimum treatment effect. The different components 
of treatment are presented and examples provided in Table 2.1. 
Table 2.1. Components of a treatment dose.
 Components of a mobilisation treatment dose 
Position of person and joints  For example the patient may lie prone with the lumbar spine 
positioned in extension, flexion, lateral flexion, rotation or in 
a combination of these positions (McCarthy, 2010).
Level of treatment   Normally applied to the most symptomatic level as 
determined by the physical examination (Maitland, 2005).
Direction of mobilisation force  The inclination of the applied mobilisation, eg caudad, 
cephalad, medial or lateral (McCarthy, 2010).
Grade  Includes a description of the region of resistance reached 
and amplitude of mobilisation. For example, grade III- is a 
large amplitude mobilisation in the first third of resistance 
and grade IV+ is a small amplitude mobilisation in the last 
third of resistance (Petty, 2011).
Rate  Commonly applied at a rate of 1-2Hz. 1-2 mobilisation 
cycles per minute (Souvlis et al., 2004). Can be quasi-static 
(Petty, 2011).
Rhythm  May be slow and smooth or staccato (Petty, 2011).
Duration  How long the treatment is applied for. Typically up to 3 sets 
of 30-60 seconds (Maitland, 2005).
Symptom reproduction  Treatment may be applied short of reproduction of 
symptoms, or to the point of partial or full reproduction of 
symptoms (Petty, 2011). 
8Examples of typical treatment doses, incorporating the components 
outlined in Table 2.1, are:
•		In	prone,	lumbar	extension,	central	PA	to	L4	III-	slow	and	smooth,	 
1 x 30 seconds, to the first point of pain reproduction.
•		In	left	side	lying,	lumbar	right	lateral	flexion,	transverse	to	L3	IV+	staccato, 
3 x 60 seconds, to the point of full reproduction of symptoms.
Clinical decision making and studies investigating the mechanisms of pain relief 
through mobilisations are somewhat inhibited by lack of evidence regarding the 
optimum dose of mobilisation treatment. Two studies included in this thesis (chapter 
6 and 7) did not only investigate the effects of mobilisations, but also the influence 
of duration of treatment, the evidence related to applying different durations of 
treatment is considered in section 2.11, page 21.
2.4. The biomechanical and analgesic effects of mobilisations
The effects of mobilisations can be broadly divided into biomechanical effects 
and neurophysiological effects. The biomechanical effects are those that change 
the mechanics of the spine, resulting in changes in ROM or spinal stiffness. The 
neurophysiological effects of mobilisation treatment are the effects on muscle 
activity (Krekoukias et al., 2009; Sterling et al., 2001), proprioception (Cho et al., 
2012), and pain. This thesis focuses on the effects of mobilisation treatment on 
ROM, stiffness and pain and therefore this section reviews the current evidence 
regarding the effects of mobilisations on these variables.
2.5. The effects of mobilisation treatment on ROM in asymptomatic participants
Therapists apply mobilisation treatment, aiming to restore normal ROM in patients 
with limited range (Schmid et al., 2008), although the evidence supporting this 
practice is sparse. The effect of PA mobilisations on lumbar sagittal mobility has 
been investigated in both asymptomatic (Stamos-Papastamos et al., 2011; Petty, 
1995; McCollam and Benson, 1993), and symptomatic participants (Powers et al., 
2008; Chiradenjant et al., 2003 and 2002; Goodsell et al., 2000). 
The studies performed on asymptomatic participants have reported contradictory 
results. Differences in the number of levels treated, duration of treatment and 
the demographics of the participants may explain the contradiction (Table 2.2). 
Petty, (1995) applied an oscillatory PA mobilisation on one vertebral level (L3) for 
two minutes on three consecutive days and found no significant effect on sagittal 
mobility. Stamos- Papastamos et al., (2011), employed a similar treatment dose 
of 3 minutes applied to L4; again no significant changes in ROM were found. 
Conversely McCollam and Benson, (1993) measured ROM in 130 participants after 
3 x 1 minute bouts of grade IV+ PA mobilisations to L3, L4 and L5, (resulting in 
9treatment being applied to three levels and a total duration of 9 minutes) and found 
a significant increase in lumbar extension. 
Another difference between the studies was the differences in the population 
groups used. In the study by McCollam and Benson, (1993) participants consisted 
of 18-51 year old males who were engaged in active military service, in contrast 
to the younger exclusively female (18-32 years) population used by Petty, (1995). 
There may well be age and gender differences in the effect of mobilisations on 
ROM, furthermore the level of physical training in the military population may 
influence the effects of treatment (20% of participants were reported to have been 
on a 25 mile road march during the course of the study). Although statistically 
significant differences were reported by McCollam and Benson, (1993) this 
amounted to a 7.1% increase in extension, equivalent to a 2-degree change, 
which may not represent a clinically meaningful or clinically detectable change. 
Moreover McCollam and Benson, (1993) did not comment on the measurement 
reliability of the inclinometer which is likely to have a greater measurement error 
than the electromagnetic tracking device employed by Stamos-Papastamos et al., 
(2011) and Petty, (1995). 
Another factor that may explain the differences between these studies was that 
Petty, (1995) preconditioned the lumbar spine with 5 repetitions of flexion and 
extension. These repeated physiological movements may have had an effect 
on the tissues similar to the treatment effect from mobilisations; Lee and Evans, 
(1992) demonstrated that the response to PA loading of the spine stabilised after 
the first 2 cycles of loading, therefore the preconditioning implemented by Petty, 
(1995) may have resulted in the greatest tissue changes occurring prior to baseline 
measurements.
2.6. The effects of mobilisation treatment on ROM in symptomatic participants
It could be proposed that mobilisations might produce a greater increase in ROM 
in symptomatic subjects, many of whom complain of a decreased ROM associated 
with their symptoms. However there is limited evidence to support this (see Table 
2.2). In a same-subject control study, Goodsell et al., (2000) investigated the 
effects of applying a mobilisation treatment to 26 patients with non-specific LBP 
and reported no significant difference in extension ROM between the control and 
intervention groups. However the control intervention was applied immediately 
before or after the mobilisation according to randomisation, thereby not allowing 
a washout period between interventions. The strength of this study would have 
been improved if patients had returned on a different occasion for the second 
intervention. In a much larger study Chiradejnant et al., (2002) found that PA 
mobilisations did not change ROM in 120 participants suffering from LBP. These 
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findings were confirmed in a later study applying 2 x 1 minutes of mobilisations 
to 140 participants with non-specific LBP (Chiradejnant et al., 2003). The 
measurement tools used in these studies were fingertip to floor method for 
flexion and an inclinometer for extension. The reliability of these methods could 
be questioned, however when the use of these tools is carefully standardised, 
reliability can be good. Chiradenjnant et al., (2003) reported an intraclass 
correlation coefficient (ICC) of 0.95 for fingertip to floor measurements and 
Pearson’s r of 0.75 for inclinometer measurements. 
Only one study involving symptomatic participants has reported a significant 
increase in extension range of movement; Powers et al., (2008) used MRI to 
measure range of extension in prone after mobilisations or press up exercises in 
30 patients with non-specific LBP. Three x 40 second sets of mobilisations were 
applied to the most symptomatic level and 2 x 40 second sets were applied to 
each of the other lumbar vertebral levels. A significant increase in extension 
range was observed but there was no difference between groups. Similar to the 
study in asymptomatic participants that reported significant findings (McCollam 
and Benson, 1993), Powers et al., (2008) employed a total treatment duration 
of 7 minutes. This was 5 minutes more than that used by Chiradejnant et al., 
(2003) and may explain the difference in results. Powers et al., (2008) sought 
to assess the difference between extension exercises and mobilisations so 
did not include a control group and therefore the significant change could be 
due to natural variation or non-specific effects of treatment such as placebo. 
Furthermore the mean difference in range, post mobilisation, was 3.6 degrees 
(standard deviation (SD) 5.1.) The authors reported excellent reliability with this 
method with a standard error of mean (SEM) of 0.66 degrees suggesting the 
change was not a result of measurement error. However the clinical relevance 
of a change of 3.6 degrees is perhaps questionable. Moreover all lumbar levels 
were treated which may not replicate clinical practice where treatment may 
only be applied to the most symptomatic level (Chiradenjnant et al., 2003 and 
2002). Another explanation for the contradictory findings reported by Powers 
et al., (2008) is the inclusion criteria of increased pain on extension, and 
reduced range of extension. These criteria may have resulted in the selection of 
participants who were most likely to respond to mobilisation treatment. 
In summary, studies report that mobilisations do not change ROM when applied 
to asymptomatic or symptomatic populations. The exceptions to this are two 
studies which applied mobilisations to more lumbar levels, resulting in longer 
treatment duration. Further research is warranted in order to establish whether 
either of these variables is responsible for the observed treatment effect. A 
single-arm trial (chapter 6) and randomised-placebo controlled trial (chapter 
12
7) included in this thesis, aimed to determine the influence of one of these factors, 
treatment duration, on range of movement. 
The following sections consider the evidence that patients suffering from LBP 
have stiffer lumbar spines than asymptomatic individuals. In addition evidence is 
examined regarding the effect of mobilisation treatment on lumbar stiffness.
2.7. Lumbar spine stiffness in patients with LBP
Clinicians may apply treatment aiming to reduce perceived stiffness, although there 
is limited evidence that patients with LBP have stiffer spines than asymptomatic 
individuals; with only a small pilot study reporting increased stiffness in 2 
participants with low back pain compared to 6 control subjects (Shirley and Lee, 
1993). However, there is evidence to suggest that a relationship between pain and 
stiffness exists. Latimer et al., (1996b) found stiffness was significantly reduced (by 
a mean of 8%) in patients after participants symptoms had resolved by 80%, no 
significant change was seen in a non LBP group over the same time period. The 
patients in the Latimer et al., (1996b) study had a mean duration of symptoms of 
18.1 days. The point at which their symptoms had reduced by 80% ranged from 
2-105 days (mean 22.64). 
2.8. The effects of mobilisation treatment on lumbar stiffness.
Physiotherapists frequently use mobilisations to reduce lumbar stiffness, as 
perceived in the physical examination. However, there is a paucity of evidence 
to support this reasoning as there are few studies examining the effectiveness of 
mobilisation treatment in reducing lumbar stiffness. This section therefore considers 
the effects of lumbar mobilisation treatment on stiffness (also see Table 2.3).
Therapist reliability at perceiving spinal stiffness is poor (van Trijffel et al., 2005), 
so mechanical devices have been built to measure spinal stiffness. However the 
use of this equipment is largely confined to laboratories, subsequently limiting 
widespread usage. To overcome these difficulties Ferreira et al., (2009) measured 
stiffness on an 11-point scale using a portable stiffness spring reference device. 
One hundred and ninety one LBP patients were divided into three groups, a 
general exercise group, a motor control exercise group and a group receiving 
mobilisations. A significant decrease in stiffness was found immediately following 
treatment (mean 1.2 point decrease on an 11-point scale); however there was no 
difference between groups and since no control group was included, differences 
may have been due to natural resolution over the eight-week intervention period 
(stiffness was shown to decrease significantly (by 8%) in a group of patients 
whose symptoms had resolved by 80% (Latimer et al., 1996b)). Furthermore, 
the methodology, comparing stiffness against a spring is not comparable to the 
13
stiffness assessment carried out by physiotherapists who assess resistance to the 
application of manually applied force. 
Other studies investigating the effects of treatment have used instrumented three-
point bending and displacement methods of measuring stiffness (these methods 
are fully considered in section 3.2, page 28). Using the displacement method, 
Allison et al., (2001) reported no change in stiffness immediately following 2 
minutes of PA mobilisations applied to L3 in asymptomatic participants.
  
It could be argued that a significant decrease in stiffness may not be found in 
an asymptomatic population who do not suffer from spinal stiffness. However 
studies in symptomatic populations reported similar results; using the same 
(displacement) method of stiffness measurement Goodsell et al., (2000) found 
no significant change in stiffness following 3 x 1 minutes of PA mobilisation in 
patients with LBP. The dose of treatment employed by Goodsell et al., (2000) 
Table 2.3. The immediate effects of a single mobilisation treatment dose on stiffness.
Rx = treatment; sig = significant; SD = standard deviation; Mob = mobilisation; PA = posterioranterior; N = Newtons.
Reference Design Participants Technique Dose Stiffness 
measurement
Result
Goodsell et 
al., 2000
Crossover.
Treatment and 
control (no 
contact)
26 with LBP PA 
mobilisation 
to the most 
symptomatic 
level
3x60secs
Rx force 60-
250N (mean 
137N)
Displacement method 
using mechanically 
driven indenter 
No significant 
change in 
stiffness (p>.05)
Allison et al., 
2001
Single-arm trial 24 
asymptomatic 
Central  
PA to L3
2 minutes
Rx mean 
force 146N
1.5Hz
Displacement method 
using mechanically 
driven indenter
No significant 
change in 
stiffness
p=.17
Lee et al., 
2005b
Parallel groups:
1. LBP 
participants
2. Asymptomatic 
participants
19 with LBP
20 asymptom- 
atic
PA mobili- 
sation to 
the most 
symptomatic 
level
Grade III for 
30 secs.
1.2Hz (SD 
0.6)
Three-point bending 
method
Significant 
reduction in 
stiffness  (p<.05)
Ferreira et 
al., 2009
Parallel groups:
1. General 
exercise
2. Motor control 
exercise
3. Mobilisation / 
manipulation
191 with LBP
71 received 
mobilisations / 
manipulation
Mobilisation 
or 
manipulation 
chosen by 
therapist
Varied Stiffness measured of 
11-point scale using a 
spring reference device
Sig main effect  
of time (p<.05)
No significant 
difference 
between groups 
(p>.05).
Stamos-
Papastamos 
et al., 2011
Same-subject 
repeated 
measures 
crossover design.
Manipulation 
group and 
mobilisation 
group
32 
asymptomatic
Central PA 
to L4
3x60
Grade IV+
2Hz
Three-point bending 
method
No sig effect of 
condition (p=.18)
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replicated those used in clinical practice as it was applied to the symptomatic 
level using rates and forces that were determined to be appropriate by the 
therapist. One limitation of this study was that a large range of forces was used 
(60-250N) and some may not have been sufficiently large to alter stiffness. 
However, post hoc analysis suggested that this was not a factor as there was  
no correlation between treatment force and changes in stiffness. 
Contradictory findings were reported by Lee and colleagues (Lee et al., 2005b). 
who reported a significant reduction in three-point bending stiffness following lumbar 
PA mobilisation treatment in both 19 participants with LBP and in 20 asymptomatic 
participants. This study did not included a placebo or control group and thus should 
be interpreted with caution. 
These contradictory results may be due to the different method of stiffness 
measurement. Lee et al., (2005a) used the three-point bending method of stiffness 
testing which was designed to account for the geometry of participants’ spines. 
However, the three-point bending method has been used to assess the effects 
of lumbar mobilisations more recently (Stamos-Papastamos et al., 2011) and no 
significant effect on stiffness was observed (the different methods of stiffness 
measurement are considered in section 3.2, page 28).
In conclusion, despite reducing stiffness being a common aim of treatment, there 
are few studies investigating the effects of mobilisations on stiffness. One study has 
demonstrated a change in stiffness following mobilisations, using the less widely 
employed three-point bending method of stiffness measurement (Lee et al., 2005b), 
but did not compare the effects against placebo or control intervention. The maximum 
treatment duration used in these studies was 3 minutes. There is some indication 
from studies measuring the effects of mobilisations on ROM that a longer duration of 
treatment may result in a greater biomechanical treatment effect (Powers et al., 2008; 
McCollam and Benson, 1993). Therefore a single-arm trial (chapter 6) included in 
this thesis aimed to evaluate the effects of mobilisation treatment duration on stiffness 
using both displacement and three-point bending methods of stiffness measurement.
This section has considered the biomechanical effects of mobilisations on ROM 
and stiffness. Mobilisations are also thought to have an analgesic effect. The 
following section considers the effects of mobilisations on pain and the possible 
underlying analgesic mechanisms.
2.9.The effect of mobilisations on pain measures
Mobilisations are often applied to patients with the aim of reducing pain and thus 
a number of studies have investigated the effects of mobilisation on pain. Many of 
these studies have been conducted in asymptomatic participants and therefore 
15
use experimental measures of pain, such as pressure pain thresholds (PPTs), 
to determine whether a hypoalgesic effect has occurred. The measurement of 
PPTs involves using an algometer to apply pressure to pre-determined points 
and asking participants to indicate when the sensation changes from pressure to 
pain. In addition to PPTs, studies performed in symptomatic participants may also 
include patient reported measures such as pain rating scales. 
2.9.1. Changes in PPT following mobilisation treatment
No studies have investigated the immediate effects of a single mobilisation 
treatment dose in patients with LBP. However, a number of studies have 
investigated the immediate effects of a single mobilisation treatment dose to 
other regions and in the lumbar spine in asymptomatic participants (Table 2.4). 
These studies have all reported a hypoalgesic response to mobilisation of the 
cervical spine (Sterling et al., 2001; Vicenzino et al., 1998 and 1996; Vicenzino, 
1995), elbow (Paungmali et al., 2003; Vicenzino et al., 2001), knee (Moss et al., 
2007), ankle (Yeo and Wright, 2011) and lumbar spine (Pentelka et al., 2012; 
Krouwel et al., 2010; Willett et al., 2010). The studies in the cervical spine, elbow, 
knee and ankle have been conducted with symptomatic subjects. Two studies 
have reported contradictory results, finding that mobilisations had no significant 
effect on PPT – Soon et al., (2010) in asymptomatic participants and Sterling et 
al., (2010) in patients with whiplash of at least 3 months duration. Sterling et al., 
(2010) proposed that the difference in results could be explained by mobilisations 
having a different effect in participants with different musculoskeletal conditions. 
However another possible reason for the difference reported by Sterling et al., 
(2010) is the duration of the participants’ symptoms; all of the other studies 
utilising symptomatic participants (Table 2.4) recruited participants with a mean 
symptom duration of less than 3 months. Whether the effects on PPT would be the 
same in a population with more chronic symptoms remains unknown and thus the 
studies in chapter 6 and 7 of this thesis investigated the effects of mobilisations in 
participants with chronic low back pain.
The studies shown in Table 2.4 all investigated the immediate effects of mobilisation. 
Although a few studies have investigated within- and between-session changes 
in pain (Cook et al., 2012; Tuttle, 2005; Hahne et al., 2004). These were 
pragmatic studies which included a number of manual therapy treatments and 
home exercises and did not provide further information about the longevity of 
mobilisation effects in isolation. There is no evidence on the longer-term effects of 
a single mobilisation treatment dose. Two studies included in this thesis (a single-
arm trial and a randomised-placebo controlled trial (RCT)) have investigated the 
immediate effects of mobilisations in participants with chronic LBP. In addition the 
RCT investigated the effects 24 hours after treatment (chapter 6 and 7). 
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2.9.2.  Changes in patient reported pain measures 
following mobilisation treatment
Although there is strong evidence that mobilisations result in decreased PPT, this 
change may not be relevant to patients, as it may not relate to a change in their 
symptoms. In order to explore the effect of mobilisation on pain some studies have 
measured changes in visual analogue scale (VAS) scores after mobilisation treatment. 
For example Goodsell et al., (2000) investigated the effect of mobilisations on clinical 
measures of pain (VAS and patient reported pain relief scale) during either active 
physiological flexion or extension (whichever was worse). This was a randomised 
controlled same-subject design, where participants received a control intervention, 
consisting of lying prone for 3 minutes, immediately before or after treatment. Pain 
on flexion decreased by 41% following a mobilisation treatment, and a subsequently 
applied control intervention resulted in a further decrease of 15%. Whereas, when the 
control intervention was applied first there was a 7% decrease in pain on flexion followed 
by a further 11% decrease with the mobilisation treatment. Mobilisations resulted in pain 
on extension decreasing by 19% and the subsequent control intervention produced 
a further 18% decrease in pain. When the control intervention was applied first this 
produced a 6% decrease in pain on extension and the subsequent mobilisation a 33% 
decrease. These results represent a significant decrease in pain on worst movement, 
which was significantly greater with mobilisation than control intervention. However, the 
differences between the treatment and control group should be interpreted with caution 
as the two conditions were applied consecutively, with no wash out period; therefore, the 
temporal effects of the previous intervention may have affected the results. 
Chiradejnant et al., (2002) investigated the effects of 2 x 1 minute of  
mobilisations in 120 patients with LBP and reported a significant reduction in current 
pain intensity (measured using a numeric rating scale) but no change in the pain 
associated with movement. The mean change in scores on an 11-point scale was 
1.34 (SD 1.27), equivalent to a 31% decrease. In a randomised placebo control 
study, Sterling et al., (2001) found that cervical mobilisations resulted in a significant 
decrease in VAS at rest, however the magnitude of change was small (mean 0.34cm, 
SD 0.02) and a change in VAS of this magnitude is not thought to be clinically 
meaningful (Rowbotham et al., 2001). Furthermore there was no difference between 
the treatment and placebo groups so the changes may have resulted from non-
specific effects of treatment. There was no change in VAS on active physiological 
rotation. The lack of change in pain on rotation may have been because this was the 
movement tested in all subjects irrespective of whether it was their most symptomatic 
movement. Importantly, Sterling et al., (2001) also found a significant reduction in PPT 
but these were not correlated with VAS scores. The relationship between PPT and 
patient reported measures of pain was explored further in the studies in the current 
thesis (chapters 6 and 7).
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In summary, most studies report an increase in PPT immediately following a 
mobilisation treatment, however the longer-term effects have not been investigated. 
There is some evidence to suggest that patients experience an immediate 
reduction in resting pain following mobilisations, but conflicting evidence regarding 
the effect of mobilisations on pain during movement. There is limited evidence on 
the relationship between PPT and VRS of pain. This was explored in chapters 6 and 
7 of this thesis. 
2.10. Mechanisms of analgesia
Although it has been established that mobilisation results in a decrease in 
pain (Sterling et al., 2001; Vicenzino et al., 1998 and 1996), the underlying 
mechanisms are largely unknown (Coronado et al., 2012). This section outlines 
the analgesic mechanisms and considers which of these may be responsible for 
the pain relief resulting from mobilisation treatment. The interpretation of studies 
on the hypoalgesic and analgesic response to mobilisation often draws on the 
understanding gained through animal studies. Thus the evidence from animal and 
human studies will be considered alongside the potential analgesic mechanisms 
through which mobilisations may elicit a pain relieving response.
2.10.1. The pain gate theory
Pain is transmitted by thin myelinated A delta and unmyelinated C-fibres to the 
dorsal horn of the spinal cord. Nociceptive information is then conveyed via the 
midbrain and thalamus to the cerebral cortex, where it is perceived. Melzack 
and Wall (1965) described the pain gate theory as a mechanism whereby large 
diameter, fast conducting fibres (A beta fibres) inhibit small diameter, slower 
conducting fibres (A delta and C-fibres) in the substantia gelatinosa in the dorsal 
horn of the spinal cord, thereby reducing the nociceptive information reaching the 
brain. The pain gate mechanism may be stimulated by PA mobilisations (Souvlis et 
al., 2004; Wyke and Polacek, 1975). PA mobilisations produce movement of joints, 
muscles, nerves and skin and in doing so, activate cutaneous, articular, muscular 
and neurovascular afferents (Souvlis et al., 2004). This provokes discharge by 
mechanoreceptors, which is conveyed to the spinal cord by large diameter 
afferents (A beta fibres), where they reduce the input from nociceptors, thus 
reducing the awareness of pain (Wyke and Polacek 1975). 
In order to explore whether the pain gate was responsible for the pain relief 
resulting from manual therapy treatment in a human population, George et al., 
(2006) and Bialosky et al., (2009) used quantitative sensory testing to establish 
the effect of a high velocity thrust (manipulation) on A and C fibre activity and 
found lessening of C nerve fibre mediated temporal summation (a measure of 
dorsal horn excitability) following treatment. This hypoalgesia was evident in the 
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lumbar innervated but not cervical innervated areas suggesting a local mechanism 
mediated by the dorsal horn of the spinal cord. However, the effects of low velocity 
PA mobilisations are not necessarily the same as the effects of manipulation.
One study in rats found the analgesia resulting from mobilisations may be 
mediated at spinal cord level; Malisza et al., (2003) investigated the effect of  
knee joint mobilisations in rats and found a decrease in activity (using functional 
MRI) in the areas of the spinal cord associated with pain, suggesting that the 
analgesic response from mobilisations, may at least in part, be mediated at the 
level of the spinal cord. These studies provide speculative evidence to support 
the theory that the pain gate mechanism may be a mechanism involved in the 
analgesia resulting from mobilisations. In addition to stimulating the pain gate 
mechanism, mobilisations are thought to provide a powerful input to the central 
nervous system via afferent neurons which may cause descending modulation  
of pain (Souvlis et al., 2004). 
2.10.2. Descending modulation of pain 
Electrical stimulation of various regions of the brain (in both rats and humans)  
has been shown to induce analgesia and has confirmed that descending 
systems contribute to pain modulation (Souvlis et al., 2004; Sluka and Rees, 
1997; Hosobuchi et al., 1977; Mayer and Liebeskind, 1974; Reynolds, 1969). 
Much of this work has focused on the Periaqueductal Gray (PAG) of the 
midbrain and the Nucleus Raphe Magnus (Sluka and Rees, 1997). The effect of 
stimulation of the PAG have been found to create strong analgesic responses; in 
a landmark study Reynolds (1969) highlighted the importance of the PAG area 
in the control of nociception by observing that analgesia could be produced 
by electrical stimulation of the PAG of the midbrain in rats. This analgesia 
was sufficient to allow surgery without an anaesthetic and with no aversive 
reactions in the rats. A later study (Hosobuchi et al., 1977) found that stimulating 
the central gray area in humans with intractable pain resulted in pain relief, 
suggesting that the PAG area of the brain is also important in mediating an 
analgesic response in humans.
Lovick et al., (1991) found that descending pain inhibitory systems, and 
particularly the PAG area, play an important integrative role for behavioural 
response to pain, stress and other stimuli by co-ordinating responses of a 
number of systems including the nociceptive system, autonomic nervous 
system and the motor system. Stimulation of the dorsal PAG in rats resulted 
in mechanical hypoalgesic, sympathetic excitation and increased muscle 
activity. This response in rats has been compared to the effects of mobilisation 
treatments in humans and has been considered as evidence regarding the brain 
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regions responsible for pain relief resulting from mobilisations (Sterling et al., 
2001, Wright et al., 1995). This comparison arises from studies investigating 
the effects of mobilisations on the human cervical spine (Sterling et al., 
2001; Vicenzino, 1995; Vicenzino et al., 1996) that have reported concurrent 
sympathetic excitation and mechanical hypoalgesia. The measures of 
sympathetic nervous system used in these studies were skin temperature and 
skin conductance which are indirect measures of sympathetic nervous system 
activity. These measures may be considered to lack validity and are subject to 
influence from psychological factors (Arena and Hobbs, 1995). Furthermore 
the reliability of SNS measures was not reported in any of the aforementioned 
studies. If the validity and reliability of these SNS measures were established any 
effect observed post mobilisation would remain indirect evidence of stimulation 
of the dorsal PAG. 
In summary, there is some indirect evidence that that the analgesic response to 
mobilisations may at least in part be mediated by the dorsal PAG.
2.10.3. Opioid analgesia 
Another mechanism of pain relief is endogenous opioid analgesia. This does 
not appear to be a mechanism involved with mobilisation induced analgesia 
as studies in humans have also found that the hypoalgesia resulting from 
mobilisations is not reversed by systemic administration of the opioid antagonist 
naloxone (Paungmali et al., 2004; Vicenzino et al., 2000). 
2.10.4. The extent of the hypoalgesic effect of PA mobilisation treatment
In order to provide insight into the potential mechanisms evoking an analgesic 
response resulting from mobilisations, some studies have measured PPT at sites 
chosen to establish the extent (local, segmental or systemic) of the analgesic 
effect (Pentelka et al., 2012; Krouwel et al., 2010; Willett et al., 2010). These 
studies have reported widespread changes in PPT following lumbar mobilisation in 
asymptomatic participants. However some studies reported changes local to the 
site of treatment were significantly greater than those in distant locations (Pentelka 
et al., 2012; Willett et al., 2010), suggesting that more than one analgesic 
mechanism is stimulated. The widespread changes are indicative of modulation 
of pain within the central nervous system, whereas the local changes may 
indicate modulation at spinal cord level. This suggests that mobilisation-induced 
hypoalgesia is mediated by an interaction between spinal cord and central 
mechanisms. These studies were all conducted with asymptomatic populations 
and it is not known whether the extent of the analgesic effect would differ in a 
symptomatic population; this remains an area for further investigation which is 
considered in chapter 6 and 7 of this thesis.
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2.11. The effects of different durations of mobilisation treatment
The focus of two studies in this thesis, a single arm trial (chapter 6) and an RCT 
(chapter 7), was on the effect of different durations of mobilisations treatment. 
Clinically, PA mobilisations are performed for varying amounts of time. The 
conventional duration of treatment applied in one session would normally be up to 
60 seconds of mobilisations repeated 3 times (3 x 60 seconds), resulting in a total 
of 3 minutes of mobilisations (Petty, 2011). However evidence has indicated that 
longer treatment duration may have an increased analgesic effect (Pentelka et al., 
2011; Sluka and Wright, 2001). 
In a placebo-controlled study, Sluka and Wright, (2001) compared the effects of 
applying 3, 9 and 15 minutes of mobilisation on rats knees and found that only 
9 and 15 minutes produced a significant increase in mechanical withdrawal 
thresholds (indicating an analgesic effect). No significant findings were found with 
placebo (manual contact only) or control (no contact) groups (Sluka and Wright, 
2001). This study indicated that, in rats, duration of mobilisation treatment is 
important in producing an analgesic effect. 
Studies investigating the analgesic effect of PA mobilisations, utilising human 
participants, typically employ treatment durations of 1.5 to 3 minutes. Only two 
studies to date have investigated treatment duration in a human population; 
Souvlis et al., (2001) compared 3 x 30 seconds, 6 x 30 seconds and 3 x 60 
seconds of mobilisations to the cervical spine, on SNS measures, and reported 
that the largest changes from baseline were provided by 3 x 60 secs followed by  
3 x 30 secs. These results may suggest that the number of sets of treatment is 
more important than the total duration of treatment. However no pain measures 
were included and the relevance of isolated changes in SNS measures is 
questionable. One recent study has investigated longer durations of mobilisation 
applied to the lumbar spine in asymptomatic participants; Pentelka et al., (2012) 
applied 5 sets of mobilisations of 30 and 60 seconds duration (resulting in a 
total treatment duration of 2.5 and 5 minutes). PPT measurements were taken 
between each set of mobilisation. A significant effect was observed after the first 
set of mobilisations – PPT increased gradually over the following sets, reaching 
further significance following the 4th set of mobilisations. These timings suggest 
that applying more sets of mobilisations resulted in a greater hypoalgesic effect. 
However the study was designed to compare the effects of 30 and 60 second 
sets of mobilisations and did not include a control group. There was no difference 
between 30 and 60 second set durations. 
In summary, the duration of PA mobilisation treatment used by physiotherapists at 
present is not highly evidence based. Evidence suggests that a greater analgesic 
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effect may be produced by longer durations of treatment than those commonly 
employed in clinical practice. To date no studies have investigated the effect of 
longer duration of treatment on lumbar spine ROM or stiffness. The overall aim 
of this thesis was therefore to investigate the effects of mobilisation treatment 
duration on ROM, stiffness and pain, and thus the following chapter considers the 
measurement of these variables.
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Chapter 3
Methods of measurement of pain and lumbar 
spine range of movement and stiffness
The studies included in this thesis investigated the effects of PA mobilisation 
on lumbar spine range of movement (ROM), stiffness and pain. In this chapter 
consideration is given to the methods of measurement of lumbar spine ROM 
and the two methods of stiffness measurement found in the literature. The use of 
pressure algometry, to measure pressure pain thresholds (PPT) and VRS (verbal 
rating scale), a patient reported measure of pain, are also explored. 
3.1. Measurement of lumbar spine ROM
Historically measurements of spinal ROM were made using biplanar radiography 
which involved taking lateral and antero-posterior radiographs and identifying the 
change in position of anatomical landmarks on each vertebra in both views (Pearcy, 
1985). This continues to be considered a valid measure of actual spinal motion. 
However it requires a skilled operator, can only be used in a radiology department, 
involves exposing subjects to radiation and is costly. Currently most studies 
measuring spinal ROM involve taking measurements at the skin surface. However 
it is accepted that skin movement will contribute an error to surface measurements 
and that these measures may overestimate the actual motion of the spine. The 
advantages of systems that measure movement at the skins surface are that they 
can be widely used in situ without exposing participants to radiation. 
There are a number of measurement tools that enable measurement of lumbar  
ROM at the skins surface; some simple measures of lumbar spine movement  
such as fingertip to floor and inclinometer readings (protractors that measure 
the change in angle or tilt of the spine) have been used extensively but these 
are limited to measuring sagittal plane movement. Electrogoniometers have also 
received widespread use but only measure movement in two dimensions. Other 
surface measurements that have been widely employed are three dimensional 
measurement methods such as inertial measurement systems and electromagnetic 
tracking devices. The reliability of electromagnetic tracking devices in measuring 
spinal ROM has been considered in the following section.
3.1.1. Reliability of ROM measurements of the lumbar spine using 
electromagnetic tracking systems
When considering the ROM and comparing it to that reported in other studies, it is 
essential to consider the system that was used. Even studies using a similar or the 
same system may yield different ranges of lumbar movement (Table 3.1). In those 
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using the same system the method of sensor fixation may be different. For example, 
some studies use the velcro straps provided by the manufacturer, whilst others 
have designed fixing plates which are attached to the skin with double sided sticky 
tape and are said to minimise the influence of skin movement (Mannion and Troke, 
1999). The participants themselves will create a variation, due to within participant 
variation and between participant differences (such as age and gender). The 
difficulties in comparing measurements using different systems were highlighted in 
a study by Mannion and Troke, (1999); the range of lumbar rotation measured using 
two electromagnetic tracking systems (Fastrak and CA6000 Spine Motion Analyser) 
was compared and the two systems were found to yield different results. The 
greatest difference was observed in the range of rotation; the mean range recorded 
was 11.3 degrees with the CA spine motion analyser and 34 degrees when using 
Fastrak. So therefore caution should be applied when comparing measurements 
reported in studies using different devices (Table 3.1). 
Despite the variations in measurements obtained, when using the same device, 
with the same methods of fixation, reliability of measurements can be good. Using 
the Fastrak electromagnetic tracking device, Lee and Wong, (2002) reported a co-
efficient of multiple determination of 0.98 for 3 ROM measurements conducted at 5 
minutes intervals. Also using Fastrak to measure lumbar ROM, Mannion and Troke, 
(1999) reported within-day intraclass correlation coefficients (ICC’s) of 0.82-0.99 
and between-day ICC’s of 0.72-0.81. 
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In summary due to skin movement electromagnetic tracking devices may 
overestimate lumbar range of movement. However, the advantages of these 
systems have led to their widespread usage. When using the same device 
and fixation method, electromagnetic tracking devices provide a reliable way 
of measuring lumbar ROM. Because electromagnetic tracking devices have 
been found to be reliable and able to monitor three-dimensional movements an 
electromagnetic tracking device was chosen to measure the effects of mobilisations 
on lumbar spine ROM in a single-arm trial included in this thesis (chapter 6). 
3.2. Measurement of lumbar spine stiffness
In addition to measuring lumbar ROM, studies in this thesis measured stiffness of 
the lumbar spine. One of the techniques used during the examination of patients 
with LBP is the application of PA mobilisation to the spine. When applying a PA 
force to the spine, the therapist makes an assessment of spinal stiffness, which is 
the resistance of the spine to deformation. The ability of the therapist to discriminate 
the spinal levels that are stiff and those that are not and the inter-therapist and intra 
therapist reliability of this assessment is poor (Snodgrass et al., 2009; Binkley et 
al., 1995; Maher and Adams, 1994). For this reason researchers have developed 
instrumented methods of measuring stiffness that measure the force applied and 
the corresponding displacement or movement of the lumbar spine. This section 
considers the different methods of measuring stiffness that have been developed. 
The second part of this section considers the stiffness values that have been 
reported using these systems and the factors that may influence the stiffness  
values obtained.
3.2.1. The displacement method of spinal stiffness measurement
Several systems have been employed which measure stiffness by calculating 
the amount of displacement in response to the force applied (Table 3.2). These 
constitute the majority of the studies using instrumented measurement of stiffness. 
The first device designed to measure stiffness using this displacement method 
was the spinal physiotherapy simulator (SPS), developed by Lee and Svensson, 
(1990). The SPS system consists of a load cell mounted on an indenter, through 
which pressure is applied to the spine. Movement of the indenter is controlled by a 
variable speed motor to allow oscillations to be applied at varying (standardised) 
speeds (Lee and Svensson, 1990). To allow measurement of stiffness in Newtons 
per millimetre (N/mm), the load cell measures the force, while a linear inclinometer 
measures vertical displacement of the tissues under the indenter. Lee and 
Svensson, (1990) established the reliability and validity of the SPS in making 
stiffness measurements by testing an elastic beam with a known stiffness value. 
The SPS was found to underestimate stiffness by less than 1% of the true value. 
The test re-test reliability was good, resulting in an ICC of 0.88.
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The same research group developed a similar, portable version of the SPS, (called 
the Stiffness Assessment Machine (SAM) (Latimer et al., 1996a). The reliability 
of this system was established using repeated measures (taken 5 minutes apart) 
performed at the most symptomatic vertebral level in patients with LBP. Excellent 
reliability was found as an ICC of 0.96 (95% confidence interval of 0.91-0.98) was 
reported (Latimer et al., 1996b). Validity was not as good as with the non-portable 
device as when testing the elastic beam it was found to underestimate stiffness by 
less than 2.5% (1.5% greater error then the SPS). Although validity of these systems 
has been reported, one requisite of validity testing is that it is performed in light of 
the measure’s intended use (Streiner and Norman, 2008). Testing against a beam, 
as was the case with these systems, is likely to be a less complex task than testing 
of stiffness in the lumbar spine, where error may be greater, and thus validity of 
spinal stiffness measurements may not be as good. 
A different research group (Edmonston et al., 1998) developed a third, similar 
device, called the Spinal Postero Anterior Mobiliser (SPAM). Like previous devices  
it consists of a mechanically driven load cell. This group reported excellent 
reliability of spinal stiffness measurements (ICC of 0.98 and standard error of 
measurement (SEM) of 0.52N/mm).  
More recently an American Chiropractic research group developed another 
system using similar technology and calculation methods (Owens et al., 2007a). 
As with the previous systems a load cell was mounted on the indenter, but in this 
system an electromagnetic sensor was mounted on top of the load cell in order to 
measure displacement. Reliability testing of this system resulted in an ICC of 0.74 
and a SEM of 1.62N/mm (Owens et al., 2007a). In contrast to the other systems, 
where the indenter is mechanically driven, in this system the therapist applied 
the force manually using the indenter. The disadvantage of this is that there will 
be variations in the way the therapist applies the force on different occasions; 
for example even with considerable effort to standardise application, rate and 
angulation of force may be inconsistent. However the hand held indenter does  
not require the complex and expensive mechanical devices used by Edmonston  
et al., (1998) and Latimer et al., (1996a).
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All the above methods measure vertical displacement of the indenter while the 
load cell measures the applied force. This is where the main potential limitation 
arises. It is widely recognised that these systems do not purely measure 
intervertebral movement at the point of application (Lee and Evans, 2000 and 
1997; Lee et al., 1996), but the displacement measurement is made up of regional 
spinal movement, compression of the plinth padding, abdomen and thoracic cage, 
rotation of the pelvis and displacement of the overlying soft tissues (Chansirinukor 
et al., 2003 and 2001; Kulig et al., 1994). Gliding at the zygapophyseal joints 
adjacent to the point of application is thought to be a small contributor to the 
overall movement (Kulig et al., 2004; Powers et al., 2003; Lee and Evans, 2000; 
Lee and Evans, 1997; Lee and Svensson, 1993). Therefore if the aim is to purely 
measure the resistance to spinal joint movement then there is certainly potential 
error with the use of this method. However if the aim is to measure what a 
physiotherapist perceives when applying a PA mobilisation (including compression 
of soft tissue, the abdomen and the plinth) during assessment and reassessment 
of stiffness in patients then this may be considered to be a valid measure, i.e.,  
a measurement that is a good measure of what it intends to measure (Streiner  
and Norman, 1989). 
3.2.2. Three-point bending method of stiffness measurement
In order to minimise the contribution from soft tissue and plinth compression to 
stiffness measurements, Lee et al., (2005a) developed the three-point bending 
model of measuring lumbar stiffness, involving measurement of movement of 
the whole lumbar spine. Participants were asked to lie on a plinth mounted on a 
force plate and electromagnetic sensors were placed on the sacrum and T 8/9. 
An equation was developed to calculate stiffness that used the force measured 
and the corresponding change in angle of the spine. This equation assumed 
an engineering three-point bending beam model, where the lumbar spine is 
theoretically supported at the rib cage and pelvis, both of which are constrained 
from vertical movement but free to rotate. Using engineering equations for beam 
bending a stiffness value was calculated linking the PA force, the rotation of the 
sensors and the measurements of the ‘beam length’, in this case the distance 
between the sensors and the point of force application. With this system a 
therapist applied the PA force (as opposed to the load cell developed by Latimer 
et al., 1996a). One disadvantage of this system, like the system used by Owens  
et al., (2007a,b) is that it introduces operator error into the application of force. 
The difference between stiffness measurement methods, displacement and  
three-point bending methods of stiffness measurement are displayed in Table 3.2.  
In addition to the different measurement systems other experimental variables can 
influence stiffness measurement; these have been considered in the following section.
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3.2.3. Experimental variables influencing stiffness measurements 
As discussed the manual application of force introduces potential error in stiffness 
measurement that might not be evident with motor driven indenters. The following 
variables, which are also less controllable with manual application of force, have 
been shown to influence stiffness measurements: peak force (Latimer et al., 1998), 
rate of application (Lee and Liversidge, 1994; Lee and Svensson, 1993) and angle 
of application (Allison et al., 1998). 
There are a number of other experimental factors that can affect stiffness 
measurements (see Table 3.2). These include differences in the amount of 
plinth padding and size of the indenter head – both of which have been found 
to significantly affect stiffness measurements (Latimer et al., 1997). There are 
also within- and between-subject factors that can affect stiffness. These include 
body composition (Owens et al., 2007b; Lee et al., 1998; Viner et al., 1997) and 
the spinal level tested (Chansirinukor et al., 2003; Lee and Liversidge, 1994). 
Methodologically, the amount of preconditioning (applying loading cycles prior 
to data collection to stabilise the response of the tissues) and the range of force 
used in stiffness calculations may influence measurements (for differences in these 
between studies see Table 3.3). The calculation of stiffness values is considered in 
the following section.
3.2.4. Stiffness calculations using the displacement method of measurement
All of the above systems calculate stiffness from a force displacement graph, 
on which the application of a PA force can be depicted. The initial part of the 
force displacement graph (Figure 3.1) is generally recognised as non-linear and 
represents small forces producing a relatively large displacement (Lee and Evans, 
1992, 1994). Typically the tissues become gradually stiffer until a more linear part of 
the force displacement graph is reached.
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Figure 3.1. Force displacement graph of PA pressure applied to the lumbar spine. 
The toe region of the force displacement curve (Figure 3.1) is thought to occur 
when collagen fibres are uncurling. Stiffness increases and the curve becomes 
more linear once the collagen fibres are straight (Lee and Evans, 1994). 
Compression of soft tissues overlying the spinous process is also thought to 
contribute to the toe region (Lee and Svensson, 1993). Latimer et al., (1996b) 
examined the force displacement graphs produced from the application of a 
PA mobilisation to the lumbar spine in 22 participants and found that the non-
linear region representing the low stiffness part of the curve occurred during the 
application of the first 30 Newtons (N) of force.
When calculating stiffness most studies have fitted the slope of a regression line 
to the linear region of the force displacement chart (Table 3.3); this represents 
the stiffness coefficient K (Figure 3.1). Some studies have also looked at 
the displacement (in millimetres) during the non-linear portion of the force 
displacement curve up to 30N (D30). Like the majority of studies, in this thesis 
stiffness was calculated by linear regression of the loading phase between 30-100N 
on the force-displacement curve.
Stiffness (K) =
Slope of line
D30 Value
Displacement
Force displacement curve showing
stiffness K and D30 (toe region)
30N
100N
ORIGINAL IN COLOUR
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Table 3.3. Method of stiffness calculation for the lumbar spine at different spinal levels and with 
different angles of force application. K =stiffness expressed in Newtons per milimetre (N/mm), 
D = displacement expressed in millimetres; The range of D and K are stated for example D5-30  
is the displacement that occurs between 5 and 30 Newtons of applied force. Ceph=cephlad,  
Caud =caudad. Note: continues on next page.     
Reference Method of  
calculation
(loading cycles 
used in analysis)
Spinal level /
angle of force 
(degrees)
Stiffness
Mean (standard deviation)
Lee et al., 1994. Mean of 5 cycles.  greater than 50N L3 K= 13.4  (3.13) N/mm 
Latimer et al.,1996a. Cycles 2-5D30 also calculated.
L2: 5.5° ceph
L3: 5.5° caud
L4: 4.5° caud
L5: 16° caud
K= L2 (n=2): 12.78 N/mm
K= L3 (n=1): 17.46 N/mm
K= L4 (n=4): 15.94 N/mm
K= L5 (n=15): 15.14 N/mm
Latimer et al.,1996b.
Cycles 2-5
K: 30-100
D 0.5-30
LBP:
K: 14.96
(2.74) N/mm 
D:  4.50 mm (1.43)
Non LBP:
K: 14.84  (3.46) N/mm 
D: 4.88 (1.14) mm
Latimer et al., 1997. K: 30-90 L3 L3: 14.87 (3.21) N/mm rigid plinth12.01 N/mm (2.51) padded plinth
Viner et al., 1997. D5-30K: 30-100
L1: 6° ceph
L2: 3° ceph
L3: 1° caud
L4: 5° caud
L5: 14° caud
S1: 19° ceph
D5-30 mm
L1: 1.77 (0.98)
L2: 1.92 (1.04)
L3: 2.09 (1.09) 
L4: 2.31 (1.47) 
L5: 2.61 (1.49)
S1: 2.38 (1.21)
K 30-100 N/mm
L1: 14.05 (2.97)
L2: 14.17 (2.54)
L3: 14.48 (3.02) 
L4: 15.50 (3.30) 
L5: 16.41 (3.77)
S1: 16.95 (3.67)
Lee et al., 1998. K: 30-100 L1: 4.5° caudL4: 12.50ceph
L1: 10.4 N/mm
L4: 13.3 N/mm
Goodsell et al., 2000.
Cycles 2-5. 
D30 and K (30-90N) 
calculated
L2: 5.5° ceph
L3: 5.5° caud
L4: 4.5° caud
L5: 16° caud
Most symptomatic
Mean of stiffness measurement
at all levels  reported
K= 15.11 (4.7)
D30: 5.01 (1.1)
Chansirinukor et al., 
2001.
Slope of least 
regression line: 30-
100N
L2: 3° ceph
L3: 1° caud
L4: 5° caud
L5:14° caud
K= L3: 8.93 N/mm
K= L5: 11.02 N/mm
No gender difference
Other values not reported
Caling and Lee, 2001.
Two cycles collected. 
First cycle used for 
analysis.
3 direction
L3: 11° caud, 1° 
caud, 9° ceph
L5: 24° caud, 14° 
caud, 4° caud
D5-30 mm
L3: 11° caud: 3.9,
1° caud: 3.5,
9° ceph: 3.9
L5: 24° caud: 5.4,
14° caud: 5.3,
4° caud: 4.8
K:30-100 N/mm
L3: 110 caud: 14.1
10 caud: 15.8
90 ceph: 13.5
L5:  240 caud: 16.4
140 caud: 16.1
40 caud: 15.2
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Reference Method of  
calculation
(loading cycles 
used in analysis)
Spinal level /
angle of force 
(degrees)
Stiffness
Mean (standard deviation)
Shirley et al., 2002.
D30 -2-30N
Within test:  
cycles 1-5
Between tests:  
mean of cycles 2-5
L4 D30: 5.97 (0.37) mmK: 13.218(0.71) N/mm
Owens et al., 2007a.
Cycles 2-5 
Slope of force  
displacement 55-75N
L1-L5
Straight PA
L1: 11.18 N/mm
L2: 11.38 N/mm
L3: 11.09 N/mm
L4: 11.37 N/mm
L5: 11.87 N/mm
Standard deviations not reported
Owens et al., 2007b.
Cycles 2-5 
Slope of force 
displacement 55-75N
(In subjects unable 
to tolerate 80N (20N 
range from 5N less 
than max force)
L1-L5
Straight PA
L1: 10.25 N/mm
L2: 10.45 N/mm
L3: 10.82 N/mm
L4: 10.81 N/mm
L5: 11.12 N/mm
Standard deviations not reported
Table 3.3. (continued) Method of stiffness calculation for the lumbar spine at different spinal  
levels and with different angles of force application. K = stiffness expressed in Newtons per 
millimetre (N/mm), D = displacement expressed in millimetres; The range of D and K are stated 
for example D5-30 is the displacement that occurs between 5 and 30 Newtons 
of applied force. Ceph = cephlad, Caud = caudad.
This section has considered the methodological and patient variables, which can 
affect stiffness measurements. The different methods of spinal stiffness measurement 
were explored. However there was little comparison between stiffness methods in the 
literature so it was not possible to clarify the best method for measuring spinal stiffness. 
After initial pilot work (section 4.4) identified the need for experimental comparison 
of these methods both three-point bending and displacement methods have been 
employed and the results compared during the studies in chapter 5 and 6 of this 
thesis. As described, both three-point bending and displacement methods of stiffness 
measurement involve the measurement of applied force. The following section considers 
the different systems used to measure force when investigating spinal stiffness. 
3.3. Measurement of forces
Spinal stiffness is the extent to which the spine resists deformation in response to an 
applied force and thus stiffness measurement involves the measurement of applied 
force. In previous studies, the force has been applied and thus measured using a 
load cell (Owens et al., 2007 a,b; Lee and Svennson, 1990; Latimer et al., 1996a), 
or applied by a therapist and measured indirectly through force plates (Lee et al., 
2005a; Harms et al., 1995). The studies in this thesis used indirect measurements  
of applied force and thus these have been considered in further detail below.
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The first system employed to indirectly measure applied force, indirectly measured 
the change in force when a mobilisation was performed by a therapist standing on 
a force platform (Matyas and Bach, 1985). Applied force was calculated using the 
equation F+G –W =ma, where F is the reaction to the force applied by the therapist 
to the patient, G is the ground reaction force, W is the weight of the therapist and ‘a’ 
is the acceleration of the centre of gravity of the therapist. It has been argued that 
because therapists use acceleration of the upper body when applying force, the 
change may not represent that applied to the patient (Harms et al., 1995). However, 
Petty and Messenger, (1996) argued that the average acceleration of the therapist 
over time must be zero, otherwise the therapist would acquire a net positive or 
negative velocity; for this reason, acceleration was considered to be zero or so 
small it could be ignored. The influence of acceleration has been investigated 
experimentally by sampling data from the force plates over 20 oscillations and 
it was found that total acceleration was virtually zero (Matyas and Bach, 1995). 
However, although measuring acceleration over a period of time was zero, it will 
not be zero at the instant of measurement and therefore other systems have been 
developed to overcome this error.
To overcome the problems with acceleration, Harms et al., (1995) developed 
a plinth with force transducers mounted in the frame plinth. Lee et al., (1990) 
described an alternative technique where the plinth is mounted on a force plate; 
this was the method of force measurement employed in the studies contained in 
this thesis.
3.4 Measurement of pain
In addition to investigating the effects of lumbar mobilisations on lumbar spine 
ROM and stiffness, the researcher also sought to examine the analgesic effects of 
lumbar mobilisations. Therefore the following section considers the measurement 
of pain. 
3.4.1. Pressure algometry
The studies in this thesis (chapters 5-7) included a number of pain related 
measures used to assess the hypoalgesic effects of mobilisations. One of the 
pain related measures was pressure pain threshold (PPT). Pressure algometry 
has been used extensively to quantify people’s pain experience. Algometers are 
used to measure pressure pain threshold and involve the application of pressure 
to the skin. Perceived pain is quantified by determining the point at which the 
sensation of pressure changes to one of pain or discomfort. Algometry has been 
used to measure soft tissue tenderness (Nussbaum and Downes, 1998), to quantify 
trigger points (Delaney and McKee, 1993), to assess the effects of treatment 
regimens (Dhondt et al., 1999; Fryer et al., 2004; Willett et al., 2010) and to assess 
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the relationship between PPT and disability in patients with LBP (Farasyn, 2005). 
There are two main types of algometer, non-electronic ones and electronic ones. 
The electronic ones often have the advantage of including functions which are 
designed to enhance the reliability of measures, such as patient control switches 
and indicators of force application rate.
Pressure algometry tests the response of nociceptors in both deep and superficial 
tissues. Kosek et al., (1999) compared PPT before and after the application 
of a local anaesthetic cream and a control cream and reported that PPT were 
significantly lower when the control cream was applied. This demonstrated that 
cutaneous receptors contribute to the pain experienced during pressure algometry. 
However blunt pressure, as produced with a pressure algometer, is also thought 
to activate nociceptors in deep tissue (Treede et al., 2002). It has been suggested 
that in order to maximise the contribution from deep tissues, probe sizes of 1cm2 
and above should be used as they deform both the epidermis and deeper tissue; 
rounded or padded tips minimize deformation of the epidermis and it is thought that 
this may result in preferential activation of nociceptors in deeper tissues (Treede 
et al., 2002). For the studies in this thesis a 1cm2 padded probe was used for all 
testing sites so both deep and superficial nociceptors are likely to have contributed 
to the discomfort experienced by participants. 
3.4.2. Reliability of pressure pain threshold measurements
PPT can be measured at various locations. The choice of testing location may 
depend on the aims of testing. However readings taken at different sites cannot 
be compared due to large inter-site variations in PPT readings (Fischer, 1987). In 
contrast, testing the contralateral side on the same muscles has been shown to 
have excellent intra-subject reliability (Fischer, 1987). It can be seen in Table 3.4, 
that the reliability of repeated PPT measures has consistently been shown to be 
very good. It is important to note that there are often methodological explanations 
for the studies reporting lower ICC’s for example the lower values (0.64-0.96) 
reported by Vanderween et al., (1996) can be explained as in this study testing 
sites were not marked, therefore in addition to the reliability of PPT measures, these 
figures are also a measure of the examiner’s ability to return to the same testing 
point. All PPT sites used in the studies reported in this thesis were marked to allow 
accurate repositioning of the algometer.
Debate in the literature has focused on the optimum number of repetitions  
required to achieve the most reliable result. Some authors have advocated taking 
3 measurements and discarding the first (Nussbaum and Downes, 1998). However 
careful inspection of their data does not support this conclusion; Nussbaum 
and Downes, (1998) examined which combination of 3 trials produced the most 
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reliable results. The first trial alone produced ICC’s of 0.74-0.78, which were lower 
than those produced by the mean of 1 and 2, 1,2 and 3 and 2 and 3. All of these 
combinations produced ICC’s of 0.8; an alternative conclusion from these figures 
could be that the use of the first trial alone produces less reliable results than any 
other combination of the 3 trials. 
Research has suggested that the mean of 2 measurements may be sufficient  
to achieve good reliability. Ohrbach and Gale (1989) investigated the reliability  
of 5 measurements taken 4-5 minutes apart and found that more than 2 
measurements was not justified. This is in agreement with Chesterton et al.,  
(2003) who calculated the mean of 2 PPT measurements taken 10-15 seconds apart 
and a further 2 PPT taken every 10 minutes thereafter, resulting in 14 readings over 1 
hour. There was no significant difference between repeated measures. 
The instructions given to participants may be important in the reliability of PPT 
measurements. Most of the published work seems to have used the term ‘pressure 
to pain’ for example Fischer et al., (1987) and Chesterton et al., (2003) used the 
instruction ‘say stop immediately when a discernible sensation of pain distinct from 
pressure or discomfort is felt’. However, other authors noted that participants found 
this point difficult to determine and altered the standard instructions for example 
Dhondt et al., (1999) used the phrase ‘the moment the applied force becomes 
unpleasant’, Buchanan and Midgley, (1987) described the sensation as ‘barely 
perceptible pain’ and Delaney and McKee, (1993) asked participants to say yes 
when they ‘first felt discomfort’. 
In summary the evidence suggests that reliability is improved when more than 
one PPT measure is taken. It appears that there is no justification in terms of 
enhanced reliability for using the mean of more than 2 measures. The literature 
review highlighted the importance of the number of repeated PPT measures and 
the testing instructions. These methodological factors were investigated during 
preliminary work for this thesis (section 4.4).
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3.4.3. Verbal Rating Scale (VRS) of pain measurements.
When assessing a patient in clinical practice and monitoring changes in 
patients’ symptoms within- and between-treatment sessions physiotherapists 
use reassessment asterisks. These are clinical tests that reproduce the patient’s 
symptoms. For example resting pain levels and reproduction of pain during active 
physiological movement may be used as reassessment asterisks. Patients may be 
asked to score their pain on a verbal rating scale (VRS). An 11-point verbal rating 
scale is often used, 0 being no pain and 10 being the most pain imaginable. VRS 
are often used to establish the effects of treatment, for example patients may be 
asked to rate their pain on movement before and immediately after a mobilisation 
treatment. This scale is often used by therapists in clinical practice and thus was 
utilised in the studies included in this thesis. 
3.5. Questionnaires
The studies in this thesis (chapters 6 and 7) examined the analgesic effects 
of lumbar mobilisation treatment utilising a symptomatic population. Analgesia 
was measured using PPT and participants’ VRS of pain. However, pain is a 
multidimensional experience and is based on factors such as physiology, 
personality, previous life experiences and family and cultural factors. In order 
to gain an understanding of their pain experience participants were asked to 
complete a number of questionnaires on their first attendance (see appendix 7  
for full questionnaires). 
To capture multiple aspects of participants’ pain experience, questionnaires were 
used to measure participants’ description of the pain, the disability resulting from 
the pain, the impact of the pain and their levels of anxiety/depression (as emotions 
have been shown to influence pain processing in the central nervous system (Atlas 
and Wager, 2012)). The questionnaires utilised in the studies in this thesis have 
been considered below. This includes details of their psychometric properties.  
For the purposes of the studies in this thesis only one measurement will be taken 
and thus validity of these questionnaires is of greatest importance.
3.5.1. Measures to describe pain
The McGill Pain Questionnaire (MPQ) is a tool for quantifying dimensions of pain 
and is able to discriminate between different pain problems (Melzack, 1983). It 
is sensitive in detecting differences between analgesic methods (Melzack, 1975) 
and has good test-rest reliability (Grafton et al., 2005). The questionnaire contains 
different categories which represent different dimensions of pain, these are sensory, 
effective and evaluative perceptions of a person’s pain (Strong, 1999). Participants 
are required to choose words describing the pain experience, different words in 
each subclass represent the intensity of the pain (Melzack, 1983). 
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3.5.2. Measurement of the response to pain
The survey of pain attitudes (SOPA) had adequate construct and discriminant 
validity for patients with LBP (Strong et al., 1992). The SOPA is also reported to 
have good internal consistency and test-retest reliability (Jensen et al., 2000).  
It consists of subgroups of questions designed to measure the multidimensional 
nature of pain beliefs and has been shown to correlate well with the areas that 
they aim to measure (Tait and Chibnall, 1998). The SOPA assesses 7 different 
pain dimensions which allow patients to be grouped into categories representing 
differences in their pain attitudes and clinical status (Tait and Chibnall, 1998).  
These categories are: 
 Control  The extent to which patients believe they can control their pain.
 Disability  The extent to which they are disabled by pain.
 Exercise   Beliefs that they are damaging themselves through  
exercise and activity.
 Emotion   The extent to which their emotions affect their pain.
 Medication   Their beliefs that the use of medications is appropriate.
 Solicitude    Their expectation that their family should help  
and take care of them more.
 Medical cure  Expectations of a medical cure.
3.5.3. Measurement of the impact of the pain
The Oswestry disability questionnaire (ODQ) was designed to measure disability 
in patients with LBP, it assesses the person’s functional status, their activity levels 
and how the pain is affecting their lifestyle by asking them about the amount to 
which pain affects their daily activities. It includes nine functional categories and 
a pain intensity scale. Each functional category consists of six statements that 
describe their difficulties in different functional activities. Fisher and Johnston, 
(1997) compared patients’ responses to the ODQ to their performance on a number 
of functional tasks and concluded that there is some evidence of criterion related 
and factorial validity and good face validity. Vianin, (2008) reported good construct 
validity when compared to other measures of back pain disability. The ODQ has 
been shown to have reasonable internal consistency (Strong, 1994).    
3.5.4. Measurement of depression / anxiety
The general health questionnaire (GHQ) is a tool for measuring minor 
psychopathology (Gibbons et al., 2004), it measures two elements of depression; 
the ability to continue functioning as normal and symptoms of emotional distress. 
It includes four subscales; somatic, emotional, social dysfunction and depression. 
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In a study validating the GHQ against an interview it was correlated with measures 
of anxiety and depression and demonstrated high sensitivity and specificity when 
compared to an interview (Gibbons et al., 2004).
3.5.5 Demographic questionnaire
A demographic questionnaire (Appendix 7) was utilised in order to gain information 
about factors which may influence prognosis of recovery from LBP. These included 
cultural and social factors, the type and effectiveness of any previous treatment 
participants had received, and the type and the amount exercise participants were 
engaged in on a regular basis.
3.5.6 Nicotine and alcohol dependency questionnaires
Nicotine and alcohol questionnaire were utilised as these substances may  
influence the analgesic mechanisms (Heatherton et al., 1991) through which 
mobilisation are mediated.
3.6. Summary of the literature review and overview of studies
In summary there is limited evidence demonstrating that longer duration of 
mobilisation treatment influences lumbar ROM (Powers et al., 2008; McCollam 
and Benson, 1993), and only one study (Lee et al., 2005b) demonstrating that 
mobilisation treatment results in a significant effect on lumbar stiffness. 
There is evidence to suggest that mobilisations produce an analgesic effect 
(Sterling et al., 2010), however this has not been established in a population 
with low back pain. Furthermore, the optimum treatment dose has not been 
established, although some research in an asymptomatic population suggests 
that longer durations of mobilisation treatment may have a greater analgesic effect 
(Pentelka et al., 2012). Only the immediate effects of lumbar mobilisation have been 
investigated. This review identified the need to investigate the mid to long-term 
effects of mobilisations. 
The relationship between experimental pain such as pressure pain thresholds 
(PPT) and patient reported measures such as verbal rating scales of pain or global 
perceived effect has not been established. 
This literature review confirmed that electromagnetic tracking devices were  
highly reliable and suitable for use on large numbers of participants. Therefore  
an electromagnetic tracking system was employed in two of the studies in this 
thesis (chapter 5 and 6) in order to obtain both ROM and stiffness measurements. 
A lack of experimental comparison between the displacement and three-point 
bending methods of stiffness measurement was evident and thus the best method 
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for stiffness measurement was not identified. These two methods of stiffness 
measurement are compared in chapters 5 and 6. 
PPT are used widely to measure pain and were applied in the studies in this thesis. 
In order to replicate pain measures taken in clinical practice and develop  
an understanding of participants’ perception of changes in their symptoms,  
VRS of pain were also employed in these studies.
Review of the literature resulted in a number of research questions which underpin 
a series of studies outlined in the following section. The overall aim of the thesis 
was to establish whether longer durations of lumbar mobilisation treatment resulted 
in greater effects on ROM, stiffness and pain in participants with chronic non-
specific LBP. Figure 3.2 provides an overview of the studies in this thesis. 
3.7. The research questions addressed in the studies in this thesis
	 •	 	What	is	the	test-retest	reliability	and	measurement	error	of	ROM	(using	 
an electromagnetic tracking device), stiffness (using three-point bending  
and displacement methods) and PPT measurements? 
	 •	 	Which	is	the	most	valid	and	reliable	method	for	measuring	the	effects	 
of mobilisation on lumbar stiffness?
	 •	 	What	are	the	immediate	effects	of	lumbar	mobilisations	on	pain,	stiffness	 
and ROM in patients with chronic non-specific LBP?
	 •	 	What	are	the	short-term	effects	of	lumbar	mobilisations	on	pain,	stiffness	 
and ROM in patients with chronic non-specific LBP?
	 •	 	What	is	the	effect	of	a	longer	duration	of	mobilisation	treatment	on	ROM,	
stiffness and pain in patients with chronic non-specific low back pain? 
	 •	 	What	is	the	relationship	between	PPT	and	VRS	of	pain?
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Figure 3.2. Flowchart depicting the sequence of studies and the research question 
addressed in each study of this thesis.
Chapter 4
Pilot work
Reliability and validity of fastrak measurements (page 47)
Validation of sychronisation of force and motion measurements (page 49) 
Study to calibrate the algometer (page 50)
Study to assess the procedure and data analysis for ROM, stiffness and PPT measurements (page 50)
Development of a hand held indenter for displacement method of stiffness measurement (page 61)
➜
Chapter 5  (page 65)
The reliability of pressure pain thresholds, physiological range of movement,
and stiffness measurements of the lumbar spine.
What is the reliability of ROM (using an electromagnetic tracking device), stiffness
(using three-point bending and displacement methods) and PPT measurements?  
➜
Chapter 6  (page 95)
A single arm trial investigating the immediate effects of 3 and 6 minutes of lumbar
mobilisation treatment on physiological range of movement, stiffness and pain.
What are the immediate effects of lumbar mobilisations on pain, stifffness
and ROM in patients with chronic non-specific LBP?
➜
Chapter 7  (page 127) 
The effects of duration of lumbar mobilisations on pressure pain thresholds
and patient reported pain measures. A placebo controlled trial
W at are the immediate and short term analgesic effects of different durati s
of mobilisation treatment in patients with chronic non-specific low back pain? 
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Chapter 4.
Preliminary studies
This chapter outlines the preliminary work that informed the protocols used  
in the main studies of this thesis. The calibration procedures, reliability (which 
reflects the amount of measurement error) and validity (accuracy) testing of the 
equipment are detailed. The experimental procedures employed in later studies 
required synchronisation of two pieces of equipment; therefore this chapter also 
includes details of a pilot study that was conducted to establish the accuracy  
of this synchronisation. The development of a standardised protocol for ROM,  
stiffness and PPT testing is also detailed. The preliminary work was as follows:
4.1.  Study to establish the validity and reliability of Fastrak 
4.2. Study to establish the synchronisation of force and motion measurements 
4.3. Study to calibrate the algometer
4.4.  Study to assess the procedure and assessment of the quality of the  
data for range of movement (ROM), stiffness and pressure pain  
threshold (PPT) measurements.
4.5.  Development of a hand held indenter for stiffness measurements. 
4.1. Study to establish the validity and reliability of Fastrak 
Studies in this thesis used the Fastrak electromagnetic tracking system  
to measure both ROM and stiffness. The manufacturers of the Fastrak 
(electromagnetic tracking) system (3SPACE Fastrak, Polhemus Inc. Colchester,  
VT, USA) claim that it has excellent accuracy (0.8mm for sensor position and  
0.15 degrees for sensor orientation). However, the system used in the studies  
for this thesis had been in use in the University laboratory for a number of  
years and thus could have developed an error over time. This study was 
performed in order to establish the reliability and validity of the measurements 
recorded by this particular Fastrak system prior to the main studies in this thesis. 
This was intended to be a preliminary procedure as a more involved study 
establishing the reliability of Fastrak in measuring lumbar spine ROM  
was conducted and is reported on in chapter 5.
4.1.1. Pilot study aim
This study was designed to test the validity and test-retest reliability of Fastrak  
in the measurement of various goniometer angles.
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4.1.2. Equipment
The ‘Fastrak’ electromagnetic tracking system (3SPACE Fastrak, Polhemus 
Inc. Colchester, VT, USA). This system uses a stationary source to generate an 
electromagnetic field. The position of the electromagnetic sensors (with dimensions 
28.3mm by 22.9mm by 15.2mm) was tracked in three dimensions in relation to  
the source. 
4.1.3. Methods
The Fastrak sensors were mounted on a goniometer using double-sided sticky 
tape. The Fastrak recording was initiated with the goniometer positioned at 0 
degrees. After several seconds the goniometer was moved to a position of 20 
degrees, after a further few seconds it was moved to a position of 40, then 60 
then 80 degrees with a pause of several seconds between angles. This was 
repeated on 3 occasions at 5 minute intervals. The angles recorded by the Fastrak 
electromagnetic system were compared to the angles set on the goniometer.
4.1.4. Data analysis
Scatter graphs were used to determine the time at which each angle was 
maintained. The mean and standard deviation of 2 seconds of data was calculated 
for each angle.
4.1.5. Results 
There were minor differences between the Fastrak and goniometer angles (Table 
4.1). The range of differences between the angle recorded by the Fastrak and the 
position on the goniometer was 0 - 0.54 degrees.
Fastrak angles with goniometer positioned at 20 / 40 / 60 and 80 degrees
Occasion 20° (mean) 40° (mean) 60° (mean) 80° (mean)
1 19.56 (0.04) 39.65 (0.05) 59.60 (0.11) 79.77 (0.05)
2 20.00 (0.06) 40.18 (0.05) 60.02 (0.07) 79.95 (0.05)
3 19.81 (0.06) 39.82 (0.08) 59.87 (0.08) 79.84 (0.07)
Table 4.1. Comparison of Fastrak and goniometry measurements. The goniometer was positioned 
at 20 /40 /60 and 80 degrees. Data are mean and standard deviations (SD) of Fastrak angles over 
a 2 second period on 3 occasions.
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4.1.6. Discussion
The small discrepancies between the goniometer and Fastrak angles were 
of expected magnitude and may have been due to errors in positioning the 
goniometer or inaccuracies in Fastrak measurements. The measurement error 
shown in this pilot study was considered to be small and unproblematic for the 
studies in this thesis. The validity of using this device to measure spinal ROM 
maybe different, due to errors from factors such as slippage of the sensors on 
the skin, skin movement and variability in participants’ movement. The following 
chapter in this thesis (chapter 5) investigated the reliability of Fastrak in measuring 
lumbar ROM using skin-mounted sensors.
4.2. Study to establish the synchronisation of force and 
motion measurements
Two studies in this thesis (chapter 5 and 6) included measurement of lumbar 
spine stiffness. Stiffness measurements required calculations using simultaneously 
collected force and motion data. This required synchronisation of these 
measurements. Earlier work in the laboratory had indicated that there was a phase 
difference in the synchronised data collection (due to Fastrak losing time). It was 
important to investigate this phase difference to establish whether it would cause 
errors in the calculation of stiffness. A longer period of data collection would result 
in a greater phase difference; the maximum period of data collection proposed for 
future work was 1 minute.
4.2.1. Pilot study aim
The aim of this study was to establish the phase difference between data from the 
force plates and motion data from Fastrak over a 1-minute period.
4.2.2. Instrumentation and measurements
Motion was measured using Fastrak (section 4.1.2) electromagnetic tracking 
system. Force was measured using non-conductive ground reaction force plates 
(AMTI OR6-7 – Advanced Mechanical Technology Inc., Watertown, MA, USA). 
The force and motion data was synchronised using a TG200 function generator, 
(Thurlby Thandar Instruments Ltd., Cambridgeshire, England).
4.2.3. Method
The Fastrak sensors were attached to a modified plinth (mounted on the force 
plates) approximately 10cms apart using double-sided sticky tape. Data collection 
was started. After 1 minute of data collection (of force and motion data) the 
researcher depressed the padding on the plinth between the sensors in a  
cyclical manner.
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4.2.4. Data analysis
The differences between the onset of change in force observed from the force 
plate data and onset of movement from the Fastrak data was calculated. This 
represented the phase difference after 1 minute of data collection.
4.2.5. Results and discussion
Over the 1 minute data collection period, there was a 0.1 second phase difference 
between the force plate and Fastrak measurements. This was considered to be 
insignificant as it was not of a magnitude that would affect the results. 
4.3. Study to calibrate the algometer
PPT have been employed previously to investigate the effects of mobilisations 
(Pentelka et al., 2012; Sterling et al., 2010). The studies in this thesis used an 
electronic algometer (Tracker computerised algometry system, JTECH medical 
industries, Salt Lake City, Utah) to measure PPT. The algometer was zeroed as part 
of the start-up procedure in the software. If a zero value was not recorded further 
testing could not be conducted. In addition the manufacturers recommend re-
calibration against known weights every 6 months. The algometer readings were 
checked against 0.5kg, 1kg, 2kg, 2.5kg and 5kg weights. This procedure was 
repeated on a six-monthly basis through the course of the studies for this thesis.
4.4. Study to assess the procedure and data analysis for ROM, stiffness 
and PPT measurements 
Following the calibration of the equipment detailed in sections 4.1-4.3, the protocol 
for the main studies was evaluated and the data scrutinised. This involved 
measurements of PPT, lumbar ROM and stiffness. 
 
The electromagnetic sensors were used for measurement of lumbar ROM and 
stiffness. For this reason the sensors would need to be placed to enable measurement 
of any movement in the entire lumbar region. This required identification of the first 
lumbar vertebra (L1) and the sacrum (the bottom of the lumbar region). The fixation 
method of these sensors was also evaluated. Standardised instructions for ROM 
measurements were also assessed for clarity.
The measurement of PPT was designed to determine the extent of the analgesic 
effect (local, systemic or segmental). In order to achieve this PPT testing sites 
needed to be identified local to the site of treatment, at a point in the upper 
quadrant, distant from the site of treatment and because later studies included 
in this thesis applied mobilisation treatment to participants’ most symptomatic 
vertebral level, it was necessary to determine PPT testing sites in each of the 
lower limb dermatomes. The spinous process and paravertebral muscles and 
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deltoid muscle met the criteria for being local and distant from the site of treatment 
respectively, and have been sites used in previous research (Persson et al., 2004; 
Dhondt et al., 1999; Antonaci et al., 1998).
Identifying sites in each dermatome was more challenging as dermatome maps 
vary between texts. This originates from two early studies demarcating the 
dermatomes by Foerster (1933) and Haymaker and Woodhall (1953) the difference 
in these maps occurred due to differences in the authors’ understanding of 
the embryology of dermatomes (Butler, 2000). Furthermore there is variation in 
dermatome positions between individuals and overlap of adjacent dermatomes 
within one individual (Butler, 2000). Nitta et al., (1993) determined distinctive or 
signature zones within each lower limb dermatome (areas of most overlap of 
sensory loss and least involvement when adjacent segments were blocked) by 
mapping the area of sensory impairment in patients receiving spinal nerve blocks 
at L4, L5 and S1 levels. Sites in these signature zones were used for testing in each 
lower limb dermatome.
Ensuring exact repositioning of the algometer tip and ensuring application at 90 
degrees to the testing sites are two methodological factors important in maximising 
the reliability of measurements (Vanderween et al., 1996). Repositioning the 
algometer tip is easier within sessions as the sites can be marked. However, it 
creates a greater challenge when taking measurements on different occasions. For 
this study, once the optimum sites for testing were established, it was necessary to 
develop a protocol that enabled relocation of the same anatomical site on different 
sized individuals, whilst allowing the researcher to apply the force at 90 degrees to 
the point of application, and maintaining a comfortable position for participants.
4.4.1. Pilot study aim
The aim of this study was to develop the PPT, lumbar ROM and stiffness procedure 
for the main studies in this thesis. 
4.4.2. Ethics approval
This pilot work was approved by the Faculty of Health and Social Science Research 
Ethics and Governance Committee (FREGC) (Appendix 2).
4.4.3. Participants
Two asymptomatic participants were recruited via word of mouth. Potential 
participants were sent a participant information sheet and list of inclusion and 
exclusion criteria and asked to contact the principal researcher again if they wished 
to take part, at which point an appointment was made for them to attend the human 
movement laboratory, Robert Dodd Annex, Eastbourne.
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4.4.4. Inclusion and exclusion criteria 
Potential participants were required to be between 18-70 years of age.
Potential participants for this study were excluded if they had a history of back pain 
as it may have affected the reliability of readings. To prevent potential soreness 
or damage to their spine participants with conditions that may have affected their 
spine and associated structures were excluded from the study. This resulted in the 
following exclusion criteria:
	 •	 	Spinal	congenital	abnormality
	 •	 	History	of	spinal	fracture
	 •	 	History	of	malignancy
	 •	 	Bone	disease	(osteoporosis,	osteomyelitis,	tuberculosis,	Paget’s)
	 •	 	Inflammatory	arthritis	(rheumatoid	arthritis,	ankylosing	spondylitis,	gout)
	 •	 	Congenital	generalised	hypermobility	(Ehlers-Danlos	syndrome)
	 •	 	Advanced	degenerative	changes
Participants with the following precautions to mobilisations were also excluded:
	 •	 History	of	steroid	therapy
	 •	 Pregnancy
	 •	 Current	anticoagulant	medication
4.4.5. Confidentiality
All participant information was kept confidential and only made available to the 
study investigator and supervisors. Both participants were allocated with a code; 
to ensure anonymity and all data was stored under that code, the key to which 
was kept on a password protected computer. To fulfil the requirements of the 
Data Protection Act 1998 all personal data was destroyed at the end of the study. 
Anonymised data will be kept for 10 years following completion of the study.
4.4.6. Instrumentation and measurements
Range of Movement was measured using Fastrak (section 4.1.2, page 48). 
Lumbar spinal stiffness was measured using three-point bending (force/angle) 
method. This required force and Fastrak motion sensor data measurements to be 
taken simultaneously during PA loading. Fastrak was used to measure the change 
in the curvature of the spine (angular rotation). For force measurements, a lightly 
padded wooden plinth was mounted on non-conductive ground reaction force 
plates (AMTI OR6-7 – Advanced Mechanical Technology Inc., Watertown, MA, 
USA). The force plates indirectly measured the force applied by the therapist  
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(Lee, 2005a). The researcher stood on a wooden platform with a lean bar  
(Figure 4.1) during the stiffness testing procedure to ensure that only the 
therapist’s mobilising force was measured by the force plates. The force and 
motion data was synchronised using a TG200 function generator, (Thurlby  
Thandar Instruments Ltd., Cambridgeshire, England).
Figure 4.1. Plinth mounted on force plates and lean bar
Pain Pressure Thresholds were measured using an electronic pressure algometer 
(Tracker computerised algometry system, JTECH medical industries, Salt Lake 
City, Utah) fitted with a 1cm2 tip. The algometer had two features designed to aid 
reliability. Firstly an on-screen dial to facilitate the researcher in standardising the 
rate of application at 1kg/cm2/sec (see Figure 4.2); standardisation of the rate 
of application has been shown to vary results (List, 1991; Jensen et al., 1986). 
Secondly, a patient control switch, which enabled the participants to freeze the 
recording at the point ‘that the sensation of pressure changes to pain’. The patient 
control switch prevented a time delay between the participant communicating the 
point of change and the researcher recording a measurement, PPT readings were 
automatically saved when the patient control switch was pressed. 
ORIGINAL IN COLOUR
54
Figure 4.2. Algometer software with on screen scale to indicate rate of application.
4.4.7. Procedure
To allow measurement of lumbar range of movement and stiffness, the Fastrak 
sensors (section 4.1.2) were mounted on thin plastic plates (103 x 48 x 1mm) in 
a fixation method previous found to be reliable (Ha, 2010) and positioned on the 
sacrum and L1 spinous process (Figure 4.3) using the following procedure: The 
skin on the participants’ back was cleaned using an alcohol wipe. The sacral base 
was located through palpation and marked with a temporary marker pen. From 
the sacral base, the researcher counted up the vertebra to L1, in order to count 
up to L1 the tip of L5 was palpated in the lumbosacral depression, the researcher 
then moved up one spinous process to L4. The L4 and L5 were cross-referenced 
by palpating the iliac crests. Oliver and Middleditch, (2004) found that in 60% 
of participants the iliac crests were level with the L4/5 interspace, but in 20% of 
individuals they were level with the vertebral body of L4 and in the remaining 20% 
they were level with the body of L5; because of this anatomical variation once the 
researcher had counted up from L4 to L1, L1 was cross-referenced by palpating 
the 12th rib and following the rib posteriorly to ascertain the T12 spinous process. 
The plastic plates were attached to the skin overlying the 1st lumbar vertebra and 
sacral base with double-sided tape. The bottom edge of the superior plastic plate 
was aligned with the spinous process of L1 and the top of the inferior plate was 
aligned with the base of the sacrum (Figure 4.3). 
ORIGINAL IN COLOUR
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Figure 4.3 Fastrak sensor placement on base of sacrum and L1.
4.4.8. Range of movement measurements
Participants were asked to stand upright with their feet hip width apart whilst a 
neutral position of the electromagnetic sensors was set (this allowed the starting 
position of the sensors to be recorded). The following instructions were given for 
the movements indicated (also see Figures 4.4 and 4.5). 
	 •	  Flexion: ‘bend forwards, as far as possible, running your hands down the front of your thighs.’ 
	 •	  Extension: ‘lean backwards as far as possible.’
 •	 	Lateral flexion: (indicating the participants left side) ‘running your hand down the side  
of your leg bend as far sideways as possible.’ ...‘and to the other side.’
 
•	 	Rotation: ‘crossing your arms across your chest turn to your left as far as possible.’  
...‘and to the other side.’
Figure 4.4. Lumbar extension (a)
and flexion (b) range of movement.         
Figure 4.5. Lumbar lateral
flexion range of movement.
a  b
Fastrak 
Sensors
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4.4.9. Stiffness measurements
For the stiffness measurements, the participant was asked to take a deep breath 
in, breathe out and refrain from breathing in (Shirley et al., 1999) whilst 5 cycles 
of PA mobilisations were applied to L4 spinous process by the researcher using 
the indenter at a rate of 0.5Hz (equivalent to one PA cycle every 1.5 seconds) 
standardised by the use of a metronome.
4.4.10. Pressure pain threshold measurements 
In order to test the sensitivity of points within each signature zone (identified 
by Nitta et al., 1993), PPT were tested at different locations within each zone. 
The algometer was applied to the skin and depressed at a rate of 1kg/cm2/sec; 
participants were asked to depress the patient control switch ‘at the point where the 
sensation of pressure turned to the sensation of pain’, at which point the algometer 
was removed and a PPT reading was recorded. Participants were asked for 
feedback on the sensitivity of the area. A testing point was deemed to be suitable if 
it was not too sensitive (some sites were sore with the application of the algometer 
head, even before pressure has been applied), or too insensitive (some sites 
required a lot of pressure which was difficult for the operator to apply and may have 
caused bruising which would have affected the reliability of subsequent readings). 
The same procedure was followed for sites on and close to the spinous process of 
the vertebra and the deltoid muscle. 
In order to identify the same site on different individuals and reliably return to the 
same site on one individual (when testing on different occasions), the relationship 
between anatomical landmarks and these sites was established.
It was important to standardise the algometer application at 90 degrees. In order to 
identify the best position for this to be achieved, the participants firstly lay prone, 
then supine, then side lying and finally in supported long sitting on a modified plinth 
whilst the researcher identified the optimum position to achieve a 90-degree angle 
at each PPT site. The plinth was a fixed height plinth (modified so that it could be 
mounted on the force plates); therefore in order to achieve the optimum testing 
position the researcher stood on different sized wooden blocks.
4.4.11. Results and discussion
Examination of range of movement data demonstrated clear traces for flexion, 
extension and lateral flexion demonstrating good face validity. Figure 4.6 depicts 
a graphical representation of the data for one participant for movement over 
time. The first movement performed was flexion, followed by extension (in red). 
Participants were then asked to move into left and right lateral flexion movements 
(demonstrated by changes in the green trace). The last movements that were 
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performed were left and right rotation (blue trace). As seen in Figure 4.6,  
left rotation (positive values) which preceded right rotation (negative values)  
was not clear and it was not possible to be certain when left rotation was starting  
or when it had reached maximum range. This cast doubt over the face validity  
of rotation movement measurements (that it appeared to measure what it is 
supposed to measure (Streiner and Norman, 2008)). Because range of rotation  
in the lumbar spine is small, amounting to approximately 5 degrees in total 
(Kapandji, 1974), and due to the difficulties in measurement, it was decided  
not to include measurements of rotation in the main procedure. 
Figure 4.6. A plot of Fastrak data for range of movement. Discernable peaks for flexion and 
extension and lateral flexion are indicated. Left lateral flexion was followed by right lateral 
flexion (positive range figures). Peaks for left rotation are unclear.
28.125
Lumbar spine range of movement
LEFT LATERAL FLEXION
ORIGINAL IN COLOUR
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On stiffness testing, visual inspection of sensor movement during the application  
of PA force to the spine suggested that skin movement as opposed to angular 
rotation dominated movement of the sensors. This suggested that movement 
did not follow the three-point bending theory of movement during PA loading 
and raised concerns over the choice of stiffness measurement methods. These 
observations caused the researcher to revisit the alternative, displacement method, 
of stiffness measurement. Most studies using the alternative force /displacement 
method of stiffness testing had employed a motor driven indenter (see section 
3.2.1) which was not available. However other researchers had developed a hand 
held indenter and reported good reliability (Owens et al., 2007a,b). Because 
this pilot work raised concerns regarding the validity of three-point bending 
measurements and a lack of comparison between the methods was evident in the 
literature, a hand held indenter (similar to that developed by Owens et al (2007a,b)) 
was developed to enable measurements of the displacement method of stiffness 
measurement to be obtained, alongside the three-point bending measurements. 
The reliability study and single-arm trial (chapters 5 and 6), compared stiffness 
measures simultaneously collected using both displacement and three-point 
bending methods. 
It was immediately apparent that some potential PPT sites were very sore, causing 
the participants to indicate that the pain threshold had been reached with little 
more than the weight of the algometer itself. Small differences in positioning of the 
algometer tip appeared to make large differences to the PPT.
 
The following points are of particular note:
	 •	 	The	insertion	area	of	deltoid	was	very	sensitive	compared	 
to the middle of the muscle.
	 •	 	The	area	immediately	over	the	spinous	processes	was	found	to	be	particularly	
sensitive; moving 2 fingers breadth laterally, over the paravertebral muscles 
resulted in less immediate soreness. Possible S1 sites on the little toe sites 
were sensitive with minimal pressure (often less than 1kg) and thus a site on 
the lateral heel was used for the S1 signature zone. 
	 •	 	L1	signature	zone	(below	the	anterior	superior	iliac	spine	in	the	groin	area)	
proved to be very sensitive. It was also difficult to preserve participants’ 
modesty whilst testing this area which created an ethical dilemma. It was 
decided that it was not possible to find an L1 site that was within a signature 
zone and appropriate for testing. 
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Finding the same anatomical location on two, different sized participants proved 
difficult; for example when trying to reproduce a position in the mid-thigh, 
measuring 15 cm above the patella produced a reproducible point on a single 
individual but located a different anatomical location on the leg in the two different 
sized participants included in this study. Therefore when measuring PPT in the 
mid-thigh (for the L2 dermatome), the length of the participant’s leg was measured 
from the participants’ anterior superior iliac spine to the base of the patella. This 
measurement was halved to identify the PPT testing site. The same issue arose with 
the L3 measurements; a site a set distance above the patella produced a different 
location in the different individuals (in one it was at a point in the quadriceps 
muscle belly whilst on the other it was at a point where the muscle was becoming 
tendinous). This study found that using three of the participant’s finger widths to 
measure above the patella produced a similar anatomical position in different sized 
participants. Identifying a site three of the participant’s fingers breadth below the tip 
of the acromion was also found to locate a consistent site in the deltoid muscle. The 
locations for all algometry testing sites determined by this study were used in the 
main studies included in this thesis.
Repeated testing of PPT was problematic due to increasing sensitisation of the 
area. This was particularly evident where one test was completed soon after the 
previous test at that site. Participants commented on the ‘memory’ of the previous 
test inhibiting their concentration on the subsequent test. Sensitivity resulting 
from repeated testing has been acknowledged by other authors (Pentelka et al., 
2012; Ohrbach et al., 1998). Indeed, the number of repeated measures needed 
to ensure reliable PPT measurements has been a matter for debate (see section 
3.4.2, page 38). Ohrbach and Gale (1989) found that the mean of the first two 
measurements was better than the first or second measurement on their own, but 
more than 2 measurements was not justified. The studies in chapters 5 and 6 of this 
thesis included 3 sets of measurements within a 1-hour period; if the mean of three 
measurements was taken this would result in 9 pressures at each site. Considering 
the evidence from studies examining the reliability of combined data from different 
trials and the problems with sensitisation at the testing sites it was decided that 
future studies would use the mean of 2 PPT measurements, reducing the amount  
of repeated tests to 6. 
 
Participants commented on the difficulty in assessing the exact point of pain onset, 
sometimes participants commented that there was lingering soreness after testing 
and it appeared to the researcher that they had depressed the switch later than the 
first onset of pain. Additionally, one of the two participants seemed very stoic and 
appeared to try and tolerate pain, this participant had initial high PPT followed by 
a much lower second set of readings, possibly caused by peripheral sensitisation. 
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Most of the published work seems to use the term ‘pressure to pain’. However 
other work has noted that participants found this point difficult to determine and 
have altered the standard instructions for example to ‘the moment the applied force 
becomes unpleasant’ (Dhondt et al., 1999) and ‘barely perceptible pain’ (Buchanan 
and Midgley, 1987). For this reason it was decided to emphasise to participants 
that the desired measure was not how much pain they can tolerate, but ‘the point 
at which the sensation changes from one of just pressure, to either discomfort 
or pain’. Indeed a recent unpublished study (McCardle, 2013), found that the 
instructions given to participants influenced the measurement error. Instruction of 
‘pressure to pain’ had greater measurement error than ‘pressure to discomfort’.
Another issue that arose during this pilot study was the importance of the 
participant’s full engagement in the testing procedure. It was important that 
participants concentrated on the exact point of change. On some occasions this 
didn’t occur due to distractions, e.g. where the participant lost attention, and the 
sensation sometimes became painful. For this reason the following was added to 
future instructions ’it is important that you attend to the point of change from just 
pressure to something else; you might call it ‘discomfort’ or ‘pain’.
Rotating through the measurements in each position resulted in a longer time 
interval between repeated measures. So whilst participants were lying prone,  
1 measurement was performed at the symptomatic spinal level, paravertebral 
muscle site, followed by 1 measurement at the T10 paravertebral muscle site 
followed by a 2nd measure at the symptomatic level paravertebral muscle site  
and a 2nd measure at T10 paravertebral muscle site. This was thought to be 
beneficial, as participants had concentrated on at least one different reading  
before they returned to the same site; it also allowed a ‘recovery period’ from the 
previous reading.
This pilot study resulted in the protocol detailed in Table 4.2. This was determined 
to be the optimum protocol in terms of participant and researcher positions and 
identification of PPT sites. In each position participants were required to lie on 
the edge of the plinth closest to the researcher. The PPT instructions provided 
to participants were standardised and carefully worded to try and maximise 
participant concentration and avoid participants tolerating any pain.
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Table 4.2. Algometry testing procedure established from pilot work. 
The researcher stood on a block to perform testing.
Site 
Number PPT site Participant position Landmark Blocks
1 Paravertebral muscles 
at L4 level
(chapter 5) or at 
symptomatic level 
(chapter 6 and 7)
Prone Paravertebral muscles two fingers 
breadth from spinous process.
20cm high 
block
2 Paravertebral muscles 
at T10 level 
Prone Paravertebral muscles two fingers 
breadth from spinous process.
20cm high 
block
3 Deltoid Side lying.
Participant with elbow 
positioned in waist
Two participant fingers breadth 
below the middle of the acromion.
20cm high 
block
4 S1 dermatome Side lying 
Bottom leg bent forward to 
allow testing leg to lie flat 
against plinth
Posterolateral heel. Two fingers 
breadth below and one fingers 
breadth posterior to the tip of the 
lateral malleolus.
10cm high 
block
5 L2 dermatome Supine Mid-thigh. Mid way between the 
anterior superior iliac spine and the 
base of the patella (measured using 
a tape measure).
20cm high 
block
6 L3 dermatome Supine Two participant fingers breadth 
above base of patella
20cm high 
block
7 L4 dermatome Supine 
Leg turned out (hip in 
flexion lateral rotation)
Two fingers above medial malleolus. 10cm high 
block
8 L5 dermatome Supine
Knee flexed so sole of  
foot flat on plinth.
Proximal to head of metatarsal. 10cm high 
block
4.5. Development of a hand held indenter for the displacement  
method of spinal stiffness measurement
The researcher manufactured a 15cm long cylindrical indenter (see Figure 4.7). 
It consisted of a 3.2cm diameter dowel (to avoid electromagnetic interference 
it was made from wood) with 0.5cm of thick, firm foam padding. A Fastrak 
electromagnetic sensor was mounted on the top of the indenter to measure 
vertical displacement and measurements of this system were validated against a 
ruler. This was similar to the hand held indenter used by Owens et al., (2007a,b). 
It is recognised that the compression of the foam padding will have contributed 
towards the measured displacement; however this will have produced a small and 
systematic error. This is not considered to be a serious limitation as the intention 
was to use the indenter to compare serial measurement. 
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Table 4.7. Handheld indenter 
4.6. Key learning points from the preliminary studies.
The preliminary work in this thesis identified a number of key learning points which 
were carried forward to the main studies. These were as follows:
	 •	 	Measurement	of	rotation	range	of	movement	was	not	easily	distinguishable	on	
the movement graphs and thus the face validity of rotation movements was 
questioned. Therefore rotation range of movement measurements was not 
included in the main studies.
	 •	 	During	PPT	measurements	the	positioning	of	the	participant	and	researcher	
was important during PPT measurements in order to ensure consistent 
application of pressure.
	 •	 	The	instruction	given	during	PPT	measurements	appeared	to	be	important	in	
reducing soreness resulting from repeated testing. 
	 •	 	Observation	of	three-point	bending	data	cast	doubt	over	the	validity	of	these	
measurements.
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4.7. Pilot work conclusion
Examination of ROM data highlighted the difficulties in measuring rotation. 
Therefore range of rotation was not measured in the later studies. Examination  
of three-point bending data raised concerns about the validity of measurements. 
This resulted in a hand held indenter being developed in order to enable 
synchronised measurement of stiffness using both methods evident in the literature 
(three-point bending and displacement). A standardised protocol for identification 
of PPT sites and positioning for algometry testing was established. During the 
course of this study it became apparent that instructions given during testing  
might influence sensitisation of the testing site. Modification of the instruction 
appeared to reduce sensitisation and discourage the participants from tolerating 
pain. These instructions were used in the later studies in this thesis.
The following chapter reports on a study which assesses the reliability of the 
stiffness, pain and ROM measurements used in later studies in this thesis.
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Chapter 5.
The within- and between-day test-retest reliability  
of pressure pain thresholds, range of movement 
and stiffness measurements of the lumbar spine.
5.1. Introduction
This study was conducted to establish the within- and between-day reliability of 
pain, ROM and stiffness measures in order to underpin later studies in this thesis 
(chapter 6 and 7), when the effects of a mobilisation treatment dose on these 
variables were investigated.
Reliability is a measure of the amount of error in a measurement (Streiner and 
Norman, 2008). Good test-retest reliability of lumbar ROM measurements using 
electromagnetic tracking devices has been reported (see section 3.1.1, page 25);  
as have stiffness measurements using both deformation (see section 3.2.1, page 
28) and three-point bending methods (see section 3.2.2, page 32). However 
reliability can vary according to the instruments used and methodological 
differences such as sensor fixation and thus it was deemed necessary to 
investigate reliability of ROM and stiffness measurements using the protocols  
that would be employed in the later studies in this thesis. 
Excellent PPT test-retest reliability has also been reported (see section 3.4.2, 
page 38) but it varies according to the PPT site tested. Later studies in this thesis 
(chapter 6 and 7) investigated the extent of the hypoalgesic effect of mobilisations 
applied to the symptomatic vertebral level and thus measured PPT in 8 different 
locations, not all of these locations have been previously tested for reliability. Thus 
an investigation of the reliability of measurements at all 8 PPT sites was necessary 
prior to the later studies in this thesis. 
In a later study (chapter 7) the immediate and short-term effects of a mobilisation 
treatment were investigated. For this reason the current study was designed 
to establish both within- and between-day reliability of ROM, stiffness and PPT 
measurements. Pilot work (section 4.4) highlighted potential problems with the 
validity of three point bending stiffness measurements. For this reason an indenter 
was developed to enable comparison of three-point bending and displacement 
methods of stiffness measurement.
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5.1.1. Research questions
What is the within- and between-day reliability and measurement error of the 
following measurements: ROM measures using an electromagnetic tracking 
device, stiffness (using three-point bending and displacement methods) and 
pressure pain thresholds (at each of 8 sites)?
5.1.2. Study aims
1.  To determine the within- and between-day reliability of measurements 
of ROM, stiffness and pressure pain thresholds.
2. To explore the validity of stiffness measurements
5.2. Method
5.2.1. Study design
This was a within- and between-day reliability study
5.2.2. Ethics approval
This study was approved by the Faculty of Health and Social Science Research 
Ethics and Governance Committee (FREGC) (Appendix 2). 
5.2.3. Participants
Twenty asymptomatic participants were recruited via posters placed on the 
university email. Potential participants were sent a participant information sheet 
and list of inclusion and exclusion criteria and asked to contact the principal 
researcher again if they wished to take part, at which point an appointment was 
made for them to attend the human movement laboratory, Robert Dodd Annex, 
Eastbourne.
5.2.4. Inclusion criteria and exclusion criteria 
Potential participants were required to be between 18-70 years of age.
Potential participants for this study were excluded if they had a history of back pain 
as it may have affected the reliability of readings. To prevent potential soreness 
or damage to their spine participants with conditions that may have affected their 
spine and associated structures were excluded from the study. This resulted in the 
following exclusion criteria:
	 •	 	Spinal	congenital	abnormality
	 •	 	History	of	spinal	fracture
	 •	 	History	of	malignancy
	 •	 	Bone	disease	(osteoporosis,	osteomyelitis,	tuberculosis,	Paget’s)
67
	 •	 	Inflammatory	arthritis	(rheumatoid	arthritis,	ankylosing	spondylitis,	gout)
	 •	 	Congenital	generalised	hypermobility	(Ehlers-Danlos	syndrome)
	 •	 	Advanced	degenerative	changes
Participants with the following precautions to mobilisations were also excluded:
	 •	 	History	of	steroid	therapy
	 •	 	Pregnancy
	 •	 	Current	anticoagulant	medication
5.2.5. Confidentiality
All participant information was kept confidential and only made available to the 
study investigator and supervisors. All participants were allocated with a code; 
to ensure anonymity and all data was stored under that code, the key to which 
was kept on a password protected computer. To fulfil the requirements of the 
Data Protection Act 1998 all personal data was destroyed at the end of the study. 
Anonymised data will be kept for 10 years following completion of the study.
Figure 5.1. Flowchart depicting the reliability study procedure.
DAY ONE
➜
Physiological range of movement (4 movements)
(see section 5.2.10., page 70) 
3 times with 1 minute rest between reps
➜
Stiffness measurements (5 cycles)
(see section 5.2.11., page 71) 
3 times with 1 minute rest between reps
  ➜
 
 
PPT (mean of 2 measurements at 8 sites)
3 times with 1 minute rest between reps
DAY TWO
within 14 days
➜
Physiological range of movement (4 movements)
3 times with 1 minute rest between reps
➜
Stiffness measurements (5 cycles)
3 times with 1 minute rest between reps
  ➜
 
 
PPT (mean of 2 measurements at 8 sites)
3 times with 1 minute rest between reps
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5.2.6. Research approach and methods
This study was a same subject repeated measures design. Measurements were 
taken	3	times	on	participants’	first	visit	to	establish	within-day	(intra-day)	reliability.	
Three measurements were also taken on a second visit to enable calculation of 
between-day	(inter-day)	reliability.	See	Figure	5.1	for	participants’	journey	through	
the study.
5.2.7. Instrumentation and measurements
ROM was measured using Fastrak electromagnetic tracking system (3SPACE 
Fastrak, Polemus Inc. Colchester, VT, USA). Lumbar stiffness was measured 
simultaneously using three-point bending (force/angle) and displacement (force/
displacement) methods. This required force and Fastrak motion sensor data 
measurements to be taken simultaneously during the application of PA force. 
Motion was measured using Fastrak and force was measured using non-conductive 
ground reaction force plates (AMTI OR6-7 – Advanced Mechanical Technology Inc., 
Watertown, MA, USA). The force and motion data was synchronised using a TG200 
function generator, (Thurlby Thandar Instruments Ltd., Cambridgeshire, England).
For three-point bending measurement two electromagnetic sensors measured 
the change in the curvature of the spine (angular rotation) and to measure 
displacement measurements, the electromagnetic sensor mounted on the indenter 
(as described in section 4.5, page 61) measured vertical displacement.
The force plates indirectly measured the force applied by the therapist (Lee, 
2005a). The researcher stood on a wooden platform with a lean bar (see Figure 
4.1, page 53) during the stiffness testing procedure to ensure that only the 
therapist’s	mobilising	force	was	measured	by	the	force	plates.	The	force	and	
motion data was synchronised using a TG200 function generator, (Thurlby Thandar 
Instruments Ltd., Cambridgeshire, England).
PPT were measured using an electronic pressure algometer (Tracker computerised 
algometry system, JTECH medical industries, Salt Lake City, Utah) fitted with a 1cm2 
tip. The algometer had two features designed to aid reliability. Firstly an on-screen 
dial to facilitate the researcher in standardising the rate of application at 1kg/cm2/
sec (see Figure 4.2, page 54); standardisation of the rate of application has been 
shown to vary results (List, 1991; Jensen et al., 1986). Secondly, a patient control 
switch, which enabled the participants to freeze the recording at the point ‘that the 
sensation	of	pressure	changes	to	pain	or	discomfort’.	The	patient	control	switch	
prevented a time delay between the participant communicating the point of change 
and the researcher recording a measurement. PPT readings were automatically 
saved when the patient control switch was pressed. 
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5.2.8. Procedure
Participants	attended	the	human	movement	laboratory	at	the	University	of	Brighton	
on two days. On each day the principal researcher greeted them and led them to 
a screened area. On the first day participants received a verbal explanation of the 
study and were asked to sign a consent form. The time period between days was 
not standardised but was kept to a maximum of 14 days. ROM, stiffness and PPT 
measurements were taken 3 times on each day as depicted in Figure 5.1. 
This study was designed to underpin later studies in this thesis which investigated 
the effects of a lumbar mobilisation treatment applied to the most symptomatic 
vertebral	level.	Because	participants	in	this	study	were	asymptomatic	the	L4	
vertebral	level	was	chosen	to	represent	the	‘symptomatic	level’.	The	L4	spinous	
process was located through palpation of bony landmarks (see following section) 
and marked with a pen, as were the points for PPT testing. The sites for PPT 
testing (Figure 5.3, page 72) were located using the landmarks detailed in Table 
4.2 (page 61). The algometer tip was placed on the skin and drawn around, to 
allow for accurate repositioning with repeated testing.
5.2.9. Fastrak sensor placement
To allow measurement of lumbar range of movement the Fastrak sensors were 
mounted on thin plastic plates (103 x 48 x 1mm) in a fixation method previous  
found to be reliable (Ha, 2010), and positioned on the sacrum and L1 spinous 
process using the following procedure: The skin on the participants back was 
cleaned using an alcohol wipe. The plastic plates were attached to the skin 
overlying the 1st lumbar vertebra and sacral base with double-sided tape (see 
section 4.4.7, page 54 for details on palpation of these anatomical landmarks). 
The bottom edge of the superior plastic plate was aligned with the spinous 
process of L1 and the top of the inferior plate was aligned with the base of the 
sacrum (Figure 5.2).
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Figure 5.2 Fastrak sensor placement on base of sacrum and L1.
5.2.10. Range of movement measurements
On both days, prior to taking ROM readings, participants were asked to bend as  
far as possible; forwards, backwards and to each side from a standing position.  
This was repeated 3 times. This enabled the fixing of the sensors to be checked  
and served to precondition the spine. Participants were then asked to stand upright 
with their feet hip width apart whilst a neutral position of the electromagnetic  
sensors was set (this allowed the starting position of the sensors to be recorded). 
The following instructions were given for the movements indicated. 
	 •	  Flexion: ‘bend forwards, as far as possible, running your hands down the front of your thighs.’ 
	 •	  Extension: ‘lean backwards as far as possible.’
 •	 	Lateral flexion: (indicating the participants left side) ‘running your hand down the side  
of your leg bend as far sideways as possible.’ ...‘and to the other side.’
(Figures 4.4 and 4.5, page 55).
The first cycle of movements was followed by a one minute rest period where 
participants were allowed to move around on the spot; a further two repetitions 
of ROM measurements with an intervening one minute rest period followed. This 
resulted in 3 ROM measurements on the 1st Day. This procedure was repeated  
on a 2nd day which occurred at least 24 hours (maximum 14 days) later. 
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In this study the reliability of measurements of single movements were  
explored (as opposed to taking the mean of 3 (Petty, 1995) or mean of 6 
(Stamos-Paspastamos	et	al.,	2011).	This	was	to	reflect	clinical	practice,	where	
physiotherapists perform a treatment and in order to assess the effectiveness 
of this treatment, immediately reassess the effect the treatment has had on 
physical tests such as ROM. Most of the previous studies investigating the 
effects of mobilisation on ROM have also used 1 repetition (Powers et al., 2008; 
Chiradenjnant et al., 2002 and 2003; Goodsell et al., 2000) (Table 2.2, page 10).
5.2.11. Measurement of stiffness
Lumbar spinal stiffness (with the force applied at L4) was measured simultaneously 
using three-point bending (force/angle) and displacement (force/displacement) 
methods. For three-point bending measurement two electromagnetic sensors 
(positioned as detailed in section 5.2.9 and Figure 5.2) were used to measure 
the change in the curvature of the spine (angular rotation) and to measure 
displacement, the electromagnetic sensor mounted on the indenter (section 4.5, 
page 61) measured vertical displacement.
Prior to stiffness measurement, 30 seconds of grade IV+ (small amplitude in the 
last third of resistance) PA mobilisations were applied to the L4 spinous process  
to precondition the spine (Lee and Evans, 1994). The indenter was positioned over 
the L4 spinous process and to allow accurate repositioning, drawn around with a 
temporary marker pen. 
For the stiffness measurements, the participant was asked to take a deep breath 
in, breathe out and refrain from breathing in (Shirley et al., 1999) whilst 5 cycles 
of PA mobilisations were applied to L4 spinous process by the researcher using 
the indenter at a rate of 0.5Hz (equivalent to one PA cycle every 1.5 seconds), 
standardised by the use of a metronome.
5.2.12. Procedure and order of PPT testing.
At the start of PPT testing, a familiarisation PPT was carried out on the dorsal aspect 
of the hand at the web-space between the thumb and index finger (enabling 
participant’s	to	experience	PPT	at	one	site,	prior	to	measurements	being	recorded).	
The algometer was applied perpendicular to the marked area of skin at all 
testing sites. It was explained to participants that the desired measurement 
point was when the sensation exceeded that of just pressure. Participants were 
asked	to	press	the	button	‘as	soon	as’	the	sensation	changed	from	just	pressure	
to	something	else	—	‘you	might	call	it	discomfort	or	pain’.	Once	participants	
depressed the button the pressure was removed and the PPT data was saved. 
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The order of testing was designed to allow sufficient rest between repetitions 
with	the	least	changes	in	participant’s	position.	All	tests	(see	Table	4.1,	page	48	
and Figure 5.3) were completed sequentially in one position before changing the 
participant’s	position.	Therefore	2	repetitions	were	completed	at	each	site	tested	
in prone (sites 1,2,1,2,) before moving into side lying and performing the testing 
sequentially in this position (sites 3,4,3,4). Participants were then asked to turn 
supine where the remaining sites were tested sequentially (sites 5,6,7,8,5,6,7,8). 
This procedure was carried out twice more to gain repeated measurements for the 
overall testing procedure. The testing positions for T10, deltoid, L3 and S1 can be 
seen in Figure 5.4 – 5.7. The same procedure was carried out on a second day to 
enable calculation of between-day reliability.
Figure 5.3. PPT testing sites.  
PPT sites
Paravertebral Muscles 
1. Symptomatic level 1.5cm left of symptomatic spinous process
2. T10 1.5cm left of T10 spinous process
3. Deltoid 3 fingers breadth from acromion
4. S1 Dermatome Lateral heel, 2 fingers posteroinferior to malleolus
5. L2 Dermatome Measured mid-thigh
6. L3 Dermatome 3 fingers above patella
7. L4 Dermatome 1 finger below medial malleolus
8. L5 Dermatome Great toe, proximal to metatarsal head
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Figure 5.4. PPT testing at T10 paravertebral muscles.
Figure 5.5. PPT testing at the Deltoid site
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Figure 5.6. PPT testing at L3 dermatome site.
Figure 5.7. PPT testing at S1 site.
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5.3. Data analysis
5.3.1. Analysis of range of movement data (ROM).
The	raw	data	for	ROM	was	processed	using	a	macro	written	in	Visual	BASIC 
for Applications (Microsoft Inc., Redmond, Washington) in Microsoft Office Excel 2007 
(Version 12.0, Microsoft UK, Reading, England) see Appendix 3. The processed data 
was checked for errors by hand. Descriptive statistics were performed on all data 
using Statistical Package for the Social Sciences (PASW version 18.0 for Windows). 
For	ROM	the	maximum	values	of	each	movement,	(flexion,	extension,	left	lateral	
flexion	and	right	lateral	flexion)	was	used	for	further	analysis.	Due	to	large	amounts	
of skin movement during ROM testing, slippage of the electromagnetic sensors can 
occur. Therefore data that greatly exceeded the ranges reported in previous literature 
utilising electromagnetic tracking systems was removed (see Table 3.1, page 27). The 
maximum ranges beyond which data sets were removed were as follows:
	 •	 	Flexion	100	degrees
	 •	 	Extension	70	degrees
	 •	 	Lateral	flexion	80	degrees
5.3.2. Analysis of stiffness data
The raw data for ROM and stiffness was processed using a macro written in Visual 
BASIC	for	Applications	(Microsoft	Inc.,	Redmond,	Washington)	in	Microsoft	Office	
Excel 2007 (Version 12.0, Microsoft UK, Reading, England). The processed data 
was checked for errors by hand. The macro calculated the stiffness coefficient 
using force/angle (three-point bending) and force/vertical displacement 
(displacement) data by linear regression of the loading phase between 30-100N on 
the force-displacement curve (see Appendix 3). For stiffness the mean of cycles 
2-5 was calculated and used in further analysis (cycle one was discarded due to 
transient behaviour on start-up). Descriptive statistics were performed on all data 
using Statistical Package for the Social Sciences (PASW version 18.0 for Windows). 
5.3.3. Analysis of pressure pain threshold data
For PPT the mean of the two measurements at each site was used for further 
analysis. Descriptive statistics were performed on all data using Statistical 
Package for the Social Sciences (PASW version 18.0 for Windows). 
5.3.4. Normality testing of data
Processed data was analysed for normality in Statistical Package for the Social 
Sciences (PASW version 18.0 for Windows) using the Shapiro-Wilk test. 
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5.3.5. Reliability analysis
For reliability testing of ROM, stiffness and PPT measurements, a two-way random 
effects model ANOVA was used to break down the total variance score into 
variance due to patients, day and error (Streiner and Norman, 2008). The variation 
in intra-day and inter-day measures were calculated separately from the variance 
breakdown of the ANOVA using the random factor Intraclass Correlation Coefficients 
(ICC’s)	described	by	Eliasziw	et	al.,	(1994).	In	order	to	improve	precision	this	
method uses all observations in the analysis (Eliasziw et al., 1994). One-sided 95% 
confidence intervals (CI) for the ICC, standard error of measurement (SEM) and 
minimal detectable change (MDC) were calculated as recommended by Eliasziw 
et al., (1996). The SEM and MDC were calculated as it was recommended that this 
degree of change was necessary when evaluating pre and post treatment measures 
in order to be able to attribute the change to treatment (Eliasziw et al., 1994). 
5.3.6. Analysis of the correlation between three-point bending and deformation
The relationship between three-point bending and deformation data sets was 
analysed	using	Spearman’s	correlation.	
5.4. Results of the reliability study.
Three males and 17 females participated in the study. Participants had an age 
range of 18-40 years, and a mean age of 23.2 years (SD 6.48); their mean height 
was 168cm (SD 8.9) and weight 65.9kg (SD 7.9). All participants completed the 
study	without	reporting	any	adverse	effects.	The	time	between	participant’s	first	
and second attendance ranged from 1-13 days (mean 5.45, SD 3.91). Due to 
some	corrupted	data	not	all	participant’s	data	was	used	for	each	measure;	for	this	
reason demographic data for the participants included is presented individually in 
each measurement section. 
5.4.1. Results of reliability of range of movement measurements
One ROM file for one participant (participant 4) was corrupted. Four participants 
(6,	8,16	and	17)	exhibited	extreme	ranges	for	right	lateral	flexion	(see	Figure	5.8)	
so these data sets were removed as outlined in section 5.3.1 (page 75).
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Figure 5.8. Right lateral flexion (RLF) range of movement for all participants on all occasions 
(RLF 1-6). Data for participants 6, 8, 16 and 17 was excluded, as it was greater than anatomically 
possible and greater than ranges reported in previous studies.
Data for 2 male and 13 female participants (age range 18-31 years, mean 20,  
SD 4.5) were included in the analysis. Normality testing revealed that 22 of the 24 
data sets (for 4 movements on 6 occasions) were normally distributed. There were 
minor deviations on two data sets (p=0.009 and p=0.024) Appendix 4. 
The differences between mean measures of range of movement were less than  
3.5 degrees within one day and less than 5 degrees between days (Figures 5.9 
and 5.10). This demonstrated small variation in mean measurements.
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Figure 5.8. Right lateral flexion (RLF) range of movement for all 
participants on all occasions (RLF 1-6). Data for participants 6, 8, 16 and 
17 was excluded, as it was greater than anatomically possible and greater 
than ranges reported in previous studies. 
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Figure 5.9. Range of flexion and extension for all 6 trials (3 trials on 2 
different days). The data are means. Error bars represent +/- standard 
deviation. 
 
 
 
Figure 5.10. Range of lateral flexion for all 6 trials (3 trials on 2 different 
days). The data are means. Error bars represent +/- standard deviation. 
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Figure 5.9. Range of flexion and extension for all 6 trials (3 trials on 2 different days). 
The data are means. Error bars represent +/- standard deviation (n=15).
Figure 5. . ange of lateral flexion f r all 6 trials (3 trials on 2 different days). 
The data are means. Error bars represent +/- standard deviation (n=15).
Reliability statistics for ROM are displayed in Table 5.1. The within-day reliability 
for	lateral	flexion	and	extension	(ICC	0.80-0.94;	one	sided	CI	0.62-0.86),	fall	within	
the	range	of	ICC’s	described	by	Fleiss	(1986)	as	excellent.	The	ICC	(ICC	0.69;	
one	sided	CI	0.39)	for	flexion	suggested	that	reliability	of	flexion	ROM	fall	within	
the range representing fair to good (Fleiss,1986). The ICC only provides a point 
estimate	and	the	lower	CI	for	flexion	(0.39)	indicates	that	on	different	occasions	
reliability may be poor.
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Between-day	reliability	was	lower	than	within-day	in	all	cases;	ICC’s	for	lateral	
flexion	demonstrated	that	between-day	reliability	remained	excellent	(ICC	0.75-
0.79; one sided CI 0.59-0.61). However, between-day reliability for extension (ICC 
0.48;	CI	0.03)	and	flexion	(ICC	0.43;	CI	0.14)	were	fair	(Table	5.1)	and	they	fell	
just above the level representing poor reliability. Again, the lower CI (0.03-0.14) 
suggested that on other occasions reliability may be poor.
Movement
Within-
day
ICC
Within-
day  
lower CI
Within-
day SEM
(°)
Within-
day MDC
(°)
Between-
day ICC
Between-day 
lower CI
Between-day
SEM
(°)
Between-
day MDC
(°)
Flexion 0.69 0.39 5.6 15.4 0.43 0.14 7.7 21.4
Extension 0.95 0.88 2.2 6.0 0.48 0.03 7.0 19.6
Left Lateral 
flexion 0.94 0.86 1.4 3.8 0.79 0.61 2.5 6.8
Right lateral 
flexion 0.80 0.62 2.7 7.5 0.75 0.59 3.0 8.3
Table 5.1. Within-day and between-day reliability of ROM measurements (n=15). Figures are 
Intraclass Correlation Coefficient (ICC), 95% one sided confidence Intervals (ICC), standard error 
of measurement (SEM) and minimal detectable change (MDC). SEM and MDC are in degrees. 
5.4.2. Results of reliability of stiffness measurements.
There was an error in the Fastrak and force plate files for 5 participants where  
they failed to synchronise. Therefore 15 data sets were suitable for analysis.  
Data for 1 male and 14 female participants (age range 18-40 years, mean 23,  
SD 6) were included in the analysis. Three-point bending data displayed much 
greater range and standard deviation than the displacement data (Figures 5.11 
and 5.12), suggesting that there was greater variability in three-point bending  
than displacement measurements. Normality testing revealed that 7 of the 12  
data sets (for 2 methods on 6 occasions) were normally distributed. 
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Figure 5.11. Three-point bending measurements for all 6 trials (3 trials on 2 different days).
The data are means. Error bars represent +/- standard deviation (n=15). 
Figure 5.12. Displacement measurements for all 6 trials (3 trials on 2 different days).
The data are means. Error bars represent +/- standard deviation (n=15).
Reliability of stiffness measurements are displayed in Table 5.2. The ICC value  
for within-day three-point bending measurements was excellent (ICC 0.77). 
Between-day	stiffness	(0.47)	was	just	sufficient	to	achieve	the	fair	to	good	range	
described by Fleiss, (1986). The ICC values (0.56-0.61) within- and between-days 
for displacement measurements of stiffness fell within the range representing fair  
to good reliability. 
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Figure 5.11. Three-point bending measurements for all 6 trials (3 trials on 2 
different days). The data are means. Error bars represent +/- standard deviation.  
 
  
 
Figure 5.12. Displacement measurements for all 6 trials (3 trials on 2 different 
days). The data are means. Error bars represent +/- standard deviation. 
between days for displacement measurements of stiffness fell within the range 
representing fair to good reliability.  
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Figure 5.11. Three-point bending measurements for all 6 trials (3 trials on 2 
different days). The data are means. Error bars represent +/- standard deviation.  
 
  
 
Figure 5.12. Displacement measurements for all 6 trials (3 trials on 2 different 
days). The data are means. Error bars represent +/- standard deviation. 
betwe n days for displacement measurements of stiffness fell withi  the range 
representing fair to good reliability.  
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Stiffness 
method
Within-
day ICC
Within-day 
lower CI
Within-
day SEM
Within-
day MDC
Between-
day ICC
Between-
day lower 
CI
Between-day 
SEM
Between-day 
MDC
Three-point
bending 0.77 0.52 0.20 N/°
0.57
N/° 0.47 0.18 0.31 N/° 0.87 N/°
Displacement 0.56 0.30 0.14N/mm
0.39
N/mm 0.61 0.44
0.13
N/mm 0.37 N/mm
Table 5.2. Within-day and between-day reliability of three-point bending and displacement 
stiffness measurements (n=15). Figures are Intraclass Correlation Coefficient (ICC), 95% one 
sided confidence Intervals (ICC), standard error of measurement (SEM) and minimal detectable  
change (MDC). SEM and MDC are expressed in Newton /degrees (N/0) for three-point bending 
and N/mm for displacement. 
5.4.3. Correlation between three-point bending and displacement measurements.
Visual inspection of the force displacement curves revealed quite different force 
displacement profiles for the displacement and three-point bending data. The 
displacement curves during the loading cycles appeared sinusoidal with smooth 
peaks. In contrast the three-point bending (angle) data showed a more saw, or 
sharks’	tooth	pattern,	with	an	irregular	peak	(see	Figure	5.13).
A correlation between baseline data from the first day for three-point bending and 
displacement demonstrated that there was a significant (p=.01) but moderate 
(r=0.64) positive correlation, 95% confidence interval (CI) 0.20-0.87 (Figure 5.14). 
This correlation was repeated on baseline data from the second day (Figure 
5.15), this resulted in a positive correlation with an increased significance level 
(p=.003, r=0.70) 95% CI 0.30-0.89 (Appendix 5). These correlations demonstrated 
that higher three-point bending measurements were associated with higher 
displacement measurements.
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Figure 5.13. Example of a force / displacement and angle graph. Angle data has a saw tooth 
pattern as opposed to the sinusoidal pattern of deformation data.
Figure 5.14. Correlation between three-point bending and displacement measurements at 
baseline on day 1 demonstrated that there was a significant (p=.01) but moderate (r=0.64) 
positive correlation, 95% confidence interval (CI) 0.20-0.87.
 
 4 
 
 
 
 
Figure 5.13. Force / displacement and angle graph. Angle data has a saw 
tooth pattern as opposed to the sinusoidal pattern of deformation data. 
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Figure 5.14. Correlation en thr e-point be ding and displace nt 
measurements at baseline on day 1 ndemonstrated that there was a significant 
(p=.01) but moderate (r=.64) positive correlation, 95% confidence interval (CI) 0.20-
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Figure 5.15. Correlation between three-point bending and displacement measurements 
at baseline on day 2 demonstrated a positive correlation with an increased significance 
level (p =.003, r=0.70) 95% CI 0.30-0.89
5.4.4. Results of reliability of Pressure Pain Thresholds
All PPT data sets were suitable for analysis. Descriptive statistics for all 6 
repetitions (3 repetitions on each of 2 days) are displayed in Figures 5.16 and 
5.17. The largest within-day difference between mean measurements (0.5 kg/cm2) 
was at the S1 dermatome site. The largest within-day difference between mean 
measurements was (0.6 kg/cm2) at the L4 paravertebral site. This demonstrated 
that there were small variations in mean PPT measurements.
 
Figure 5.16. PPT measurements for all 6 trials (3 trials on 2 different days).
The data are means. Error bars represent +/- standard deviation (n=20). 
 
 
Figure 5.14. Correlation between three-point bending and displacement 
measurements at baseline on day 1 ndemonstrated that there was a significant 
(p=.01) but moderate (r=.64) positive correlation, 95% confidence interval (CI) 0.20-
0.87. 
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Figure 5.16. PPT measure ents for all 6 trials (3 trials on 2 different days). The 
data are means. Error bars represent +/- standard deviation.  
 
 
Figure 5.17. PPT measurements for all 6 trials (3 trials on 2 different days). The 
data are means. Error bars represent +/- standard deviation. 
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Figure 5.17. PPT measurements for all 6 trials (3 trials on 2 different days).
The data are means. Error bars represent +/- standard deviation (n=20).
Normality testing revealed that 46 of the 48 data sets (for 8 sites on 6 occasions) 
were normally distributed. There were minor deviations on two data sets (p=.012 
and p=.015). The reliability results for PPT are shown in Table 5.3. 
Within-day	reliability	was	excellent	at	all	PPT	sites	(Table	5.3).	Between-day	
reliability for the PPT at L4 and T10 paravertebral muscles, L2, L3 and L5 
dermatome	signature	zones	was	excellent	(ICC	0.72-0.84).	Between-day	reliability	
at Deltoid muscle and L4 and S1 dermatomes (ICC 0.56-0.68) fell within the range 
representing fair to good reliability (Fleiss, 1986).
PPT
site
Within
-day ICC
Within-
day 
lower CI
Within-
day SEM 
kg/cm2
Within-
day MDC 
kg/cm2
Between-
day ICC
Between-
day lower 
CI
Between-
day SEM
kg/cm2
Between-
day MDC
kg/cm2
L4 sp 0.88 0.78 0.62 1.71 0.84 0.75 0.69 1.91
T10 0.84 0.72 0.54 1.49 0.79 0.67 0.62 1.71
Deltoid 0.84 0.70 0.51 1.41 0.64 0.42 0.80 2.19
S1 0.76 0.56 0.65 1.81 0.56 0.35 0.90 2.49
L2 0.86 0.74 0.62 1.71 0.72 0.55 0.89 2.44
L3 0.89 0.80 0.62 1.71 0.78 0.63 0.89 2.47
L4 0.87 0.75 0.55 1.53 0.68 0.48 0.88 2.43
L5 0.92 0.85 0.51 1.42 0.82 0.69 0.78 2.16
Table 5.3. Within-day and between-day reliability of PPT measurements (n=20). Figures are 
Intraclass Correlation Coefficient (ICC), 95% one sided confidence Intervals (ICC), standard error 
of measurement (SEM) and minimal detectable change (MDC). SEM and MDC are in kg/cm2. 
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Figure 5.16. PPT measurements for all 6 trials (3 trials on 2 different days). The 
data are means. Error bars represent +/- standard deviation.  
 
 
Figure 5.17. PPT measurements for all 6 trials (3 trials on 2 different days). The 
data are means. Error bars represent +/- standard deviation. 
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5.5. Discussion 
This study investigated the reliability of ROM, stiffness and PPT measures in order 
to underpin later studies in this thesis which investigated the effects of lumbar 
mobilisations on these variables. The Intraclass Correlation Coefficient (ICC) was 
used to give a measurement of reliability (1 being almost perfect and 0 being most 
unreliability (Landis and Koch, (1977)). The SEM and MDC were calculated for 
consideration alongside the results of a later study (chapter 7) in order to identify 
participants who responded to treatment. Measurements of lumbar stiffness were 
obtained using two different methods and the results from these methods have 
been compared.
5.5.1. Discussion of reliability of range of movement measurements 
Previous	studies	have	reported	similar	within-day	ICC’s	to	those	reported	in	 
this	study;	for	example	Mannion	and	Troke,	(1999)	reported	within-day	ICC’s	
of 0.82-0.99 and Lee and Wong, (2002) reported a co-efficient of multiple 
determination of 0.98. Lower between-day reliability was expected, as it required 
highly accurate identification of bony landmarks and repositioning of the 
electromagnetic sensors. However Mannion and Troke, (1999) reported higher 
between-day	ICC’s	(0.72-0.81)	than	those	in	this	study.
Unfortunately Mannion and Troke, (1999) only reported a point estimate (the ICC) 
and therefore their results do not provide a complete picture of reliability. The 
interpretation of ICC scores varies (Table 5.4) and is considered to be an arbitrary 
interpretation	as	reliability	data	should	be	considered	in	relation	to	the	measure’s	
intended use (Fleiss, 1986) and alongside the CI, SEM and MDC statistics 
(Eliasziw et al., 1994). The SEM and MDC provide a greater picture that can be 
contextualised in relation to the intended use. The MDC in this study indicated that 
a	measurement	change	above	15.41°	flexion	within	one	day	and	21.4°	between	
days would be necessary to be 95% sure that an actual change had occurred 
(rather than a change due to natural variability and measurement error). This 
represents a change of nearly one-third of the total range – a difference that is 
unlikely to occur with treatment. MDC for other movements was less than that of 
flexion;	for	example	for	lateral	flexion	the	within-day	MDC	was	3.78°	and	inter-day	
MDC was 6.81°. The reliability of these measurements may be suitable for the 
intended use but required further consideration alongside the change seen with 
treatment explored in the following study in this thesis.
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Reliability classifications
Landis and Koch (1977)
0.81 - 1 Almost perfect
0.61 - 0.80 Excellent
0.41- 0.60 Moderate
< 0.40 Fair to poor
Table 5.4. Different interpretation of intraclass correlation coefficients.
The ranges of movement reported in the current study were similar to those 
identified	in	the	literature	review;	the	mean	range	of	flexion	in	this	study	was	 
50°- 52°,	comparable	to	previously	reported	flexion	ranges	of	58°	(Lee	and	Wong,	
2002) and 49° (Lee et al., 2003). The mean range of extension in the current 
study was 25-27°, similar to the extension range (mean 23°) reported by Stamos-
Papastamos	et	al.,	(2011).	Range	of	lateral	flexion	in	the	current	study	was	26°	for	
left	lateral	flexion	and	25-26°	for	right	lateral	flexion,	similar	to	the	22°	reported	by	
Lee and Wong, (2002).
Although the ROM in the current study was similar to those previously reported, 
some	measurements	for	right	lateral	flexion	were	very	large	(as	high	as	157.56°	for	
a single reading). These aberrant data sets were removed in accordance with the 
criteria set out in section 5.3.1 (page 75). These measurements were considerably 
greater than anatomically possible and although measurements of physiological 
range	taken	at	the	skin’s	surface	overestimate	the	range	of	joint	movement	due	to	
movement of the skin, the aberrant movements in this study far exceeded those 
reported in previous studies measuring ranges using electromagnetic tracking 
systems (Hindle et al., 1990; Peach et al., 1998; Mannion and Troke, 1999). 
Some participants in this study were perspiring heavily as they had cycled to 
the laboratory; every attempt was made to clean and dry the skin but on some 
individuals good adhesion was not possible and on a few occasions the tape fixing 
the electromagnetic sensor became unstuck and required reapplication.  
On some individuals the sensors required re-sticking after each cycle of movements. 
Right	lateral	flexion	was	the	last	in	the	cycle	of	movements	(the	movement	order	
in	one	cycle	was	flexion,	extension,	left	lateral	flexion,	right	lateral	flexion)	and	
therefore would have been more likely to be subject to error due to the sensors 
becoming unstuck. This may have occurred without the researcher becoming aware 
and may have affected readings on an individual basis. Fixation of the sensors on 
the skin whilst participants moved over large ranges proved difficult and has been 
recognised and received considerable attention previously (Ha, 2010). Moreover on 
participants with high level of perspiration this remains an on-going challenge. 
Fleiss (1986)
> 0.75 Excellent
0.40 - 0.75 Fair to good
< 0.40 Poor
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In	summary	although	on	initial	appraisal	the	ICC’s	could	be	regarded	as	
acceptable,	the	CI’s	suggest	that	on	other	occasions	reliability	may	be	insufficient.	
The MDC indicated that in some cases a large difference would need to have 
occurred before it could be attributed to a treatment effect. These reliability 
statistics required further consideration alongside studies investigating the effect 
of treatment. The ranges of movement were comparable with the published 
literature. Where anomalies were evident it is likely that these were due to poor 
fixation of the sensors. In future work it will be important that considerable care 
is paid to preparation of the skin, ensuring it is dry and cleansed with alcohol 
wipes	to	remove	any	oils	on	the	skin’s	surface.	It	is	also	important	to	emphasise	to	
participants that they should not exercise immediately prior to data collection. 
5.5.2. Discussion of reliability of stiffness measurements 
Only one study has previously reported on within-day reliability of three-point 
bending,	quoting	ICC’s	of	0.97-0.99	(Lee	et	al.,	2005a).	Within-day	reliability	of	
three-point bending measurements in this study was lower (ICC 0.77). Lee et 
al., (2005a) calculated reliability of stiffness measurements of three consecutive 
oscillatory cycles whereas those for this study were calculated using the mean 
of cycles 2-5 repeated at 5-minute intervals. There are a number of factors 
that could explain the lower within-day reliability figures reported in the current 
study. These include inaccuracy in repositioning of the indenter over the spinous 
process (following the 5-minute interval), and measuring at a different point in the 
respiratory cycle. The lower between-day reliability (ICC 0.47) can be explained by 
additional between-day variables such as inaccurate identification of the vertebral 
level at which testing took place, inaccurate re-positioning of the electromagnetic 
sensors and within-subject variation. 
In the current study reliability of the displacement method of stiffness measurement 
was	lower	than	that	in	previous	research	reporting	within-day	ICC’s	ranging	from	
0.88-0.96 (Latimer et al. 1996a; Lee and Svensson 1990) and a between-day 
ICC of 0.88 (Shirley et al., 2002). These studies all used a mechanically driven 
indenter which was able to standardise the rate and amount of force applied. 
An important difference in the current study was the use of a hand held indenter, 
which introduced human error into the application of force. For this reason it 
was anticipated that the reliability of measures in this study would be lower than 
those in published studies. Although every attempt was made during the current 
study to standardise the application of force, operator variation (of maximum 
force, frequency and angulation) could not be removed altogether. One group of 
researchers have used a hand held manually operated indenter similar to the one 
used in the current study and reported an ICC of 0.79 (CI 0.74-0.83, SEM 1.62 N/
mm) in measurements taken 5 minutes apart (Owens et al., 2007a). This is higher 
88
than the reliability seen in this study. However Owens et al., (2007a) removed 10% 
of the cycles, as they did not show a linear force displacement graph, which may 
have resulted in improved reliability. It is questionable whether it was appropriate 
to	remove	these	cycles	as	it	is	common	for	force	displacement	graphs	from	PA’s	to	
be non-linear (Nicholson et al., 2001). The only cycles removed from testing in the 
current study were those where there was an error with synchronisation of the force 
and motion data. 
When considering the reliability of both three-point bending and displacement 
methods of measuring stiffness it is important to take into account the size of 
the	between-subject	variation	as	this	can	lead	to	unrepresentatively	high	ICC’s	
(Portney and Watkins, 1990). The large range and standard deviation of three-
point bending measurements indicated that either a large amount of random error 
occurred during testing or that there was a high variability of stiffness between 
participants (Figure 5.11). The standard deviation was smaller on the second day 
of testing suggesting that a learning effect had occured. This could be explained 
by participants becoming accustomed to force being applied to their spine 
through the indenter. High between-subject variability has been widely observed in 
previous studies using both the three-point bending method (Stamos-Papastamos 
et al., 2011) and displacement method (Lee et al., 1996). It has been suggested 
that normal subjects will display stiffness values ranging from 50-200% of the mean 
value (Lee and Liversidge, 1994). However the greater spread of data with three-
point	bending	than	with	displacement	measurements	may	have	resulted	in	inflated	
ICC’s	for	three-point	bending.
Mean three-point bending measurements in this study (37.5 – 50.1 N/degree (SD 
11.6 - 36.7)) were considerably higher than those reported by Stamos-Papastamos 
et al., (2011) who reported mean stiffness of 23.14 N/degree (SD 19.66). No other 
studies have calculated three-point bending measurements in N/degree. Although 
the three-point bending method used in this study was similar to that used by 
Lee et al., (2005a) there are important differences between the methods and data 
analysis that make comparisons between the data inappropriate. Firstly the sensor 
placement was different from that used by Lee at al., (2005a). In order to measure 
both lumbar ROM and stiffness, in this study, the cephalic electromagnetic 
sensor was positioned on L1, whereas Lee et al., (2005a) placed the cephalic 
sensor on T8/9. Furthermore Lee et al., (2005a) developed an equation, which 
reportedly took into account the geometry of the spine when calculating stiffness 
measurements. In this study three-point bending was calculated simply by dividing 
the force applied by the resulting change in angle of the spine, thereby producing 
a measure of stiffness. This calculation method was also used by Stamos-
Papastamos et al., (2011).
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The stiffness figures for the displacement method (9.0-10.0 N/mm) are lower than 
those reported in previous literature; Shirley et al., (1999) reported stiffness values 
at L4 of 14.8 N/mm (SD 5.2). Other authors have reported mean values of 15.5N/
mm (Viner et al., 1997) and 13.3 N/mm (Lee et al., 1998). The lower figures in this 
study may be due to participant or methodological difference; spinal stiffness has 
been shown to be greater in males (Snodgrass et al., 2008; Owens et al., 2007b) 
and all but one of the participants in this study were female. Previous studies 
applied force at angles varying from 4.5 degrees caudad (Shirley et al., 1999) to 
13.3 degrees caudad (Lee et al., 1998), whereas the current study applied force 
at zero degrees (as it was not possible to standardise other angles using the hand 
held indenter). However the difference in angulation does not necessarily explain 
the lower figures reported in this study as applying inclined pressure means that 
the force is more in line with the facet joint and therefore might be more likely to 
result in lower stiffness values than pressure applied at zero degrees. 
In summary, although within-day reliability of three-point bending was excellent, 
between-day reliability was fair. Furthermore the high between-subject variation 
may	have	resulted	in	inflated	ICC’s.	These	results	suggest	that	further	investigation	
of this method is necessary before it is used in future work. The displacement 
measurements of stiffness showed good reliability. For either method of stiffness 
measurement the magnitude of the changes must be large enough to be 
statistically and clinically significant (Portney and Watkins, 2000), so it is necessary 
to consider the reliability figures reported in this study alongside the results of work 
investigating the effects of mobilisation treatment on stiffness. The reliability of 
stiffness in this study is lower than in previous studies. This is largely explained by 
the use of a manually applied indenter.
Preliminary work (section 4.4) had cast doubt over the validity of the three-point 
bending method. One aim of this study was to explore the validity of stiffness 
measurements in order to establish which method would be most suitable for 
monitoring change resulting from mobilisation treatment. The following section 
considers the validity of stiffness measurements.
5.5.3. Validity of three-point bending and displacement methods 
of stiffness measurements. 
One aim of this study was to explore the validity of three-point bending 
and displacement methods of stiffness measurements. Visual inspection of 
movement during the application of force to the spine demonstrated that skin 
movement resulting from the application of force dominated movement of the 
sensors. Furthermore, when watching the electromagnetic sensor motion during 
the application of a PA pressure they did not appear to produce the angular 
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displacement that would be evident if three-point bending were occurring. This 
raised concerns about the face validity of three-point bending measurements. 
Establishing the validity of the stiffness measurements is difficult as it requires one 
to determine that three-point bending measures what they intended to measure 
(Portney and Watkins, 2000) – in this case spinal stiffness. 
This study investigated criterion validity, which is the ability of one test to predict 
the results of another (Streiner and Norman, 2008). In this case of spinal stiffness 
tests using three-point bending and displacement methods a component of 
criterion related validity called concurrent validity (when measures are taken at the 
same	time	so	they	reflect	the	same	event)	was	explored.	The	correlation	performed	
calculated the extent to which the relationship between three-point bending and 
displacement	could	be	described	by	a	regression	line,	and	therefore	reflected	
the association between the two sets of data (Portney and Watkins, 2000). The 
correlations found in this study were significant and moderate to very strong 
positive correlations, demonstrating that higher three-point bending measurements 
were associated with higher displacement measurements.
Criterion validity, ideally compares one test considered to be the gold standard 
measurement for that variable to predict the results of another (Streiner and 
Norman, 2008). Although the displacement method has been used widely in 
the measurement of spinal stiffness (see section 3.2.1), it is not necessarily 
considered to be a gold standard. Portney and Watkins, (2000) emphasised the 
need of establishing the validity of the gold standard measure using three criteria; 
it is reliable, it is independent and free from bias and most importantly that it is 
relevant to the behaviour being measured. It is essential to consider the validity 
of the displacement method using these three criteria: Firstly the displacement 
method of stiffness testing has been shown to be reliable in previous work (Lee 
and Svensson, 1990 and Latimer et al., 1996b), however only moderate reliability 
was achieved in this study. Secondly testing is standardised by the indenter. 
In this study the indenter was applied by a human operator (as opposed to the 
mechanical indenters used in some previous work) and for this reason in this 
study it may be considered not to be entirely free from bias. The final criterion of 
a gold standard is that it is relevant to the behaviour being measured and if the 
aim is to test the stiffness that physiotherapists perceive during assessment, then 
the displacement method of stiffness measurement would meet this criterion. 
Accepting the displacement method of stiffness measurement as a gold standard 
is not without its limitations, however there is no other method of stiffness 
testing against which to judge three-point bending. Portney and Watkins, (2000) 
advocated that where testing against a gold standard is not possible, construct 
validity should be considered. 
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Construct validity is an on-going process, which involves continually testing its 
predictions. An example of this for stiffness testing would be the ability of the 
measure to detect change over time. This relies on scores remaining stable when 
the patient is unchanged, and scores changing with changes in the patient. In the 
current study three-point bending was measured on 6 occasions (3 measures on 
each of two days, 1-13 days apart); although the ANOVA showed that there were no 
significant differences in stiffness values over these occasions (p=.27), the between-
day	reliability	was	fair	(ICC	0.46).	It	is	unknown	how	actual	changes	in	participant’s	
spinal stiffness contributed to the poor reliability, however these were asymptomatic 
participants and it has been demonstrated that stiffness remained consistent in 
asymptomatic individuals over a similar period of time (Shirley et al., 2002). 
Validity of displacement method of measuring stiffness has previously been 
established when tested against a beam of known stiffness value (Lee and Svensson, 
1990 and Latimer et al., 1996b). However this may not transfer to valid measurement 
of	spinal	stiffness	due	to	the	spine’s	complex	structure.	The	displacement	method	
measures stiffness in a similar way to stiffness testing performed by a therapist and 
therefore is likely to represent what therapists perceive. For this reason it could be 
considered to have face validity and be suitable for the purpose it is intended.
Another component of construct validity is assessing the responsiveness to 
treatment. In this case, assessing the responsiveness of stiffness to treatments 
designed to reduce stiffness. When comparing the responsiveness of both methods, 
one may show a change with treatment whilst the other does not. This is further 
explored for stiffness measurements in a single-arm trial in chapter 6 of this thesis.
In summary, observation of the sensor movement occurring during testing cast 
doubt over the validity of three-point bending measurements. There was a significant 
and strong positive correlation between three-point bending and displacement 
methods of stiffness testing demonstrating that these measurements were 
associated with one another. However displacement has not been accepted as gold 
standard for stiffness measurement and therefore this association does not confirm 
the validity of three-point bending measurements. Further consideration of the 
validity of stiffness measurements by assessing the responsiveness to mobilisation 
treatment is reported on in the following single-arm trial in this thesis (chapter 6).
5.5.4. Discussion of reliability of pressure pain thresholds
As expected the PPT reliability within one day was higher than reliability over two 
occasions some days apart. Within-day reliability at all sites was excellent (ICC 
0.76-0.92). The MDC (depending on the testing site) indicated that a 1.4-1.8 kg/
cm2 change in PPT would need to occur before change within one day to be 95% 
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sure that the change could be attributed to treatment as opposed to measurement 
error.	Between-day	reliability	was	fair	to	excellent,	depending	on	the	testing	site	
(Table	5.3	page	85).	Between-day	reliability	at	Deltoid	muscle	and	L4	and	L2	were	
moderate. MDC statistics indicated that changes above 1.7- 2.5 kg/cm2 (depending 
on site) would be necessary to be certain that change was due to treatment. These 
reliability figures are similar to those reported previously (see Table 3.4, page 40). 
The reliability of PPT in this study suggests that they are suitable for measuring the 
effects of mobilisation treatment.
The PPT measured in the current study at the paraspinal sites (at the level of T10 (4.6 
kg/cm2, SD 1.4) and L4 (4 .7 kg/cm2, SD 1.8) were slightly lower than those reported 
in previous studies; mean PPT values reported in the literature vary, but range from 
7.4kg/cm2 (Farasyn and Meeusen, 2005) to 5.0kg/cm2 (Dhondt et al., 1999) at the T10 
paravertebral level. The higher values quoted in previous studies may be explained by 
differences	in	participants’	gender;	over	50%	of	the	participants	in	the	study	by	Farasyn	
and Meeusen, (2005) and a quarter of the participants in the study by Dhondt et al., 
(1999) were men, who have been shown to have higher PPT values (Riley et al., 1998). 
In the current study there were only 2 male participants (10%). Additionally, slightly lower 
values could be anticipated from this study as unlike previous studies the algometer 
had a patient control switch which may have reduced any delay between the participant 
indicating that the threshold has been reached and recording of the PPT value.
PPT at the L4 paraspinal site were also lower than those reported in previous work. 
Fischer, (1987) reported paraspinal mean PPT at the L4 level in females of 6.1kg/
cm and in males of 8.8 kg/cm2, however these measurements were taken at a point 
more lateral that the site used in this study. A mean PPT of 5.0kg/cm2 was reported 
at a more medial site at the paravertebral level of L5 (Dhondt et al., 1999), which 
was similar to the figure found at the L4 paravertebral site in the current study. 
Previous work has reported mean PPT in Deltoid of 5.1 Kg/cm2 (Fischer, 1987) and 
5.0 kg/cm2 (Antonaci et al., 1998), similar to the mean value of 4.2 kg/cm2 in the 
current study. The other sites used in this study have not been used in previous 
work hence comparisons are difficult. A site described as ‘ventral to the lateral 
malleolus’	was	used	by	Dhondt	et	al.,	(1989);	a	mean	PPT	of	5.0	kg/cm2 (SD1.83) 
was reported. This site is in a similar position to S1 where a mean reading recorded 
in this study was 5.3kg/cm2. 
In summary the reliability of PPT measures was good to excellent. The magnitude 
of readings found in the current study are slightly lower than those reported in 
previous studies but can be explained by the low proportion of male participants 
(who have higher PPT (Riley et al., 1998)) and the use of a patient control switch 
93
(which reduces a delay between participants indicating the point of change and 
the measurement recording). 
5.5.5. Key learning points form the test-rest reliability study.
Conducting the reliability study identified a number of key learning points which 
were carried forward to the later studies in this thesis. These were as follows:
	 •		 	Rebooting	the	computer	between	each	set	of	measurements	reduced	the	
number of synchronisation errors and corrupted data sets (potentially due  
to	reducing	errors	resulting	from	buffer	overflow).
	 •	 	Considerable	attention	needed	to	be	made	to	cleaning	and	drying	the	
skin prior to application of the Fastrak sensors. Time in the data collection 
schedule	is	required	to	enable	participants	to	‘cool	down’	if	they	cycle	to	 
the laboratory.
5.5.6. Overall summary of discussion
The first aim of this study was to establish the within- and between-day reliability 
and	measurement	error	of	ROM,	stiffness	and	PPT	measurements.	Reliability	reflects	
the extent to which a measurement is consistent and free from error or variation; it 
is a measure of the extent to which observed scores vary from true scores (Portney 
and Watkins, 2000). Measures both within a day and between days will always be 
subject to some variation, particularly when measuring factors on people; a number 
of factors including the time of day, their mood, hormonal cycle or diet and what they 
did	the	night	before	(be	it	exercise	or	a	late	night)	may	influence	the	repeatability	of	
measurements. The aim of this study was to establish the variation in measures that 
could be attributed to day-to-day variations and within-day variations, and to establish 
the magnitude of change required to be sure a treatment effect had occurred. 
The SEM and MDC were calculated for consideration alongside the following 
studies in this thesis. An important reason for calculating SEM and MDC is that 
high	between-subject	variation	can	lead	to	inappropriately	high	ICC’s;	using	
the SEM alongside the ICC allows greater interpretation of the usefulness of a 
measure. For this reason, when using pre and post intervention measures to 
determine the effects of treatment, Eliasziw et al., (1994) recommended calculation 
of the MDC in addition to the SEM. Changes found in the data should be greater 
than the MDC to consider that a clinical effect has occurred. These will be used  
in later studies (chapter 6 and 7) to identify the number of individuals experiencing 
a clinical meaningful difference in these measures.
The following chapter reports on a study that investigates the effect of different 
durations of mobilisation of pain, ROM and stiffness. 
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Chapter 6
A single-arm trial investigating the  
immediate effects of duration of lumbar 
mobilisation treatment on pain, stiffness  
and ROM in patients with LBP.
6.1 Introduction
Although mobilisations applied to the lumbar spine have been shown to produce 
a hypoalgesic effect in asymptomatic participants (Krouwel et al., 2010 and Willett 
et al., 2010), no studies have established whether an analgesic effect occurs in 
patients	with	LBP	(see	section	2.9,	page	14	for	further	details).	
Physiotherapists commonly use 30 or 60 seconds of mobilisations, repeated up  
to 3 times (up to 3 minutes in total). This treatment dose was advocated in  
a seminal text by Maitland first published in 1964 and has not been subjected to 
experimental evaluation since. Despite there being some evidence to suggest that 
longer treatment duration may create a greater effect on ROM (as discussed in 
sections 2.5 and 2.6 pages 8-11) and pain (as discussed in section 2.9, page 14), 
studies have not investigated the effects of duration of mobilisation treatment  
(on pain, ROM or stiffness).
Although the previous literature has demonstrated that mobilisation treatment 
results in an immediate pain relieving effect, as measured by PPT (Sterling  
et al., 2001; Vicenzino et al., 1996). There is limited evidence on the effect of 
mobilisation treatment on patient reported measures of pain (as discussed in 
section 2.9.2). Furthermore the relationship between changes in PPT and clinical 
outcome remains speculative, with Sterling et al., (2001) reporting dissociation 
between change in PPT and VRS after mobilisation to the cervical spine. The 
relationship between PPT and patient reported outcomes therefore require  
further investigation. 
Studies examining the extent of the hypoalgesic effect of lumbar mobilisations in 
asymptomatic populations have reported widespread changes in PPT (Krouwel 
et al., 2010; Willett et al., 2010) and have suggested that this is indicative pain 
modulation via a systematic analgesic mechanism (as discussed in section 2.10.4, 
page 21). This has not been investigated in a symptomatic population. 
The previous study in this thesis (chapter 5) established the within- and between-day 
reliability of ROM, stiffness and PPT measurements. ICC results varied from good to 
poor, when using interpretation of ICC suggested by Fleiss, (1986) and Landis and 
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Koch, (1977). However (Fleiss, 1986) deemed this an arbitrary classification and 
advocated consideration of reliability figures against their intended use. One aim of 
the current study was to investigate the magnitude of change in ROM, stiffness and 
PPT resulting from a mobilisation treatment dose for consideration alongside these 
reliability statistics in order to focus the forthcoming study in this thesis.
Anecdotal evidence suggests that some patients are likely to experience 
immediate relief of their symptoms following mobilisations, whereas others may 
experience an exacerbation of their symptoms. Furthermore, previous work has 
attempted to identify clinical features in patients that may predict their response to 
treatment, but the results of these studies are inconclusive (Kamper et al., 2010). 
This study sought to explore responders to mobilisations and investigate factors 
that	may	influence	patients’	response	to	mobilisations.	
6.1.1. Research question
What are the immediate effects of 3 and 6 minutes of lumbar mobilisation treatment 
on pain, stiffness and ROM in patients with non-specific low back pain?
6.1.2. Study aims 
To establish whether 6 minutes of lumbar mobilisation treatment has a greater 
immediate effect on pain, stiffness and ROM than 3 minutes of lumbar mobilisation 
treatment	in	patients	with	chronic	non-specific	LBP.
	 •	 	To	establish	whether	there	is	a	correlation	between	changes	in	 
patients’	reported	measures	of	pain	relief	and	changes	in	PPT	 
following lumbar mobilisations. 
	 •	 	To	determine	the	extent	(local,	segmental,	systemic)	of	the	analgesic	 
effect resulting from a lumbar mobilisation treatment dose.
	 •	 	To	consider	factors	(from	the	questionnaires	and	examination	findings)	 
which	may	predict	patients’	response	to	lumbar	mobilisations.
	 •	 	To	compare	the	responsiveness	to	treatment	of	three-point	bending	 
and displacement methods of stiffness measurement. 
6.2. Methods
6.2.1. Study design
This was a single arm trial investigating the effects of applying a longer duration  
of treatment. The single-arm design was employed as a precursor to an RCT. 
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6.2.2. Ethics approval
This study was approved by the Faculty of Health and Social Science Research 
Ethics and Governance Committee (FREGC) (Appendix 2). 
6.2.3. Participants
PS power and sample size calculations (version 2.1.31) were used to determine 
the required sample size for a power of 0.8 with a p value of .05. Calculations were 
made using means and standard deviation from published data, examining the 
immediate effects of mobilisation. Maximum difference 25.81 Kpa and standard 
deviation of 20.4Kpa were used for PPT measurements (Vicenzino et al., 1998). 
Maximum difference of 0.41 Nm/degree and standard deviation of 0.4 Nm/degree 
were used for stiffness measurements (Lee et al., 2005b). A minimum sample size of 
16 was suggested. Eighteen potential participants met the inclusion criteria and were 
recruited to the study. Recruitment posters were placed on the university email and in 
local shops and community centres. Advertisement of the study also occurred through 
word of mouth, for example, those participating in the study informed friends or 
colleagues about the study and provided them with the contact details of the principal 
researcher. Potential participants were sent a participant information sheet and list of 
inclusion and exclusion criteria and asked to contact the principal researcher if they 
wished to take part, at which point an appointment was made for them to attend the 
human movement laboratory, Robert Dodd Annex, Eastbourne.
6.2.4. Inclusion and exclusion criteria
Potential participants were required to be between 18 and 70 years of age, have 
suffered	from	LBP	for	a	minimum	of	3	months	and	experience	their	symptoms	on	
active movement and PA pressure to the spine.
Participants with precautions and contraindications to mobilisations were excluded 
from the study. This resulted in the following exclusion criteria:
	 •	 Spinal	congenital	abnormality
	 •	 History	of	spinal	fracture
	 •	 	History	of	malignancy
	 •	 Bone	disease	(osteoporosis,	osteomyelitis,	tuberculosis,	Paget’s)
	 •	 Inflammatory	arthritis	(rheumatoid	arthritis,	ankylosing	spondylitis,	gout)
	 •	 Congenital	generalised	hypermobility	(Ehlers-Danlos	syndrome)
	 •	 Advanced	degenerative	changes
	 •	 History	of	steroid	therapy
	 •	 Pregnancy
	 •	 Current	anticoagulant	medication	
	 •	 Pins	and	needles,	tingling	or	numbness	in	the	lower	limbs
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	 •	 	Severe	and	/	or	irritable	symptoms	(symptoms	which	are	so	intense	 
that they prevent the participant from moving, or which result in one 
movement producing lasting pain).
Potential participants were also excluded if they were undergoing current treatment 
for low back or leg pain (or had done so in the last 3 months). 
6.2.5. Confidentiality
All participant information was kept confidential and only made available to the 
study investigator and supervisors. All participants were allocated with a code; to 
ensure anonymity all data was stored under that code, the key to which was kept 
on a password protected computer. To fulfil the requirements of the Data Protection 
Act 1998 all personal data was destroyed at the end of the study. Anonymised data 
will be kept for 10 years following completion of the study.
6.2.6. Instrumentation and measurements
ROM was measured using Fastrak (section 5.2.7., page 68). The electromagnetic 
sensors were placed on L1 and the sacrum as detailed in section 5.2.9. (page 69). 
Lumbar stiffness was measured simultaneously using three-point bending (force/
angle) and displacement (force/displacement) methods. This required force and 
Fastrak motion sensor data measurements to be taken simultaneously during 
the application of PA force (section 5.2.7., page 68). For three-point bending 
measurement two electromagnetic sensors measured the change in the curvature 
of the spine (angular rotation) and to measure displacement measurements, the 
electromagnetic sensor mounted on the indenter (as described in section 4.5., 
page 61) measured vertical displacement. For Force Plate descriptions see section 
5.2.7., page 68. PPT were measured using an algometer (as described in section 
5.2.7, page 68).
A verbal rating scale (VRS) was utilised to gain a score of pain intensity at the end 
of each physiological movement and on the application of PA force to the most 
symptomatic vertebral level. The VRS is a scale that is used extensively in clinical 
practice and requires patients to score their pain on a scale of 0-10; 0 no pain and 
10 being the most pain imaginable.
6.2.7. Pilot work
This study aimed to standardise all components of treatment dose (for components 
of treatment dose see section 2.3, page 6). However, during pilot work, it became 
apparent that standardisation of the grade of treatment was not possible. In some 
participants a grade III or III+ mobilisation was too painful and it was deemed 
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unethical to apply mobilisations without regard for symptom reproduction. The element 
of standardising grade of treatment was re-evaluated and a decision was made to 
apply the grade pragmatically.
6.2.8. Procedure
Potential participants attended the Human Movement Laboratory at the University of 
Brighton;	School	of	Health	Professions	on	two	occasions	each	lasting	for	approximately	
45 minutes. On each occasion the researcher greeted them and led them to a screened 
area. The researcher performed all examinations and treatments in the study. To avoid 
potential bias, a co-researcher took all of the experimental measurements.
6.2.9. Occasion one procedure
On the first occasion participants received a verbal explanation of the study and 
were given an opportunity to ask questions. They were then asked if they wished 
to take part in the study before being asked to sign a consent form. This was 
followed by a physiotherapy assessment. The assessment was conducted to 
ensure that participants met the inclusion criteria (of pain on active movement and 
PA pressure) and determine the vertebral level from which their symptoms were 
arising. A past medical and drug history were also taken to ensure that participants 
had no exclusion criteria. This assessment was typical of the assessment 
performed by physiotherapists in clinical practice (see Appendix 6 for details). 
Once the physiotherapy assessment was completed and inclusion and exclusion 
criteria were confirmed, participants were asked to complete the questionnaires detailed 
in section 3.5, page 41, and given an opportunity to clarify questions that they were 
unsure	of.	The	following	questionnaires	were	included	to	assesses	the	participants’	pain	
experience	and	risk	factors	for	LBP	(see	Appendix	7	for	full	questionnaires):
	 •	 	Alcohol	consumption	(Townshend	and	Duka,	2002)	and	nicotine	 
dependence questionnaire (Heatherton et al., 1991), as these  
substances may affect pain relieving mechanisms. 
	 •	 	The	McGill	pain	questionnaire	(Melzack,	1975)	describes	the	pain.	
	 •	 	The	Oswestry	disability	questionnaire	(Fairbank	et	al.,	1980)	measures	 
the impact of the pain.
	 •	 	The	survey	of	pain	attitude	(Tait	and	Chibnall,	1997)	measures	attitudes	
associated with the pain.
	 •	 	A	demographic	questionnaire,	which	includes	questions	regarding,	
education, employment, income and activity levels. 
	 •	 	The	General	Health	Questionnaire	(GHQ28,	Goldberg	et	al.,1979)	 
provides an assessment of psychiatric distress.
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6.2.10. Occasion two procedure
Participants attended on a second occasion for the experimental testing (see 
Figure 6.1). They were greeted by the researcher and led to a screened area and 
asked to undress to shorts (and for female participants shorts and bra), before 
their height and weight were measured and recorded.
Participants were asked to lie prone on a plinth whilst the symptomatic spinous 
process, sites for Fastrak sensor placement (detailed in section 5.2.9., page 69) 
and	PPT	testing	were	identified	by	manual	palpation	(see	Table	6.2).	Baseline	
ROM, stiffness and pain measures were taken (Figure 6.1).
Figure 6.1: a flowchart to depict participants’ journey through the study.
 
RECRUITMENT
Consideration of participant information sheet
➜
VISIT 1
Signing of consent form
Physiotherapy assessment and diagnosis of symptomatic level
Completion of questionnaires
➜
VISIT 2
Height and weight taken
Measurement of:  ROM 
VRS of pain on movement 
VRS of pain on application of PA force 
Stiffness 
Pressure pain thresholds
3x1 minute of PA mobilisations to symptomatic level
Measurement of:  ROM 
VRS of pain on movement 
VRS of pain on application of PA force 
Stiffness 
Pressure pain thresholds
3x1 minute of PA mobilisations to symptomatic level
Measurement of:  ROM 
VRS of pain on movement 
VRS of pain on application of PA force 
Stiffness 
Pressure pain thresholds
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6.2.11. Range of movement measurements
Participants were asked to stand upright with their feet hip width apart whilst  
a neutral position of the electromagnetic sensors was set (this allowed the starting 
position	of	the	sensors	to	be	recorded).	Before	participants	started	to	move	they	
received the following instructions: ‘I would like you to perform some movements 
of your low back. At the end of each movement I would like you to tell me how bad 
your symptoms are out of 10; 0 being no pain and 10 being the worst pain you 
could imagine’. At the end of range of each movement participants were prompted 
for the VRS. The instructions provided for each movement are shown in Table 6.1.
Table 6.1. Instructions given to participants during ROM testing.
Movement Instructions 
Flexion  ‘Bend forwards, as far as possible, running your hands down the  
 front of your thighs… How many on a scale of 0 -10 is that?’ 
Extension ‘Lean backwards as far as possible… How many out of 10 is that?’  
Lateral flexion  Indicating participants’ right / left side: ‘run your hand down the side of your  
leg, bending as far sideways as possible… How many out of 10 is that?’ 
Rotation  Indicating participants’ right / left side: ‘keeping your feet where they are, 
twist as far to this side as possible… How many out of 10 is that?’  
6.2.12. Verbal rating of pain on PA pressure to the symptomatic vertebral level
Following rating pain on active movement, participants were asked to lie prone and 
rate their pain on an 11-point VRS, whilst the researcher applied a PA force to the 
symptomatic vertebral level (identified on their first visit). 
6.2.13. Three-point bending and displacement stiffness 
measurement procedures.
The indenter was positioned over the symptomatic spinous process and to allow 
accurate repositioning, drawn around with a temporary marker pen. After the 
neutral position of the Fastrak sensors was set, participants were asked to take 
a deep breathe in, breathe out and refrain from breathing in (Shirley et al., 1999) 
whilst 5 cycles of PA mobilisations were applied by the researcher using the 
indenter at a rate of 0.5Hz (standardised by the use of a metronome). During 
stiffness measurement the researcher stood on a wooden lean bar to ensure that 
all the therapists force was transferred to the force plates.
6.2.14. Pressure pain threshold measurement procedure
Pressure Pain Threshold testing was performed using the sites and positions 
indicated in Table 6.2. Two pressure pain thresholds (PPT) readings were taken 
at each of the eight sites. Prior to testing, a familiarisation PPT was taken on the 
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dorsal aspect of the hand at the web-space between the thumb and index finger 
(enabling participants to experience PPT at one site). It was clearly explained that 
this was not intended to be a test of pain tolerance and that the intended point of 
measurement was when the sensation became anything more than just pressure, 
whether that was discomfort or pain. During the testing participants were asked 
to ‘push the button as soon as the sensation of pressure turned to a sensation of 
discomfort	or	pain’,	at	which	point	the	pressure	was	removed	and	the	PPT	data	
was saved.
Table 6.2. PPT testing procedure.
Site 
Number PPT site Participant position Landmark Blocks
1 Paravertebral muscles 
at symptomatic level 
Prone Paravertebral muscles two 
fingers breadth from spinous 
process.
20cm High block
2 Paravertebral muscles  
at T10 level 
Prone Paravertebral muscles two 
fingers breadth from spinous 
process.
20cm High block
3 Deltoid Side lying.
Participant with elbow 
positioned in waist
Two participant fingers breadth 
below the middle of the acro-
mion.
20cm High block
4 S1 dermatome Side lying 
Bottom leg bent  
forward to allow  
testing leg to lie flat 
against plinth
Posterolateral heel. Two fingers 
breadth below and one fingers 
breadth posterior to the tip of 
the lateral malleolus.
10cm High block
5 L2 dermatome Supine Mid-thigh. Mid way between the 
anterior superior iliac spine and 
the base of the patella (meas-
ured using a tape measure).
20cm High block
6 L3 dermatome Supine Two participant fingers breadth 
above base of patella
20cm High block
7 L4 dermatome Supine 
Leg turned out (hip in 
flexion lateral rotation)
Two fingers above medial 
malleolus. 
10cm High block
8 L5 dermatome Supine
Knee flexed so sole of 
foot flat on plinth.
Proximal to head of metatarsal. 10cm High block
Wooden blocks were utilised to ensure the researcher was at an optimum height for PPT testing
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The algometer was applied perpendicular to the marked area of skin at all testing 
sites. The order of testing was designed to allow sufficient rest between repetitions 
with	the	least	changes	in	a	participant’s	position.	All	tests	were	completed	sequentially	
in	one	position	before	changing	the	participant’s	position.	Therefore	2	repetitions	were	
completed at each site tested in prone (sites 1,2,1,2,) before moving into side lying 
and performing the testing sequentially in this position (sites 3,4,3,4). Participants 
were then asked to turn supine where the remaining sites were tested sequentially, 
(sites 5,6,7,8,5,6,7,8). The testing positions for T10, deltoid, L3 and S1 can be seen in 
Figure 5.4-5.7 (pages 73-74).
6.2.15. Mobilisation treatment
A central PA mobilisation technique consisting of repeated oscillatory  
movements was applied to the most symptomatic vertebral level for 3 x 60 
seconds with a 60-second rest between sets. Mobilisations were performed  
using the pisiform grip (Figure 2.2 page 6) at a rate of 1.5Hz standardised by a 
metronome. The amount of treatment force applied was determined according 
to the severity of symptoms and in negotiation with the participant as pilot work 
(section 6.2.7., page 98) had established that standardisation of the treatment 
force	might	have	resulted	in	undue	reproduction	of	participants’	symptoms.		
Following 3 minutes of mobilisations measurements of ROM, stiffness and pain 
were retaken, this was followed by a further 3 x 60 second sets of mobilisations 
and a further set of measurements (as depicted in Figure 6.1).
6.3. Data Analysis
The raw data for ROM and stiffness was processed using a macro written in  
Visual	BASIC	for	Applications	(Microsoft	Inc.,	Redmond,	Washington)	in	Microsoft	
Office Excel 2007 (Version 12.0, Microsoft UK, Reading, England) see Appendix 
3 for details on how the macro processed the data. The processed data was 
checked for errors by hand. 
For	ROM	the	maximum	values	of	each	movement	(flexion,	extension,	left	lateral	
flexion	and	right	lateral	flexion)	was	used	for	further	analysis.	Due	to	large	amounts	
of skin movement during ROM testing, slippage of the electromagnetic sensors 
can occur. Therefore data that greatly exceeded the ranges reported in previous 
literature was removed. The maximum ranges beyond which data sets were 
removed were as follows:
	 •	 Flexion	100	degrees
	 •	 Extension	50	degrees
	 •	 Lateral	flexion	85	degrees
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The macro calculated the stiffness coefficient using force/angle (three-point 
bending) and force/vertical displacement (displacement) data by linear regression 
of the loading phase between 30-100N on the force-displacement curve (see 
Appendix 3). For stiffness the mean of cycles 2-5 was calculated and used in 
further analysis (cycle one was discarded due to transient behaviour on start-up 
(Latimer et al., 1996a)). 
Descriptive statistics were first calculated for all data (questionnaire, ROM, 
stiffness, PPT and VRS of pain) using Statistical Package for the Social 
Sciences (PASW version 18.0 for Windows). Percentage differences in stiffness 
measurement were calculated (using the equation 100  x (post treatment stiffness-
pre treatment stiffness) / (pre treatment stiffness)) to allow comparison of the 
change in stiffness using three-point bending and displacement methods. For 
PPT the mean of the two measurements at each site was used for subsequent 
analysis. Percentage changes in PPT after 3 and 6 minutes of treatment were 
calculated (using the equation 100 x (post treatment PPT-pre treatment PPT) / pre 
treatment PPT)) to allow comparison with previous research. Verbal rating of pain 
on individual movements were summed and used in  
further analysis.
6.3.1. Analysis of response to treatment
Cumulative	proportion	of	responders’	analysis	was	used	to	describe	the	likelihood	
of response over a range of response levels (Farrar et al., 2006). 
Responders’	analysis	was	performed	to	explore	the	number	of	participants	
experiencing a minimal clinical important change. For PPT clinical important 
changes were determined from the SEM and MDC statistics from the reliability 
study (chapter 4) and improvements of greater than 15%. As previous studies 
have reported greater local changes in PPT following mobilisations (Pentelka et 
al.,	2012;	Willett	et	al.,	2010)	PPT	responders’	analysis	was	determined	for	sites	
local to the treatment. The site most distant to treatment was also used in order to 
compare local and systemic difference between treatment durations.
For VRS of pain scores, change of 1-point was used to represent a clinically 
important difference as it has been suggested that changes of these magnitudes 
represent clinically meaningful change for participants with low starting pain score 
(Salaffi et al., 2004). There is no agreed level of change for VRS that is recognised 
to represent clinically meaningful change, Farrar et al., (2001) suggested 2-point 
change in VRS a clinically important difference. However it has been recognised 
that studies determining clinical significance often exclude participants with an 
initial pain score of less than 4/10 (Rowbotham, 2001). Participants in the current 
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study had low initial pain scores and it is recognised that when pain scores start 
at	less	than	4/10	a	reduction	smaller	than	0.5	may	represent	‘much	improved’	
(Rowbotham, 2001). 
6.3.2. Normality testing of data
Iterative statistical analyses were performed using Statistical Package for the 
Social Sciences (PASW version 18.0 for Windows). All the data were tested for 
normality using the Shapiro-Wilk test. ANOVA was used when minor departures 
from normality were evident as ANOVA is robust to minor departures of normality 
(Agresti and Finlay, 2009). Where major deviations from normality were observed, 
they were transformed. Data were transformed using Logarithms to the power  
of 10 (Lg10). All transformed data were retested for normality. 
6.3.3. Analysis of Variance
The effect of duration of treatment was analysed separately for ROM and PPT 
data using two-way repeated measures analysis of variance (ANOVA). For ROM 
the two independent variables were duration, which had three levels (before, 
after 3 minutes and after 6 minutes of treatment) and movement, which had four 
levels	(flexion,	extension,	right	lateral	flexion	and	left	lateral	flexion).	For	PPT	
the two independent variables were duration, which had three levels (before, 
after 3 minutes and after 6 minutes of treatment) and site, which had 8 levels 
(symptomatic paravertebral, T10, deltoid, S1, L2, L3, L4, L5) of deviations. 
Stiffness was analysed separately for displacement and angle data using one-way 
repeated measures ANOVA the independent variable was duration, which had 
three levels (baseline, after 3 minutes and after 6 minutes of treatment).
Verbal rating of pain on movement and verbal rating of pain on the application of 
PA force to the symptomatic level were analysed using one way repeated measures 
(ANOVA). For both measures, the independent variable was duration of treatment, 
which had 3 levels (baseline, after 3 minutes and after 6 minutes of treatment). 
In order to test for prognostic or confounding variables, covariate adjustments 
between pain measures and questionnaire data (SOPA, Oswestry disability and 
GHQ28)	were	preformed	using	analysis	of	covariance	(ANCOVA).	Because	
PPT were performed at 8 different sites covariate analysis was performed 
using the changes local to the treatment site (the symptomatic paravertebral 
site), as previous studies have reported greater local changes in PPT following 
mobilisations (Pentelka et al., 2012; Willett et al., 2010).
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6.3.4. Correlation between measures
Pearson’s	correlations	were	performed	to	investigate	the	relationship	between	
three-point bending and displacement methods of stiffness measurement. 
Pearson’s	correlations	were	also	performed	to	investigate	the	relationship	between	
changes in verbal rating of pain and change in PPT.  
6.4. Results 
Thirty potential participants were recruited via University email; 18 met the physical 
testing	inclusion	criteria	and	became	participants	in	the	study.	One	subject’s	pain	
increased considerably after the first set of treatment; clinically no further treatment 
would have been applied to this participant so the researcher advised them to 
withdraw from the study. Seventeen participants completed the study. 
The demographic data and details of duration of symptoms and symptomatic  
level are displayed in Table 6.3. One participant failed to complete the 
questionnaires so the questionnaire results (displayed in Table 6.4 and 6.5) are  
for 16 participants. The McGill pain questionnaire was not completed by a 
further 3 participants so McGill pain scores are for 13 participants. The Oswestry 
disability questionnaire scores demonstrated that most participants were in the 
lowest scoring band (0-20%) and are described as having minimal disability.  
The range indicated that some participants fell in the moderate disability-scoring 
band	(20-40%).	The	mean	GHQ28	score	indicated	that	all	participants	had	low	
levels of psychiatric distress (Richard et al., 2004).  
Table 6.3. Demographic and symptom information for participants, n=17.
Sex Age
(years)
Height
(cm)
Weight
(kg)
Symptomatic 
level (number 
of particpants)
Symptom
Duration (years)
7 female
11 male
Mean 44 
SD10.7
Range 25-58
Mean 178 
SD10
Mean
83 
SD12
L5 (11)
L4 (4)
L1 (2)
Mean
12.25
SD 9.55
Range 0.25-30
Table 6.4. Questionnaire results, n=17. 
Alcohol
Smoking GHQ28 McGill Oswestry% scoreUnits Binge
score
Mean 10
SD 7
Range 2-33
Mean 8
SD 6
Range 1-22
1 smoker
score 2 
Median 0
Mean 0.8
SD 2
Range 0-5
Mean 18
SD 11
Range 6-36
Mean 16
SD 8
Range 6-36
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Table 6.5. Survey of pain attitudes scores. The data are means, standard deviation (SD) 95% 
confidence interval (CI) and range (n=17).
Control Disability Harm Emotion Medication Solicitude Medical cure
Mean 11.4 4.4 4.6 5.3 3.3 4.2 10.3
SD 3.2 3.0 3.5 5 2.3 3.3 3.4
95% CI 9.6-13.1 2.8-6.0 2.8-6.5 2.6-7.9 2.2-4.5 2.4-5.9 8.5-12.1
Range 6-18 0-10 0-12 0-15 0-8 0-10 3-16
6.4.1. Results of mobilisation treatment on lumbar range of movement
Out of the 12 sets of data (4 movements on three occasions) 11 were normally 
distributed (Appendix 8). The two-way ANOVA (sphericity assumed) indicated that 
neither 3, or 6 minutes of treatment had a significant effect on ROM (F 2,32 =0.89, 
p=.42) – see Figure 6.2 (and Appendix 9 for statistical output). 
Mean	ROM	varied	between	measurements.	For	example	mean	flexion	range	
decreased after 3 minutes of treatment (by 2.8°) and decreased further after a 
further 3 minutes of treatment (a total decrease of 4.7°). There was a negligible 
mean	increase	in	extension	(1.2°)	and	left	lateral	flexion	(1.8°).	Mean	range	of	right	
lateral	flexion	increased	after	the	first	3	minutes	(by	5.8°)	but	there	was	a	reduction	
in the increase after a further 3 minutes of treatment resulting in a variation of 1° 
from baseline following 6 minutes of treatment (Figure 6.2).
Figure 6.2. Range of movement at baseline and after 3 and 6 minutes of mobilisation treatment.
The data are means. Error bars represent +/- standard deviation, n=17. 
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6.4.2. Results of mobilisation treatment on lumbar stiffness 
Three stiffness data sets were excluded from the main analysis as there was an 
error with the synchronisation of the force plates and Fastrak. 
The stiffness data sets were tested for normality using the Shapiro-Wilk test and 
found to be normally distributed (see Appendix 8). The one-way ANOVA (Appendix 
9) revealed that neither 3 nor 6 minutes of mobilisation treatment had a significant 
effect on stiffness, for three-point bending (F2,26=0.14, p=.99) or displacement  
(F2,26=2.39, p=.11). See figure 6.3.
The mean variation in three-point bending measurements was -1.86N/degree 
following 3 minutes of treatment and 0.60 N/degree following 6 minutes of 
treatment. The mean variation in displacement measurements was 1.25N/mm 
following 3 minutes of treatment and -0.16N/mm following 6 minutes  
of treatment (Figure 6.3).
Figure 6.3. Stiffness at baseline and after 3 and 6 minutes of mobilisation treatment.
The data are means. Error bars represent +/- standard deviation, n=14. 
To enable comparison between changes using displacement and three-point 
bending methods of stiffness measurement (which are in different units of 
measurement) percentage changes in stiffness after 3 and 6 minutes of  
treatment are presented in Table 6.6. For change after 6 minutes of treatment 
1 additional data set was included as this was not affected by the error in 
synchronisation.
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Three-point  
bending.
% change after
3 minutes Rx
n=14
Three-point 
bending.
% change after
6 minutes Rx
n=15
Displacement
% change after
3 minutes Rx
n=14
Displacement. 
% change after
6 minutes Rx
n=15
Mean -0.3 6.3 15.9 -1.1
SD 41.2 33.8 27.2 22.8
Range 161.8 129.1 94.8 96.0
Table 6.6. Percentage change in three-point bending and displacement stiffness values  
after 3 and 6 minutes of treatment. The data are means, standard deviation (SD) and range.
The	Pearson’s	correlation	using	baseline	data	revealed	that	there	was	no	
correlation between three-point bending and displacement measurements  
(p=.17, r=0.38). See Appendix 10. To assess responsiveness to treatment 
correlations were also performed on the percentage change following 3 and 
6 minutes of treatment. There was no correlation between percentage change 
in three-point bending and displacement methods of measuring stiffness after 
3 minutes of treatment (p=.75, r=0.09), (Appendix 10), however there was a 
significant positive correlation between the percentage changes in three-point 
bending and displacement measurements after 6 minutes of treatment  
(p<.01, r=0.69), (Figure 6.4 and Appendix 10), demonstrating that following  
6 minutes of mobilisation treatment, percentage change in three-point bending 
increased as percentage change in displacement also increased.
Figure 6.4. Scatter plot demonstrating positive correlation between the percentage  
changes in three point bending and displacement measurements after 6 minutes of treatment 
(p<.01, r=0.69), n=15.
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6.4.3. Results for pressure pain thresholds
One set of data was excluded as an operational fault had resulted in the loss of 
three readings (for one participant). PPT data sets were not normally distributed 
and therefore the data was transformed using Logarithms (Lg10). Re-testing for 
normality revealed that minor deviations from normality were found (Appendix 8).
The two-way ANOVA revealed that duration of treatment had a significant effect  
on PPT (F2, 30=19.02, p<.01).	See	Appendix	11.	Bonferroni	pairwise	comparisons	
demonstrated significant difference between baseline and 3 minutes of treatment 
(p<.01) and baseline and 6 minutes of treatment (p<.01) see Appendix 11. There 
was no significant difference between 3 and 6 minutes of treatment (p=.72). See 
Figures 6.5 and 6.6.
There was a significant site*duration interaction effect (F14, 210=1.79, p=.04).  
Post hoc testing was performed to establish the effect of both durations at each 
site. Compared to baseline a significant effect was observed following both 3 and 
6 minutes of mobilisation at the symptomatic and T10 paravertebral, and the  
L2, L4 and L5 dermatome sites. At the L3 dermatome site there was a significant 
change in PPT following 6 minutes of mobilisations. No significant changes were 
observed at the deltoid or S1 dermatome sites (Figures 6.5 and 6.6).
Planned	covariate	adjustment	for	Oswestry	disability,	GHQ28	and	SOPA	
questionnaire results demonstrated that the variance in PPT did not alter  
with covariate adjustment. 
At all sites PPT measurements after treatment exceeded baseline values  
(Figures 6.5 and 6.6). The largest mean difference in PPT between measurements 
was observed at the paravertebral muscle site adjacent to the level of treatment. 
At all sites except S1 and L4 dermatomes mean PPT measurements were greater 
after 6 minutes of treatment than after 3 minutes of treatment. Previous studies 
often report percentage changes and to enable comparison these are presented  
in Table 6.7.
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Figure 6.5. PPT at baseline and after 3 and 6 minutes of mobilisation treatment.
The data are means. Error bars represent +/- standard deviation.
* p< .05 versus baseline, ** p< .01 versus baseline  n=16
Figure 6.6. PPT at baseline and after 3 and 6 minutes of mobilisation treatment.
The data are means. Error bars represent +/- standard deviation.
* p< .05 versus baseline, ** p< .01 versus baseline. Derm=dermatome   n=16
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% change mean (SD)
3 mins Rx (n=16)
% change mean (SD)
6 mins Rx (n=16)
Sympt paravertebral muscle 31 (36.1)** 46.5 (54.7)**
T10 25.2 (36.4)* 34.8 (36.6)**
Deltoid 8.0 (22.1) 21.7 (39.1)
S1 14.7 (36.2) 13.4 (31.6)
L2 15.8 (33.3)* 16.7 (23.0)*
L3 14.9 (24.1) 21.2 (24.0)**
L4 19.8 (18.6)** 17.7 (26.8)*
L5 29.7 (24.0)** 30.9 (33.9)**
Table 6.7. Percentage change in PPT at each site after 3 and 6 minutes of treatment. 
* p < .05 versus baseline, ** p < .01 versus baseline.
Cumulative	proportion	of	responders’	analysis	(Figure	6.7)	demonstrated	that	at	
the symptomatic paravertebral PPT site, approximately 80% of participants had 
increased PPT immediately following treatment. 40% had an increase in PPT of 
approximately 50%; this was similar for both 3 and 6 minutes of mobilisations. 
Following 3 minutes of treatment 14, and following 6 minutes of treatment 15 of  
the 16 participants and were classified as responders (Table 6.8).
Figure 6.7. Cumulative proportion of responder analysis for PPT at the  
symptomatic paravertebral level following 3 and 6 minutes of treatment. n=16.
Vertical line represents clinically relevant change (>15%).
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Figure 6.6. PPT’s at baseline and after 3 and 6 minutes of mobilisation 
treatment. The data are means. Error bars represent +/- standard 
deviation. * p< .05 v rsus baseline, ** p< .01 v rsus baseline. 
Derm=dermatome. 
 
 
 
 
 
 
 
Figure 6.7. Cumulative proportion of responder analysis for PPT at the symptomatic 
paravertebral level following 3 and 6 minutes of treatment. 
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Number of participants =16 3 minutes treatment 6 minutes treatment
Increase exceeding SEM 11 9
Increase exceeding MDC 3 6
SEM and MDC combined 14 15
Greater than 15% increase 12 11
Table 6.8. Number of responders to treatment based on changes in symptomatic paravertebral PPT. 
SEM= number of participants with change greater than standard error of measurement;
MDC= number of participants with change greater than minimal detectable change;
%= number of participants with change greater than 15%.
In summary these results demonstrate that a mobilisation treatment may have a 
hypoalgesic effect as measured by PPT, however there was no difference between 
3 and 6 minutes of treatment. The change in PPT was not observed at all sites.
6.4.4. Results for verbal ratings of pain
Participants’	verbal	rating	of	pain	for	each	physiological	movement	are	presented	
in Figure 6.8. After 3 minutes of treatment 10 of the 17 participants experienced an 
overall reduction in verbal rating of pain on movement. After 6 minutes treatment 
14 participants experienced an overall reduction in verbal rating of pain on 
movement. Three participants reported an increase in VRS after 3 minutes and  
2 experienced an increase after 6 minutes of treatment. 
Figure 6.8. Verbal rating of pain on movement.
The data are means. Error bars represent + standard deviation (n=17).
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Normality testing of VRS revealed that minor deviations from normality were 
present. Observation of the data suggested that this was due to an outlier (see 
scatterplot in Appendix 8). For these reasons the data was not transformed. The 
total score of pain on movement (for all movements combined) was used in the 
ANOVA for VRS of pain on movement. 
There was a significant main effect of duration of treatment on VRS of pain on 
movement (F2, 30=7.09, p<.01). Pairwise comparisons revealed that a significant 
decrease in verbal rating of pain occurred between baseline and 6 minutes of 
treatment (p<.01) and between 3 and 6 minutes of treatment (p=.03). Relative to 
baseline there was no significant change in VRS following 3 minutes of treatment 
(p=1.00). This demonstrated that 6 minutes produced a significantly greater 
reduction in pain on movement than 3 minutes of treatment. Furthermore 6 minutes 
of treatment was required to produce a significant reduction in verbal rating of pain 
on movement.
Planned	covariate	adjustment	for	Oswestry	disability,	GHQ28	and	SOPA	
questionnaires demonstrated that the variance in VRS of pain on movement  
did not alter with covariate adjustment (Appendix 12)
Cumulative	proportion	of	responders’	analysis	(Figure	6.9)	demonstrated	that	
over 60% of participants receiving 3 minutes of treatment and over 85% of those 
receiving 6 minutes of treatment experienced a decrease in pain on movement. 
The number of responders to 3 and 6 minutes of treatment for individual and 
summed VRS scores is shown in table 6.9.
Figure 6.9. Cumulative proportion of responder analysis for verbal rating
of pain on movement following 3 and 6 minutes of treatment (n=17).
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Number of 
participants = 17 3 minutes treatment 6 minutes treatment
Flexion 5 7
Extension 7 6
Right lateral flexion 4 9
Left lateral flexion 4 8
Total VRS (sum of VRS 
on all movements) 10 14
Table 6.9. Number of participants who had a positive response to treatment, based on changes 
in VRS of pain on movement of 1 or more. Numbers are shown for individual movements and for 
combined VRS of pain.
Verbal rating of pain of the application of PA force to the symptomatic spinal 
level are presented in Figure 6.10. Importantly 6 out of the 17 participants did 
not experience any pain on application of PA force at baseline, so in these 
participants no improvement was possible. Mean VRS scores were less on the 
application of PA force after 3 and 6 minutes of treatment than at baseline (Figure 
6.10). After both 3 and 6 minutes of mobilisation treatment 8 out of 17 participants 
experienced less pain on the application of a PA force and 1 experienced an 
increase. Relative to baseline mean VRS reduced by 0.9 (SD 2.7) after 3 minutes 
and 1.0 (SD 2.1) after 6 minutes of treatment.
Figure 6.10. Verbal rating of pain on application of PA force.
The data are means. Error bars represent + standard deviation 
Mauchly’s	test	demonstrated	that	sphericity	could	not	be	assumed	so	the	
Greenhouse-Geisser was used to correct for violations of sphericity. ANOVA 
suggested that there was a significant difference in VRS of pain on the application 
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of a PA force to the most symptomatic level (F 1.2, 18.02=5.65, p=.02). However 
posthoc correction for multiple comparisons revealed that no significant 
differences occurred between baseline and 3 minutes of treatment (p=.07) or 
between baseline and 6 minutes of treatment (p=.06). 
Planned	covariate	adjustment	for	Oswestry	disability,	GHQ28	and	SOPA	
questionnaires demonstrated that the variance in VRS of pain the application  
of PA force did not alter with covariate adjustment (Appendix 13).
6.4.5. The relationship between change in PPT and change in VRS.
Correlations established that there was dissociation between change in PPT and 
change in verbal rating of pain on movement (change from baseline to 3 minutes 
treatment p=.83, r=.75, change from 3 minutes to 6 minutes of treatment p=.60, r=.14, 
change from baseline to 6 minutes of treatment p=.22, r=-.33) (see Appendix 14). 
Due to the large number of participants with no pain on the application of PA force at 
baseline, correlations were not performed with VRS of pain on PA force and PPT.
6.4.6. Summary of findings
	 •	 	6	minutes	of	mobilisation	treatment	was	required	to	produce	a	significant	
reduction of pain on movement, producing significantly greater reduction  
in pain relative to baseline than 3 minutes of treatment.
	 •	 	3	and	6	minutes	of	mobilisation	treatment	both	resulted	in	significant	
increases in PPT relative to baseline indicating a hypoalgesic effect.  
There was no overall difference between durations. However there was  
a significantly greater reduction in PPT at the L3 dermatome site after 6 
minutes of mobilisation compared to 3 minutes of mobilisation treatment.
	 •	 	The	increase	in	PPT	was	not	evident	at	all	sites.	Changes	at	the 
S1 dermatome and deltoid muscle site failed to reach significance.
	 •	 	The	greatest	percentage	changes	in	PPT	were	at	the	paravertebral	 
muscles sites local to the site of treatment.
	 •	 	There	was	dissociation	between	PPT	and	VRS	of	pain	on	movement.
	 •	 	The	effects	of	3	and	6	minutes	of	mobilisation	treatment	on	verbal	rating	 
of pain of the application of PA force to the symptomatic level failed to  
reach significance.
	 •	 	The	effects	of	3	and	6	minutes	of	mobilisation	treatment	on	ROM	and	 
stiffness failed to reach significance.
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6.5. Discussion
 
6.5.1. Discussion of the effects of mobilisation on lumbar range of 
movement
There was no significant change in ROM relative to baseline with either 3 
or 6 minutes of treatment. This is in agreement with most of the published 
literature, which has found that mobilisations do not have an effect on range of 
physiological movement (Petty 1995; Goodsell et al., 2000; Chiradejnant et al., 
2002). Although two studies have found an increase in extension these applied 
mobilisations to all lumbar levels resulting in longer treatment durations of 7 
and	9	minutes	(Powers	et	al.,	2008;	McCollam	and	Benson,	1993).	Although	the	
duration used in this study was not as long, the results suggest that duration of 
treatment may not be the factor. It could be that the reported change in range 
occured when treating multiple spinal levels. This is the first study to report the 
effects of different durations of treatment on ROM.
The variation in mean ROM ranged from 1° - 5.8°. The largest difference in mean 
range	relative	to	baseline	was	in	right	lateral	flexion	which	demonstrated	the	
poorest reliability and greatest measurement error in the reliability study (chapter 
5); the minimum detectable change (MDC) reported in the reliability study was 
7.5°. The variation in ROM measurements is similar to that reported in other studies 
investigating the response to mobilisation treatment (Power et al., (2003) reported 
a	3.6°	increase	and	McCollam	and	Benson,	(1993)	a	2-3°	increase	in	ROM	after	
treatment). These variations in measurement following treatment are small and are 
likely to be due to measurement error. This is confirmed by comparing the effect 
size to the MDC reported in the reliability study (chapter 5, page 65).
6.5.2. Discussion of the effects of mobilisation on stiffness
Relative to baseline there were no significant differences in stiffness after 3 or 6 
minutes of treatment using either three-point bending or displacement methods 
of measurement. This is in agreement with most previous studies investigating 
the effect of mobilisation treatment on lumbar spine stiffness (Latimer et al., 
1996b; Stamos-Papastamos et al., 2011). Conversely studies led by one author, 
using the three-point bending method, found a reduction in stiffness following 
mobilisations in both symptomatic and asymptomatic populations (Shum et al., 
2013; Lee et al., 2005b). One study is only available in poster format allowing 
limited evaluation (Lee 2005b). The later study (Shum et al., 2013), compared 
the immediate effects of mobilisation treatment on pain and stiffness in 
asymptomatic	participants	and	participants	with	LBP	(and	thus	did	not	include	
a placebo-control group). A greater reduction in stiffness following treatment in 
participants	with	LBP	was	reported.	However	participants	with	LBP	had	higher	
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pre-treatment stiffness values and there is no mention of correction for baseline 
differences.	Furthermore	the	LBP	patients	received	a	higher	force	of	treatment	
(121N as opposed to 105N in the asymptomatic participants). Another difference 
in the study by Shum et al., (2013) is the high values over which stiffness was 
calculated (50-250N). Previous studies have calculated force over various 
ranges but mostly with a peak force of 100N or less (see Table 3.3, page 35 for 
further information). The application of 250N of force is likely to have elicited a 
pain	response	in	participants	with	LBP	–	this	may	have	resulted	in	increased	
muscle activity or the participants tensing, explaining the higher baseline 
stiffness levels. 
The mean difference in three-point bending measurements between testing 
occasions was -1.86N/degree following 3 minutes of treatment and 0.60 N/
degree following 6 minutes of treatment. Using the same method Stamos-
Papastamos et al., (2011) reported a larger but also insignificant mean change 
of 4.27 N/degree. The corresponding range of variation in measurements 
was very large, 48.46 N/degree (after 3 minutes) and 58.62 N/degree (after 
6 minutes). This was equivalent to a range of 161.77% difference following 3 
minutes of treatment and a range of 129.11% difference following 6 minutes of 
treatment. It is possible that the low mean difference in stiffness was caused 
by a wash-out effect created by some participants experiencing an increase 
in stiffness following treatment whilst others experienced a decrease in 
stiffness following treatment. Alternatively the differences could be caused by 
measurement error. 
The mean difference in displacement measurements between testing occasions 
was 1.25N/mm following 3 minutes of treatment and -0.16N/mm following 6 
minutes of treatment. This is similar to that reported by Goodsell et al., (2000) 
who reported a -0.31N/mm change after 3 minutes of mobilisations. The 
corresponding range of change was smaller than that for three-point bending 
(9.60N/mm and 10.05 N/mm) – equivalent to a 94.78% range after 3 minutes and 
96% range after 6 minutes. The difference in range and standard deviation of 
measurements and the discrepancy between the percentage changes suggests 
that the two measurement methods may not be measuring the same behaviour. 
6.5.3. Comparison of three-point bending and displacement stiffness 
measurements.
Previous work in this thesis (section 4.4.11. and section 5.5.2.) cast doubt over  
the validity of three-point bending stiffness measurement. The reliability 
study (chapter 5) reported an association between three-point bending and 
displacement stiffness measurements. In order to further consider the validity 
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of stiffness measurements this study evaluated responsiveness to mobilisation 
treatment by comparing synchronised measurements of three-point bending and 
displacement measurements of spinal stiffness at baseline and after treatment. 
There was no significant correlation between baseline measurements of three-
point bending and displacement. This is contradictory to the association between 
measures reported in an asymptomatic population (chapter 5). 
To explore responsiveness to treatment percentage change figures from this study 
were correlated. There was dissociation between percentage change in three-point 
bending and displacement following 3 minutes of treatment, but percentage change 
was associated following 6 minutes of treatment. The variability in the association 
between three-point bending and displacement measurements reported in this 
study could be due to random variation of measurements. Additionally the varying 
association between measurements taken using the two methods suggests that 
three-point bending and displacement are not necessarily measuring the same 
behaviour. This is further supported by the large differences in between-subject 
variability observed with three-point bending (evident from the large range and 
standard deviation of measurements), compared to much smaller (although still 
relatively large) between-subjects variability with displacement. Comparison of the 
range of percentage change with the two methods also shows a marked difference, 
again suggesting that they are not measuring the same behaviour. 
None of these results clarify whether three-point bending or displacement is the 
best method for measuring stiffness, however the displacement method is similar 
to the procedure performed by physiotherapists assessing spinal stiffness so may 
have more face validity than three-point bending. Furthermore the displacement 
method of measuring stiffness could be considered to be more experimentally 
robust as there is only one sensor that is securely mounted on the indenter. With 
the three-point bending method 2 sensors are placed on the spine and may be 
accidently moved or loosened during the application of mobilisation without the 
researcher becoming aware. Reliability of the displacement method (chapter 
5) may be improved with the use of a mechanically driven indenter to ensure 
standardisation of rate and maximum mobilisation force. This method has been 
reported to be reliable in previous research (Latimer et al., 1996b). 
Observation of the electromagnetic sensors movement during testing casts doubt 
over the assumptions underpinning the three-point bending method of stiffness 
measurement. As explained in section 3.2.2 (page 32) three-point bending theory 
uses engineering equations for beam bending. A stiffness value is calculated 
linking the PA force, the rotation of the sensors and the measurements of the 
‘beam	length’,	in	this	case	the	distance	between	the	sensors	and	the	point	of	force	
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application. This engineering theory hinges on a number of assumptions. These 
assumptions are as follows; that the spine is supported only at either end by the 
rib cage and pelvis; there are no significant horizontal compressive forces (Lee 
and	Evans,	1994),	and	that	the	slope	and	deflection	of	the	beam	are	very	small.	In	
order to accept this mathematical model the appropriateness of these assumptions 
warrants scrutiny.
Kulig et al., (2004) used MRI to investigate intervertebral movement during PA 
loading and found that the application of force produced movement in consecutive 
segment. This motion was found to propagate caudad and cephalad – Kulig et 
al., (2004) claimed that this was not the way predicted by the three-point bending 
model, which would predict that the amount of movement was greater at the target 
vertebra with less motion at adjacent segments. 
The engineering model describes the lumbar spine as a beam supported at either 
end by the pelvis and thoracic cage; this assumes that the abdomen provides little 
or	no	support	or	resistance	to	PA	loading	(Lee	and	Evans,	1997).	However,	the	BMI	
of	a	typical	population	would	mean	that	in	many	individuals,	the	‘beam’	described	
by Lee et al., (2005a) would be supported centrally by the abdomen in addition 
to the support at either end. Therefore the three-point bending theory may only be 
applicable on slight individuals. 
Furthermore, the thoracic end of the beam was assumed to be a pin joint.  
This assumption of the three-point bending theory was based on pilot work 
which reported that no significant movement occurred at the thoracic cage during 
the application of a mobilisation force (Lee et al.,2005a). However the contribution 
of movement of the thoracic cage has been demonstrated experimentally by 
Chansirinukor et al., (2003) who investigated the difference in stiffness (using 
the displacement method) on PA loading to T12 to L4 when the thoracic spine 
was unconstrained and when it was constrained in a clamping device. Stiffness 
significantly increased with a constrained thoracic spine irrespective of the level 
tested. Moreover Caling and Lee, (2001) reported 1.1 – 1.4 degrees of thoracic 
rotation during the application of a PA force; although clinically this is a small 
amount of rotation it may not be considered small in mathematical terms. The 
predictability of pelvic movement is also questionable as demonstrated by Caling 
and	Lee,	(2001)	who	investigated	the	influence	of	direction	of	PA	force	applied	
to L5 and found a significant linear trend for sacral rotation to decrease as the 
direction of application changed from cephalad to caudad. Importantly pelvic 
rotation changed from anterior rotation when forces were directed more cephalad 
to posterior rotation when forces were applied caudad. This would mean that 
the three-point bending method is not an appropriate model for forces applied 
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in a caudad direction. A number of the current studies measuring stiffness at L5 
have used a caudad force (Goodsell et al., 2000; Shirley et al., 1999; Lee et al., 
1998), which may not have produced three-point bending. Therefore, if all other 
assumptions are accepted it may be that three-point bending will only occur in 
response to forces angulated in a cephalad direction. 
Another assumption of the three-point bending method is that there are no 
significant horizontal compressive forces. However in order for the individual 
vertebra and intervening discs to form a beam some horizontal compressive force 
would be necessary. The acceleration of the vertebrae during mobilisation was 
also assumed to be negligible (Lee and Evans, 1994). This is an assumption that 
remains	untested.	It	is	also	assumed	that	slope	and	deflection	of	the	beam	were	
very small. Yet due to the structure of the lumbar spine vertebrae and intervening 
discs,	and	measurable	intervertebral	movement	on	PA	loading,	deflection	is	likely.	
The concerns regarding the movement of the sensors and the safety of 
the assumption underpinning three-point bending theory suggest that the 
displacement method of stiffness measurement is preferable for future research. 
Furthermore this method does not represent how physiotherapists assess stiffness 
and in terms of measuring the stiffness that therapist perceive it lacks face validity. 
6.5.4. Discussion of pain related measures
The main analysis found that there was a significant increase in PPT with both  
3 and 6 minutes of treatment relative to baseline. The difference between durations 
failed to reach significance. The cumulative proportion of responder analysis 
(Figure 6.7) suggested that a slightly greater proportion of participants responded 
to a slightly greater increase in PPT with the longer duration of treatment. However 
as seen in Table 6.8 a similar number of participants experienced clinically 
meaningful changes with both 3 and 6 minutes of treatment, with most participants 
experiencing a clinically meaningful increase in PPT after both 3 and 6 minutes of 
treatment. This suggests that there is no additional change in PPT when applying 
mobilisations for longer than 3 minutes.
There was a 33% change in PPT at the symptomatic level, paravertebral muscle 
site, after 3 minutes of treatment. This is similar to that reported in previous studies 
(Sterling et al., 2001 and Vicenzino et al., 2000). The percentage change after 6 
minutes was greater than that reported previously. However these values should 
be interpreted with caution, as although previous studies examining the effects of 
mobilisation have reported percentage change, often in the absence of reporting 
actual change values. This may be slightly misleading as demonstrated by the 
results of the current study, where despite their being a small actual change in PPT 
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in the paravertebral muscles (1kg/cm2 after 3 minutes of treatment and 1.5Kg/cm2 
after 6 minutes), it was equivalent to a 31% change (SD 36.1) after 3 minutes and  
a 46.5% change (SD 54.7) after 6 minutes. 
Post-hoc analysis revealed that significant analgesic effects were not evident at 
all PPT sites (Figures 6.5 and 6.6). Three minutes of mobilisations resulted in a 
significant difference at the paravertebral muscle PPT sites (both at the level of 
symptoms and at T10) and the L2, L4 and L5 dermatome sites. A further 3 minutes 
of treatment (6 minutes) resulted in significant changes also occurring at the L3 
dermatome site. The differences at the S1 dermatome and deltoid site failed to 
reach significance. The greatest percentage changes were at the paravertebral 
muscle PPT sites, local to the site of treatment. These results suggest that analgesia 
is at least in part mediated by local rather than systemic analgesic mechanisms. The 
participants in this study were treated at the L1, L4 and L5 levels. Although signature 
zones were affected at dermatomal levels where treatment was not applied, this 
can be explained by the variability in and overlap between dermatomes (Nitta et 
al., 1993). Furthermore PA mobilisations have been shown to create movement 
throughout the lumbar spine (Lee and Evans, 1992), so a local, segmental analgesic 
effect, stimulated by the movement created through the lumbar spine may be 
evident at more than one level. The mechanism likely to be responsible for the 
analgesic effect observed in this study is the pain gate mechanism. Previous studies 
would support this hypothesis; Malisza et al., (2003) found that mobilisation of the 
knee in rats produced increased activity in areas of the spinal cord associated with 
pain (measured by MRI). Mobilisations have also been found to have a localised 
effect on temporal summation, suggesting inhibition of C-fibre activity in the dorsal 
horn of the spinal cord (George et al., 2006). Although widespread changes in PPT 
following mobilisation to the lumbar spine have been reported (Krouwel et al., 2010; 
Willett et al., 2010), these were conducted in asymptomatic participants. 
These findings provide inconclusive evidence regarding the extent of the 
analgesic effect resulting from mobilisations but suggest a local or segmental,  
as opposed to a systemic, treatment effect. This casts doubt over the extent to 
which the hypoalgesia associated with mobilisations is mediated by higher  
centres in the brain such as the Periaqueductal Gray (and associated areas) as 
suggested previously (Wright, 1995 and Sterling et al., 2001). As discussed in 
section 2.10.2., descending inhibition of pain was proposed based on increases  
in SNS activity following mobilisations, which was also observed when stimulating 
the Periaqueductal Gray area in rats.
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6.5.5. Discussion of the effect of mobilisation duration on verbal rating 
scales of pain.
Relative to baseline there was no significant decrease in participants rating of 
pain on movement after 3 minutes of treatment, but there was a significant change 
relative to baseline after 6 minutes of treatment. The difference between 3 and 6 
minutes of treatment was significant. These results demonstrate that 6 minutes of 
mobilisation treatment was required to produce a significant reduction of pain on 
movement – producing significantly greater reduction in pain relative to baseline 
than 3 minutes of treatment.
Pain on movement scores (combined for all movements) reduced by 1.1 (SD 
5.1) points on an 11-point VRS after 3 minutes of treatment and reduced by 3.4 
(SD 4.3) points after 6 minutes of treatment. These changes are similar to those 
reported previously; Sterling et al., (2001) reported a 0.34 (SD 0.02) decrease 
of pain on neck rotation following 3 minutes of mobilisation to the cervical spine 
and Goodsell et al., (2000) reported a 13.4mm (SD 13.3) on a 100mm scale after 
3 minutes of mobilisation treatment to the lumbar spine. Previous studies have 
calculated clinically meaningful changes in VRS. These values range from 1.5 -2 
depending on the population (Rowbotham, 2001). The mean effect of 6 minutes 
of treatment in the current study exceeded these values which suggests that the 
change may be attributable to treatment. 
Relative to baseline there was no significant decrease in pain during the 
application of PA force to the symptomatic level. The low baselines scores may 
have contributed to this finding, as 6 of the 17 participants had no pain on the 
application of PA force at baseline so no improvement in VRS was possible 
for these participants. Mobilisations may have a greater effect on pain on the 
application of PA force in a population suffering from more severe symptoms. 
6.5.6. Discussion of the relationship between verbal rating scales of pain and PPT.
There	was	dissociation	between	participants’	verbal	rating	of	pain	on	movement	and	
PPT values. Although a change in PPT suggests that an analgesic mechanism has 
been stimulated, clinically changes in patient reported pain measures are of upmost 
importance. Sterling et al., (2001) also found dissociation between VRS and PPT in 
patients with neck pain. Despite these findings PPT are widely used to demonstrate 
pain relief in both symptomatic and asymptomatic participants. Further investigation 
would help to establish the relationship between PPT and patient reported outcomes 
and is an important area for future research. 
6.5.7. Discussion of prediction of responders to treatment
It is well recognised by researchers and clinicians alike that not all patients 
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respond to mobilisation treatment. This has resulted in a number of studies 
investigating	clinical	prediction	rules	(factors	which	may	predict	individual	patient’s	
response to mobilisation). The large between-subject variability in percentage 
change has been recognised in previous studies (Willett et al., 2010). It has been 
suggested that 15% change in pain represents a clinically significant change 
(Salaffi et al., 2004). For this reason those participants who experienced a greater 
than 15% change in PPT are highlighted in Table 6.8. Nearly all of the participants 
in this study experienced a clinically significant change in PPT local to the site of 
treatment following both 3 and 6 minutes of mobilisation treatment.
Previous work has attempted to predict which patients will respond to mobilisation 
treatment but is inconclusive (Haskins et al., 2012 and Kamper et al., 2010). During 
the current study the results of the questionnaires were added as covariates to take 
into account the variance in change in pain that was attributable to these factors and 
thus establish whether they could be prognostic factors. The questionnaire results 
did	not	have	an	influence	on	pain	and	these	factors	could	not	be	considered	to	be	
prognostic of the effects of mobilisation treatment on PPT or verbal rating of pain. 
6.5.8. Study limitations
A single arm design was chosen as the effect of duration has not been previously 
investigated and it was important to establish whether duration had an effect 
before progressing to a randomised controlled trial. The single arm design 
does not rule out bias, regression to the mean or natural resolution of symptoms 
(although this is unlikely in this study because this study was investigating the 
immediate	treatment	effects	in	participants	with	a	long	history	of	LBP	(mean	
12.25 years)). Furthermore due to the single arm design, the temporal effect 
of	the	3-minute	period	of	mobilisation	may	have	influenced	the	measurements	
after 6 minutes. Due to these limitations, a subsequent study was conducted 
incorporating a control group and removing the temporal element of the different 
durations of treatment and is reported on in the following chapter.
Because	this	was	the	first	study	to	investigate	the	effect	of	different	durations	of	
mobilisation treatment the sample size calculation was based on the difference 
between treatment and no treatment, as opposed to between two different treatments. 
This may have resulted in the study being underpowered; this would have been 
particularly likely for the covariate adjustment. Retrospective power analysis based on 
the results from the current study suggested that 36 participants would be required to 
achieve sufficient power to detect a main effect of duration. Sample size calculations 
based on the difference between treatment duration reported in this study were used 
in the design of a subsequent study reported on in the following chapter. 
125
Only the immediate changes in pain measures were investigated in this study. The 
longer-term effects have not been studied. The clinical relevance of findings would 
be enhanced if measures were obtained over a longer period following treatment. 
Furthermore there is empirical evidence which suggests that some patients 
demonstrate initial soreness but report improvement in their symptoms 24-48 
hours after treatment. Future work should aim to look at the mid- and longer-term 
effects of mobilisation treatment. The following study, reported on in chapter 7, has 
reported on the analgesic effects of mobilisation 24-hours after treatment.
During this study all mobilisations were applied centrally to the spinous process 
irrespective of the area of symptoms and whether a central or unilateral mobilisation 
maximally	reproduced	the	participants’	symptoms.	This	did	not	reflect	clinical	
practice where the most symptomatic site and orientation of mobilisation would be 
applied (where the symptoms are non-severe and non-irritable). This standardised 
approach	to	choice	of	mobilisation	may	have	influenced	the	effect	of	treatment.	Future	
work should consider using a pragmatic choice of both technique and direction of 
mobilisation and is further considered in the study reported on in chapter 7.
Because	this	study	recruited	a	population	of	participants	who	were	not	currently	
undergoing	treatment	for	their	LBP,	many	potential	participants	did	not	experience	
pain on simple movements of the lumbar spine and thus were excluded from 
the study. Those included often reported low ratings of pain on movement and 
the application of PA force to the symptomatic level. Indeed 6 of the participants 
who experienced pain on the application of PA force to the spine on the initial 
assessment did not report any symptoms when force was applied on their second 
attendance. Future work should consider using a population with more severe 
symptoms and including the incorporation of pain on the application of pressure 
(overpressures) at the end of physiological movement.  
6.6. Key learning point from the single-arm trial
Conducting the single-arm trial identified that neither 3 nor 6 minutes of 
mobilisations resulted in changes in lumbar range of movement or stiffness. For 
this reason these measurements were excluded from the final study in this thesis. 
6.7. Conclusions
This study demonstrated that relative to baseline VRS of pain on movement was 
significantly greater with 6 minutes of treatment than with 3 minutes of treatment. 
Both	3	and	6	minutes	of	mobilisations	resulted	in	a	significant	increase	in	PPT	local	
to the site of treatment and in the signature zones of most lower limb dermatomes 
but not at a site unrelated to treatment. These findings suggest that the change 
in PPT is mediated via a local, segmental (as opposed to systemic) analgesic 
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mechanism. This is the first study to compare the effect of different durations 
of mobilisations in a symptomatic population and suggests that there may be a 
beneficial effect of applying longer durations of treatment than those advocated in 
clinical texts or investigated in previous research.
The dissociation between PPT and verbal rating of pain suggests that analgesia 
measured by PPT and patient report pain measures may be mediated by different 
analgesic mechanisms and highlights the need for inclusion of a number of 
different pain measures in order to gain a wide appreciation in change in pain 
experienced by patients. 
This study found that neither 3 nor 6 minutes of mobilisations had an effect on 
range of movement and stiffness. This suggests that the immediate effects of 
mobilisations are predominantly neurophysiological. The following chapter reports 
on a randomised controlled trial which further explored the effects of mobilisation 
treatment on pain.
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Chapter 7
A randomised placebo-controlled study 
investigating the immediate and 24 hour  
effects of mobilisation treatment duration  
on pain in participants with chronic LBP.
7.1. Introduction
The previous chapter in this thesis reported on a single-arm trial investigating the 
effects of 3 and 6 minutes of lumbar mobilisations on ROM, stiffness and pain in 
participants	with	chronic	LBP.	It	was	the	first	study	to	investigate	the	effects	of	
different durations of mobilisations in a symptomatic population.
The single-arm trial found that 6 minutes of mobilisations was required to produce an 
analgesic effect as measured by a decrease in pain on movement. A hypoalgesic 
effect of mobilisations was also demonstrated by an increase in PPT. This was 
evident following both 3 and 6 minutes of treatment. There was dissociation between 
mobilisation-induced changes in PPT and changes in VRS of pain on movement. 
Since changes in PPT are often used to demonstrate an analgesic effect it was 
important to further investigate the relationship between these and patient reported 
changes in pain. This current study included a larger population of participants 
with	LBP	and	as	in	the	previous	study	measured	PPT	and	verbal	rating	of	pain	on	
movement and on the application of PA force (applied to the most symptomatic 
spinal level) as well as incorporating additional patient reported outcome measures 
(verbal rating of pain at rest and global rating of perceived change). This study 
was also developed from the single arm trial by incorporating a placebo-control 
intervention and removing the temporal effects of one treatment duration on another.
The single arm trial measured the immediate effects of mobilisation. 
Anecdotal evidence suggests that some patients exhibit soreness immediately 
after treatment which is followed by a subsequent improvement of their symptoms 
(Maitland et al., 2005). However only one study has investigated the longer-term 
effects of a single dose of mobilisation treatment; in a placebo controlled study, 
Vicenzino et al., (1996) reported a significant reduction in the patients VRS of worst 
pain over the 24-hour period following 3 minutes of mobilisations to the cervical 
spine. The current study was therefore extended to measure the analgesic effect  
of lumbar mobilisations both immediately and 24 hours after application. 
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It is recognised that people respond to mobilisation treatment in different ways. 
For this reason there has been a move towards identifying factors that may predict 
patients response to mobilisation treatment (Childs et al., 2004). The single arm trial 
found that 80% of participants displayed a hypoalgesic response to mobilisations, 
demonstrated by increased PPT. However 20% experienced a decrease in PPT. 
Covariate analysis did not identify any predictor of mobilisation treatment outcome, 
however this may have been the result of the study being underpowered. Therefore 
this study continued to investigate the interaction between changes in pain and 
factors	that	may	influence	the	analgesic	response	(such	as	disability,	type	of	pain	
and pain attitudes). 
It	has	been	recognised	that	patients’	expectations	and	experiences	of	pain	are	
important. For example, a positive association between positive expectations 
and good functional outcomes has been reported previously (Kalauokalani et 
al., 2001). Specific to manual physiotherapy treatment, a study investigating the 
effects of expectations on the analgesic effects of manipulation treatment found that 
participants who were given negative expectations demonstrated hyperalgesia (an 
increase	in	pain)	following	treatment	(Bialosky	et	al.,	2008).	This	may	suggest	that	
participants who had low expectation of mobilisation treatment would experience 
an increase in pain following treatment and could explain the 20% of patients who 
experienced a decrease in PPT following mobilisations in the single arm trial.  
In	order	to	explore	the	influence	of	participants’	expectations	and	experience	of	
receiving a mobilisation treatment this study incorporated a questionnaire asking 
participants about these factors.
In summary, although there is evidence that participants with neck pain experienced 
an immediate hypoalgesic effect following mobilisations, this remains un-investigated 
in	participants	with	LBP.	Furthermore	there	is	limited	evidence	of	the	influence	of	
duration of treatment on pain. Most studies have investigated the immediate post 
treatment period and the mid- to longer-term effects of a single treatment dose 
remain unknown. The need to identify predictors of treatment response has been 
identified but at present there is inconclusive evidence and this remains an area of 
on-going research. This study therefore set out to investigate the immediate and 
short-term effects of lumbar mobilisation on pain and identify factors which may 
predict response to treatment.
7.1.1. Research questions 
1.  What are the immediate effects of 1 and 6 minutes of lumbar mobilisation 
treatment on pain in patients with non-specific low back pain?
2. What is the effect of 1 and 6 minutes of treatment on pain at 24-hour follow-up?
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7.1.2. Study aims
 
1. To establish the effects (immediately and after 24 hours) of a lumbar  
mobilisation treatment on PPT and patient reported pain measures in patients 
with	non-specific	LBP. 
 
2. To establish whether 1 minutes or 6 minutes of mobilisation treatment produces  
a greater analgesic response. 
 
3. To determine the extent of mechanical analgesia (using pressure pain 
thresholds) occuring after mobilisation of the lumbar spine (local, segmental  
or systemic). 
4. To establish the relationship between changes in PPT and changes in patient 
reported pain measures. 
5. To consider factors (demographics, anxiety and aspects of participants pain 
experience (pain description, disability due to the pain, pain beliefs and attitudes 
toward	the	pain))	which	may	predict	patients’	response	to	lumbar	mobilisations. 
6. To	explore	whether	participants’	expectations	and	experiences	of	receiving	
mobilisations	influence	their	response	to	treatment.
7.2 Methods
7.2.1. Study design
This	study	employed	a	randomised	placebo-controlled	research	design.	A	flow	
chart depicting the study design and participants journey through the study is 
shown in Figure 7.1. Two parallel groups (a short treatment duration group and a 
long treatment duration group), each received two interventions. The short duration 
treatment group initially received a placebo intervention consisting of 2 minutes of 
sham mobilisation followed by 1 minute of mobilisation treatment. The long duration 
treatment group received 2 minutes, followed by 4 minutes of mobilisation treatment. 
Participants were randomly allocated to either the short or long treatment duration 
group, using an online randomisation tool (Research randomizer.org).
Participants attended the laboratory on 3 occasions. Occasion 1 was conducted 
to	enable	a	thorough	exploration	of	the	history	of	participants	LBP	to	be	gained	
through a subjective examination and for the symptomatic level to be identified 
through physical examination. Occasion 1 also allowed time for the completion  
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of questionnaires which collected information on factors (demographics, smoking 
and	alcohol	use,	anxiety,	and	pain	beliefs)	which	may	have	influenced	participants	
response to treatment. Occasion 2 occurred at least 48 hours after occasion 1 to 
allow a washout period for any potential effects of the physical examination. 
On occasion 2 all measurements were taken by a research assistant who exited 
the room whilst all treatment interventions were applied to ensure blinding to 
participants’	group	allocations.	Baseline	measurements	were	followed	by	two	
treatment periods with an intervening measurement period (see Figure 7.1). The 
first treatment period enabled a comparison of 2 minutes of sham mobilisation and 
2 minutes of mobilisation treatment. The second treatment period enabled short 
and long durations of treatment to be compared. In treatment period 2, longer rest 
periods (see Figure 7.1) were incorporated for the short duration treatment group to 
ensure equitable treatment periods between groups.
Occasion 3 was conducted to establish the effects of mobilisations 24 hours after 
treatment. Measurements were taken by the research assistant (see Figure 7.1). 
Participants then completed a questionnaire on their expectations and experiences of 
receiving a mobilisation treatment. On completion of the study participants were given 
exercise	and	advice	for	their	LBP.
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Figure 7.1. Participants journey through the study
OCCASION 1
Physiotherapy assessment of the participant by the principal researcher
Participants completion of questionnaires:
Demographic 
McGill pain
Oswestry disability
Survey of pain attitudes
General Health 
Alcohol consumption and nicotine dependence      
OCCASION 2
Randomisation in to treatment group
Baseline: measurements of; Verbal rating scale of resting pain, 
Verbal rating scale of pain of movements of the lumbar spine,
Verbal rating scale of pain on posteroanterior pressure to the lumbar spine,
Pressure Pain Thresholds      
        Short treatment duration group  Long treatment duration group      
TREATMENT PERIOD 1  Placebo = 2 minutes    
            sham mobilisation   2 minutes mobilisation treatment      
Measurement of:
Verbal rating scale of resting pain 
Verbal rating scale of pain of movements of the lumbar spine
Verbal rating scale of pain on posteroanterior pressure to the symptomatic vertebral level
Global rating of perceived change
Pressure Pain Thresholds      
TREATMENT PERIOD 2      
 1 minute of mobilisation 4 minutes of mobilisation 
 30 seconds mobilisations 2 minutes mobilisations
 4 minute rest period 1 minute rest period
 30 minutes mobilisations 2 minutes of mobilisations      
Measurement of:
Verbal rating scale of resting pain 
Verbal rating scale of pain of movements of the lumbar spine
Verbal rating scale of pain on posteroanterior pressure to the symptomatic vertebral level 
Global rating of perceived change 
Pressure Pain Thresholds
Occasion 3 – 24 hour follow-up
Measurement of:
Verbal rating scale of resting pain 
Verbal rating scale of pain of movements of the lumbar spine
Verbal rating scale of pain on posteroanterior pressure to the symptomatic vertebral level 
Global rating of perceived change
Pressure Pain Thresholds
Questionnaire:
Participant completion of a questionnaire about their expectation and experience of receiving mobilisation technique.
End of study exercise and advice
➜
➜
➜
➜
➜
➜
➜
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7.2.2. Ethics approval
This study was approved by the Faculty of Health and Social Science Research 
Ethics and Governance Committee (FREGC) (for approval letter please see 
Appendix 2). 
7.2.3. Participants 
This study recruited a population with chronic low back pain. The power calculations 
performed using Minitab (version 16) were used to determine the required sample 
size for a power of 0.8 with a p value of .05. Calculations were made using the 
differences (mean difference 2.2kg and standard deviation (4.5kg)) between 3 and 
6 minutes of mobilisation treatment reported in the previous study (chapter 6). Power 
calculation suggested a minimum sample size of 36 in each group. Recruitment 
posters were placed on university email and in local shops and community centres. 
Advertisements	were	also	placed	in	local	newspapers,	on	the	website	‘gum	tree’	
(www.gumtree.com), in parent newsletters of local schools and through local church 
newsletters and intranet. Advertisement also occurred through word of mouth, for 
example, those participating in the study informed friends or colleagues about 
the study and provided them with the contact details of the principal researcher. 
Potential participants who contacted the researcher were sent a participant 
information sheet (Appendix 15) and a list of inclusion and exclusion criteria and 
to avoid coercion they were asked to contact the researcher again if they wished 
to take part. At this point an appointment was made for them to attend the Human 
Movement laboratory, Robert Dodd Annex, Eastbourne.
7.2.4. Inclusion criteria and exclusion criteria
Potential participants were required to be between 18-70 years of age, have 
experienced	LBP	for	a	minimum	of	3	months	and	experience	their	symptoms	 
on active movement.
Participants with precautions and contraindications to mobilisations were excluded 
from the study. This resulted in the following exclusion criteria:
•	 Spinal congenital abnormality
•	 History of spinal fracture
•	 History of malignancy
•	 Bone	disease	(osteoporosis,	osteomyelitis,	tuberculosis,	Paget’s)
•	 Inflammatory	arthritis	(rheumatoid	arthritis,	ankylosing	spondylitis,	gout)
•	 Congenital generalised hypermobility (Ehlers-Danlos syndrome)
•	 Advanced degenerative changes
•	 History of steroid therapy
•	 Pregnancy
•	 Current anticoagulant medication  
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•	 Pins and needles, tingling or numbness in the lower limbs
•	 Severe and / or irritable symptoms (symptoms which are so intense that  
they prevent the participant from moving, or which result in one movement 
producing lasting pain).
Potential participants were also excluded if they were undergoing current treatment 
for low back or leg pain (or had done so in the last 3 months). 
7.2.5. Confidentiality
All participant information was kept confidential and only made available to the 
study investigator and supervisors. All participants were allocated with a code; to 
ensure anonymity all data was stored under that code, the key to which was kept on 
a password protected computer. To fulfil the requirements of the Data Protection Act 
1998 all personal data was destroyed at the end of the study. Anonymised data will 
be kept for 10 years following completion of the study.
7.2.6. Instrumentation and measurements
PPT were measured using an electronic pressure algometer (Tracker computerised 
algometry system, JTECH medical industries, Salt Lake City, Utah) fitted with a 1cm2 
tip. The algometer had an on-screen dial to facilitate the researcher in standardising 
the rate of application a patient control switch.
A verbal rating scale (VRS) was utilised to gain a score of pain intensity at the end 
of each physiological movement and on the application of PA force to the most 
symptomatic vertebral level. The VRS is a scale that is used extensively in clinical 
practice and requires patients to score their pain on a scale of 0-10; 0 no pain and 
10	being	the	most	pain	imaginable.	To	assess	participants’	perceptions	of	the	effect	
of	their	LBP	a	global	rating	of	perceived	change	(GRPC)	scale	was	utilised.	The	
GRPC is an 11-point scale where 0 is on change, +5 is completely recovered and  
-5 is very much worse.
To measure the forces used in treatment, a lightly padded wooden plinth was 
mounted on non-conductive ground reaction force plates (AMTI OR6-7 – Advanced 
Mechanical Technology Inc., Watertown, MA, USA). The force plates indirectly 
measured the force applied by the therapist (Lee et al., 2005a). The researcher 
stood on a wooden platform with a lean bar (see Figure 4.1, page 53) to ensure that 
only	the	therapist’s	mobilising	force	was	measured	by	the	force	plates.
7.2.7. Procedure
On each attendance participants attended the Human Movement Laboratory at the 
University	of	Brighton,	Eastbourne	site.	They	were	greeted	by	the	author	and	led	to	 
a screened area.
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7.2.8. Occasion one procedure
On the first occasion participants received a verbal explanation of the study and 
were given an opportunity to ask questions. Participants were asked whether 
they would still like to participate before being asked to sign a consent form. This 
was followed by a physiotherapy assessment conducted by the researcher. The 
assessment was conducted to ensure that participants met the inclusion criteria (of 
pain on active movement, with or without overpressure) and determine the vertebral 
level(s) from which their symptoms were arising (see Appendix 6). This assessment 
was typical of the assessment performed by physiotherapists in clinical practice 
(Petty, 2011). Past medical and drug histories were also taken to ensure that 
participants had no exclusion criteria.
Participants were then asked to complete the following questionnaires which 
were included to measures factors that have previously been identified as risk 
factors	for	LBP,	or	potential	indicator	of	treatment	outcome	(see	Appendix	7	for	full	
questionnaires):
•	 Alcohol consumption (Townshend and Duka, 2002) and nicotine dependence 
questionnaire (Heatherton et al., 1991), as these substances may affect pain 
relieving mechanisms. 
•	 The McGill pain questionnaire (Melzack, 1975) describes the pain. 
•	 The Oswestry disability questionnaire (Fairbank et al., 1980) measures the 
impact of the pain.
•	 The survey of pain attitude (Tait and Chibnall, 1997) measures attitudes 
associated with the pain.
•	 A demographic questionnaire, which includes questions regarding, education, 
employment, income and activity levels. 
•	 The	General	Health	Questionnaire	(GHQ28,	Goldberg	et	al.,1979)	provides	an	
assessment of psychiatric distress.
7.2.9. Occasion two procedure
The most symptomatic vertebral level (identified from the physiotherapy assessment 
on occasion 1) was located through palpation of bony landmarks and marked with a 
temporary pen, as were the points for PPT testing (Table 7.2). 
7.2.10. Baseline measurements of verbal ratings of pain
Participants were asked to verbally rate their resting pain on an 11-point scale. 
Following rating of resting pain, participants were asked to stand with their feet hip 
width apart and active movements with overpressure (where the physiotherapist 
applied additional pressure at the end of range) were conducted. For participants 
with minimal or no symptoms on active movements with overpressure, combined 
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movements	were	also	performed	at	the	end	of	flexion	and	extension	range,	lateral	
flexion	and	ipsilateral	rotation	were	added	passively	by	the	physiotherapist.	The	
instructions provided to participants are provided in Table 7.1.
Table 7.1. Instructions given for verbal rating of pain during active movement.
Movement Instructions
Starting instructions ‘I would like you to perform some movements of your low back. At the end of each movement I 
would like you to tell me how bad your pain is out of 10; 0 being no pain and 10 being the worst 
pain you could imagine. At the end of each movement I will apply some pressure to your back 
and again, I will ask you to rate the pain out of 10’.  
Flexion ‘Bend forwards, as far as possible, running your hands down the front of your thighs. How many 
out of 10 is that? I am going to apply some pressure to your back, let me know what happens to 
your symptoms…How many out of 10 is that?’
Extension ‘Lean backwards as far as possible. How many out of 10 is that? I am going to apply some pres-
sure to your back, let me know what happens to your symptoms… How many out of 10 is that?’
Lateral flexion Indicating participants’ right / left side: ‘run your hand down the side of your leg, bending as far 
sideways as possible. How many out of 10 is that? I am going to apply some pressure to your 
back, let me know what happens to your symptoms…How many out of 10 is that?’
Rotation Indicating participants’ right / left side: ‘keeping your feet where they are, twist as far to this side 
as possible… How many out of 10 is that? I am going to apply some pressure to your back, let 
me know what happens to your symptoms…How many out of 10 is that?’ 
Flexion /lateral 
flexion/rotation
‘Bend forwards, as far as possible, running your hands down the front of your thighs….Now cross 
your arm across your chest…. I am going to apply some extra movements to your back’ right lateral 
flexion, followed by right rotation were added passively by the physiotherapist. …How many out of 
10 is that?’ This procedure was repeated adding left lateral flexion and left rotation.
Extension/lateral 
flexion/rotation
‘Lean backwards as far as possible.?’ …. I am going to apply some extra movements to your back’ 
right lateral flexion, followed by right rotation were added passively by the physiotherapist. …How 
many out of 10 is that?’ This procedure was repeated adding left lateral flexion and left rotation.
Following rating pain on active movement, participants were asked to lie prone on 
a plinth and rate on an 11-point scale their pain whilst the researcher applied a PA 
force to the symptomatic vertebral level. 
7.2.11. Baseline measurements of PPT
PPT testing was performed using the sites and positions indicated in Table 7.2. 
Two pressure pain threshold (PPT) readings were taken at each of the eight sites. 
Prior to testing, a familiarisation PPT was taken on the dorsal aspect of the hand 
at	the	web-space	between	the	thumb	and	index	finger	(enabling	participant’s	to	
experience PPT at one site). It was clearly explained that this was not intended to be 
a test of pain tolerance and that the intended point of measurement was when the 
sensation became anything more than just pressure, whether that was discomfort or 
pain. During the testing participants were asked to ‘push the button as soon as the 
sensation	of	pressure	turned	to	a	sensation	of	discomfort	or	pain’,	at	which	point	the	
pressure was removed and the PPT data was saved.
136
The algometer was applied perpendicular to the marked area of skin at all testing 
sites. The order of testing was designed to allow sufficient rest between repetitions 
with	the	least	changes	in	participant’s	position.	All	tests	were	completed	sequentially	
in	one	position	before	changing	the	participant’s	position.	Therefore	2	repetitions	
were completed at each site tested in prone (sites 1,2,1,2,) before moving into 
side lying and performing the testing sequentially in this position (sites 3,4,3,4). 
Participants were then asked to turn supine where the remaining sites were tested 
sequentially, (sites 5,6,7,8,5,6,7,8). The testing positions for T10, deltoid, L3 and S1 
can be seen in Figure 5.4-5.7 (pages 73-74).
Order of test Testing position Site Landmark identification
1 Prone L4/ symptomatic 
level
two fingers breadth lateral to the spinous process.
2 Prone T10 two fingers breadth lateral to the spinous process.
3 Side lying Deltoid the middle fibres, two fingers breadth below the tip of 
the acromion),
4 Side lying S1 dermatome posterolateral heel, two fingers breadth below and 
one fingers breath posterior to the tip of the lateral 
malleolus.
5 Supine L2 dermatome mid-thigh: using a tape measure, calculated by halving 
the distance measured from the anterior superior iliac 
spine to the base of the patella).
6 Supine L3 dermatome two fingers breadth above patella.
7 Supine L4 dermatome one finger breadth below the medial malleolus
8 Crook lying L5 dermatome proximal to the head of the 1st metatarsal
Table 7.2. The order of PPT testing: participant position and landmarks for each PPT testing site.
7.2.12.  Treatment period 1: Placebo (2 minutes of sham mobilsation) 
intervention versus 2 minutes of mobilisation treatment
Following baseline measurements participants lay prone on the plinth whilst receiving 
the intervention – the short duration treatment group received 2 minutes of sham 
mobilisation which consisted of the principal researcher applying manual contact at the 
symptomatic vertebral level using the ulnar border of their hand or thumbs (whichever 
hand position was subsequently used to apply mobilisations for that participant in 
treatment period 2 – see below). All the studies in Table 2.3 (page 13) investigating the 
effects of mobilisation used a similar sham mobilisation for the placebo intervention. 
Participants in the long duration of treatment group received 2 minutes of 
oscillatory PA mobilisation treatment applied to the most symptomatic level. Either 
a central or unilateral technique was selected, again based on which was the 
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most symptomatic. Unilateral mobilisations were applied using thumbs and central 
mobilisation applied using the ulna border of the hand. To replicate clinical practice 
the amount of treatment force applied was determined according to the severity of 
symptoms and in negotiation with the participant. The force was not standardised 
as pilot work had established that this might have resulted in undue reproduction of 
participant’s	symptoms	(section	6.2.7,	page	97).		
7.2.13. Measurements after treatment period 1.
Immediately following 2 minutes of sham or PA mobilisation treatment, repeated 
measurements	of	participants’	verbal	rating	of	pain	on	movement	and	PA	force	to	
the symptomatic vertebral level were performed, followed by repeat testing of PPT. 
An additional measurement, global rating of perceived change (GRPC), measured 
on an 11-point scale, was also included (Appendix 16). Measurements after 
treatment period 1 measurements were followed by a second treatment period.
7.2.14. Treatment period 2: one minute of mobilisation treatment versus  
6 minutes of mobilisation treatment
During the second period of mobilisation (Figure 7.1) participants lay prone on the 
plinth. The short treatment duration group received 30 seconds of mobilisations 
applied twice with a 4-minute rest period between repetitions. The longer treatment 
duration group mobilisations received 2 minutes of mobilisation treatment, applied 
twice, with 1-minute rest between repetitions. The rest period were included 
to replicate the use of mobilisations in clinical practice (see page 3 for typical 
treatment doses). 
7.2.15. Measurements after treatment period 2 
After	the	second	period	of	mobilisation	treatment,	participants’	verbal	rating	of	pain	
on movement and PA force to the symptomatic vertebral level were performed, 
followed by repeat testing of PPT and GRPC.
7.2.16. Occasion 3 – 24 hour follow-up procedure
Participants attended on a third occasion a mean of 24 hours later (SD 1.8 hours, 
range	17.5-27).	On	this	occasion	participants’	verbal	rating	of	pain	on	movement	
and PA pressure to the symptomatic vertebral level were performed, followed by 
repeat testing of PPT and GRPC.
On completion of all the experimental measurement, participants completed a 
semi-structured questionnaire (Table 7.3 and Appendix 17) on their expectations 
and experience of receiving mobilisations. The questions were designed by the 
researcher and the questionnaire was piloted on two participants prior to the onset 
of	the	study.	The	questionnaire	enabled	participants’	subjective	expectations	and	
experience to be compared to their response to treatment.  
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Questions
Have you had previous experience of receiving this mobilisation technique?  
Please describe any previous mobilisations that you have had.
What were you expecting from having this ‘mobilisation technique’ applied on this occasion?
Was there anything that you didn’t expect about the mobilisation technique?  
If so, what happened that you didn’t expect?
What were you thinking and feeling when the mobilisation technique was applied?
How comfortable was the technique?
What effect do you think the mobilisation technique had on your back?
Any other comments:
Table 7.3. The questions in the ‘expectations and experience of receiving mobilisations’ questionnaire.
7.3. Data Analysis
Descriptive	statistics	were	first	calculated	for	all	data	(participants’	demographic,	
questionnaire, PPT and VRS of pain) using Statistical Package for the Social 
Sciences (PASW version 20.0 for Windows). For PPT the mean of the two 
measurements at each site was used for subsequent analysis. Percentage changes 
in PPT were calculated (using the equation 100x ((post treatment PPT-pre treatment 
PPT) / pre treatment PPT)) to allow comparison with previous research reporting 
percentage change rather than actual measures. Verbal rating of pain on individual 
movements were summed and used in further analysis. 
7.3.1. Normality testing of data
Iterative statistical analyses were performed using Statistical Package for the Social 
Sciences (PASW version 20.0 for Windows). All the data were tested for normality 
using the Shapiro-Wilk test. Where data were not normally distributed, they were 
transformed using Logarithms to the power of 10 (Lg10). All transformed data was 
retested for normality. Analysis of variance (ANOVA) was used even when minor 
departures from normality remained, as ANOVA is robust to minor departures of 
normality (Agresti and Finlay, 2009). 
7.3.2. Mann-Whitney U test and independent samples T-test
Mann-Whitney tests (for skewed data) and independent samples T-tests (for 
normally distributed data) were used to examine for baseline differences between 
groups. Independent samples T-tests were also used to analyse differences in 
global rating of perceived effect between long and short duration treatment groups.
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7.3.3. Analysis of Variance 
The differences between groups for each measurement point were analysed 
individually (see Figure 7.1). 
PPT	data	were	analysed	using	a	three-way	mixed	ANOVA	with	two	within	subjects’	
variables, time (before and after) and site, which had 8 levels (symptomatic 
paravertebral, T10, deltoid, and S1, L2, L3, L4, L5 dermatomes). The between 
subjects variable was duration (either placebo/treatment or short/long). 
Planned covariate adjustments for demographic and questionnaire factors were 
performed	using	analysis	of	covariance	(ANCOVA).	Because	PPT	were	performed	at	
8 different sites stratified and covariate analysis was performed using the changes 
local to the treatment site (the symptomatic paravertebral site), as previous studies 
have reported greater local changes in PPT following mobilisations (Pentelka et al., 
2012; Willett et al., 2010).
VRS (for resting pain, pain on movement, pain on the application of PA force 
were	analysed	separately	using	two-way	mixed	ANOVA’s,	with	one	within	subject	
variable (time) and one between subject variable duration (either placebo/
treatment or short/long). 
7.3.4. Stratified analysis
Force of treatment was a potential confounding variable and therefore stratified 
analysis was performed using linear regression (Katz, 2003), to determine the 
proportion of the change in PPT that could be accounted for by the force of 
treatment. Analysis was performed for the change after treatment period 2,  
when all participants had received a mobilisation treatment dose and for changes  
at 24-hour follow-up.
7.3.5. Correlations
Spearman’s	correlations	were	used	to	investigate	the	relationship	between	verbal	
rating of pain on movement, pain on the application of PA force, resting pain and 
PPT.Bootstrapping	was	performed	and	95%	confidence	intervals	calculated	as	
recommended when performing multiple correlations (Field, 2012). 
7.3.6. Analysis of the expectations and experience of mobilisations questionnaire
At the end of the study the data gathered from the semi-structured questionnaire 
investigating	participants’	expectations	and	their	experience	of	receiving	a	
mobilisation	treatment	was	analysed	using	content	analysis	(Bryman,	2008).	The	
expectations and experience of receiving a mobilisation treatment were evaluated 
separately for treatment responders and non-responders.
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7.3.7. Analysis of response to treatment
Responder’s	analysis	was	performed	to	explore	the	number	of	participants	
experiencing minimal but clinically important change. For PPT a clinically important 
change was determined from the SEM and MDC statistics from the reliability study 
(chapter 5) and improvements of or more 15% as determined previously (Salaffi et 
al., 2004). For VRS of pain clinically important improvement was considered to have 
occurred with a reduction of pain greater than 1 (on a 0-10 scale). This has been 
determined to represent a clinically important change in previous research (Salaffi 
et al., 2004). Cumulative proportion of responders analysis was used to describe 
the likelihood of response over a range of response levels (Farrar et al., 2006). 
Chi-square test was conducted on PPT measures to establish whether there was 
a significant effect of the duration of mobilisation treatment or of expectations of 
treatment on the number of responders. As previous studies have reported greater 
local changes in PPT following mobilisations (Pentelka et al., 2012; Willett et al., 
2010) PPT responders were determined for sites local to the treatment and for the 
site most distant to treatment in order to compare local and systemic difference 
between treatment durations.
In	order	to	explore	the	factors	that	may	influence	participants’	response	to	treatment,	
the questionnaire results for responders and non-responders were compared 
using Mann-Whitney tests (for skewed data) and independent samples T-tests (for 
normally distributed data).
7.4. Results 
Two hundred and twenty one potential participants responded to University email, 
advertisements in local papers and shops and via word of mouth; Ninety-four 
did not report any exclusion criteria and received a physiotherapy assessment. 
Twenty participants were excluded after the physiotherapy assessment as they did 
not experience pain with active movement with overpressure (14) or were taking 
medication (6). Seventy-four participants met the inclusion criteria and became 
participants in the study. One participant had an acute injury to their lower back whilst 
playing rugby after the first session and did not attend the 24-hour follow-up. At the 
end of the study, two participants revealed that they took medication and so were 
excluded from the analysis. A total of 72 participants data were used in the analysis. 
This was the minimum number suggested in the power analysis (section 7.2.3).
Fifty participants complained of symptoms contained to their low back (34 with 
central pain and 16 with pain to one side), 6 complained of symptoms extending 
into the buttocks, 14 had low back and posterior leg pain (10 of these had pain 
extending	below	the	knee)	and	2	had	LBP	and	anterior	thigh	pain.	The	most	
symptomatic level determined through the physical examination is displayed in 
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Table 7.4. Thirty-nine participants received a central PA mobilisation technique 
and	33	participants	received	a	unilateral	PA	mobilisation	technique.	Participant’s	
weight, height, age and duration of symptoms are displayed in Table 7.4. There 
was a significant difference in the age of participants in the short and long duration 
treatment groups. Participants in the long duration treatment group were significantly 
younger t69= 3.06, p<.01 (Appendix 19).
Group Sex Age Height
(cm)
Weight
(kg)
Symptom
Duration 
(years)
Symptomatic 
level (number  
of participants)
Treatment 
technique
Short duration
n=33
22 male
11 
female
Mean 
46
SD13
Mean 
175
SD8
Mean
78kg 
SD15
Mean 11 
SD 11
Range
0.3-35
L5 (21)
L4 (6)
L3 (5)
L2 (1)
Unilateral 17
Central 16
Long duration
n=39
23 male
16 
female
Mean 
36
SD14
Mean 
175
SD10
Mean
80kg 
SD16
Mean 7 
SD 6
Range
0.8-31
L5 (23)
L4 (11)
L3 (5)
Unilateral 16
Central 23
Table 7.4. Demographic, symptom and treatment details. 
One participant failed to complete the questionnaires so the questionnaire results, 
presented in Table 7.5 and 7.6, are for 71 participants. The 7 participants who smoked 
had a low mean dependency score. Most participants were in the lowest Oswestry 
disability scoring band (0-20%) indicating minimal disability. The range indicated that 
some participants fell in the moderate disability-scoring band (20-40%). The mean 
GHQ28	scores	indicated	that	participants	did	not	suffer	from	psychiatric	distress	 
(a	GHQ28	of	5	or	above	indicates	psychiatric	distress	(Richard	et	al.,	2004)).	 
However,	eighteen	of	the	71	participants’	scores	exceeded	this	threshold.	
There were no significant differences for questionnaire data between groups, 
except for the solicitude subscale of the SOPA (U= 409.50, p=.012, see Appendix 
19) indicating that participants in the short duration group had significantly higher 
solicitude scores. The two groups were comparable on all other demographic  
and	questionnaire	results	(age,	hours	of	exercise,	alcohol	consumption,	GHQ28,	
McGill, Oswestry).
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Alcohol Smoking Exercise 
per week 
(hours)
GHQ28 McGill Oswestry
% score
Units Binge
score
Short  
duration
n=33
Mean 8
SD 6
Range 
0-24
Mean 6
SD 9
Range 
0-37
2 smokers
Mean 3.8
Range 3-6
Mean 5
SD 4 
Range 
0-48
0-11
Median 2
Mean 3
SD 4
Range 
0-16
Mean 17
SD 8
Range 
5-37
Mean 18
SD 8
Range 
8-36
Long  
duration
n=39
Mean 7
SD 6
Range 
0-21
Mean 7
SD 10
Range 
0-21.5
5 smokers
Mean 3.5
Range 3-6
Mean 5
SD 5 
Range 
0-48
0-21.5
Median 3
Mean 4
SD 5
Range 
0-19
Mean 18
SD 10
Range 
4-39
Mean 15
SD 6
Range 
2-27
Table 7.5. Questionnaire results 
Control Disability Harm Emotion Medication Solicitude Medical cure
Short
Duration
n=33
10 (3) 6 (3) 5 (3) 5 (4) 4 (3) 6 (4) 10 (4)
Long
Duration
n=39
10 (4) 5 (3) 6 (4) 5 (5) 3 (3) 4 (3) 12 (4)
Table 7.6. Survey of pain attitudes raw scores. Mean (standard deviation).
The forces used in treatment are described in Table 7.7. There was no significant 
difference between the treatment force used in the short and long duration treatment 
groups t68 =.97, p=.34. As expected the placebo sham treatment was significantly 
lower than the mobilisation treatment force U=1,191.0, p<.01 (Appendix 21).
Short duration condition, n=33 Long duration condition, n=39
Placebo (sham treatment) 1 minute 2 minutes 4 minutes
Mean 26 142 139 129
SD 12 54 50 57
Range 8-52 52-303 65-279 41-238
Table 7.7. The forces (in Newtons) applied in each condition. 
7.4.1. Results for PPT
PPT data sets were not normally distributed and therefore the data was transformed 
using Logarithms (Log10). Re-testing for normality revealed that minor deviations 
from normality were found (see Appendix 18).
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Due to random allocation to experimental groups, differences between the  
baseline PPT measurements were not anticipated. However observation of the  
data suggested that a difference might have been present. This was particularly 
notable at the symptomatic paravertebral level and T10 sites. No significant 
differences in baseline measurements were evident (see Appendix 19 for 
significance levels for each site).
Comparing PPT between baseline and after treatment period 1 (after 2 minute sham 
mobilisation and 2 minutes of mobilisation treatment), there was no significant effect 
of time (F 1,70 =0.06, p=.81) or condition (F 1,70 =0.28, p=.60) and no significant 
time*condition interaction effect (F1,70 =3.3, p=.07). There was no 3-way interaction 
between condition*site*time (F1,70 =2.1, p=.55). These results demonstrated that 
2 minutes of mobilisations did not significantly change PPT, relative to placebo 
(Figures 7.2-7.5). See Appendix 20.
Comparing PPT between baseline and after treatment period 2 demonstrated 
that there was no significant effect of time (F 1,70 =0.09, p=.76), and no significant 
time*condition interaction effect (F1,70 =2.78, p=.10). There was a significant 
interaction between condition*site *time (F1,70 =2.71, p=.02). However post hoc 
analysis with adjustment for multiple comparisons found no 3-way interaction effect 
(See Appendix 20 for p values at each site). This demonstrated that the longer 
duration of mobilisations did not produce a greater change in PPT.
The difference between PPT at baseline and 24 hours revealed a significant main 
effect for time (F 1,69 =16.69, p<.01). There was a significant interaction between 
time*condition (F1,69 =7.59, p=.01). However post hoc analysis with adjustment 
for multiple comparisons found that there was no two-way interaction effect (see 
Appendix 20). These results demonstrate that PPT were significantly reduced at 
24-hour follow-up compared to baseline, but the difference between short and the 
long duration treatment groups failed to reach significance.
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Figure 7.2. Paravertebral PPT measurements After treatment period 1: following 2 minutes 
sham mobilisation (short duration group) and following 2 minutes mobilisation treatment (long 
duration group). After treatment period 2: following 2 minutes sham mobilisation and 1 minute 
mobilisation treatment (short duration group) and following 6 minutes of mobilisation treatment  
(long duration group). The data are means. Error bars represent +/- standard deviation. 
Figure 7.3. PPT measurements After treatment period 1: following 2 minutes sham mobilisation 
(short duration group) and following 2 minutes mobilisation treatment (long duration group). 
After treatment period 2: following 2 minutes sham mobilisation and 1 minute mobilisation 
treatment (short duration group) and following 6 minutes of mobilisation treatment (long 
duration group). The data are means. Error bars represent +/- standard deviation.
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Figure 7.4. PPT measurements  After treatment period 1: following 2 minutes sham mobilisation 
(short duration group) and following 2 minutes mobilisation treatment (long duration group). 
After treatment period 2: following 2 minutes sham mobilisation and 1 minute mobilisation 
treatment (short duration group) and following 6 minutes of mobilisation treatment (long 
duration group). The data are means. Error bars represent +/- standard deviation. 
Figure 7.5. PPT measurements After treatment period 1: following 2 minutes sham mobilisation 
(short duration group) and following 2 minutes mobilisation treatment (long duration group). 
After treatment period 2: following 2 minutes sham mobilisation and 1 minute mobilisation 
treatment (short duration group) and following 6 minutes of mobilisation treatment (long 
duration group). The data are means. Error bars represent +/- standard deviation.
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Planned covariate adjustment for duration of symptoms, age, and question scores 
(Oswestry	disability,	McGill,	GHQ28,	SOPA)	did	not	demonstrate	any	interactions.	
(Appendix 20). This indicated that the questionnaire data did not help to predict 
participants’	response	to	mobilisations.
To enable comparison with previous studies reporting percentage change values 
these are presented in Table 7.8. The mean percentage differences in PPT following 
all treatment durations were small as depicted. The large standard deviations 
indicate	a	large	variation	in	participants’	response	to	mobilisation	treatment.	Analysis	
of treatment responders and non-responders is further explored in section 7.4.9. 
 
In summary there were no difference between placebo, short and long duration of 
mobilisation treatment on PPT. Relative to baseline there was a significant reduction 
in PPT at 24 hour follow-up evident in both short and long treatment duration groups. 
This demonstrated that participants in both groups exhibited hyperalgesia 24-hours 
after the experimental session. Covariate analysis failed to identify any predictors of 
treatment response.
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 Percentage change in Pressure Pain Threshold
PPT Site Short duration group n=33 Long duration group n=39
Placebo (2 minutes sham mobilisation) 2 minutes mobilisation Rx
Symptomatic
Paravertebral muscle -4.1 (19.0) 3.2 (24.3)
T10
Paravertebral muscle -3.7 (18.5) 8.6 (27.7)
Deltoid -2.7 (17.7) 6.0 (22.0)
S1 Dermatome -1.2 (21.4) 0.3 (16.8)
L2 Dermatome 4.0 (15.6) 2.1 (20.4)
L3 Dermatome 3.3 (17.7) 5.2 (19.8)
L4 Dermatome 3.3 (24.1) 12.0 (18.1)
L5 Dermatome 5.2 (21.9) 4.5 (18.6)
Additional 1 minute
mobilisation Rx 
Additional 6-minutes
mobilisation Rx
Symptomatic
Paravertebral muscle -6.1 (23.9) 7.8 (26.2)
T10
Paravertebral muscle -6.5 (16.9) 6.9 (27.7)
Deltoid 1.6 (28.6) 7.7 (30.7)
S1 Dermatome 1.5 (20.5) 2.9 (24.5)
L2 Dermatome 2.9 (23.2) 3.5 (25.9)
L3 Dermatome 0.6 (16.0) 8.5 (23.7)
L4 Dermatome -1.1 (24.1) 17.2 (24.6)
L5 Dermatome 8.3 (25.9) 1.1 (22.0)
24-hour follow-up, n=33 24-hour follow-up, n=38
Symptomatic
Paravertebral muscle -12.9 (29.5) -2.3 (35.2)
T10
Paravertebral muscle -10.7 (20.4) 5.3 (38.0)
Deltoid -12.8 (23.6) -3.0 (35.2)
S1 Dermatome -12.5 (20.9) -5.5 (26.4)
L2 Dermatome -6.7 (19.2) -7.3 (29.1)
L3 Dermatome -8.3 (21.1) 1.9 (27.3)
L4 Dermatome -11.0 (24.1) -0.5 (30.7)
L5 Dermatome -5.9 (25.8) -0.7 (31.0)
Table 7.8. Percentage change in PPT at each site at each measurement point.
Data are mean percentage changes (standard deviation).
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7.4.2. Results for verbal rating scale of pain on movement
Active movements with overpressure were applied to 64 participants. The remaining 
ight participants did not receive overpressures due to the severity of their symptoms (4 
participants in the short duration group and 4 participants in the long duration group). 
Six participants had minimal symptoms so combined movements were included (2 in 
the short duration group and 4 in the long duration group).
Movement Short duration group, n=33 Long duration group, n=39
Baseline Baseline
Flexion 2.7 (2.5) 1.9 (2.1)
Extension 2.8 (2.2) 2.4 (2.0)
Left lateral flexion 1.9 (2.1) 1.6 (2.0)
Right lateral flexion 2.0 (1.7) 1.5 (1.9)
Left rotation 1.1 (1.3) 0.7 (1.3)
Right rotation 1.3 (1.6) 0.6 (1.3)
Placebo (2 minutes sham mobilisation) 1 minute mobilisation Rx
Flexion 2.1 (2.0) 1.8 (2.0)
Extension 2.3 (2.3) 2.0 (2.0)
Left lateral flexion 1.3 (1.9) 1.2 (1.4)
Right lateral flexion 1.8 (1.8) 1.1 (1.7)
Left rotation 0.8 (1.3) 0.6 (1.2)
Right rotation 1.1 (1.7) 0.6 (1.3)
Additional 1 minute mobilisation Rx Additional 4-minutes mobilisation Rx
Flexion 2.2 (2.3) 1.8 (2.0)
Extension 1.9 (2.1) 1.7 (1.9)
Left lateral flexion 1.3 (1.8) 1.1 (1.6)
Right lateral flexion 1.5 (1.5) 1.0 (1.5)
Left rotation 0.7 (1.2) 0.6 (1.5)
Right rotation 0.9 (1.6) 0.7 (1.3)
24-hour follow-up, n=33 24-hour follow-up, n=38
Flexion 1.6 (1.8) 1.3 (2.1)
Extension 2.9 (2.6) 2.4 (1.8)
Left lateral flexion 1.6 (2.1) 1.4 (1.4)
Right lateral flexion 2.2 (2.1) 1.6 (1.5)
Left rotation 1.1 (1.8) 0.9 (1.2)
Right rotation 1.5 (2.2) 0.7 (1.0)
Table 7.9. Verbal rating scales of pain (0-10) on individual movements. Data are means (standard deviation). 
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Mean VRS of pain on individual movement were very low, never exceeding 3/10 
(Table 7.9). There was no significant difference in the baseline measurement of VRS 
(combined for pain on all movements) between the long and short duration treatment 
groups (t70= 1.148, p=.23).
Verbal rating of pain on movement data was skewed and thus transformed data 
was	used	in	the	analysis	(Appendix	18).	For	two-way	mixed	ANOVA’s	for	verbal	
rating of pain on movement (Appendix 22) there were only two time points and thus 
sphericity was assumed.  
Comparison of verbal rating of pain on movement between baseline and after 
treatment period 1 (between baseline and 2 minutes sham mobilisation and 
baseline and 2 minutes of mobilisations) revealed a significant main effect of 
time (F1,70 =30.8, p<.01), demonstrating a significant reduction in VRS of pain on 
movement. There was no significant main effect of condition (F1,70 =1.29, p=.28) 
and there was no significant interaction effect for time*condition (F1,70 =0.02, p=.90). 
These results demonstrate that there was no difference in the effects of placebo 
(sham mobilisation) and 2 minutes of mobilisation on verbal rating of pain on 
movement (see Figure 7.6). 
After treatment period 2 (between baseline and 6 minutes and baseline and 1 
minute (plus 2 minutes sham mobilisation)) there was a significant main effect of 
time (F1,70 =45.5, p<.01), demonstrating a significant reduction in VRS of pain on 
movement. There was no significant main effect of condition (F1,70 =0.55, p=.46). 
There was no significant interaction between condition*time (F1,70 =0.60, p=.44). 
These results demonstrate that 1 minutes of mobilisations treatment did not 
significantly change verbal rating of pain on movement, relative to 6 minutes of 
mobilisation treatment (see Figure 7.6). 
At 24 hour follow-up there was a significant effect of time on verbal rating of pain on 
movement (F1,70 =51.3, p<.01), demonstrating that there was a significant reduction 
in VRS of pain on movement. There was no significant main effect of condition (F1,70 
=0.98, p=.33).There was no significant interaction between condition*time (F1,70 
=0.01, p=.94). These results demonstrate that 24 hours after treatment, 1 minute 
of mobilisations did not significantly change verbal rating of pain on movement, 
relative to 6 minutes of mobilisations (see Figure 7.6). 
Covariate analysis with VRS of pain on movement did not find any interactions 
between the response to treatment and the questionnaire responses. 
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Figure 7.6. Verbal rating of pain on movement (combined for all movements).
After treatment period 1: following 2 minutes placebo (sham mobilisation)(short duration group) 
and following 2 minutes mobilisation treatment (long duration group). After treatment period 
2: following 2 minutes placebo and 1 minute mobilisation treatment (short duration group) and 
following 6 minutes of mobilisation treatment (long duration group). The data are means. Error 
bars represent +/- standard deviation. 
In summary relative to baseline, there was an immediate decrease in verbal pain 
rating on movement with both treatment groups. This was also evident at 24-hour 
follow-up. However the difference between placebo and 2 minutes of treatment and 
between 1 minute and 6 minutes of treatment failed to reach significance. 
7.4.3. Results for verbal rating scale of resting pain
Many	participants	didn’t	experience	any	resting	pain	(15	out	of	33	in	the	short	
duration group and 24 out of 39 in the long duration group) and mean levels of 
resting pain were low. There were minimal variations in mean resting pain scores 
between time points (Figure 7.7). There was no significant difference in the baseline 
measurements of VRS of resting pain between the long and short duration treatment 
groups (t70= 1.445, p=.15). Due to the low baseline scores and high number of 
participants with no pain at rest the data was skewed. This was not corrected with 
transformation of the data. However a two-way mixed ANOVA was used as there is 
no non-parametric equivalent and ANOVA is robust to deviations from normality.
Relative to baseline there was no significant effect of time or time*condition for 
resting pain after treatment periods 1 or 2 or at 24-hour follow-up (see Table 7.10 for 
statistical values). This indicated that relative to baseline there was no immediate 
or short-term effect of mobilisations on resting pain in the placebo, short, or long 
duration of treatment groups (Appendix 22). 
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Figure 7.7. Verbal rating of resting pain  After treatment period 1: following 2 minutes placebo 
(sham mobilisation) (short duration group) and following 2 minutes mobilisation treatment (long 
duration group). After treatment period 2: following 2 minutes placebo and 1 minute mobilisation 
treatment (short duration group) and following 6 minutes of mobilisation treatment (long 
duration group). The data are means. Error bars represent + standard deviation. 
7.4.4. Results for verbal rating scale of pain on the application of PA force  
to the symptomatic level 
The overall variations in mean verbal rating of pain scores on the application  
of PA force to the symptomatic level were small; the largest mean change was  
0.8 on an 11-point scale (Figure 7.8). There was no significant difference in the 
baseline measurements of verbal rating of pain between the short duration and  
long duration treatment groups (t70= .83, p=.41).
There was a significant main effect of time for pain on PA pressure to the 
symptomatic level between baseline and both time points 1 (F1,70 =6.28, p=.02)  
and 2 (F1,70 =5.67, p=.02) demonstrating that relative to baseline there was an 
immediate decrease in pain on the application of PA force. There was no significant 
main effect of condition or time*condition interaction (see Table 7.10 for statistical 
values) indicating that the difference between sham mobilisation and 2 minutes 
of mobilisation and 1 minute and 6 minutes of mobilisations failed to reach 
significance. The main and interaction effects at 24-hour follow-up failed to reach 
statistical significance (see Table 7.10 for statistical values).
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Figure 7.7. Verbal rating of resting pain 
After treatment period 1: following 2 minutes placebo (short duration group) and following 
2 minutes mobilisation treatment (long duration group)  
After treatment period 2: following 2 minutes placebo and 1 minute mobilisation treatment 
(short duration group) and following 6 minutes of mobilisation treatment (long duration 
group). 
The data are means. Error bars represent + standard deviation.  
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Figure 7.8. Verbal rating of pain on the application of PA force to the most symptomatic vertebral level.
After treatment period 1: following 2 minutes sham mobilisation (short duration group) and 
following 2 minutes mobilisation treatment (long duration group). After treatment period 2: 
following 1 minute sham mobilisation and 1 minute mobilisation treatment (short duration group) 
and following 6 minutes of mobilisation treatment (long duration group). The data are means. 
Error bars represent + standard deviation.
Verbal rating scale After treatment period 1 n=72
After treatment period 2 
n=72
At 24-hour follow-up
n=71
Verbal rating of pain on movement
Time F= 1,70 30.8, p<.01** F= 1,70 45.5, p<.01** F= 1,70 51.3, p<.01**
Condition F= 1,70 1.29, p=.28 F= 1,70 0.55, p=.46 F= 1,70 0.98, p=.33
Time*condition F= 1,70 0.17, p=.90 F= 1,70 0.60, p=.44 F= 1,70 0.01, p=.94
Verbal rating of pain resting pain
Time F= 1,70 0.28, p=.60 F= 1,70 0.07, p=.79 F= 1,70 1.30, p=.26
Condition F= 1,70 1.96, p=.15 F= 1,70 0.04, p=.85 F= 1,70 2.56, p=.11
Time*condition F= 1,70 0.27, p=.60 F= 1,70 2.38, p=.13 F= 1,70 0.07, p=.93
Verbal rating of pain on the application of PA force
Time F= 1,70 6.28, p=.02* F= 1,70 5.67, p=.02* F= 1,70 1.77, p=.19
Condition F= 1,70 2.89, p=.09 F= 1,70 0.27, p=.61 F= 1,70 0.76, p=.39
Time*condition F= 1,70 2.57, p=.11 F= 1,70 0.92, p=.34 F= 1,70 0.01, p=.92
Table 7.10. Two way mixed ANOVA results for VRS of pain.
RP= resting pain; PA =PA pressure at most symptomatic level;
Bold values indicate a significant effect, *denotes p<.05, **denotes p<.01.
7.4.5. Global rating of perceived change
There was a small mean GRPC at all measurement points, greatest 24 hours after 
treatment (see Table 7.11). The difference in GRPC between short and long duration 
groups failed to reach significance (after treatment 1: t70= .399, p=.69, after treatment 
2: t70= .472, p=.64 and at 24-hour follow-up: t69= .200, p=.84). See Appendix 23.
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Figure 7.7. Verbal rating of resting pain 
After treatment period 1: following 2 minutes placebo (short duration group) and following 
2 minutes mobilisation treatment (long duration group)  
After treatment period 2: following 2 minutes placebo and 1 minute mobilisation treatment 
(short duration group) and following 6 minutes of mobilisation treatment (long duration 
group). 
The data are means. Error bars represent + standard deviation.  
 
 
 
  
Figure 7.8. Verbal rating of pain on the application of PA force to the most 
symptomatic vertebral level. 
After treatment period 1: following 2 minutes placebo (short duration group) and following 
2 minutes mobilisation treatment (long duration group)  
After treatment period 2: following 2 minutes placebo and 1 minute mobilisation treatment 
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Short duration group, n=33 Long duration group, n=39
Placebo 2 minutes mobilisation Rx
0.7 (1.7) 0.5 (1.7)
1 minute mobilisation Rx (+ 2 minutes Placebo) 6-minutes mobilisation Rx
0.6 (2.2) 0.8 (1.7)
24-hour follow-up, n=33 24-hour follow-up, n=38
1.3 (1.9) 1.2 (1.8)
Table 7.11. Global rating of perceived change (on an 11-point scale) at each measurement point
(-5 = very much worse, 0 = unchanged, +5 = very much better).
In most cases GRPC scores were correlated with change in all pain measures 
(Table 7.12). Following treatment period 1, change in PPT and verbal rating of pain 
on movement were not associated with participants perceived rating of change. 
However there was association between GRPC and verbal rating of resting pain 
and pain on the application of PA force to the symptomatic level. The dissociation 
between GRPC and PPT and verbal rating of movement were the same for the short 
duration treatment group (PPT p=.12, r=.27; VRS p=.75, r=.06 ) and for the long 
duration treatment group (PPT p=.69, r=.-07; VRS p=.39, r=.14) After treatment 
period 2, there was association between GRPC and all pain measures, except pain 
on the application of PA force to the symptomatic level, where the association just 
failed to reach significance. At 24-hour follow-up there was significant association 
between GRPC and all pain measures (Table 7.12).
The associations between GRPC and change in PPT were positive associations, 
demonstrating that a improvement in symptoms was associated with an increase in 
PPT, suggesting a hypoalgesic effect (Figure 7.9). The associations between GRPC 
and change in verbal ratings of pain were negative associations, demonstrating that 
an improvement in symptoms was associated with a reduction in pain (Figure 7.10). 
PPT Verbal rating of pain on movement
Verbal rating  
of resting pain
Verbal rating of pain on 
application of PA force
Treatment period 1, n=72 p=.47, r=.09 p=.49, r=.08 p=.01, r=-.32** p=.02, r=-.27*
Treatment period 2, n=72 p<.01, r=.35** p<.01, r=-.41** p<.01, r=-.34** p=.06, r=-.22
24 hour follow-up, n=71 p=.03, r=.26* p<.01, r=-.53** p=.05, r=-.24* p<.01, r=-.49**
Table 7.12. Spearman’s correlation between change in pain and GRPC in short and long duration  
groups combined. PA =PA pressure at most symptomatic level. Bold values indicate a significant 
effect, *denotes p<.05, **denotes p<.01. (see appendix 23).
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Figure 7.9. Scatter plot demonstrating positive correlation between GRPC
and change in PPT at the symptomatic paravertebral level (p<.01, r=.35).
Figure 7.10. Scatter plot demonstrating negative correlation between GRPC and
verbal rating of pain on movement after treatment period 2 (p=.02, r=.28).
7.4.6. Stratified analysis of force
Force	of	treatment	varied	depending	on	participants’	clinical	presentation	and	 
thus was a potential confounding or mediating variable. For stratified analysis was 
performed for changes at the paravertebral muscles site local to the site of treatment 
where the greatest changes in PPT were observed and for the Deltoid muscle site 
distant from the site of treatment, where less change was observed following treatment.
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Figure 7.9. Scatter plot demonstrating positive correlation between GRPC 
and change in PPT at the symptomatic paravertebral level (p=.00, r=.35). 
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and change in PPT at th  symptomatic paravert bral level (p=.00, r=.35). 
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At the symptomatic paravertebral PPT, after treatment period 2, there was a 
significant mediating effect of force F1,69 =8.32, p=.01, the R
2 (0.109) demonstrated 
that 11% of the variation in effect at the symptomatic paravertebral PPT site could be 
accounted for by force (Figure 7.11). The mediating effect of force at 24-hour follow 
up failed to reach significance (F1,69 =8.32 p=.67). See Appendix 21.
Figure 7.11. At the symptomatic paravertebral PPT, after treatment period 2, there  
was a significant mediating effect of force F 1,69 =8.32, p =.01, the R
2 (.109) demonstrated  
that 11% of the variation in effect at the symptomatic paravertebral PPT site could be  
accounted for by force.
The R 2 0.09 at the T10 paravertebral PPT site demonstrated that 9% of the  
variation in effect could be accounted for by force immediately following treatment 
(F1,69 =6.81, p= .01) (Figure 7.12), indicating that force was a significant mediating 
factor. The mediating effect of force was not evident at the deltoid muscle PPT site 
R2=.02: F1,69 =0.88, p=.35). These results indicate that higher treatment forces result 
in greater increases in immediately following treatment local to the site of treatment, 
but not at a more distant location.
 19 
Figure 7.10. Scatter plot demonstrating negative correlation between GRPC 
and verbal rating of pain on movement after treatment period 2 (p=.02, r=.28). 
 
 
 
 
 
 
 
Figure 7.11. At the symptomatic paravertebral PPT, after treatment period 2, there 
was a significant mediating effect of force F 1,69 =8.32, p=.005, the R2 (0.109) 
demonstrated that 11% of the variation in effect at the symptomatic paravertebral 
PPT site could be accounted for by force 
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Figure 7.12. The R2 0.09 at the T10 paravertebral PPT site demonstrated that 9% of the variation 
in effect could be accounted for by force immediately following treatment (F 1,69 =0.89, p= .66).
Stratified analysis also found that force had a significant mediating effect on verbal 
rating of pain on movement (F1,69 =10.38, p<.01). The R
2 (0.132) demonstrated that 
13% of the variation in effect could be accounted for by force of treatment, with 
higher force resulting in greater reductions in verbal rating of pain on movement 
(Figure 7.13). The mediating effect of treatment force on change in verbal rating  
of pain on movement was still evident at 24-hour follow-up (F1,68 =4.337, p=.04).  
The R2 (0.06) demonstrated that the variation in effect that could be accounted for 
by force of treatment had reduced to 6% at this measurement point (Figure 7.14).
Figure 7.13. Treatment force had a significant mediating effect on verbal rating of pain on 
movement (F1,69 =10.38, p<.01). The R
2 (0.132) demonstrated that 13% of the variation in 
effect could be accounted for by force of treatment
ORIGINALS IN COLOUR
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Figure 7.13. Treatment force had a significant mediating effect on verbal rating of 
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Figure 7.14. Treatment force had a significant mediating effect on verbal rating of pain on 
movement (F1,68 =4.337, p=.04). The R2 (.06) demonstrated that 6% of the variation in effect 
could be accounted for by force of treatment.
There was no significant mediating effect of treatment force on resting pain (R2=.03: 
F1,69 =2.36, p=.13) or pain on the application of PA force to the most symptomatic 
level (R2=.01: F1,68 =0.815, p=.37).
In summary there was a significant immediate mediating effect of treatment force 
on PPT at the symptomatic paravertebral muscles sites and on verbal rating of pain 
on movement, suggesting that higher treatment forces create a greater analgesic 
effect. The mediating effect of force on verbal rating of pain on movement remained 
evident at 24-hour follow-up. There was no difference in the effect on resting pain or 
pain on the application of PA force to the symptomatic level.
7.4.7. The Relationship between PPT and participants’ VRS.
Correlations demonstrated that there was dissociation between PPT at the 
symptomatic paravertebral site and VRS of pain on movement and resting pain. 
There was a negative correlation between PPT at the symptomatic paravertebral 
site and pain on the application of PA force at the symptomatic level for 2 out of the 
4 time points (Table 7.13). However the effect size was small and this suggests that 
there is little to no association between PPT and patient reported pain measures 
(Appendix 24).
Correlations	between	participants’	verbal	rating	of	pain	on	movement,	PA	force	to	
the symptomatic spinal level and resting pain established that there was a positive 
correlation between the different patient-reported pain measures on 9 out of 12 
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Figure 7.15. Scatter plot demonstrating positive correlation between verbal 
rating of pain on movement and resting pain at baseline (p=.03, r=.26). 
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occasions (Table 7.13). These results demonstrate that higher ratings of pain on  
one patient reported measure are associated with higher pain ratings on other 
patient reported measures (see Figures 7.15 – 7.18 for examples). The r values 
mostly suggest medium effect sizes. 
Figure 7.15. Scatter plot demonstrating positive correlation between verbal rating of pain  
on movement and resting pain at baseline (p=.03, r=.26, 95% CI -.00 to .49).
Figure 7.16. Scatter plot demonstrating positive correlation between verbal rating of resting  
pain and pain on the application of PA force to the most symptomatic vertebral level after 
treatment period 1 (p<.01, r=.55, 95% CI .36 to .71).
ORIGINALS IN COLOUR
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Figure 7.14. Treatment force had a significant mediating effect on verbal rating of 
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Figure 7.16. Scatter plot d strating positive correlation b tween verbal 
rating of resting pain and pain on the application of PA force to the most 
symptomatic vertebral level after treatment period 1 (p=.00, r=.55). 
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Figure 7.17. Scatter plot demonstrating positive correlation between verbal rating of pain 
on movement and pain on the application of PA force to the most symptomatic vertebral  
level after treatment period 2 (p<.01, r=.31, 95% CI -.17 to .60).
Figure 7.18. Scatter plot demonstrating negative correlation between verbal rating of pain  
on the application of PA force to the most symptomatic vertebral level and PPT at the 
symptomatic paravertebral level after treatment period 2 (p=.02, r=-.28, 95% CI -.51 to -.03).
ORIGINALS IN COLOUR
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Figure 7.17. Scatter plot demonstrating positive correlation between verbal 
rating of pain on movement and pain on the application of PA force to the 
most symptomatic vertebral level after treatment period 2 (p=.00, r=.31). 
 
 
 
 
 
Figure 7.18. Scatter plot d monstrating negative or elation between verbal 
rating of pain on the application of PA force to the most symptomatic vertebral 
level and PPT at the symptomatic paravertebral level after treatment period 2 
(p=.02, r=.28). 
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Correlations between measures p value Correlationcoefficient r 95% confidence interval
lower upper
Correlations between Pressure pain thresholds  
and VRS of pain (at rest (RP), on movement (Mvt)  
and with PA force (PA))
Symp PPT baseline Mvt baseline .45 -.09 -.15  .32
Symp PPT after treatment 
period 1 Mvt after treatment period 1 .93 .01 -.21 .25
Symp PPT after treatment 
period 2 Mvt after treatment period 2 .99 .00 -.23 .25
Symp PPT 24hr follow-up Mvt 24hr follow-up .99 .00 -.26 .23
Symp PPT baseline PA baseline .10 -.19 -.43 .04
Symp PPT after treatment 
period 1 PA after treatment period 1 .38 -.25 -.46 .00
Symp PPT after treatment 
period 2 PA after treatment period 2 .02* -.28 ¢ -.51 -.03
Symp PPT 24hr follow-up PA 24hr follow-up .04* -.25 ¢ -.47 -.00
Symp PPT baseline RP baseline .92 -.01 -.27 .22
Symp PPT after treatment 
period 1 RP after treatment period 1 .83 .03 -.21 .26
Symp PPT after treatment 
period 2 RP after treatment period 2 .08 -.21 -.43 .05
Symp PPT 24hr follow-up RP 24hr follow-up .85 -.02 -.29 .23
Correlations between VRS of pain at rest (RP),  
on movement (Mvt) and with PA force(PA).
Mvt baseline PA baseline .21 .15 -.12 .39
Mvt after treatment period 1 PA after treatment period 1 .01** .31 ‡ .09 -.52
Mvt after treatment period 2 PA after treatment period 2 .01** .33 ‡ .10 .55
Mvt 24hr follow-up PA 24hr follow-up .01** .32 ‡ .08 .65
Mvt baseline RP baseline .03* .26 ¢ -.00 .49
Mvt after treatment period 1 RP after treatment period 1 .01** .33 ‡ .06 .56
Mvt after treatment period 2 RP after treatment period 2 .01** .33 ‡ .08 .56
Mvt 24hr follow-up RP 24hr follow-up .17 .17 -.09 .40
PA baseline RP baseline .02* .27 ¢ .02 .49
PA after treatment period 1 RP after treatment period 1 .00** .55 § .36 .71
PA after treatment period 2 RP after treatment period 2 .00** .40 ‡ -.17 .60
PA 24hr follow-up RP 24hr follow-up .39 .10 1.15 .35
Table 7.13. Correlations between PPT at the symptomatic paravertebral site and patients VRS 
of pain. Symp PPT= symptomatic paravertebral muscle pressure pain threshold, Mvt= verbal 
rating scale of pain on movement. PA= verbal rating scale of pain on PA pressure to the 
symptomatic level, RP= verbal rating scale of resting pain. *denotes p<.05, **denotes p<.01. 
¢ indicates small effect size r+/- .1, ‡ indicates medium effect size r+/- .3, § indicates large  
effect size r+/- .3 (See Appendix 24).
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7.4.8. Participants’ expectation and experience of receiving  
a mobilisation treatment
All 72 participants completed the end of study questionnaire. Thirty participants thought 
that the mobilisation treatment would be beneficial. Thirty-five participants did not 
express any expectations of mobilisations so had unknown expectations. The remaining 
8 of participants thought that treatment would be of limited benefit (Figure 7.19).
Figure 7.19. Participants’ expectations were categorised in beneficial, limited benefit or unknown.
Figure 7.20. Expectations of participants who thought that mobilisation would be beneficial.
Of the 30 participants who expected the mobilisation treatment to be beneficial, 
some expressed more than one expected treatment outcome. Twenty participants 
thought that the treatment would decrease pain (n=20), Eight that it would increase 
range of movement and 5 that it would reduce stiffness or tension. Nine participants 
also expected that the treatment would identify the source of their pain (Figure 7.20).
ORIGINALS IN COLOUR
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Figure 7.19. Participants’ expectations were categorised in beneficial, limited 
benefit or unknown. 
 
 
 
 
 
Figure 7.20. The nature of expectations of participants who thought that 
mobilisation would be beneficial. 
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Participants’	expectations	of	the	pain	during	mobilisation	treatment	were	varied.	
Some participants described expecting treatment to be painful (n=7), whilst others 
expected pain relief (n=20). Of the 7 participants who described an expectation of 
pain during treatment, 2 appeared to perceive pain as a necessary component of 
extolling a beneficial treatment effect, of the remaining 5, two described pain during 
treatment	as	‘kill	or	cure’	(participants	51	and	54)	and	the	remaining	3	thought	
that treatment would be of limited benefit. Three participants commented that they 
expected the effects of mobilisations to be short-term. 
Participants described a number of experiences related to receiving the mobilisation 
treatment. Thirty-three participants described the experience as “comfortable”. 
Twelve participants described experiencing a sense of relaxation and even a sense 
of wellbeing during the application of the mobilisation treatment. Nine participants 
commented on the simplicity of the mobilisation technique. Sixty-eight participants 
experienced a change in pain associated with treatment, but the nature of this 
change varied between individuals (Figure 7.21). Thirty-four described feeling pain 
during the application of the mobilisation treatment. Ten described initial soreness 
followed by pain relief. Thirty-one participants felt less pain after treatment and ten 
described an increase in pain following treatment.
Figure 7.21. Participants had varied experience of pain associated with mobilisation treatment.
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Prior to entry into this study, 26 participants had not received treatment for their 
symptoms. The 46 participants who had received treatment had experienced a range of 
interventions including exercise, massage, acupuncture, mobilisations and manipulation 
– from chiropractors, osteopaths and physiotherapists. Eight participants had seen 2 
different	professionals	for	their	LBP	(e.g.	a	physiotherapist	and	a	chiropractor),	and	7	
had seen three different health professionals (e.g. a physiotherapist, chiropractor and an 
osteopath). Fifteen participants who had previously received manual therapy stated that 
it	had	helped	a	lot,	17	stated	it	helped	a	little,	12	said	it	didn’t	help	and	2	commented	
that any benefits had been short term. Seventeen of the 35 participants who expressed 
no expectations of mobilisation had received mobilisation or manipulation in the past.
7.4.9. Analysis of treatment responders and non-responders
The	cumulative	portion	of	responders’	analysis	suggested	that	immediately	following	
mobilisation treatment fewer participants experienced a positive response to 
placebo (sham mobilisation) than to 2 minutes of mobilisation (Figure 7.22).
This	difference	in	the	amount	of	responders’	and	level	of	response	was	greater	
immediately following 1 and 6 minutes of mobilisations, with a greater proportion 
of responders in the group receiving a longer duration of treatment (Figure 7.23-
7.25). This response was most evident at the symptomatic paravertebral PPT, where 
in the short duration of treatment group 35% of participants had increased PPT 
immediately following treatment compared to 60% in the long duration group (Figure 
7.23). In addition to more participants responding in the longer duration of treatment 
group, the level of response was also greater in this group.
Figure 7.22. Responders’ analysis at the symptomatic PPT following treatment period 1.  
Vertical line represents clinically relevant change (>15%).
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Figure 7.21. Participants had varied experience of pain associated with 
mobilisation treatment. 
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Figure 7.23. Responders’ analysis at the symptomatic paravertebral PPT site following treatment period 2.
Vertical line represents clinically relevant change (>15%).
A similar response was seen at the T10 paravertebral PPT site (Figure 7.24).  
Although a difference in response between groups was still evident at the deltoid 
muscle PPT site, there was a less obvious difference between treatment durations 
(Figure 7.25). 
Figure 7.24. Responders’ analysis at T10 paravertebral PPT site for after treatment period 2. 
Vertical line represents clinically relevant change (>15%).
ORIGINALS IN COLOUR
 27 
Figure 7.22. Responders’ analysis at the symptomatic PPT following 
treatment period 1 
 
Figur  .23. Responders’ an lysis at the symptomatic paravertebral PPT sit  
following treatment period 2. 
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Figure 7.22. Responders’ analysis at the symptomatic PPT following 
treatment period 1 
 
Figure 7.23. Responders’ analysis at the symptomatic paravertebral PPT site 
following treatment period 2. 
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Figure 7.25. Responders’ analysis at Deltoid PPT site for after treatment period 2
Vertical line represents clinically relevant change (>15%).
A similar response was seen at 24-hour follow-up, where again, the cumulative 
portion of responder analysis demonstrated that fewer participants experienced a 
positive response to the short duration of treatment at the symptomatic paravertebral 
PPT, 23% of the short treatment duration group had increased PPT compared to 
47% in the long treatment duration group (Figure 7.26). 
Figure 7.26. Responders’ analysis at the symptomatic paravertebral PPT site at 24-hour follow-up
Vertical line represents clinically relevant change (>15%).
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Figure 7.24. Responders’ analysis at T10 paravertebral PPT site for after 
treatment period 2 
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The number of responders for each condition, at each time point, based on changes 
in PPT local to the site of treatment (symptomatic paravertebral PPT), is displayed 
in Table 7.14. Chi-square analysis using the frequency of responders at each time 
point found that there was a significant association between duration of treatment 
and whether participants responded immediately after treatment, with significantly 
more responders in the long duration treatment group (Table 7.14). There was no 
association between response to treatment and group after placebo / 1 minute of 
mobilisations or at 24 hour follow-up (Appendix. 25).
Number of participants with changes in PPT at the
symptomatic paravertebral level exceeding
SEM MDC >15% SEM MDC >15%
Short duration Long duration
After treatment period 1 (n=72)
2 mins sham mobilisation (short)
2 mins mobilisation Rx (long)
5 2 4 7 4 10
Chi-square analysis based on SEM/MCD x2 (1)=0.47 p= .50
Chi-square analysis based on % change x2 (1)=2.07 p= .15
After treatment period 2  (n=72)
2 mins sham mobilisation  
+ 1 min mobilisation Rx (short)
6 min mobilisation Rx (long)
2 3 4 13 8 19
Chi-square analysis based on SEM/MCD x2 (1)=11.60 p= .001
Chi-square analysis based on % change x2 (1)=11.01 p= .001
24 hour follow-up  (n=71)
2 mins sham mobilisation  
+ 1 min mobilisation Rx (short)
6 min mobilisation Rx (long)
2 3 5 6 6 13
Chi-square analysis based on SEM/MCD x2 (1)=2.42 p= .12
Chi-square analysis based on % change x2 (1)=3.15 p= .08
Table 7.14. Number of responders to treatment based on changes in symptomatic paravertebral 
PPT. SEM= number of participants with change from baseline greater than standard error of 
measurement. MDC= number of participants with change from baseline greater than minimal 
detectable change. >15%= number of participants with change greater than 15%.
The cumulative responders analysis for change in verbal rating of pain demonstrated 
that participants in the short treatment duration group exhibited a similar decrease in 
pain on movement (Figure 7.27). There was no significant difference in the number of 
responders after treatment period 2, when all participants had received mobilisation 
treatment (x2 (1)=0.00 p= .99). See Table 7.15. 
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Short Duration
After treatment period 2
After 2 min placebo + 1 min Rx (n=33)
Long Duration
After treatment period 2
After 6 min Rx  (n=39)
Flexion 14 14
Extension 15 19
Right lateral flexion 15 12
Left lateral flexion 9 15
Right rotation 9 7
Left rotation 5 11
Total VRS (sum of VRS 
on all movements) 25 28
Table 7.15. Number of participants who had a positive response to treatment, based on changes 
in VRS of pain on movement of 1 or more. Numbers are shown for individual movements and for 
combined VRS of pain.
Figure 7.27. Similar amounts of participants responded in the short and long duration groups.
7.4.10. Profile of treatment responders
To investigate the profile of participants who responded to mobilisation treatment 
the characteristics, expectations and experience of those participants who were 
deemed to have responded to mobilisations based on either changes in MDC/SEM 
or % change in PPT at the symptomatic paravertebral muscle site were explored. 
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Figure 7.2 . i il r amounts of participant  responded in the short an  long 
duration groups. 
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Overall 35 out of the 72 participants were considered to be responders in terms  
of changes in PPT at the symptomatic level (11 participants in the short duration  
of treatment group and 24 in the long duration group). After treatment period 2, 
when all participants had received mobilisation treatment, there was a significantly 
greater number of responders in the long duration of treatment group. At this time 
point, 5 participants in the short duration of treatment group and 21 in the long 
duration group were deemed to have responded to mobilisations in term of PPT 
and 53 out of the 72 participants were considered to be responders in terms of 
change in verbal rating of pain on movement (25 participants in the short duration 
of treatment group and 28 in the long duration group). Despite the high number of 
VRS responders, not all those participants that were classified as PPT responders 
were VRS responders (Tables 7.16 and 7.17). This dissociation between PPT and 
participants’	verbal	rating	of	pain	was	also	evident	in	the	main	analysis.
The expectation and experience of treatment responders are summarised in  
Tables 7.16 and 7.17. The number of responders in terms of a minimum change  
in PPT at the symptomatic level, of the SEM or more, was used in further analysis. 
There was no difference in the expectations of treatment in responders and  
non-responders (x2 (1)=.523 p= .77). Appendix 25.
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There were no significant differences between questionnaire results for responder 
and non-responders (Tables 7.18 and 7.19 and Appendix 25 for statistical output) 
and there was no significance in the duration of symptoms or force of treatment in 
responders to non-responders. The only observable difference between responders 
and	non-responders	was	participants’	age.	Responders	were	significantly	younger	
than non responders U=802, p=.047 (Table 7.18).
Alcohol
Age
(years)
Exercise 
per week 
(hours)
GHQ28 McGill Oswestry% scoreUnits Bingescore
Short duration
responders
n=11
Mean 8
SD 6
Mean 9
SD 11
Mean 41
SD 11
Mean 6
SD 4
Median 3
Mean 2
SD 4
Mean 17
SD 9
Mean 18
SD 10
Long duration 
responders
n=24
Mean 7
SD 6
Mean 8
SD 11
 Mean 35
SD 13
Mean 6
SD 5
Median 3
Mean 4
SD 
Mean 18
SD 10
Mean 15
SD 6
Non-responders
n=37
Mean 7
SD 6
Mean 6
SD 8
Mean 44
SD 14
Mean 4
SD 3
Median 3
Mean 4
SD 6
Mean 17
SD 9
Mean 17
SD 6
Table 7.18. Questionnaire results of responders to mobilisations
Control Disability Harm Emotion Medication Solicitude Medical cure
Responders n=35 10 (3) 5 (3) 6 (4) 4 (4) 4 (3) 5 (4) 12 (4)
Non-responders n=37 11 (4) 6 (3) 5 (3) 6 (5) 4 (3) 5 (4) 10 (4)
Table 7.19. Survey of pain attitudes for responders and non-responders
A	number	of	other	factors	that	may	have	influenced	the	response	to 
treatment were also examined and were similar between responders and  
non-responders as follows:
	 •	 	There	was	no	difference	in	the	expectations	of	treatment	responders	 
(x2 (1)=.523 p=.77).
	 •	 	There was no significant difference in the treatment force received  
in responders and non-responders (U=533, p=.35).
	 •	 	There	was	dissociation	between	change	in	PPT	at	the	symptomatic	
paravertebral level and change in verbal rating of pain in treatment 
responders (PPT and verbal rating of pain on movement p=.06, r= -0.31  
PPT and verbal rating of resting pain p=.63, r= -0.08 PPT and verbal rating  
of pain on PA force p=.19, r= -.022. See Appendix 24).
172
	 •	 	Seven	physiotherapists	(4	students	and	3	qualified)	took	part	in	the	study.	
Three of these were classified as responders to mobilisation treatment  
(2 qualified and 1 student) and 4 as non-responders. 
	 •	 	Ten	participants	had	pain	referred	below	the	knee.	Two	of	these	were	
classified as responders (one responded to placebo but not to the 
mobilisation intervention). 
	 •	 	Fifteen	treatment	responders	received	a	central	technique	and	20	 
a unilateral technique. 
	 •	 	Responders	did	not	necessarily	perceive	treatment	to	be	beneficial,	but	14	out	 
of 35 thought that the treatment had been beneficial (see tables 7.16 and 7.17).
7.4.11. Summary of findings
	 •	 	Cumulative	proportion	of	responders’	analysis	suggested	that	there	is	greater	
immediate increase in PPT at the symptomatic paravertebral level after 6 
minutes mobilisation treatment than after 1 minute of mobilisation.
	 •	 	Chi-square	analysis	using	the	frequency	of	responders	at	each	time	point	 
found that there was a significant association between duration of treatment and 
whether participants responded in terms of change in PPT immediately after 
treatment, with significantly more responders in the long duration treatment group.
	 •	 	Responders	analysis	demonstrated	that	most	participants	experienced	
clinically significant changes in pain on movement. There was no significant 
difference between short and long duration groups. 
	 •	 	There were no immediate overall effects of sham mobilisation or mobilisation 
treatment on PPT, 
	 •	 	There was a significant reduction in PPT at 24-hour follow-up. The reduction in 
PPT at 24-hour follow-up was evident in both short and long duration groups. 
This demonstrated that participants in both groups exhibited hyperalgesia 
24-hours after mobilisation treatment.
	 •	 	Force of treatment had a significant mediating effect on change in PPT and change 
in verbal rating of pain on movement immediately after treatment. Force accounted 
for 9-13% of the variation in effect. Higher treatment forces were associated with a 
greater immediate hypoalgesic effect. The mediating effect of force for verbal rating 
of pain on movement remained evident at 24-hour follow-up.
	 •	 	For verbal rating of pain on movement, there was a significant main effect 
of time, which demonstrated an immediate, and mid-term decrease in pain 
on movement with all conditions (placebo and short and long durations of 
treatment). The differences between 2 minutes sham mobilisation, 1 minute  
of treatment and 6 minutes of treatment failed to reach significance.
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	 •	 	For verbal rating of pain on the application of PA force to the symptomatic 
level, there was a significant main effect of time immediately following 
treatment, which demonstrated an immediate, decrease in pain on movement 
with all conditions (placebo and short and long durations of treatment). The 
differences between 2 minutes sham mobilisation, 1 minute of treatment and 6 
minutes of treatment failed to reach significance. There was no effect of time 
at 24-hour follow-up demonstrating there was no short-term effect on resting 
pain levels.
	 •	 	GRPC was improved at all time points demonstrating a significant 
perceived effect of treatment. The differences between placebo, 1 minute 
of treatment and 6 minutes of treatment failed to reach significance. There 
were significantly significant associations between changes in pain and 
participants’	perception	of	change.
	 •	 	Mobilisation treatment did not have an effect on resting pain levels in any 
treatment group.
	 •	 	Nearly half of the participants in the study were not able or willing to express 
their expectations of receiving a mobilisation treatment. Most of the other 
participants expressed expectations of a positive outcome
	 •	 	Most participants expressing an expectation thought that the treatment  
would reduce pain and some participants also thought that treatment would 
increase their movement and decrease stiffness. Seven participants expected 
to experience pain during the treatment.
	 •	 	Most	participants’	experience	of	mobilisations	was	centred	around	pain	during	
treatment and either increasing or decreasing pain following treatment.
	 •	 	Profiling	of	the	responders	was	not	able	to	identify	any	characteristics	that	
were different from the non-responders.
7.5. Discussion of findings
7.5.1. Discussion of the immediate effects of mobilisations
This study found no change in PPT immediately following sham mobilisation,  
1	minute	of	mobilisations	and	6	minutes	of	mobilisation	in	participants	with	LBP.	
This is the first study to investigate the effects of lumbar mobilisation treatment  
on PPT in a symptomatic population. Three previous studies have investigated  
the difference between lumbar mobilisation treatment doses on PPT in 
asymptomatic participants and contrary to the results of this study, reported 
significant increases in PPT following both treatment doses (Pentelka et al., 
2012; Krouwel et al., 2010; Willett et al., 2010). However those studies were 
conducted primarily on asymptomatic physiotherapy students who may have 
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had expectations of a positive treatment effect, which might have enhanced the 
effect of treatment. Furthermore as the aim of those studies was to compare two 
treatment doses, rather than examine the effects of treatment per se, they did not 
employ a control intervention. 
A number of studies of participants with neck pain have reported immediate 
increases in PPT following cervical mobilisations (Sterling et al., 2001; Vicenzino et 
al., 1998 and 1995) (section 2.9.1, page 15). All these studies have been conducted 
by one research group and have employed a same subject placebo controlled 
design. It may be that the non-significant treatment effect observed in this study is 
due to the spinal region treated, as it has been proposed that the lower density of 
mechanoreceptors in the lumbar spine might result in a reduced effect of the pain 
gate compared to studies performed in the cervical spine (Thomson et al., 2009) 
In addition to being conducted in a different region of the spine, there are large 
differences in the duration of pre-existing symptoms experienced between 
participants in the current study and previous work. Most participants in previous 
studies had a mean duration of symptoms of a few months (6-8 months)  (Vicenzino 
et al., 2001a and 1998 and 1996), as opposed to participants in the current study 
who reported 9 years mean duration of symptoms (range 0.3-35 years). Including 
participants	with	a	greater	duration	of	symptoms	reflects	patients	in	clinical	practice,	
but may result in greater heterogeneity of this sample due to alteration of factors 
such as pain processing, pain beliefs and activity levels in chronic pain conditions. 
The	questionnaire	data	identified	that	on	the	GHQ	participants	in	the	single-arm	
trial had lower depression / anxiety levels than those in the RCT. A number of 
factors	where	explored	through	covariate	analysis,	however,	GHQ	results,	duration	
of symptoms, pain beliefs and activity levels did not alter the results of the main 
analysis. Furthermore in this study, duration of symptoms appeared to be no 
different in treatment responders and non-responders. The only factor that was 
different between responder and non-responders was age, with responders being 
significantly younger than non-responders.
Another difference between the current study and others investigating the effect 
of mobilisations in symptomatic participants is that previous results reported 
percentage change rather than actual change scores and used percentage change 
scores in their analysis (Sterling et al., 2001; Vicenzino et al., 2001a). Although 
percentages can be a useful way of presenting results descriptively, it has been 
suggested that percentage scores should not be entered for analysis (Vickers et al., 
2001;	Bonate,	2000).	The	use	of	actual	change	during	the	analysis	may	have	altered	
the conclusions of those studies. However greater percentage change in PPT were 
reported than those seen in the present study.
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Although Sterling et al., (2001) reported an immediate hypoalgesic effect of cervical 
mobilisations in patients with neck pain, a more recent study by the same authors 
reported no change in PPT following cervical mobilisations in patients with whiplash 
(Sterling et al., 2010). The authors proposed that these contradictory findings 
could be due to the greater amount of manual contact used in the more recent 
study, or due to the difference in musculoskeletal condition (Sterling et al., 2010). 
Another more recent placebo controlled study casts further doubt over previously 
consistent reports of increased PPT with mobilisation treatment – reporting no 
significant treatment effect after 3 minutes of cervical mobilisations in asymptomatic 
participants (Soon et al., 2010). It is a possibility that other studies reporting no 
treatment effect have been conducted but are not in the public domain due to a 
recognised publishing bias (Dechartes et al., 2013). 
In addition to the measurement of PPT, this study also utilised verbal rating scales 
of pain and found an immediate reduction of pain on movement, pain on the 
application of PA force to the symptomatic level and an immediate perceived 
treatment change (GRPC). There was no significant difference between placebo 
and 2 minutes of treatment and 1 minute of treatment and 6 minutes of treatment, 
suggesting that the change could be attributed to the non-specific effects of 
treatment such as placebo or stimulation of cutaneous receptors. However, any 
treatment effects between groups could have been obscured by the low mean 
verbal	rating	of	pain	indicating	low	severity	of	symptoms	and	resulting	in	a	floor	
effect, where low initial baseline scores make it difficult to detect a reduction in pain.
7.5.2. The effects of mobilisation treatment at 24-hour follow-up
Relative to baseline there was a significant reduction in PPT at 24-hour follow up, 
indicating that there was an increase in pain sensitivity. There was no significant 
interaction with site or condition, demonstrating that there was no difference 
between sites or treatment groups. It was recognised in the pilot work for this thesis 
that repeated testing of PPT can result in local soreness. In order to minimise this, 
the current study used the mean of 2 PPT measures as opposed to the mean of 3 
measures at each site. However this still resulted in 6 repetitions at each site over 
the course of an hour. At 24-hour follow-up a number of participants complained 
that	the	testing	sites	‘felt	bruised	from	the	previous	days	testing’.	It	is	likely	that	
the reduction in PPT (indicating hyperalgesia) demonstrated at 24-hour follow-up 
resulted from previous testing rather than a delayed effect of treatment. Alternatively 
they	may	have	been	suffering	from	‘treatment	soreness’	which	is	recognised	to	
occur in some patients for 24-48 hours after treatment (Maitland et al., 2005). 
At 24-hours follow-up pain on movement was significantly reduced compared to 
baseline and there was a significant perceived treatment change (GRPC). There were 
no significant difference between placebo and 2 minutes of treatment or 1 minute of 
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treatment and 6 minutes of treatment, so the reduction in pain on movement effects 
could be attributed to the non-specific effects of treatment or change over time. 
There was no difference in resting pain or verbal rating of pain on PA force in any 
treatment group. This is somewhat contradictory to the results of the one previous 
study that has investigated the short-term effects of a single dose of mobilisation 
treatment;	Vicenzino	et	al.,	(1996)	reported	a	significant	reduction	in	the	patients’	
VRS of worst pain over the 24-hour period following 3 minutes of mobilisations 
to the cervical spine compared to placebo-controlled intervention. It may be that 
worst	pain	over	a	24-hour	period	provides	a	better	representation	of	participants’	
pain experience.
In this study PPT were measured immediately after treatment and 24 hours after 
treatment. The clinical relevance of findings would be enhanced if measures were 
obtained over a longer period. The mid-term and longer-term effects of mobilisation 
treatment are important areas for future research. The current study investigated 
the effects of a single treatment dose. In clinical practice patients normally receive 
a number of treatments over several weeks and thus investigating the possible 
cumulative effect of treatment is also an area for further investigation.
7.5.3. The mediating effect of treatment force on change in pain
In the current study there was a significant mediating effect of force on change 
in verbal rating of pain, with 13% of the variation in effect being accounted for by 
force. Higher treatment forces were associated with a greater immediate reduction 
in pain. This mediating effect of force was also evident for PPT where 9-11% of the 
variation in effect could be accounted for by force. The mediating effect of force was 
evident at PPT sites local to the treatment, but not evident at the Deltoid PPT site. 
These findings support previous hypotheses that local analgesic mechanisms are 
responsible for the analgesic effects of mobilisations. The force of treatment applied 
during	this	study	was	decided	on	based	on	participants’	clinical	presentation	and	
thus the lack of overall effect of treatment on pain may have been due to the lower 
treatment forces used with some participants. 
Two studies have investigated the effect of applying different percentages of the 
perceived maximum force during a mobilisation with movement to the elbow on 
pain free grip strength (PFGS) in patients with lateral epicondylalgia; Vicenzino et 
al., (2001b) noted that there was a threshold beyond which no further increase in 
force produced any further improvement of PFGS. This force was 62.2N or 50% of 
maximum applied force. A later study looked at applying 33%, 50%, 66% and 100% 
of the maximum force and found that 66% was the force threshold beyond which 
no further improvement in PFGS occurred (McLean et al., 2002). Interestingly the 
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maximum force in the later study was considerably lower, 113.2N as opposed to 
134.8N in the first study, which may explain the difference in optimal percentage  
of perceived force between the two studies. 
Current	evidence	suggests	that	the	force	of	treatment	has	an	influence	in	
extolling an analgesic effect. This study provides evidence to support this whilst 
subsequently highlighting an area for additional research.
7.5.4. The relationship between PPT and verbal rating of pain measures
The dissociation between PPT and VRS of pain measures suggested by the 
responders’	analysis	was	confirmed	by	further	exploration	of	the	relationship	between	
these measures. This study found that the relationship between pain measures was 
variable. Mostly there was dissociation between symptomatic paravertebral PPT 
measures and VRS of pain (see Table 7.12). Conversely on most occasions different 
VRS of pain were associated with one another. One previous study explored the 
relationship between PPT and verbal rating of pain following mobilisation to the 
cervical spine and also reported dissociation (Sterling et al., 2001).
On the two occasions that there was association between PPT and verbal rating 
of pain, these associations were with pain on the application of PA force to the 
symptomatic level and verbal rating of pain on the application of force to the 
symptomatic spinal level. This association, albeit variable and potentially due to 
random error, could also be due to the fact that both these pain measures involved 
the application of pressure. 
The other verbal ratings of pain rating used in this study were more akin to pain 
participants may have experienced on a daily basis, for example VRS of pain on 
movement	and	resting	pain	could	be	considered	representative	of	a	person’s	daily	pain	
experience. Whereas participants are unlikely to experience pain produced in a similar 
manner to pain on PA force application during their daily activities. This, coupled with the 
fact that participants were not in control of the application of the PA force (as it was applied 
by a physiotherapist) may have affected the relationship with other pain measures. 
PPT are often used as a measure of the hypoalgesic effect of mobilisations. PPT 
may	represent	participants’	level	of	pain	sensitivity,	but	this	does	not	appear	to	relate	
to	the	experience	of	pain	in	participants	with	chronic	LBP.	These	findings	suggest	
that analgesia measured by these different measures may be mediated by different 
underlying neurobiological mechanisms. 
After	treatment	period	1,	there	was	a	significant	association	between	participants’	
perception of change and the change in verbal rating of resting pain and pain on 
PA force application. However there was dissociation between GRPC between 
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verbal rating of pain on movement and change in PPT. There was no difference in 
this dissociation when examined separately for placebo and 2 minutes of treatment. 
After	treatment	period	2	there	was	association	between	participants’	perception	
of change and all pain measures except for verbal rating of pain on PA force 
application (p= .06, r=-.22). At 24-hour follow-up there was a strong and significant 
association	between	the	change	in	all	pain	measures	and	participants’	perception	of	
change. These findings demonstrate that on most occasions there is an association 
between	participants’	perception	of	change	and	changes	in	pain.	
The inclusion of PPT, verbal rating scales of pain and GRPC in future studies would 
provide a more complete picture of the analgesia effects of treatment. 
7.5.5. Discussion of responders analysis
The difference in response of individuals as observed in the PPT results of this 
study can create a wash out effect, where on overall analysis those who experience 
soreness with treatment cancel out the beneficial effects experienced by other 
participants.	The	variability	in	patient’s	response	to	treatment	of	LBP	has	been	
widely	recognised	(Wand	and	O’	Connell,	2008;	Farrar	et	al.,	2006;	Childs	et	
al., 2004). For this reason Farrar et al., (2006) recommended using cumulative 
proportion of responders analysis graphs in order to compare the proportion of 
participants responding to different treatments. 
The cumulative proportion of responders analysis graphs suggested that a greater 
proportion of participants in the long duration treatment group respond to a 
greater extent than those in the short duration treatment group (Figures 7.21 and 
7.22). This was evident at the symptomatic level and T10 paravertebral PPT site, 
but not at the Deltoid muscle PPT site suggesting that the response is mediated  
by local analgesic mechanisms.  
Further analysis revealed that, in terms of local changes in PPT, there were 
significantly more responders to treatment in the long duration treatment group 
than the short duration treatment group (treatment responders were classified 
according to those who had minimally detectable change in PPT local to the site  
of treatment). The difference in the proportion of responders in the placebo and  
2 minutes of treatment groups failed to reach significance. This suggests that 
longer than 2 minutes of treatment may be necessary before a treatment effect 
exceeding that of placebo is observed. The difference in the proportion of 
participants experiencing clinically important increases in PPT in the short and  
long duration groups appears to be short lived as the difference between groups 
at 24-hour follow-up failed to reach significance. 
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Although the responders analysis of PPT results demonstrated a difference  
between treatment durations, this was not evident with VRS of pain on movement. 
The cumulative proportion of responders analysis of verbal rating of pain on 
movement demonstrated a similar pattern for both treatment durations, with over 
70% of participants achieving a beneficial effect of treatment. Responders analysis 
also revealed that a similar number of individuals experienced clinically meaningful 
changes in pain on movement in both short and long duration of treatment groups 
(Table 7.15). Profiling of responders demonstrated that those participants that were 
responders in terms of PPT measures were not necessarily those that responded 
in terms of change in verbal rating of pain on movement. This was confirmed by 
the dissociation between verbal rating and PPT measures of pain in treatment 
responders. These findings support the results of the overall analysis of the 
relationship between PPT and patient reported measures of pain.  
In summary more participants in the long duration group had an immediate 
decrease in PPT than in the short duration group. The results of this study have 
demonstrated that responders analysis is a sensitive method of observing between 
group differences in analgesia. It is recommend that future studies investigating the 
effect of different treatments on pain consider including similar analysis. 
7.5.6. Participants’ expectations of mobilisation treatment
It has been demonstrated that expectation of a beneficial treatment can positively 
influence	treatment	outcomes,	for	example,	positive	association	between	positive	
expectations and good functional outcomes has been reported previously 
(Kalauokalani et al., 2001). Specific to manual physiotherapy treatment, one study 
investigated the effects of expectations on the analgesic effects of manipulation 
treatment and found that participants who were given negative expectations 
demonstrated	hyperalgesia	(an	increase	in	pain)	following	treatment	(Bialosky	et	
al., 2008). This may suggest that those participants who had previously beneficial 
physiotherapy treatment may have been more likely to encounter a more positive 
experience on this occasion. However responders analysis in this study was not 
able	to	identify	any	significant	influence	of	treatment	expectations.	This	could	be	
due to the study context and environment (the research study was conducted in 
a	University	laboratory)	being	different	to	that	encountered	during	participants’	
previous treatment experience.
Nearly half of the participants in this study expressed neutral or unformed 
expectations of receiving a mobilisation treatment. An inability or unwillingness to 
express expectations has been described previously as unformed expectations 
(Thompson and Sunol 1995) and is thought to be present when an individual has no 
prior	experience	on	which	to	form	their	expectations	(Bialosky	et	al.,	2010).	However	
180
a lack of previous experience does not explain the higher number of unknown 
expectations in this study as half of the participants who expressed no expectations 
had received previous treatment and all but 2 of these had received mobilisation 
or manipulation. The large proportion of participants expressing neutral treatment 
expectations could be partly due to the fact that participants in this study suffered 
from	chronic	LBP	as	patients	with	chronic	conditions	have	been	found	to	have	lower	
expectations of treatment (Hills and Kitchen, 2007). 
7.5.7. Predictors of response to mobilisation treatment.
Utilising symptomatic study participants adds a number of variables such as the 
heterogeneity	of	LBP,	the	patients’	beliefs	regarding	their	condition	and	their	pain	
experience to name just a few. This adds a layer of complexity that may not be 
evident in studies utilising asymptomatic participants and may explain the varying 
response to treatment observed in the cumulative responders analysis. Studies 
in	acute	LBP	have	identified	factors	that	may	help	to	predict	patient’s	response	to	
manual therapy treatment but provide inconclusive evidence and require further 
validation before their findings can be accepted (Haskins et al., 2012 and Kamper 
et al., 2010). The current study included planned covariate analysis of PPT and 
verbal rating of pain with questionnaire data and examination findings. None of the 
covariates	(duration	of	symptoms,	age,	GHQ,	Oswestry,	McGill,	SOPA)	significantly	
influenced	treatment	outcome.	The	influence	of	these	factors	was	further	explored	
in the responders analysis, but profiling of treatment responders did not identify any 
influence	of	these	factors,	nor	of	expectation	or	experience	of	treatment.	Low	fear	
avoidance, duration of symptoms of less than 16 days and pain not extending below 
the knee have been suggested to be predictive of a positive treatment outcome 
(Childs et al., 2004; Flynn et al., 2002). These factors were explored in this study, 
however profiling of treatment responders did not find an association with duration  
of symptoms, pain distribution or pain belief and treatment outcome.
Other untested factors may be useful predictors of treatment outcome, but at 
present these findings suggest that none of the factors investigated in this study 
can predict the response to treatment and highlights the complexity of predicting 
treatment response. 
7.5.8. The extent of the analgesic effect
This study found that there was no overall site* time interaction of PPT, indicating 
that there was no difference between the change in PPT at different PPT sites. 
However, because there was no overall treatment effect of treatment no conclusions 
regarding the extent of the analgesic effect can be drawn from the overall analysis. 
However responders analysis found that there were significantly more responders 
in the long duration of treatment group. The effect was evident at PPT sites local 
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to the treatment and not at the deltoid muscle site indicating that the effects of 
mobilisations maybe mediated, at least in part, by a local analgesic mechanism. 
Further evidence of a local analgesic mechanism is provided by the mediating effect 
of force which was evident at local PPT site but not at the deltoid muscle site. 
The local treatment effects observed in this study could be explained by the pain 
gate theory whereby more afferents are stimulated by larger forces applied for 
longer, resulting in modulation of pain in the dorsal horn of the spinal cord (Wyke, 
1985). One study in rats found the analgesia resulting from mobilisations may be 
mediated at spinal cord level; Malisza et al., (2003) investigated the effect of knee 
joint mobilisations in rats and found a decrease in activity (using functional MRI) in 
the areas of the spinal cord associated with pain. Conversely, Sterling et al., (2001) 
reported concurrent sympathetic excitation and mechanical hypoalgesia observed 
following cervical mobilisations and claimed that this indicated that pain relief 
was mediated via the dorsal PAG. However the measures of SNS activity may be 
considered to lack validity (Arena and Hobbs, 1995) and at best provide indirect 
evidence of stimulation of the dorsal PAG. 
Similar to the current study, previous studies have utilised a number of different PPT 
sites in order to gain insight into the extent of the analgesic effect of mobilisations 
and thus the underlying analgesic mechanisms. Significant changes have been 
reported at sites distant and sites local to the treatment (Pentelka et al., 2012; Willett 
et al., 2010). Importantly these studies also reported that changes in PPT local to 
the site of treatment were significantly greater than more distant sites, indicating that 
more than one analgesic mechanism may be responsible for the hypoalgesic effect 
(Pentelka et al., 2012).
In summary the findings of this study suggest that the analgesia resulting from 
lumbar mobilisations is at least in part, mediated via local analgesic mechanisms. 
However these findings remain speculative and further studies utilising functional 
magnetic resonance imaging or neurochemical manipulation of neurotransmitters 
could provide more direct evidence of the underlying mechanisms and is an area  
for future research.
7.5.9. Study Limitations
The current study included a placebo intervention in order to control for the non-
specific effects of treatment. A structurally equivalent placebo was used in the current 
study as in a meta-analysis the use of structurally equivalent placebos has been 
shown	to	reduce	bias	(Baskin	et	al.,	2003).	However,	the	challenge	of	including	a	
suitable placebo condition for low back pain studies is recognised (Machado et al., 
2008; Hancock et al., 2009), as the effectiveness of placebo hinges on participants 
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believing	that	the	treatment	will	be	successful	(Bialosky	et	al.,	2011).	Similar	to	this	
study, manual contact has been used as a placebo treatment in previous studies 
investigating the effects of mobilisations (Sterling et al., 2010; Vicenzino et al., 1995). 
In this study, the mean force of manual contact used in the placebo group was 
25.6N (SD 12, range 8-52N). This force may be considered to be high for a placebo 
condition, but was employed to try and ensure the believability of the placebo and 
thus ensure blinding of participants. It is notable that there was some overlap between 
the force used in the placebo and treatment conditions as the lowest mean peak 
force used in treatment was 41 Newtons. However when inspecting the individual 
data the highest placebo force (52N) was applied to the participant that received 
the highest treatment force (303N). This was applied to a larger male participant with 
minimal symptoms. Conversely the lowest placebo force (8N) was applied to a small 
female with severe symptoms whose mean peak treatment force was 79N. It could be 
considered that the variability in the force used in the placebo group was appropriate 
for	the	participants	in	this	setting.	However,	it	is	acknowledged	that	the	influence	of	
manual contact on cutaneous and muscle receptors (Woolf, 1983; Woolf and Wall, 
1982)	in	the	placebo	condition	may	have	an	influence	on	pain	that	should	not	be	
underestimated. Future work could consider using alternative placebos, for example 
detuned shortwave diathermy.
One of the recruitment strategies employed in this study was advertising through 
the University email system. This resulted in a number of academics and research 
students taking part in the study. The wording of the participant information 
sheet (Appendix 15) was carefully considered stating the aim of the study as 
investigating	‘the	effect	of	different	amounts	of	mobilisation’	(this	was	deemed	
to be ethically acceptable as the placebo group went on to receive a treatment 
dose). Despite the fact that the participant information sheet did not describe 
the inclusion of a placebo group, 2 of the participants in the study asked if they 
would be receiving a placebo condition. The researcher explained that there were 
a number of stages to the study that could not be discussed until the completion 
of the study. Furthermore the current study did not recruit participants who were 
naïve to physiotherapy intervention and many had received physiotherapy, 
including similar techniques previously. These factors may have resulted in 
participants receiving the placebo intervention distinguishing this from an active 
treatment. Future work should consider recruiting research or physiotherapy naïve 
participants to ensure blinding or including an end of study debriefing, asking 
participants whether they thought they had received a placebo intervention and 
thus revealing the extent of un-blinding that occurred during the study.
All the participants receiving mobilisation treatment in the studies in this thesis 
received a treatment applied in neutral, prone lying position. However this does  
not	reflect	clinical	practice	where	depending	on	the	severity	and	irritability	of	a	
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patient’s	symptoms	they	may	be	treated	in	a	position	that	either	aggravates	or	 
eases their symptoms whilst the mobilisation is applied (Petty, 2011). Most elements 
of treatment dose in this study were applied pragmatically (grade, rate, rhythm),  
and for this reason the decision regarding positioning of the patient afforded 
extensive consideration prior to the onset of this study. Positioning participants in  
a symptomatic range for treatment would have created a challenge when devising  
a structurally equivalent placebo, as this would have required the placebo group 
to be positioned in symptomatic range for the same duration as the treatment 
condition. This was considered to be inappropriate due to the possible therapeutic 
effects from positioning alone. Thus, a decision was made to apply all treatment 
conditions in neutral. However it is recognised that positioning is an important 
element of treatment dose which was not incorporated into this study. Furthermore 
the position of prone lying may have resulted in an increase in symptoms for some 
participants, for example, in the subjective history several participants complained 
of being unable to lie prone because of their symptoms, some of the participants 
who were randomised to the placebo treatment, complained of increased resting 
pain and pain on movement which they attributed to lying prone.
In the current study participants received a physiotherapy assessment in order 
to identify the symptomatic level and ensure they met the inclusion criteria of 
experiencing pain on active movement. On completion of the study participants 
received	advice	and	home	exercises	for	their	LBP.	In	order	to	tailor	this	advice	to	
the needs of the individual, the initial assessment also included a full subjective 
examination;	participant’s	beliefs	about	their	symptoms	were	noted	but	not	
explored until the final advice and exercise session and there was no discussion 
regarding the cause of their symptoms until that point. Some participants 
displayed fear of movement and faulty movement patterns through the study 
but these were not addressed until the study was completed. The lack of normal 
communication	in	this	study	may	have	influenced	the	treatment	response,	as	not	
addressing	participants’	beliefs	may	have	influenced	their	responsiveness	to	
treatment. It has been suggested that if patient expectations are not addressed 
the benefits of treatment might not be maximised (Potter et al., 2003). Furthermore, 
the experimental procedure prevented the therapist from demonstrating active 
listening skills, which have been shown to be important in communicating with 
patients (Potter et al., 2003). The inability of the assessing therapist to explore 
the	participants’	beliefs	and	expectations	resulted	in	the	treatment	following	a	
biomedical model. It is widely recognised that this does not result in optimum 
treatment outcomes and assuming a biopsychosocial treatment approach is 
considered to be an essential part of the management of low back pain (Main and 
George, 2011; Nicholas and George, 2011). Additionally in clinical practice the 
examination process itself can be used as treatment, for example, physiotherapists 
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may use motivational interviewing techniques to encourage normal movement. 
This study was designed to examine the effects of mobilisations in isolation and 
thus communication with the patient not necessary for the study was kept to a 
minimum. The effects of mobilisations may be interlinked with the communication 
that	is	associated	with	them	and	thus	the	effects	seen	in	this	study	may	not	reflect	
those seen when they are utilised in clinical practice.
All participants in this study regardless of their findings were treated using a 
mobilisation	standardised	for	experimental	purpose.	This	does	not	reflect	clinical	
practice where treatment is directed at the examination findings. Options for future 
work would be including participants who respond favourably to a trial treatment 
dose (often applied in a physiotherapy assessment in order to tailor subsequent 
treatment choices). An alternative strategy, that has been employed previously, in 
LBP	studies,	is	to	investigate	the	effect	of	manual	therapy	in	participants	who	fulfilled	
a clinical prediction rule (Childs et al., 2004). These options were not employed in 
this study in order to prevent the introduction of bias. 
The	questionnaire	on	participants’	expectations	and	experience	of	receiving	a	
mobilisation treatment dose was completed at the end of the study (after participants 
had received a mobilisation technique). Participants were asked to recall their 
expectations prior to receiving the treatment, which may have been affected by their 
experience of receiving a mobilisation treatment as a participant in the study. The use of 
a semi-structured questionnaire did not enable the researcher to explore the thoughts 
or opinions expressed by participants. For example, 34 participants stated that they 
did not have any expectations of a mobilisation treatment. The use of an interview 
would	have	enabled	the	researcher	to	explore	participants’	initial	responses.	Another	
disadvantage of a semi-structured questionnaire as opposed to an interview was that 
participants were less likely to clarify the meaning of the questions and the researcher 
was unable to establish whether they had been misunderstood until the point of analysis. 
7.6. Conclusions
In summary responders analysis demonstrated that significantly more participants 
experienced immediate increases in PPT local to the site of treatment following 
6 minutes of lumbar mobilisation treatment than following 1 minute of treatment 
suggesting that longer treatment duration may have a greater hypoalgesic effect 
which may be mediated by local analgesic mechanism. This study identified that 
treatment responders were significantly younger than non-responders. No other 
predictors of treatment response were identified.
The overall analysis demonstrated that there was a significant change in verbal 
rating of pain on movement and verbal rating of pain on the application of PA force to 
the symptomatic level, but there was no difference between treatment and placebo 
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intervention, suggesting that this effect was due to natural variation or the non-specific 
effects of treatment. Overall, neither placebo intervention nor lumbar mobilisations 
changed PPT, however there was a significant mediating effect of force, with higher 
treatment forces being associated with greater immediate increases in PPT and 
decreases	in	pain	on	movement.	The	variability	in	participants’	response	to	treatment	
may explain the lack of overall effect and thus responders analysis may be a more 
sensitive way of analysing pain relief in heterogeneous populations. 
The dissociation between PPT and verbal ratings of pain reported in this study 
suggest that when investigating the analgesic effects of treatment it may be 
important to incorporate a number of pain measures in order to gain a wide 
appreciation of change in pain experienced by patients.
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Chapter 8
Overall discussion of the thesis
This thesis has presented three main studies. The first study (chapter 5) explored 
the reliability of pain, ROM and stiffness measurements to be used in later studies.  
This was followed by a single-arm trial investigating the immediate effects of 3 and  
6	minutes	of	lumbar	mobilisations	in	participants	with	LBP.	A	single-arm	trial	(chapter	
6) was employed, as this was the first study to explore the effects of mobilisation and 
duration of mobilisation treatment in participants with lumbar spine pain. Moreover 
participants had a stable condition that was being monitored within one treatment 
session so the natural history of the condition was unlikely to be responsible for any 
immediate within session changes. The final study presented in the last chapter of 
this thesis was an RCT. The RCT was a methodologically robust progression from 
the single-arm trial, which focused on both the immediate and short-term analgesic 
effects of mobilisation and incorporated a questionnaire asking participants about 
their expectations and experience of receiving mobilisation treatment. 
8.1. Analysis of treatment responders
In the RCT responders analysis of PPT results identified that there were significantly 
more responders to 6 minutes of treatment than to 1 minute of treatment 
demonstrating that there were greater numbers of participants who experienced 
clinically important increases in PPT in the long duration of treatment group. 
The difference in the proportion of responders in 3 minutes compared to 6 minutes  
of treatment in the single-arm trial failed to reach significance. This suggests that the 
difference between 3 and 6 minutes of treatment is insufficient to observe significant 
difference between durations but suggests that longer treatment results in greater 
increase in PPT in some individuals.
The	difference	between	factors	that	may	influence	the	treatment	response	was	
explored for responders and non-responders. Only one factor tested in this thesis 
was different between response groups with responders being significantly younger 
than non-responders. It is evident that responders analysis is a sensitive method for 
examining the analgesic effects of different treatments and it is recommended for 
future studies.
8.2. The effects of lumbar mobilisations on PPT
The overall analysis of PPT in the single-arm trial (chapter 6) found that both 3 and  
6 minutes of lumbar mobilisation treatment resulted in a significant change in PPT. 
The difference between durations failed to reach statistical significance which may 
have been due to the study being underpowered to detect a difference between 
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durations.	Because	there	was	no	placebo	or	control	group	claims	of	a	hypoalgesic	
effect of treatment could not be fully supported. The proceeding RCT (chapter 7) 
found that there was no immediate analgesic effect of placebo, 1, 2 or 6 minutes  
of mobilisation treatment. 
The lack of effect observed in the RCT is somewhat contradictory to the findings of 
the single-arm trial. In the single arm trial mean change in PPT at the symptomatic 
paravertebral muscle site after 6 minutes of treatment was 1.5kg/cm2 and at T10 1.2 
kg/cm2; the mean differences in the RCT study were much smaller (0.3kg/cm at both 
of these sites). The RCT included 72 participants and thus had greater statistical 
power than the single-arm trial (which included 16 participants). However in a meta-
epidemiological	study,	Dechartres	et	al.,	(2013)	investigated	the	influence	of	sample	
size on treatment effects and found that the greatest effects were observed in small 
to medium sized trials as opposed to larger trials and proposed that this could due 
to a publication bias or the greater heterogeneity when recruiting larger samples. 
The participants in the single arm trial and RCT met the same inclusion and 
exclusion criteria and the recruitment strategy was largely the same, one notable 
difference was that in addition to the recruitment strategies used in the single arm 
trial (most participants were recruited through University email) the RCT recruited 
participants through advertisements in local papers. This may have resulted in a 
more heterogeneous group of participants in the RCT. Another difference in the 
inclusion criteria is that in the single-arm trial participants had to experience pain 
on simple movement (without overpressure). Due to difficulty recruiting participants 
matching these criteria the inclusion criteria in the RCT was widened to include 
participants who experienced pain on active movement with overpressure or 
combined movements. This may have resulted in participants with less severe 
symptoms	taking	part	in	the	study	and	thus	potentially	a	floor	effect	with	smaller	
potential benefits making it difficult to detect a treatment effect. These factors may 
also explain the difference in results for verbal rating of pain on movement found in 
the single-arm trial and RCT.
In addition to examining the immediate effects of mobilisation, the RCT investigated 
the analgesic effects 24-hour after treatment. There was a significant decrease in 
PPT at 24-hour follow-up in both treatment groups. Due to observations from the pilot 
work, this was attributed to soreness from PPT testing on the previous day rather 
than a delayed effect of mobilisations treatment. Six PPT repetitions were performed 
at each site over the course of an hour and a number of participants commented 
that	some	PPT	sites	felt	‘bruised’	the	following	day.	The	reliability	study	(chapter	5)	
demonstrated adequate inter-day reliability of PPT measures, However, the time 
between days varied from 1-13 days (mean 5.45 SD 3.91) and any bruising may well 
have reduced over this timeframe and may not have been evident in the reliability 
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results. Future research should consider the number of repetitions and  
the time between repetitions when using PPT as an outcome measure.
8.3. The extent of the analgesic effect of mobilisations
The difference in response levels in the RCT was evident at the paravertebral muscle 
sites, but not at the deltoid muscle site suggesting local analgesic mechanisms (such 
as the pain gate theory) may be responsible for the increase in PPT. The significant 
difference in PPT measurements relative to baseline following both 3 and 6 minutes 
of treatment reported in the single-arm trial was not evident at the deltoid muscle 
site. This local effect was also apparent for the mediating effect of force which was 
evident at local sites but not at the deltoid site. This evidence combined suggests 
that the change in PPT is mediated by local analgesic mechanisms, however this is 
speculative evidence and further evidence should be sought through studies utilising 
functional magnetic resonance imaging or pharmacological manipulation  
of	neurotransmitters	that	influence	the	different	analgesic	mechanisms.
8.4 The effects of lumbar mobilisations on verbal ratings of pain
The single-arm trial found that 6 minutes of treatment produced a significantly 
greater reduction in verbal rating of pain on movement than 3 minutes of treatment. 
Although the RCT found a significant effect of time immediately following treatment, 
there was no difference between placebo and 2 minute and 1 minutes and 6 
minutes of treatment. Although the RCT suggests that there may be no effect on 
verbal rating of pain additional to those of placebo, in the single-arm trial the effects 
of 3 minutes of mobilisations failed to reach significance, whereas the effects of 6 
minutes of mobilisation were significant, indicating that in the single arm trial the 
effects of treatment were more than those of just placebo. Similar to the PPT results 
there appeared to be less of an analgesic effect on verbal rating of pain in the RCT 
than in the single-arm trial. This could be explained by the difference between 
participants recruited in the studies as discussed in section 8.2. 
8.5. The relationship between pain measures
An important finding of both the single arm trial and RCT was the dissociation 
between PPT and VRS measures. One other study has investigated the relationship 
between PPT and pain rating after cervical mobilisation and also found dissociation 
between measures (Sterling et al., 2001). In a study utilising asymptomatic 
participants Lacourt et al., (2012) reported only moderate correlation between verbal 
pain rating of pain experienced on PPT testing and the PPT values themselves and 
proposed that PPT and verbal rating of pain consist of different constructs.  
The dissociation between measures as found in this study may be greater in 
participants	with	a	chronic	condition	as	rating	of	‘their’	pain	may	be	more	 
influenced	by	psychosocial	factors	than	the	rating	of	pressure	threshold.
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These results suggest that different PPT and verbal ratings of pain may be mediated 
by different neurobiological mechanism. It is suggested that studies measuring 
analgesia do not use PPT in isolation and where possible patient reported pain 
measures are also used.
The	RCT	identified	an	association	between	changes	in	pain	and	participants’	
perception	of	change.	It	is	recommended	that	where	possible	participants’	
perceptions of change are monitored in order to gain an appreciation of the  
overall pain experience.
8.6. Mediating effect of force
Treatment force had a significant mediating effect on both verbal rating of pain 
on movement and PPT (local to the site of treatment), with greater forces creating 
greater reductions in pain. The lack of overall significant findings may have 
been due to the lower force used in some participants. Although there was no 
significant difference in the treatment force received by treatment responders and 
non-responders. It may be that where pain allows physiotherapists should apply 
mobilisations using higher forces. However these findings need further investigation 
and	thus	the	influence	of	treatment	force	is	an	important	area	for	future	research.
8.7. Predictors of response to treatment. 
In the RCT, the expectations and experiences of treatment responders and  
non-responders were compared but there were no apparent difference between 
groups.	This	is	the	first	study	to	investigate	the	influence	of	symptomatic	
participants’	expectations	of	receiving	a	lumbar	mobilisation	treatment.	Although	 
30 participants expected treatment to be beneficial, 35 were unable to express their 
expectations.	This	could	be	due	to	the	chronic	nature	of	the	LBP	experienced	by	
participants in this study (mean 9 years duration), as it has been recognised that 
patients with chronic conditions have lower expectations of treatment (Hills and 
Kitchen, 2007). Treatment responders did not have different expectations to non-
responders.	However	these	results	may	have	been	influenced	by	the	large	number	
of participants with unknown expectations. Future research could use interviews 
to	explore	participants’	expectations	in	greater	detail	and	look	at	the	relationship	
between	treatment	outcome	and	participants’	perceived	effects	of	treatment.
Profiling of responders in this thesis did not find a relationship between expectation 
and experience of mobilisations and treatment response.
8.8. Stiffness measurement. 
The studies presented in chapter 5 and 6 of this thesis are the first studies to compare 
the two methods of stiffness measurement (three-point bending and displacement); 
simultaneous measurements were taken using both methods in the first two studies of 
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this thesis. The reliability study found that within-day reliability of three-point bending 
was moderate and between-day reliability was poor. The within- and between-day 
reliability of displacement measurements of stiffness were moderate. 
Observation of the three-point bending electromagnetic sensor movement and 
associated data highlighted potential problems with the validity of three-point 
bending measurements. Three-point bending measures demonstrated large 
between-subject variability (evident from the range and standard deviation of 
measurements), compared to displacement measurements.
The relationship between three-point bending and displacement methods of 
stiffness measurement varied. In the reliability study there was a significant and 
strong association between three-point bending and displacement methods of 
stiffness measurement demonstrating that greater stiffness measurements with 
one method were related to greater stiffness measurements with the other method. 
However, the proceeding single-arm trial found that there was dissociation between 
baseline measurements of three-point bending and displacement. 
To gain further information about the stiffness measurements, responsiveness to 
change was assessed after 3 and 6 minutes of treatment. Interestingly there was 
dissociation of measurements after 3 minutes of treatment, but an association after 
6 minutes of treatment. The varying relationship between measures suggests that 
three-point bending and displacement are not necessarily measuring the same 
behaviour. This, coupled with concerns about sensor movement and the theory 
underpinning three-point bending, casts doubt over its usefulness in future work. 
The displacement method has greater face validity as it is similar to the stiffness 
assessment performed by physiotherapists in clinical practice, however, the 
reliability values reported in chapter 5 suggest that neither method (using manually 
applied force) is ideal for measuring stiffness changes resulting from mobilisations. 
Neither 3 nor 6 minutes of mobilisations resulted in immediate changes in three-
point bending or displacement stiffness measurements. This is in agreement with the 
majority of studies investigating the effect of mobilisations on lumbar spine stiffness.
8.9. The effects of lumbar mobilisations on range of movement
Although	on	initial	appraisal,	the	ICC’s	for	ROM	could	be	regarded	as	acceptable,	the	
real change value indicated that a large difference would need to have occurred before 
it	could	be	attributed	to	a	treatment	effect.	For	example	in	the	case	of	flexion,	treatment	
would need to produce a 15.41 degrees change in ROM to be sure that a treatment 
effect had occurred, this is approaching an increase of nearly 1/3 of the total range.  
The single-arm trial (chapter 6) found that neither 3 nor 6 minutes of mobilisations 
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resulted	in	immediate	changes	in	ROM	in	participants	with	chronic	LBP.	This	
is in agreement with the majority of studies reporting no change in ROM with 
mobilisations treatment. Two studies employing longer durations of treatment have 
reported	increased	ROM	immediately	following	treatment	(McCollam	and	Benson,	
1993 and Powers et al., 2008). The findings of the single-arm trial suggest that the 
longer treatment duration employed does not explain the change in ROM reported 
in these studies.
8.10. Summary of limitations 
	 •	 	The	single-arm	trial	in	this	thesis	investigated	the	difference	between	 
treatment durations. A single arm trial is a quasi-experimental design that 
cannot rule out bias, natural improvement or regression to the mean. It was 
used as a precursor to an RCT as an RCT is not usually the first step in 
studying an intervention (Chin and Lee, 1996). It is acknowledged that in the 
RCT, the inclusion of a third group receiving placebo condition only would 
have been a preferable study design, but the number of participants required 
for a third group was not feasible within the duration of the study. 
	 •	 	It	is	acknowledged	that	positioning	is	a	component	of	mobilisation	treatment	
that	was	not	incorporated	into	the	treatment	periods	and	may	have	influenced	
the study outcomes. 
	 •	 	The	final	study	sought	to	compare	participants’	response	to	treatment	to	 
their expectations and experience of receiving a mobilisation treatment. 
A questionnaire was used in order to categorise their responses. However,  
the use of a questionnaire did not enable exploration of their responses and 
nearly half of the participants did not express any expectations of treatment. 
	 •	 	It	is	recognised	that	patients	respond	differently	to	treatment.	However	 
none of the potential predictors of treatment outcome tested in this thesis 
significantly altered the results of the main analysis. This may have been due 
to lack of statistical power as the power analysis was calculated on the 2-way 
interaction between time and condition and may have been underpowered 
to detect subgroup effects. Research trials sufficiently powered to detect 
differences in subgroup is an important continued focus for future work. 
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8.11. Research questions addressed in the studies in this thesis 
This thesis set out to address a number of research questions (page 44).  
The findings relating to each of these questions is summarised below:
What is the test-retest reliability and measurement error of ROM (using an 
electromagnetic tracking device), stiffness (using three-point bending and 
displacement methods) and PPT measurements? 
The test-retest reliability of lateral flexion range of movement measurements  
was good to excellent, as was within-day reliability of extension. However within- 
and between-day reliability of flexion and between-day reliability of extension 
were only fair. Furthermore the MDC statistic indicated that large changes in 
range of movement would need to occur in order to be sure that a change was 
due to treatment. Within-day reliability of stiffness measurements was good to 
excellent. Between-day reliability for displacement measurements was good, but 
for three-point bending was poor. Both between- and within-day reliability of PPTs 
measurements was good to excellent (depending on the site of PPT measurement).
Which is the most valid and reliable method for measuring  
the effects of mobilisation on lumbar stiffness? 
Observation of the sensor movement occurring during testing cast doubt over 
the validity of three-point bending measurements. The concerns regarding 
the movement of the sensors and the safety of the assumption underpinning 
three-point bending theory suggest that the displacement method of stiffness 
measurement is preferable for future research. Furthermore the three-point bending 
method of stiffness measurement does not represent how physiotherapists assess 
stiffness and in terms of measuring the stiffness that therapist perceive it lacks face 
validity. These results suggest that further investigation of the three-point bending 
method of stiffness is necessary before it is used in future work. 
The displacement measurements of stiffness demonstrated good reliability both 
within- and between-day. However the reliability of stiffness was lower than in 
previous studies. This is largely explained by the use of a manually applied 
indenter in this study. It is recommended that future work uses a mechanically 
driven indenter to standardise the application of force
What are the immediate effects of lumbar mobilisations on pain,  
stiffness and ROM in patients with chronic non-specific LBP? 
The single arm trial found no significant change in ROM or stiffness relative to 
baseline with either 3 or 6 minutes of treatment. However relative to baseline there 
was a significant increase in PPTs following mobilisations (indicating a hypoalgesic 
effect). Because this was not compared to a control intervention this findings 
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could be due to natural variation over time. The single arm trial found that relative 
to baseline there was a significant increase in verbal rating of pain on movement 
following 6 minutes of mobilisations. Although this was not compared to a control 
intervention no significant difference in PPT was found after 3 minutes of treatment, 
suggesting that a treatment effect had occurred following 6 minutes of treatment.
The RCT found no overall change in PPT immediately following sham mobilisation, 
1 minute of mobilisations and 6 minutes of mobilisation in participants with 
LBP	demonstrating	that	there	was	no	overall	effect	of	treatment.	However	there	
were significantly more responders to 6 minutes of treatment than 1 minute of 
treatment.  The difference in the number of treatment responders following 2 
minutes of mobilisation treatment and 2 minutes of sham mobilisation (the placebo 
intervention) failed to reach statistical significance suggesting that 2 minutes 
of mobilisations may not be long enough duration to exceed the benefits of the 
non-specific effects of placebo. Overall these findings highlight the variability 
in	participants’	response	to	treatment	and	demonstrate	that	significantly	more	
participants respond to a longer duration of mobilisation treatment.
There was a significant change in verbal rating of pain on movement and verbal 
rating of pain, but the difference between treatment and placebo intervention failed 
to reach significance, suggesting that this change was due to natural variation or 
the non-specific effects of treatment. 
What are the short-term effects of lumbar mobilisations on pain,  
stiffness and ROM in patients with chronic non-specific LBP? 
Relative to baseline there was a significant reduction in PPT at 24-hour follow 
up, indicating that there was an increase in pain sensitivity.  It is likely that this 
reduction	in	PPT’s	(indicating	hyperalgesia)	resulted	from	previous	testing	rather	
than a delayed effect of treatment. 
At 24-hours follow-up pain on movement was significantly reduced compared to baseline. 
However there were no significant difference between placebo and 2 minutes of treatment 
or 1 minute of treatment and 6 minutes of treatment, so the reduction in pain on movement 
effects could be attributed to the non-specific effects of treatment or natural variation over 
time.  There was no difference in resting pain or verbal rating of pain on PA.
What is the effect of a longer duration of mobilisation treatment on  
ROM, stiffness and pain in patients with chronic non-specific low back pain? 
The single-arm trial found that relative to baseline VRS of pain on movement was 
significantly greater following 6 minutes of treatment but not following 3 minutes of 
treatment. 
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The RCT found no overall change in PPT immediately following sham mobilisation, 
1	minute	of	mobilisations	and	6	minutes	of	mobilisation	in	participants	with	LBP	
demonstrating that there was no overall effect of treatment. However significantly 
more participants experienced immediate increases in PPT local to the site of 
treatment following 6 minutes of lumbar mobilisation treatment than following 
1 minute of treatment. The difference in the number of treatment responders 
following 2 minutes of mobilisation treatment and 2 minutes of sham mobilisation 
(the placebo intervention) failed to reach statistical significance demonstrating 
that 2 minutes of mobilisations may not be long enough duration to exceed the 
benefits of the non-specific effects of placebo. Overall these findings highlight the 
variability	in	participants’	response	to	treatment	and	demonstrate	that	significantly	
more participants respond to a longer duration of mobilisation treatment.
These are the first studies to compare the effect of different durations of 
mobilisations in a symptomatic population and suggest that there may be a 
beneficial effect of applying longer durations of treatment than those advocated  
in clinical texts or investigated in previous research.
What is the relationship between PPT’s and VRS of pain?
There was dissociation between PPT and verbal ratings of pain reported in  
both the single-arm trial and RCT. These finding suggest that change in PPT and 
change in verbal rating of pain may be mediated by different neurobiological 
mechanisms. 
8.12. Recommendations for future work
The results presented in this thesis have highlighted some important areas  
for future work, which are discussed below.
 
	 •	 	Although	there	was	no	overall	difference	in	PPT	between	treatment	conditions,	
responders analysis found that significantly more participants in the longer 
duration treatment group experienced clinically meaningful changes in PPT. 
The responder analysis appeared to provide a sensitive way at exploring the 
difference in effect between different treatments. The inclusion of responders 
analysis is recommended for future studies.
	 •	 	The	final	study	in	this	thesis	found	that	force	had	a	mediating	effect	of	
treatment, with greater forces extolling a greater analgesic effect. The current 
thesis explored the 24-hour effects of a single mobilisation treatment dose. 
Longer–term follow up (for example 48 or 72 hours post treatment) from a 
single treatment could be explored in future research.
		•	 	Dissociation	was	found	between	PPT	measures	and	VRS	of	pain.	Further	
investigation is needed to explore the clinical relevance of changes in PPT. 
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It is recommended that future studies incorporated a number of pain related 
outcome measures.
	 •	 	A	number	of	individuals	responded	immediately	to	mobilisation	treatment.	
Although research developing clinical prediction rules for patients with acute 
LBP	is	on-going	area,	it	may	prove	to	be	too	complex	to	predict	response	in	
patients	with	a	condition	as	heterogeneous	as	chronic	LBP.	In	clinical	practice	
the	immediate	effects	of	mobilisations	are	assessed	using	a	‘trial	dose’	and	
decisions regarding whether to employ mobilisations as a treatment option are 
often based on this. It would be useful to isolate those individuals who would 
have had an immediately favourable response to a trial mobilisation dose and 
evaluate the effects over a course of mobilisation treatments. An alternative 
strategy,	that	has	been	employed	previously,	in	LBP	studies,	is	to	investigate	
the effect of manual therapy in participants who fulfilled a clinical prediction 
rule (Childs et al., 2004). These options were not employed in this study in 
order to prevent the introduction of bias. 
	 •	 	Future	studies	could	investigate	the	use	of	therapist	selected	techniques	 
or multimodal treatment.
	 •	 	Further	exploration	of	patients’	experiences	of	receiving	mobilisations	could	 
be achieved using interviews or focus groups.
	 •	 	Communication	with	participants	was	kept	to	a	minimum	during	the	course	
of the studies in this thesis and their beliefs and expectations were not 
explored at the time of the physiotherapy assessment, which may have 
influenced	the	response	to	treatment.	One	area	for	future	study	is	to	explore	
how	communication	with	participants	influences	the	clinical	response	to	
mobilisations.
	 •	 	Pilot	work	suggested	that	the	instructions	given	to	participants	during	PPT	
might affect measurement reliability. An area for future work is to investigate the 
influence	of	instructions	on	the	reliability	of	PPT.	For	example	using	the	words	
‘discomfort’	or	‘pain’,	or	emphasising	to	participants	that	this	is	not	a	measure	
of	tolerance	may	influence	reliability	of	PPT	measures	(using	instructions	such	
as ‘it is important that you do not try and tolerate any pain what so ever and 
that you indicate AS SOON AS the feeling changes from 
one	of	just	pressure’).	
	 •	 	Most	previous	studies	measuring	stiffness	have	employed	the	displacement	method	
using a mechanically driven device that standardises the maximum force and rate 
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of application. It appears from this work that the interpretation of the method used 
by Owen et al., (2007a+b) used in the studies contained in this thesis have some 
deficiencies. For this reason it might be preferable for mechanical indentation 
devices to be used in future work measuring lumbar stiffness
8.13. Original contribution to knowledge
	 •	 	The	reliability	study	in	this	thesis	provided	comprehensive	reliability	of	stiffness,	
ROM and PPT measurements, including the calculation of MDC and SEM 
which enabled responders analysis to be performed in later studies. 
	 •	 	This	is	the	first	study	to	compare	the	two	different	methods	of	stiffness	
measurement that are reported in the literature. 
	 •	 	This	thesis	is	the	first	to	report	responders	analysis	for	the	analgesic	effects	 
of mobilisations and highlights a method of analysis useful for future studies. 
	 •	 	The	single	arm	trial	and	the	RCT	were	the	first	to	investigate	the	effects	of	
different durations of lumbar mobilisations in participants with low back pain. 
These findings add to the evidence aiding clinicians in their decision-making 
when selecting mobilisation treatment dose. 
	 •	 	This	is	the	first	study	to	highlight	the	potential	influence	of	mobilisation	force	 
on the analgesic effect of mobilisations.
	 •	 	This	is	the	first	study	to	investigate	the	extent	of	the	analgesic	effect	in	
participants	with	LBP	and	provides	speculative	evidence	that	the	pain	relief	
from mobilisation is mediated by a local analgesic mechanism. 
	 •	 	The	studies	in	this	thesis	have	found	dissociation	between	PPT	and	verbal	
ratings	of	pain.	This	suggests	that	changes	in	PPT	may	not	reflect	changes	 
in	participants’	clinical	presentations	and	thus	the	clinical	meaningfulness	 
of studies reporting PPT in isolation should be questioned. 
	 •	 	The	studies	in	this	thesis	suggest	that	changes	in	PPT	and	changes	in	 
verbal rating of pain may be mediated via different analgesic mechanisms. 
	 •	 	This	study	was	the	first	to	ask	participants	about	their	expectations	and	
experience of mobilisation treatment and to compare these to treatment 
outcome.
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8.14. Conclusions
The reliability study (chapter 5) found that within-day reliability of PPT measures was 
excellent and between-day reliability of PPT measures was good to excellent. The 
reliability of range of movement measurements was good to excellent within-day, but 
only	fair	between-days.	The	CI’s	suggested	that	on	other	occasions	reliability	may	
be insufficient and the MDC indicated that in some cases a large difference would 
need to have occurred before it could be attributed to a treatment effect. 
Within-day reliability of three-point bending stiffness measurements was excellent, 
but between-day reliability was only fair. Observation of the sensor movement 
occurring during testing cast doubt over the validity of three-point bending 
measurements. These results suggest that further investigation of the three-point 
bending method of stiffness is necessary before it is used in future work. The 
displacement measurements of stiffness showed good reliability. The reliability of 
stiffness is lower than in previous studies. This is largely explained by the use of  
a manually applied indenter in this study. It is recommended that future work uses 
a mechanically driven indenter to standardise the application of force.
The single-arm trial (chapter 6) demonstrated that relative to baseline VRS of pain 
on movement was significantly greater with 6 minutes of treatment than with 3 
minutes	of	treatment.	Both	3	and	6	minutes	of	mobilisations	resulted	in	a	significant	
increase in PPT local to the site of treatment and in the signature zones of most 
lower limb dermatomes but not at a site unrelated to treatment. These findings 
suggest that the change in PPT is mediated via a local, as opposed to systemic, 
analgesic mechanism. The results of this study suggested that there may be a 
beneficial effect of applying longer durations of treatment than those advocated  
in clinical texts or investigated in previous research.
The single arm trial found that neither 3 nor 6 minutes of mobilisations had an 
effect on range of movement and stiffness. This suggests that the immediate 
effects of mobilisations may be predominantly neurophysiological.
 
In the RCT (chapter 7) responders analysis demonstrated that significantly more 
participants experienced immediate increases in PPT local to the site of treatment 
following 6 minutes of lumbar mobilisation treatment than following one minute 
of treatment. This suggests that a longer treatment duration may have a greater 
hypoalgesic effect, which may be mediated by a local analgesic mechanism.  
This study identified that treatment responders were significantly younger than 
non-responders. No other predictors of treatment response were identified.
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The overall analysis demonstrated that there was a significant change in verbal 
rating of pain on movement and verbal rating of pain on the application of PA 
force to the symptomatic level, but there was no difference between treatment 
and placebo intervention, suggesting that this effect was due to natural variation 
or the non-specific effects of treatment. Overall, neither placebo intervention nor 
lumbar mobilisations changed PPT, however there was a significant mediating 
effect of force, with higher treatment forces being associated with greater 
immediate increases in PPT and decreases in pain on movement. The variability 
in	participants’	responses	to	treatment	may	explain	the	lack	of	overall	effect	and	
thus responders analysis may be a more sensitive way of analysing pain relief in 
heterogeneous populations. 
The dissociation between PPT and verbal ratings of pain reported in both the  
single-arm trial and RCT suggest that when investigating the analgesic effects of 
treatment it may be useful to incorporate a number of pain measures in order to 
gain a wide appreciation of changes in pain experienced by patients.
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increasing sets (within one treatment session) and different set durations (between 
treatment sessions) of lumbar spine posteroanterior mobilisations on pressure 
pain thresholds. Manual Therapy, 17, 6, 526-530. 
 
Krouwel, O., Hebron, C., Willett, E., (2009) An Investigation into the Potential 
Hypoalgesic Effects of Different Amplitudes of PA Mobilisations on the Lumbar 
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Manual Therapy, 15, 2, 173-178. 
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increasing sets (within one treatment session) and different set durations (between 
treatment sessions) of lumbar spine posteroanterior mobilisations on pressure 
pain thresholds:  IFOMPT, the World Congress of Manual/Musculoskeletal 
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Appendix 2: Ethical Approval 
 
Ethical approval for: The reliability of pressure pain threshold, ROM and 
stiffness measurements of the lumbar spine. 
 
 
Subject: 
Faculty of Health and Social Science Research Ethics and Governance 
Committee - Decision on Manuscript ID FREGC-10-046.R1 
Body: 
@@date to be populated upon sending@@  
 
Dear Mrs. Hebron:  
 
It is a pleasure to approve your application entitled "The reliability of pressure pain 
threshold, ROM and stiffness measurements of the lumbar spine."  
 
 
Thank you for your correspondence and discussion on the phone today in which 
you clarified that you would take the additional precaution of using a trusted and 
suitably competent colleague to inform and consent students into the study for 
whom you have either course responsibility or, for whom you assume a direct 
personal tutor role.  
 
I have made this exception because I have been convinced that the opportunity to 
participate in this research will serve as a pedagogic opportunity to both role 
model research in physiotherapy to students, and to use the experience of 
participation to engage students in research and thinking critically about the 
research process. These benefits seem to outweigh any possible risk of coercion 
in recruiting students within one's own field of practice - especially as the research 
is low risk and consent is to be gained by a suitably competent colleague. I feel it 
would be helpful to identify on the information sheet to whom a student might 
make a complaint (as an additional precaution). This person should be a neutral 
party and I would recommend this either be the Head of School or myself if this 
would be acceptable to you and your supervisors.  
 
I wish you well with your research. Please notify the Committee of any changes to 
the design of your study and report any adverse incidents immediately.  
 
Sincerely,  
Prof. Julie Scholes  
Chair, Faculty of Health and Social Science Research Ethics and Governance 
Committee  
J.Scholes@brighton.ac.uk  
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Ethical approval for: A single-arm trial investigating the immediate effects of 
duration of lumbar mobilisation treatment on pain, stiffness and ROM in 
patients with chronic LBP  
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27-Jun-2012 
 
Dear Mrs. Hebron: 
 
It is a pleasure to approve your application entitled "The immediate and 
mid-term effects of 1 and 6 minutes of lumbar mobilisations on pressure pain 
thresholds and patient reported pain measures." which has been approved by 
the Faculty of Health and Social Science Research Ethics and Governance 
Committee.  The comments of the reviewer(s) who reviewed your manuscript are 
included at the foot of this letter. 
 
Please notify The Chair of FREGC immediately if you experience an adverse 
incident whilst undertaking the research or if you need to make amendments 
to the original application. 
 
We shall shortly issue letters of sponsorship and insurance for appropriate 
external agencies as necessary. 
 
We wish you well with your research. Please remember to send annual updates 
on the progress of your research or an end of study summary of your 
research. 
 
Sincerely, 
Prof. Julie Scholes 
Chair, Faculty of Health and Social Science Research Ethics and Governance 
Committee J.Scholes@brighton.ac.uk 
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Max FL 
Decline face of FL/EXT 
Incline face of FL/EXT 
Max 
EXT 
Max 
LFL 
Decline face of LFL/LFR 
Appendix 3: Batch process procedure for processing ROM and stiffness 
data. 
 
Excel files with Macro were created to make use of Microsoft VBA (Visual Basic for Applications) and automatically 
batch process relevant raw data files for data analysis. The following appendix explains the process used in all studies. 
References to processing of pain button data refer only to study 2 and beyond. 
 
ROM (ROM) batch processing 
The content of the ROM (ROM) batch process VBA code 
VBA identified which raw data files (ROMP, ROM, ROMplot, ROMraw) to copy onto which worksheet in the ROM 
template file. Linear interpolation of Pain button measurement (force plate) occurred in accordance to ROM range 
(fastrak). 
 
 
 
The ROM sample of the first 2seconds was used to correct the measurement offset.  
Then the maximum and minimum values for both FL/EXT and LFL/LFR waves are identified.  
This was followed by identifying the ROM at the onset of P1. In order to identify the right pain button at the right 
movement, several points were identified: 
 
Points at max FL, max EXT, and max LFL 
Point somewhere at the decline face of FL/EXT wave after max FL 
Point somewhere at the incline face of FL/EXT wave after max EXT 
Point somewhere at the decline face of LFL/LFR wave after max LFL 
 
 
 
 
 
Then it is assumed that: 
P1FL will happen before decline face of FL/EXT; P1EXT is after 
max FL and before incline face of FL/EXT; 
P1LFL is after incline face of FL/EXT and before decline face of 
LFL/LFR; P1LFR is after decline face of LFL/LFR.  
If pain button was not pressed during a movement, then “-“ is noted for P1 of that movement. 
 
 
 
Stiffness (PA) Batch Processing 
 
A Macro written in Visual Basics A (VBA). Force plate files show the forces in the X,Y and Z axis. Vertical forces are 
those in the Z axis and are shown separately for the two force plates and are shown in column D (Z axis force plate one) 
and J (Z axis for force plate two). The Macro calculated the sum of D and J columns of the Force plate file to calculate 
the total force applied over the two force plates. 
 
The Fastrak files required a timeline to be inserted. This was interpolated to the time line for the force plates. 
 
The Fastrak motion tracking system was set up with sensors 1 and 2 placed on the sacrum and L1 respectively. The 
column showing movement of sensor one in relation to sensor 2 was plotted against the sum of the forces in the Z axis to 
produce a force angle graph. A third sensor was mounted on top of the indenter used to apply the PA pressure to the spine 
during stiffness testing in order to measure vertical displacement. The macro separated the Fastrak data from the different 
sensors (from the raw file). The data for sensor was in inches. This was multiplied by 25.4 to convert into millimetre to 
allow comparison with previous studies. Vertical displacement data was plotted against the force data to produce a force 
displacement graph. 
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This data and the force displacement and force displacement graphs were transferred onto a template document to allow 
the data to be inspected visually to check for any problems. 
 
A second Macro was then used to calculate stiffness using both force angle and force displacement data using linear 
interpolation of the slope of the force displacement graph between 30-100N. The second part of this section calculates 
the slope of force-displacement curve (i.e., spinal stiffness) of the loading phase of each cycle.  By default, VBA is set to 
calculate slope between Force of 30 and 100N, or if 100N was not reached, then max force of the cycle. 
 
 
The Content of the PA Batch Process VBA code 
Measurements were converted to appropriate units: 
 Displacement from FT Sensor 3 was converted from inch to mm (divided by -0.03947) 
 Original measurement for bending angle is in degree; then was formulated to radian (“=RADIAN”) 
 
This section also includes the linear interpolation of Force and Pain button measurements (force plate) in accordance to 
displacement range (Fastrak). 
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The following part calculates the Force sample of 0-0.4seconds to correct the measurement offset.  
Then the Force at P1 during the first PA is identified by tracing the initial spike in the Pain column (value > 8). 
 
Function CopyCycle()  section identifies the first PA and 6 consecutive PA Force application. This is done by 
 first identifying the inclining face of Force on each oscillation and selecting the range of Min and Max Force on each 
cycle. 
 Each strip of cycle is then copied onto subsequent worksheets.  
 
 
 
 
 
PA Occasion Batch Processing: The Content of the PAOccasionBatchProcess VBA code 
 
  
The second part of this section calculates the slope of force-displacement curve (i.e., spinal stiffness) of the loading 
phase of each cycle.  By default, VBA was set to calculate slope between Force of 30 and 100N, or if 100N was not 
reached, then max force of the cycle.
Average stiffness of cycle 1-6 
Stiffness value measured 
between 30-100N of cycle 1-6 
Maximal force applied on each 
oscillation 
Time scale of the loading phase of 
each oscillation. Ideally should be  
=1.00 at 0.5Hz 
-Max Force during P1PA, 
-Force at P1, and 
-% of P1 Force in relation to 
Max Force 
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Sub CopyCyclesData()  section simply copies the force and displacement strips of each cycle from participant’s 
processed file to the PAOccasion template file.  
 
This section also copies P1PA measurements. If pain button was not pressed during the initial PA, then the data is 
shown as “0.00” under P1Force, resulting in P1Force(%) to be also “0.00” 
  
This is repeated for all three occasions, each set of data saved on separate files.  
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Appendix 4 
 
Reliability study. Normality testing for pressure pain threshold, ROM and 
stiffness data. 
 
Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Flex2 .190 15 .150 .950 15 .526 
Ext2 .140 15 .200* .968 15 .822 
LLF2 .167 15 .200* .941 15 .389 
RLF2 .139 15 .200* .975 15 .928 
Flex3 .106 15 .200* .976 15 .933 
Ext3 .140 15 .200* .897 15 .087 
LLF3 .122 15 .200* .950 15 .523 
RLF3 .191 15 .146 .831 15 .009 
Flex4 .117 15 .200* .941 15 .399 
Ext4 .218 15 .053 .859 15 .024 
LLF4 .174 15 .200* .950 15 .532 
RLF4 .158 15 .200* .949 15 .502 
Flex5 .150 15 .200* .895 15 .080 
Ext5 .235 15 .025 .883 15 .053 
LLF5 .169 15 .200* .910 15 .135 
RLF5 .195 15 .128 .885 15 .057 
Flex6 .197 15 .121 .959 15 .676 
Ext6 .142 15 .200* .921 15 .202 
LLF6 .158 15 .200* .953 15 .570 
RLF6 .094 15 .200* .972 15 .880 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
 
 
 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Def1 .109 15 .200* .973 15 .905 
Angle1 .151 15 .200* .931 15 .278 
Def2 .227 15 .036 .797 15 .003 
Angle2 .287 15 .002 .808 15 .005 
Def3 .105 15 .200* .952 15 .560 
Angle3 .305 15 .001 .611 15 .000 
Def4 .198 15 .116 .940 15 .383 
Angle4 .123 15 .200* .952 15 .562 
Def5 .168 15 .200* .873 15 .037 
Angle5 .131 15 .200* .977 15 .944 
Def6 .202 15 .101 .881 15 .050 
Angle6 .261 15 .007 .775 15 .002 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statisti
c 
df Sig. Statistic df Sig. 
L4sp1 .089 20 .200* .977 20 .884 
L4sp2 .116 20 .200* .943 20 .268 
L4sp3 .148 20 .200* .966 20 .672 
L4sp4 .124 20 .200* .964 20 .617 
L4sp5 .154 20 .200* .942 20 .267 
L4sp6 .147 20 .200* .937 20 .213 
T101 .105 20 .200* .976 20 .871 
T102 .119 20 .200* .963 20 .602 
T103 .140 20 .200* .974 20 .833 
T104 .100 20 .200* .981 20 .945 
T105 .144 20 .200* .941 20 .253 
T106 .143 20 .200* .938 20 .216 
Deltoid1 .129 20 .200* .969 20 .733 
Deltoid2 .139 20 .200* .965 20 .650 
Deltoid3 .121 20 .200* .957 20 .478 
Deltoid4 .148 20 .200* .944 20 .283 
Deltoid5 .134 20 .200* .958 20 .506 
Deltoid6 .165 20 .155 .960 20 .539 
S11 .151 20 .200* .946 20 .317 
S12 .210 20 .021 .910 20 .063 
S13 .167 20 .145 .937 20 .210 
S14 .124 20 .200* .956 20 .476 
S15 .122 20 .200* .954 20 .435 
S16 .115 20 .200* .981 20 .949 
L21 .151 20 .200* .946 20 .317 
L22 .210 20 .021 .910 20 .063 
L23 .167 20 .145 .937 20 .210 
L24 .124 20 .200* .956 20 .476 
L25 .122 20 .200* .954 20 .435 
L26 .115 20 .200* .981 20 .949 
L31 .141 20 .200* .903 20 .048 
L32 .083 20 .200* .985 20 .980 
L33 .114 20 .200* .974 20 .832 
L34 .166 20 .149 .933 20 .173 
L35 .138 20 .200* .945 20 .300 
L36 .139 20 .200* .955 20 .443 
L41 .140 20 .200* .963 20 .597 
L42 .116 20 .200* .946 20 .316 
L43 .156 20 .200* .932 20 .171 
L44 .181 20 .083 .922 20 .107 
L45 .180 20 .088 .935 20 .191 
L46 .224 20 .010 .877 20 .015 
L51 .146 20 .200* .952 20 .402 
L52 .165 20 .154 .919 20 .094 
L53 .188 20 .063 .871 20 .012 
L54 .115 20 .200* .967 20 .687 
L55 .146 20 .200* .957 20 .492 
L56 .162 20 .179 .953 20 .413 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
L4sp1 .089 20 .200* .977 20 .884 
L4sp2 .116 20 .200* .943 20 .268 
L4sp3 .148 20 .200* .966 20 .672 
L4sp4 .124 20 .200* .964 20 .617 
L4sp5 .154 20 .200* .942 20 .267 
L4sp6 .147 20 .200* .937 20 .213 
T101 .105 20 .200* .976 20 .871 
T102 .119 20 .200* .963 20 .602 
T103 .140 20 .200* .974 20 .833 
T104 .100 20 .200* .981 20 .945 
T105 .144 20 .200* .941 20 .253 
T106 .143 20 .200* .938 20 .216 
Deltoid1 .129 20 .200* .969 20 .733 
Deltoid2 .139 20 .200* .965 20 .650 
Deltoid3 .121 20 .200* .957 20 .478 
Deltoid4 .148 20 .200* .944 20 .283 
Deltoid5 .134 20 .200* .958 20 .506 
Deltoid6 .165 20 .155 .960 20 .539 
S11 .151 20 .200* .946 20 .317 
S12 .210 20 .021 .910 20 .063 
S13 .167 20 .145 .937 20 .210 
S14 .124 20 .200* .956 20 .476 
S15 .122 20 .200* .954 20 .435 
S16 .115 20 .200* .981 20 .949 
L21 .151 20 .200* .946 20 .317 
L22 .210 20 .021 .910 20 .063 
L23 .167 20 .145 .937 20 .210 
L24 .124 20 .200* .956 20 .476 
L25 .122 20 .200* .954 20 .435 
L26 .115 20 .200* .981 20 .949 
L31 .141 20 .200* .903 20 .048 
L32 .083 20 .200* .985 20 .980 
L33 .114 20 .200* .974 20 .832 
L34 .166 20 .149 .933 20 .173 
L35 .138 20 .200* .945 20 .300 
L36 .139 20 .200* .955 20 .443 
L41 .140 20 .200* .963 20 .597 
L42 .116 20 .200* .946 20 .316 
L43 .156 20 .200* .932 20 .171 
L44 .181 20 .083 .922 20 .107 
L45 .180 20 .088 .935 20 .191 
L46 .224 20 .010 .877 20 .015 
L51 .146 20 .200* .952 20 .402 
L52 .165 20 .154 .919 20 .094 
L53 .188 20 .063 .871 20 .012 
L54 .115 20 .200* .967 20 .687 
L55 .146 20 .200* .957 20 .492 
L56 .162 20 .179 .953 20 .413 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Appendix 5 
 
Correlation between three-point bending and displacement methods of 
stiffness measurements 
 
Reliability study. Correlation between three-point bending and displacement data at baseline on occasion 1. 
 
Correlations 
 def1notlog agle1notlog 
Spearman's rho def1notlog Correlation Coefficient 1.000 .643** 
Sig. (2-tailed) . .010 
N 15 15 
agle1notlog Correlation Coefficient .643** 1.000 
Sig. (2-tailed) .010 . 
N 15 15 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
 
 
Reliability study. Correlation between three-point bending and displacement data at baselines on the second 
occasion. 
 
Correlations 
 def4notlog angle4notlog 
Spearman's rho def4notlog Correlation Coefficient 1.000 .704** 
Sig. (2-tailed) . .003 
N 15 15 
angle4notlog Correlation Coefficient .704** 1.000 
Sig. (2-tailed) .003 . 
N 15 15 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Appendix 6 
A vignette of how a diagnosis of symptomatic level is made for a patient with non-specific LBP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Physiotherapy diagnosis of symptomatic level 
In the majority of patients with LBP it is not possible to diagnose a structural cause for their 
symptoms and these patients are diagnosed as suffering from non-specific LBP. In these patients 
physiotherapist will not make a structural diagnosis but will diagnose symptomatic level. There is 
evidence that therapists can accurately diagnose symptomatic level. Jull et al., (1988) diagnosed 
symptomatic level in 20 participants, (5 asymptomatic and 15 with neck pain) the findings of the 
physiotherapist were compared to radiologically controlled diagnostic block. There was 100% 
agreement on the symptomatic level and all asymptomatic participants were correctly identified, 
resulting in 100% sensitivity and specificity. Similar results were found in a study on the lumbar 
spine where 2 physiotherapists correctly identified the symptomatic level in 94% of patients and 
correctly identified 100% of asymptomatic participants (Phillips and Twomey, 1993). Both these 
studies investigated the accuracy of experienced physiotherapists in diagnosing symptomatic level, 
which may not reflect the ability of a wider population.  
 
In the study by Phillips and Twomey (1993) a further 23 participants were assessed by the 
physiotherapist retrospectively, lower sensitivity 61% was found in this group but can be explained 
by the time interval between diagnostic block and manual examination (a mean of 156 days). In 
this study the physiotherapists were prevented from observing the patients’ posture or general 
mobility, which may have further hindered their ability to diagnose symptomatic level. Further 
evidence of physiotherapists’ ability to diagnose symptomatic level can be found in studies 
investigating the agreement between therapists; it has been shown that there is acceptable 
A patient presents with left sided LBP referring to their left posterior thigh. The patient complains of  
pain aggravated by activities involving physiological flexion. Physical examination confirms that both 
the LBP and left  posterior thigh pain are reproduced on flexion; the symptoms increase further with  
the addition of right lateral flexion (a regular stretch pattern (Edwards, 1992). Passive accessory 
intervertebral movements (PAIVM’s) are assessed with the patient in their symptomatic position of  
flexion / right lateral flexion. A unilateral posteroanterior mobilisation on L4 on the left reproduces the 
patients LBP, when the mobilisation is directed with a cephalad inclination (towards the head) the  
LBP increases and the posterior thigh pain is reproduced. The physiotherapist diagnoses the left  
L4/5 as the symptomatic level. The cephalic inclination of the posterioanterior force produces the  
similar relative movement of local structure as the patient’s painful movement of flexion and right  
lateral flexion. The movements of flexion and right lateral flexion and the mobilisation force may  
affect all the local structures simultaneously; it is therefore not possible to determine the anatomical  
structure at fault and thus a diagnosis of symptomatic level as opposed to a structural diagnosis is  
given. 
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agreement between physiotherapists when deciding on the level to treat. In one study 6 
experienced manual therapists examined the upper cervical spine (as they deemed appropriate) in 
40 patients with neck pain and headaches, there was 70% agreement on the level of symptoms 
(Jull et al., 1997).  
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Appendix 7:  
Questionnaires. 
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SURVEY OF PAIN ATTITUDES, SHORT VERSION 
SOPA-32 
Instructions: Please indicate how much you agree with each of the following statements 
about your pain problem by using the following scale: 
0 = This is very untrue for me. 
1 = This is somewhat untrue for me. 
2 = This is neither true nor untrue for me (or it does not apply to me). 
3 = This is somewhat true for me. 
4 = This is very true for me. 
_________________________________________________ 
1. There are many times when I can influence the amount of pain I feel.. 0 1 2 3 4 
2. I will probably always have to take pain medications ........................ 0 1 2 3 4 
3. When I hurt, I want my family to treat me better ............................ 0 1 2 3 4 
4. I expect a medical cure for my pain................................................ 0 1 2 3 4 
5. I have had the most relief from pain with the use of medications ....... 0 1 2 3 4 
6. Anxiety increases the pain I feel..................................................... 0 1 2 3 4 
7. When I am hurting, people should treat me with care and concern...... 0 1 2 3 4 
8. I have given up my search for the complete elimination of my pain 
through the work of the medical profession ..................................... 0 1 2 3 4 
9. It is the responsibility of my loved ones to help me when I feel pain.... 0 1 2 3 4 
10. Stress in my life increases my pain................................................. 0 1 2 3 4 
11. Exercise and movement are good for my pain problem...................... 0 1 2 3 4 
12. Just by concentrating or relaxing, I can "take the edge" off of my pain 0 1 2 3 4 
13. Medicine is one of the best treatments for chronic pain...................... 0 1 2 3 4 
14. My family needs to learn how to take better care of me when 
I am in pain ................................................................................ 0 1 2 3 4 
15. Depression increases the pain I feel................................................ 0 1 2 3 4 
16. If I exercise, I could make my pain problem much worse................... 0 1 2 3 4 
17. I believe that I can control how much pain I feel by changing 
my thoughts ............................................................................... 0 1 2 3 4 
18. Often I need more tender loving care that I am now getting when 
I am in pain ................................................................................ 0 1 2 3 4 
19. Something is wrong with my body which prevents much movement 
or exercise.................................................................................. 0 1 2 3 4 
20. I have learned to control my pain................................................... 0 1 2 3 4 
21. I trust that the medical profession can cure my pain ......................... 0 1 2 3 4 
22. I know for sure I can learn to manage my pain ................................ 0 1 2 3 4 
23. My pain does not stop me from leading a physically active life............ 0 1 2 3 4 
24. My physical pain will eventually be cured......................................... 0 1 2 3 4 
25. There is a strong connection between my emotions and my pain level . 0 1 2 3 4 
26. I can do nearly everything as well as I could before I had 
a pain problem ............................................................................ 0 1 2 3 4 
27. If I do not exercise regularly, my pain problem will continue 
to get worse................................................................................ 0 1 2 3 4 
28. Exercise can decrease the amount of pain I experience ..................... 0 1 2 3 4 
28. I'm convinced that there is no medical procedure that will help 
my pain...................................................................................... 0 1 2 3 4 
30. My pain would stop anyone from leading an active life ...................... 0 1 2 3 4 
31. Pain means that my body is being harmed ...................................... 0 1 2 3 4 
32. If my pain continues at its present level, I will be unable to work........ 0 1 2 3 4 
 
© copyright (1991) Mark P. Jensen et Paul Karoly for the original version of the Survey of Pain Attitude 
The SOPA-32 is an adaptation of the SOPA-B (Tait & Chibnall, 1997), made by the CRIR, site Constance-Lethbridge 
Rehabilitation Centre, July, 2006. 
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Oswestry Pain Questionnaire 
 
This questionnaire has been designed to give information as to how your pain has affected your ability to manage in 
everyday life. Please answer every section, and mark in each section ONLY ONE BOX which applies to you. We realize 
you may consider that two of the statements in any one section relate to you, but please just mark the box which most 
closely describes your problem. 
 
Section 1 -- P a i n I n t e n s i t y 
o I can tolerate the pain I have without having to use pain killers 
o The pain is bad but I manage without taking painkillers. 
o Pain killers give complete relief from pain 
o Pain killers give moderate relief from pain 
o Pain killers give very little relief from pain 
o Pain killers have no effect on the pain and I do not use them 
 
 
S e c t i o n 2 - - P e r s o n a l C a r e ( W a s h i n g , D r e s s i n g , e t c ) 
o I can look after myself normally without causing extra pain. 
o I can look after myself normally but it causes extra pain 
o It is painful to look after myself and I am slow and careful 
o I need some help but manage most of my personal care 
o I need help every day in most aspects of self care 
o I do not get dressed, wash with difficulty and stay in bed 
 
S e c t i o n 3 - - L i f t i n g 
o I can lift heavy weights without extra pain 
o I can lift heavy weights but it gives extra pain 
o Pain prevents me from lifting heavy weights off the floor, but I can manage if they are conveniently positioned, e.g. on 
a table. 
o Pain prevents me from lifting heavy weights, but I can manage light to medium weights if they are Conveniently 
positioned 
o I can lift only very light weights 
o I cannot lift or carry anything at all 
 
S e c t i o n 4 - - W a l k i n g 
o Pain does not prevent me from walking any distance 
o Pain prevents me from walking more than 1 mile 
o Pain prevents me from walking more than 1/2 mile 
o Pain prevents me from walking more than 1/4 mile 
o I can only walk using a stick or crutches 
o I am in bed most of the time and have to crawl to the toilet 
 
S e c t i o n 5 - - S i t t i n g 
o I can sit in any chair as long as I like 
o I can only sit in my favorite chair as long as I like 
o Pain prevents me from sitting more than 1 hour 
o Pain prevents me from sitting more than 1/2 hour 
o Pain prevents me from sitting more than 10 minutes 
o Pain prevents me from sitting at all 
 
S e c t i o n 6 - - S t a n d i n g 
o I can stand as long as I want without extra pain 
o I can stand as long as I want but it gives me extra pain 
o Pain prevents me from standing more than 1 hour 
o Pain prevents me from standing more than 1/2 hour 
o Pain prevents me from standing more than 10 minutes 
o Pain prevents me from standing at all 
 
 
S e c t i o n 7 - - S l e e p i n g 
o Pain does not prevent me from sleeping 
o I can sleep well only by using tablets 
o Even when I take tablets I have less than six hours sleep 
o Even when I take tablets I have less than four hours sleep 
o Even when I take tablets I have less than two hours sleep 
o Pain prevents me from sleeping at all 
 
S e c t i o n 8 - - S e x L i f e 
o My sex life is normal and causes no extra pain 
o My sex life is normal but causes some extra pain 
o My sex life is nearly normal but is very painful 
o My sex life is severely restricted by pain 
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o My sex life is nearly absent because of pain 
o Pain prevents any sex life at all 
 
S e c t i o n 9 - - S o c i a l L i f e 
o My social life is normal and gives me no extra pain 
o My social life is normal but increases the degree of pain 
o Pain has no significant effect on my social life apart from limiting my more energetic interests, e.g. dancing, etc. 
o Pain has restricted my social life and I do not go out asoften. 
o Pain has restricted my social life to my home 
o I have no social life because of pain 
 
S e c t i o n 1 0 - - T r a v e l i n g 
o I can travel anywhere without extra pain 
o I can travel anywhere but it gives me extra pain 
o Pain is bad but I manage journeys over two hours 
o Pain restricts me to journeys of less than one hour 
o Pain restricts me to short necessary journeys under 30 minutes 
o Pain prevents me from traveling except to the doctor or hospital 
 
 
Number of Points: _________ 
Total Possible: _________ 
Score: _________%  
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Demographic Questionnaire 
   
 What is your date of birth?   
 
  
   
 
What is your primary language?  
 
 
  English 
  Spanish 
  Other      
 
  
 
  
    
 
What is the highest level of education you have completed?  
 
 
  O levels / GCSE’s 
 A level 
  Vocational course 
 BTech 
  Bachelor's degree 
  Master's degree 
  Doctoral degree 
  Professional degree (MD, JD, etc.) 
  Other      
 
  
 
 
  
 
  
 
How would you classify yourself? 
 
 
 White   
  Asian 
  Black 
  Multiracial 
  Would rather not say 
  Other      
 
  
 
  
    
 
  
 
 
What is your current marital status? 
 
 
  Divorced 
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  Living with another 
  Married 
  Separated 
  Single 
  Widowed 
  Would rather not say 
 
 
  
    
 
  
 
Describe your current job 
 
 
 
 
What is your current household income ? 
 
 
  Under £10,000 
  £10,000 - £19,999 
  £20,000 - £29,999 
  £30,000 - £39,999 
  £40,000 - £49,999 
  £50,000 - £74,999 
  £75,000 - £99,999 
  £100,000 - £150,000 
  Over £150,000 
  Would rather not say 
 
  
 
 
 
Have you had previous treatment for your low back pain? 
 
o Yes 
 
o No 
 
 
Who treated you? 
 
o GP 
 
o Physiotherapist 
 
o Chiropractor  
 
o Osteopath 
 
o Other 
 
 
Did the treatment help? 
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o Yes, a lot 
 
o Yes, a little 
 
o Not much 
 
o Not at all 
  
  
Describe the treatment you received. 
 
 
 
 
 
 
Please outline your exercise levels 
 
Type of exercise  Duration of exercise  Number of times per week 
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Appendix 8  
 
Normality testing for – A single-arm trial investigating the immediate effects 
of duration of lumbar mobilisation treatment on pain, stiffness and ROM in 
patients with chronic LBP  
 
 
Normality testing for ROM data. 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Flex .133 17 .200* .957 17 .568 
Ext .197 17 .078 .936 17 .277 
LLF .113 17 .200* .967 17 .758 
RLF .112 17 .200* .963 17 .680 
Flex2 .108 17 .200* .977 17 .930 
Ext2 .113 17 .200* .926 17 .188 
LLF2 .135 17 .200* .964 17 .708 
RLF2 .271 17 .002 .667 17 .000 
Flex3 .136 17 .200* .964 17 .716 
Ext3 .154 17 .200* .944 17 .375 
LLF3 .178 17 .158 .9.23 17 .166 
RFL3 .143 17 .200* .911 17 .104 
 
 
Normality testing for stiffness data. 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
def .166 15 .200* .914 15 .155 
angle .148 15 .200* .911 15 .140 
def1 .143 15 .200* .937 15 .352 
angle1 .175 15 .200* .908 15 .125 
def2 .163 15 .200* .942 15 .404 
angle2 .180 15 .200* .931 15 .279 
a. Lilliefors Significance Correction 
*. This is a lower bound of the true significance. 
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Normality testing of PPT data. 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
symp1 .249 16 .009 .818 16 .005 
sympt2 .228 16 .026 .886 16 .048 
sympt3 .217 16 .043 .878 16 .037 
T10 .281 16 .001 .887 16 .050 
T102 .094 16 .200* .964 16 .732 
T103 .109 16 .200* .977 16 .937 
delt1 .098 16 .200* .960 16 .671 
delt2 .147 16 .200* .941 16 .364 
delt3 .178 16 .189 .943 16 .382 
S1 .157 16 .200* .956 16 .593 
S12 .133 16 .200* .944 16 .401 
S13 .211 16 .054 .922 16 .179 
L2 .236 16 .018 .845 16 .012 
L22 .180 16 .177 .900 16 .081 
L23 .184 16 .149 .909 16 .111 
L3 .310 16 .000 .647 16 .000 
L32 .148 16 .200* .929 16 .231 
L33 .142 16 .200* .904 16 .094 
L4 .189 16 .131 .934 16 .284 
L42 .123 16 .200* .955 16 .571 
L43 .114 16 .200* .951 16 .501 
L5 .180 16 .176 .906 16 .100 
L52 .245 16 .011 .840 16 .010 
L53 .207 16 .065 .883 16 .044 
 
 
 
Normality testing of VRS data. 
 
 
Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
baselineVRSmvt .107 16 .200* .955 16 .581 
VRS3mvt .148 16 .200* .924 16 .195 
VRS6mvt .188 16 .134 .856 16 .017 
PAbaseline .233 16 .020 .875 16 .033 
PA3min .207 16 .066 .860 16 .019 
PA6min .241 16 .014 .827 16 .006 
*. This is a lower bound of the true significance. 
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Appendix  9.  
 
Analysis of variance  for: A single-arm trial investigating the immediate 
effects of duration of lumbar mobilisation treatment on pain, stiffness and 
ROM in patients with chronic LBP. 
 
Two-way ANOVA for ROM. 
 
 
 
  
Source Type III 
Sum of 
Squares df 
Mean 
Square F Sig. 
duration Sphericity Assumed 83.218 2 41.609 .886 .422 
Greenhouse-Geisser 83.218 1.391 59.845 .886 .391 
Huynh-Feldt 83.218 1.481 56.183 .886 .396 
Lower-bound 83.218 1.000 83.218 .886 .360 
Error(duration) Sphericity Assumed 1502.085 32 46.940   
Greenhouse-Geisser 1502.085 22.249 67.513   
Huynh-Feldt 1502.085 23.699 63.381   
Lower-bound 1502.085 16.000 93.880   
Movement Sphericity Assumed 27121.111 3 9040.370 47.154 .000 
Greenhouse-Geisser 27121.111 1.991 13621.440 47.154 .000 
Huynh-Feldt 27121.111 2.273 11929.719 47.154 .000 
Lower-bound 27121.111 1.000 27121.111 47.154 .000 
Error(Movemen
t) 
Sphericity Assumed 9202.605 48 191.721   
Greenhouse-Geisser 9202.605 31.857 288.873   
Huynh-Feldt 9202.605 36.375 252.996   
Lower-bound 9202.605 16.000 575.163   
duration * 
Movement 
Sphericity Assumed 466.409 6 77.735 1.992 .074 
Greenhouse-Geisser 466.409 2.414 193.174 1.992 .142 
Huynh-Feldt 466.409 2.874 162.282 1.992 .131 
Lower-bound 466.409 1.000 466.409 1.992 .177 
Error(duration*
Movement) 
Sphericity Assumed 3745.486 96 39.015   
Greenhouse-Geisser 3745.486 38.631 96.955   
Huynh-Feldt 3745.486 45.985 81.450   
Lower-bound 3745.486 16.000 234.093   
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Tests of Within-Subjects Effects – displacement 
 
Measure:MEASURE_1 
Source Type III Sum 
of Squares df Mean Square F Sig. 
duration Sphericity Assumed 12.175 2 6.087 2.393 .111 
Greenhouse-Geisser 12.175 1.537 7.923 2.393 .127 
Huynh-Feldt 12.175 1.702 7.152 2.393 .121 
Lower-bound 12.175 1.000 12.175 2.393 .146 
Error(duration) Sphericity Assumed 66.148 26 2.544   
Greenhouse-Geisser 66.148 19.977 3.311   
Huynh-Feldt 66.148 22.130 2.989   
Lower-bound 66.148 13.000 5.088   
 
One-way ANOVA for stiffness measurements. 
 
Tests of Within-Subjects Effects –three-point bending 
 
Measure:MEASURE_1 
Source Type III 
Sum of 
Squares df 
Mean 
Square F Sig. 
duration Sphericity Assumed 2.293 2 1.147 .014 .986 
Greenhouse-Geisser 2.293 1.954 1.173 .014 .984 
Huynh-Feldt 2.293 2.000 1.147 .014 .986 
Lower-bound 2.293 1.000 2.293 .014 .906 
Error(duration
) 
Sphericity Assumed 2057.039 26 79.117   
Greenhouse-Geisser 2057.039 25.407 80.964   
Huynh-Feldt 2057.039 26.000 79.117   
Lower-bound 2057.039 13.000 158.234   
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Appendix 10 
 
Correlation between three-point bending and displacement methods of 
stiffness measurements  
 
Pearson’s correlation between three-point bending and displacement 
data at baseline.  
 
Correlations 
 Angle Def 
Angle Pearson Correlation 1 .376 
Sig. (2-tailed)  .167 
N 15 15 
Def Pearson Correlation .376 1 
Sig. (2-tailed) .167  
N 15 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pearson’s correlation between percentage change in three-point 
bending and displacement after 3 minutes of treatment. 
 
Correlations 
 perchndis3 perchang3 
perchndis3 Pearson Correlation 1 .090 
Sig. (2-tailed)  .751 
N 15 15 
perchang3 Pearson Correlation .090 1 
Sig. (2-tailed) .751  
N 15 15 
 
 
Pearson’s correlation between percentage change in three-point 
bending and displacement after 6 minutes of treatment. 
 
Correlations 
 perchdis6 perchanang6 
perchdis6 Pearson Correlation 1 .693** 
Sig. (2-tailed)  .004 
N 15 15 
perchanang6 Pearson Correlation .693** 1 
Sig. (2-tailed) .004  
N 15 15 
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Appendix 11 
ANOVA and ANCOVA for pain measures 
 
Two-way ANOVA for PPT (with subjects factors of site and duration). 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed 1.753 7 .250 8.887 .000 
Greenhouse-Geisser 1.753 4.105 .427 8.887 .000 
Huynh-Feldt 1.753 5.845 .300 8.887 .000 
Lower-bound 1.753 1.000 1.753 8.887 .009 
Error(site) 
Sphericity Assumed 2.959 105 .028   
Greenhouse-Geisser 2.959 61.574 .048   
Huynh-Feldt 2.959 87.671 .034   
Lower-bound 2.959 15.000 .197   
duration 
Sphericity Assumed .491 2 .246 19.019 .000 
Greenhouse-Geisser .491 1.721 .286 19.019 .000 
Huynh-Feldt .491 1.922 .256 19.019 .000 
Lower-bound .491 1.000 .491 19.019 .001 
Error(duration) 
Sphericity Assumed .388 30 .013   
Greenhouse-Geisser .388 25.808 .015   
Huynh-Feldt .388 28.836 .013   
Lower-bound .388 15.000 .026   
site * duration 
Sphericity Assumed .092 14 .007 1.787 .042 
Greenhouse-Geisser .092 6.262 .015 1.787 .107 
Huynh-Feldt .092 11.236 .008 1.787 .058 
Lower-bound .092 1.000 .092 1.787 .201 
Error(site*durati
on) 
Sphericity Assumed .770 210 .004   
Greenhouse-Geisser .770 93.924 .008   
Huynh-Feldt .770 168.541 .005   
Lower-bound .770 15.000 .051   
 
 
 
 
 
Pairwise Comparisons 
Measure: MEASURE_1 
(I) duration (J) duration Mean Difference 
(I-J) 
Std. 
Error 
Sig.b 95% Confidence Interval for Differenceb 
Lower Bound Upper Bound 
1 
2 -.067* .013 .000 -.102 -.032 
3 -.082* .017 .001 -.128 -.037 
2 
1 .067* .013 .000 .032 .102 
3 -.015 .012 .721 -.048 .018 
3 
1 .082* .017 .001 .037 .128 
2 .015 .012 .721 -.018 .048 
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Post Hoc testing for the effects of duration of treatment on PPT’s with 
Bonferroni pairwise comparisons 
Pairwise Comparisons 
Measure: MEASURE_1 
site (I) time (J) time Mean Difference 
(I-J) 
Std. Error Sig.b 95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 
1 
2 -.103* .029 .003 -.164 -.041 
3 -.140* .038 .002 -.221 -.060 
2 
1 .103* .029 .003 .041 .164 
3 -.038 .021 .086 -.082 .006 
3 
1 .140* .038 .002 .060 .221 
2 .038 .021 .086 -.006 .082 
2 
1 2 -.083
* .029 .011 -.144 -.022 
3 -.116* .028 .001 -.175 -.056 
2 1 .083
* .029 .011 .022 .144 
3 -.033 .023 .162 -.081 .015 
3 1 .116
* .028 .001 .056 .175 
2 .033 .023 .162 -.015 .081 
3 
1 2 -.025 .022 .285 -.072 .023 3 -.067 .032 .055 -.135 .002 
2 1 .025 .022 .285 -.023 .072 3 -.042 .020 .059 -.086 .002 
3 1 .067 .032 .055 -.002 .135 2 .042 .020 .059 -.002 .086 
4 
1 2 -.043 .030 .181 -.107 .022 3 -.039 .030 .213 -.103 .025 
2 1 .043 .030 .181 -.022 .107 3 .004 .011 .757 -.020 .028 
3 1 .039 .030 .213 -.025 .103 2 -.004 .011 .757 -.028 .020 
5 
1 2 -.056
* .021 .018 -.101 -.011 
3 -.059* .021 .014 -.104 -.014 
2 1 .056
* .021 .018 .011 .101 
3 -.003 .019 .865 -.045 .038 
3 1 .059
* .021 .014 .014 .104 
2 .003 .019 .865 -.038 .045 
6 
1 2 -.050 .025 .061 -.103 .003 3 -.074* .024 .007 -.125 -.024 
2 1 .050 .025 .061 -.003 .103 3 -.024 .014 .104 -.054 .006 
3 1 .074
* .024 .007 .024 .125 
2 .024 .014 .104 -.006 .054 
7 
1 2 -.074
* .017 .001 -.110 -.037 
3 -.060* .025 .032 -.114 -.006 
2 1 .074
* .017 .001 .037 .110 
3 .014 .018 .462 -.025 .053 
3 1 .060
* .025 .032 .006 .114 
2 -.014 .018 .462 -.053 .025 
8 
1 
2 -.105* .021 .000 -.151 -.060 
3 -.103* .028 .002 -.164 -.043 
2 
1 .105* .021 .000 .060 .151 
3 .002 .025 .928 -.050 .055 
3 
1 .103* .028 .002 .043 .164 
2 -.002 .025 .928 -.055 .050 
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Least Significant Difference (equivalent to no adjustments). 
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ANCOVA analysis for PPT’s and Questionnaires – single-arm trial  
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed .455 7 .065 2.607 .017 
Greenhouse-Geisser .455 3.566 .128 2.607 .055 
Huynh-Feldt .455 5.682 .080 2.607 .027 
Lower-bound .455 1.000 .455 2.607 .132 
site * GHQ 
Sphericity Assumed .295 7 .042 1.692 .122 
Greenhouse-Geisser .295 3.566 .083 1.692 .175 
Huynh-Feldt .295 5.682 .052 1.692 .140 
Lower-bound .295 1.000 .295 1.692 .218 
Error(site) 
Sphericity Assumed 2.095 84 .025   
Greenhouse-Geisser 2.095 42.793 .049   
Huynh-Feldt 2.095 68.188 .031   
Lower-bound 2.095 12.000 .175   
Duration 
Sphericity Assumed .046 2 .023 1.740 .197 
Greenhouse-Geisser .046 1.557 .030 1.740 .205 
Huynh-Feldt .046 1.895 .024 1.740 .199 
Lower-bound .046 1.000 .046 1.740 .212 
Duration * GHQ 
Sphericity Assumed .004 2 .002 .148 .863 
Greenhouse-Geisser .004 1.557 .003 .148 .812 
Huynh-Feldt .004 1.895 .002 .148 .853 
Lower-bound .004 1.000 .004 .148 .707 
Error(Duration) 
Sphericity Assumed .317 24 .013   
Greenhouse-Geisser .317 18.681 .017   
Huynh-Feldt .317 22.745 .014   
Lower-bound .317 12.000 .026   
site * Duration 
Sphericity Assumed .039 14 .003 .926 .532 
Greenhouse-Geisser .039 6.932 .006 .926 .490 
Huynh-Feldt .039 14.000 .003 .926 .532 
Lower-bound .039 1.000 .039 .926 .355 
site * Duration * GHQ 
Sphericity Assumed .043 14 .003 1.026 .430 
Greenhouse-Geisser .043 6.932 .006 1.026 .419 
Huynh-Feldt .043 14.000 .003 1.026 .430 
Lower-bound .043 1.000 .043 1.026 .331 
Error(site*Duration) 
Sphericity Assumed .504 168 .003   
Greenhouse-Geisser .504 83.182 .006   
Huynh-Feldt .504 168.000 .003   
Lower-bound .504 12.000 .042   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed .561 7 .080 3.122 .005 
Greenhouse-Geisser .561 3.590 .156 3.122 .027 
Huynh-Feldt .561 5.511 .102 3.122 .011 
Lower-bound .561 1.000 .561 3.122 .101 
site * Oswestry 
Sphericity Assumed .129 7 .018 .720 .655 
Greenhouse-Geisser .129 3.590 .036 .720 .569 
Huynh-Feldt .129 5.511 .023 .720 .623 
Lower-bound .129 1.000 .129 .720 .412 
Error(site) 
Sphericity Assumed 2.334 91 .026   
Greenhouse-Geisser 2.334 46.676 .050   
Huynh-Feldt 2.334 71.644 .033   
Lower-bound 2.334 13.000 .180   
Duration 
Sphericity Assumed .092 2 .046 3.954 .032 
Greenhouse-Geisser .092 1.480 .062 3.954 .047 
Huynh-Feldt .092 1.753 .053 3.954 .038 
Lower-bound .092 1.000 .092 3.954 .068 
Duration * 
Oswestry 
Sphericity Assumed .020 2 .010 .846 .441 
Greenhouse-Geisser .020 1.480 .013 .846 .413 
Huynh-Feldt .020 1.753 .011 .846 .429 
Lower-bound .020 1.000 .020 .846 .375 
Error(Duration) 
Sphericity Assumed .304 26 .012   
Greenhouse-Geisser .304 19.237 .016   
Huynh-Feldt .304 22.791 .013   
Lower-bound .304 13.000 .023   
site * Duration 
Sphericity Assumed .051 14 .004 1.096 .364 
Greenhouse-Geisser .051 6.458 .008 1.096 .373 
Huynh-Feldt .051 14.000 .004 1.096 .364 
Lower-bound .051 1.000 .051 1.096 .314 
site * Duration * 
Oswestry 
Sphericity Assumed .024 14 .002 .511 .925 
Greenhouse-Geisser .024 6.458 .004 .511 .811 
Huynh-Feldt .024 14.000 .002 .511 .925 
Lower-bound .024 1.000 .024 .511 .487 
Error(site*Duratio
n) 
Sphericity Assumed .602 182 .003   
Greenhouse-Geisser .602 83.958 .007   
Huynh-Feldt .602 182.000 .003   
Lower-bound .602 13.000 .046   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed .161 7 .023 .902 .509 
Greenhouse-Geisser .161 3.640 .044 .902 .463 
Huynh-Feldt .161 5.620 .029 .902 .494 
Lower-bound .161 1.000 .161 .902 .360 
site * Control 
Sphericity Assumed .137 7 .020 .764 .619 
Greenhouse-Geisser .137 3.640 .038 .764 .543 
Huynh-Feldt .137 5.620 .024 .764 .593 
Lower-bound .137 1.000 .137 .764 .398 
Error(site) 
Sphericity Assumed 2.327 91 .026   
Greenhouse-Geisser 2.327 47.324 .049   
Huynh-Feldt 2.327 73.065 .032   
Lower-bound 2.327 13.000 .179   
Duration 
Sphericity Assumed .068 2 .034 2.849 .076 
Greenhouse-Geisser .068 1.554 .044 2.849 .092 
Huynh-Feldt .068 1.862 .037 2.849 .081 
Lower-bound .068 1.000 .068 2.849 .115 
Duration * Control 
Sphericity Assumed .012 2 .006 .520 .601 
Greenhouse-Geisser .012 1.554 .008 .520 .558 
Huynh-Feldt .012 1.862 .007 .520 .588 
Lower-bound .012 1.000 .012 .520 .484 
Error(Duration) 
Sphericity Assumed .311 26 .012   
Greenhouse-Geisser .311 20.207 .015   
Huynh-Feldt .311 24.211 .013   
Lower-bound .311 13.000 .024   
site * Duration 
Sphericity Assumed .026 14 .002 .582 .877 
Greenhouse-Geisser .026 6.232 .004 .582 .750 
Huynh-Feldt .026 13.516 .002 .582 .872 
Lower-bound .026 1.000 .026 .582 .459 
site * Duration * 
Control 
Sphericity Assumed .039 14 .003 .862 .601 
Greenhouse-Geisser .039 6.232 .006 .862 .530 
Huynh-Feldt .039 13.516 .003 .862 .597 
Lower-bound .039 1.000 .039 .862 .370 
Error(site*Duration) 
Sphericity Assumed .587 182 .003   
Greenhouse-Geisser .587 81.014 .007   
Huynh-Feldt .587 175.708 .003   
Lower-bound .587 13.000 .045   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed .744 7 .106 4.102 .001 
Greenhouse-Geisser .744 3.660 .203 4.102 .008 
Huynh-Feldt .744 5.663 .131 4.102 .002 
Lower-bound .744 1.000 .744 4.102 .064 
site * 
disability 
Sphericity Assumed .106 7 .015 .584 .767 
Greenhouse-Geisser .106 3.660 .029 .584 .661 
Huynh-Feldt .106 5.663 .019 .584 .732 
Lower-bound .106 1.000 .106 .584 .458 
Error(site) 
Sphericity Assumed 2.357 91 .026   
Greenhouse-Geisser 2.357 47.577 .050   
Huynh-Feldt 2.357 73.622 .032   
Lower-bound 2.357 13.000 .181   
Duration 
Sphericity Assumed .141 2 .071 5.695 .009 
Greenhouse-Geisser .141 1.595 .089 5.695 .015 
Huynh-Feldt .141 1.923 .074 5.695 .010 
Lower-bound .141 1.000 .141 5.695 .033 
Duration * 
disability 
Sphericity Assumed .001 2 .000 .032 .969 
Greenhouse-Geisser .001 1.595 .000 .032 .944 
Huynh-Feldt .001 1.923 .000 .032 .965 
Lower-bound .001 1.000 .001 .032 .862 
Error(Duratio
n) 
Sphericity Assumed .323 26 .012   
Greenhouse-Geisser .323 20.736 .016   
Huynh-Feldt .323 24.993 .013   
Lower-bound .323 13.000 .025   
site * Duration 
Sphericity Assumed .051 14 .004 1.116 .346 
Greenhouse-Geisser .051 6.497 .008 1.116 .360 
Huynh-Feldt .051 14.000 .004 1.116 .346 
Lower-bound .051 1.000 .051 1.116 .310 
site * Duration 
* disability 
Sphericity Assumed .031 14 .002 .686 .786 
Greenhouse-Geisser .031 6.497 .005 .686 .673 
Huynh-Feldt .031 14.000 .002 .686 .786 
Lower-bound .031 1.000 .031 .686 .422 
Error(site*Dur
ation) 
Sphericity Assumed .594 182 .003   
Greenhouse-Geisser .594 84.466 .007   
Huynh-Feldt .594 182.000 .003   
Lower-bound .594 13.000 .046   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean Square F Sig. 
site 
Sphericity Assumed .792 7 .113 4.383 .000 
Greenhouse-Geisser .792 3.643 .217 4.383 .005 
Huynh-Feldt .792 5.625 .141 4.383 .001 
Lower-bound .792 1.000 .792 4.383 .056 
site * Harm 
Sphericity Assumed .115 7 .016 .635 .726 
Greenhouse-Geisser .115 3.643 .032 .635 .626 
Huynh-Feldt .115 5.625 .020 .635 .692 
Lower-bound .115 1.000 .115 .635 .440 
Error(site) 
Sphericity Assumed 2.349 91 .026   
Greenhouse-Geisser 2.349 47.353 .050   
Huynh-Feldt 2.349 73.129 .032   
Lower-bound 2.349 13.000 .181   
Duration 
Sphericity Assumed .132 2 .066 5.392 .011 
Greenhouse-Geisser .132 1.604 .082 5.392 .018 
Huynh-Feldt .132 1.936 .068 5.392 .012 
Lower-bound .132 1.000 .132 5.392 .037 
Duration * Harm 
Sphericity Assumed .005 2 .003 .223 .801 
Greenhouse-Geisser .005 1.604 .003 .223 .753 
Huynh-Feldt .005 1.936 .003 .223 .794 
Lower-bound .005 1.000 .005 .223 .644 
Error(Duration) 
Sphericity Assumed .318 26 .012   
Greenhouse-Geisser .318 20.852 .015   
Huynh-Feldt .318 25.165 .013   
Lower-bound .318 13.000 .024   
site * Duration 
Sphericity Assumed .037 14 .003 .794 .675 
Greenhouse-Geisser .037 6.389 .006 .794 .584 
Huynh-Feldt .037 14.000 .003 .794 .675 
Lower-bound .037 1.000 .037 .794 .389 
site * Duration * 
Harm 
Sphericity Assumed .025 14 .002 .540 .907 
Greenhouse-Geisser .025 6.389 .004 .540 .787 
Huynh-Feldt .025 14.000 .002 .540 .907 
Lower-bound .025 1.000 .025 .540 .475 
Error(site*Duratio
n) 
Sphericity Assumed .601 182 .003   
Greenhouse-Geisser .601 83.060 .007   
Huynh-Feldt .601 182.000 .003   
Lower-bound .601 13.000 .046   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed 1.466 7 .209 9.662 .000 
Greenhouse-Geisser 1.466 3.626 .404 9.662 .000 
Huynh-Feldt 1.466 5.590 .262 9.662 .000 
Lower-bound 1.466 1.000 1.466 9.662 .008 
site * Emotion 
Sphericity Assumed .490 7 .070 3.231 .004 
Greenhouse-Geisser .490 3.626 .135 3.231 .023 
Huynh-Feldt .490 5.590 .088 3.231 .008 
Lower-bound .490 1.000 .490 3.231 .096 
Error(site) 
Sphericity Assumed 1.973 91 .022   
Greenhouse-Geisser 1.973 47.143 .042   
Huynh-Feldt 1.973 72.665 .027   
Lower-bound 1.973 13.000 .152   
Duration 
Sphericity Assumed .293 2 .146 12.233 .000 
Greenhouse-Geisser .293 1.556 .188 12.233 .001 
Huynh-Feldt .293 1.864 .157 12.233 .000 
Lower-bound .293 1.000 .293 12.233 .004 
Duration * 
Emotion 
Sphericity Assumed .013 2 .006 .525 .598 
Greenhouse-Geisser .013 1.556 .008 .525 .555 
Huynh-Feldt .013 1.864 .007 .525 .586 
Lower-bound .013 1.000 .013 .525 .482 
Error(Duration) 
Sphericity Assumed .311 26 .012   
Greenhouse-Geisser .311 20.225 .015   
Huynh-Feldt .311 24.237 .013   
Lower-bound .311 13.000 .024   
site * Duration 
Sphericity Assumed .069 14 .005 1.562 .094 
Greenhouse-Geisser .069 6.040 .011 1.562 .169 
Huynh-Feldt .069 12.730 .005 1.562 .103 
Lower-bound .069 1.000 .069 1.562 .233 
site * Duration * 
Emotion 
Sphericity Assumed .051 14 .004 1.151 .317 
Greenhouse-Geisser .051 6.040 .008 1.151 .341 
Huynh-Feldt .051 12.730 .004 1.151 .321 
Lower-bound .051 1.000 .051 1.151 .303 
Error(site*Duratio
n) 
Sphericity Assumed .575 182 .003   
Greenhouse-Geisser .575 78.521 .007   
Huynh-Feldt .575 165.494 .003   
Lower-bound .575 13.000 .044   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed 1.144 7 .163 6.718 .000 
Greenhouse-Geisser 1.144 3.483 .328 6.718 .000 
Huynh-Feldt 1.144 5.281 .217 6.718 .000 
Lower-bound 1.144 1.000 1.144 6.718 .022 
site * Medication 
Sphericity Assumed .250 7 .036 1.470 .188 
Greenhouse-Geisser .250 3.483 .072 1.470 .231 
Huynh-Feldt .250 5.281 .047 1.470 .208 
Lower-bound .250 1.000 .250 1.470 .247 
Error(site) 
Sphericity Assumed 2.213 91 .024   
Greenhouse-Geisser 2.213 45.285 .049   
Huynh-Feldt 2.213 68.647 .032   
Lower-bound 2.213 13.000 .170   
Duration 
Sphericity Assumed .116 2 .058 4.902 .016 
Greenhouse-Geisser .116 1.545 .075 4.902 .025 
Huynh-Feldt .116 1.849 .063 4.902 .018 
Lower-bound .116 1.000 .116 4.902 .045 
Duration * 
Medication 
Sphericity Assumed .016 2 .008 .683 .514 
Greenhouse-Geisser .016 1.545 .010 .683 .480 
Huynh-Feldt .016 1.849 .009 .683 .504 
Lower-bound .016 1.000 .016 .683 .424 
Error(Duration) 
Sphericity Assumed .307 26 .012   
Greenhouse-Geisser .307 20.089 .015   
Huynh-Feldt .307 24.037 .013   
Lower-bound .307 13.000 .024   
site * Duration 
Sphericity Assumed .051 14 .004 1.091 .368 
Greenhouse-Geisser .051 6.272 .008 1.091 .375 
Huynh-Feldt .051 13.687 .004 1.091 .368 
Lower-bound .051 1.000 .051 1.091 .315 
site * Duration * 
Medication 
Sphericity Assumed .023 14 .002 .504 .929 
Greenhouse-Geisser .023 6.272 .004 .504 .811 
Huynh-Feldt .023 13.687 .002 .504 .926 
Lower-bound .023 1.000 .023 .504 .490 
Error(site*Duration) 
Sphericity Assumed .603 182 .003   
Greenhouse-Geisser .603 81.539 .007   
Huynh-Feldt .603 177.933 .003   
Lower-bound .603 13.000 .046   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed .805 7 .115 4.370 .000 
Greenhouse-Geisser .805 3.646 .221 4.370 .005 
Huynh-Feldt .805 5.632 .143 4.370 .001 
Lower-bound .805 1.000 .805 4.370 .057 
site * Solicitude 
Sphericity Assumed .069 7 .010 .372 .916 
Greenhouse-Geisser .069 3.646 .019 .372 .810 
Huynh-Feldt .069 5.632 .012 .372 .885 
Lower-bound .069 1.000 .069 .372 .552 
Error(site) 
Sphericity Assumed 2.395 91 .026   
Greenhouse-Geisser 2.395 47.395 .051   
Huynh-Feldt 2.395 73.220 .033   
Lower-bound 2.395 13.000 .184   
Duration 
Sphericity Assumed .398 2 .199 20.208 .000 
Greenhouse-Geisser .398 1.599 .249 20.208 .000 
Huynh-Feldt .398 1.928 .207 20.208 .000 
Lower-bound .398 1.000 .398 20.208 .001 
Duration * 
Solicitude 
Sphericity Assumed .067 2 .034 3.413 .048 
Greenhouse-Geisser .067 1.599 .042 3.413 .061 
Huynh-Feldt .067 1.928 .035 3.413 .050 
Lower-bound .067 1.000 .067 3.413 .088 
Error(Duration) 
Sphericity Assumed .256 26 .010   
Greenhouse-Geisser .256 20.781 .012   
Huynh-Feldt .256 25.060 .010   
Lower-bound .256 13.000 .020   
site * Duration 
Sphericity Assumed .070 14 .005 1.562 .094 
Greenhouse-Geisser .070 6.211 .011 1.562 .167 
Huynh-Feldt .070 13.427 .005 1.562 .098 
Lower-bound .070 1.000 .070 1.562 .233 
site * Duration * 
Solicitude 
Sphericity Assumed .042 14 .003 .935 .522 
Greenhouse-Geisser .042 6.211 .007 .935 .477 
Huynh-Feldt .042 13.427 .003 .935 .520 
Lower-bound .042 1.000 .042 .935 .351 
Error(site*Duration) 
Sphericity Assumed .584 182 .003   
Greenhouse-Geisser .584 80.740 .007   
Huynh-Feldt .584 174.555 .003   
Lower-bound .584 13.000 .045   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed .528 7 .075 3.185 .005 
Greenhouse-Geisser .528 3.543 .149 3.185 .026 
Huynh-Feldt .528 5.407 .098 3.185 .010 
Lower-bound .528 1.000 .528 3.185 .098 
site * medcure 
Sphericity Assumed .307 7 .044 1.850 .087 
Greenhouse-Geisser .307 3.543 .087 1.850 .142 
Huynh-Feldt .307 5.407 .057 1.850 .109 
Lower-bound .307 1.000 .307 1.850 .197 
Error(site) 
Sphericity Assumed 2.156 91 .024   
Greenhouse-Geisser 2.156 46.053 .047   
Huynh-Feldt 2.156 70.294 .031   
Lower-bound 2.156 13.000 .166   
Duration 
Sphericity Assumed .026 2 .013 1.103 .347 
Greenhouse-Geisser .026 1.554 .017 1.103 .336 
Huynh-Feldt .026 1.862 .014 1.103 .344 
Lower-bound .026 1.000 .026 1.103 .313 
Duration * medcure 
Sphericity Assumed .015 2 .008 .642 .534 
Greenhouse-Geisser .015 1.554 .010 .642 .499 
Huynh-Feldt .015 1.862 .008 .642 .524 
Lower-bound .015 1.000 .015 .642 .437 
Error(Duration) 
Sphericity Assumed .308 26 .012   
Greenhouse-Geisser .308 20.206 .015   
Huynh-Feldt .308 24.209 .013   
Lower-bound .308 13.000 .024   
site * Duration 
Sphericity Assumed .044 14 .003 .980 .475 
Greenhouse-Geisser .044 6.128 .007 .980 .445 
Huynh-Feldt .044 13.086 .003 .980 .473 
Lower-bound .044 1.000 .044 .980 .340 
site * Duration * 
medcure 
Sphericity Assumed .040 14 .003 .891 .570 
Greenhouse-Geisser .040 6.128 .007 .891 .507 
Huynh-Feldt .040 13.086 .003 .891 .564 
Lower-bound .040 1.000 .040 .891 .362 
Error(site*Duration) 
Sphericity Assumed .586 182 .003   
Greenhouse-Geisser .586 79.666 .007   
Huynh-Feldt .586 170.114 .003   
Lower-bound .586 13.000 .045   
 
  
 259 
Appendix 12 
 
ANOVA and ANCOVA Verbal rating of pain on movement – single arm trial 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Duration 
Sphericity Assumed 131.760 2 65.880 7.091 .003 
Greenhouse-Geisser 131.760 1.632 80.749 7.091 .006 
Huynh-Feldt 131.760 1.803 73.064 7.091 .004 
Lower-bound 131.760 1.000 131.760 7.091 .018 
Error(Duration) 
Sphericity Assumed 278.740 30 9.291   
Greenhouse-Geisser 278.740 24.476 11.388   
Huynh-Feldt 278.740 27.050 10.304   
Lower-bound 278.740 15.000 18.583   
 
Pairwise Comparisons 
Measure: MEASURE_1 
(I) Duration (J) Duration Mean 
Difference 
(I-J) 
Std. Error Sig.b 95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 
2 1.250 1.309 1.000 -2.275 4.775 
3 3.969* .954 .003 1.400 6.537 
2 1 -1.250 1.309 1.000 -4.775 2.275 3 2.719* .929 .031 .217 5.220 
3 
1 -3.969* .954 .003 -6.537 -1.400 
2 -2.719* .929 .031 -5.220 -.217 
Based on estimated marginal means 
 
 
 
 
Analysis of covariance (ANCOVA) Pain on movement and questionnaires 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 107.561 2 53.780 1.597 .309 
Greenhouse-Geisser 107.561 1.005 106.991 1.597 .334 
Huynh-Feldt 107.561 2.000 53.780 1.597 .309 
Lower-bound 107.561 1.000 107.561 1.597 .334 
Duration * GHQ 
Sphericity Assumed 141.274 22 6.422 .191 .996 
Greenhouse-Geisser 141.274 11.059 12.775 .191 .975 
Huynh-Feldt 141.274 22.000 6.422 .191 .996 
Lower-bound 141.274 11.000 12.843 .191 .975 
Error(Duration) 
Sphericity Assumed 134.667 4 33.667   
Greenhouse-Geisser 134.667 2.011 66.977   
Huynh-Feldt 134.667 4.000 33.667   
Lower-bound 134.667 2.000 67.333   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 17.589 2 8.794 .944 .402 
Greenhouse-Geisser 17.589 1.651 10.652 .944 .388 
Huynh-Feldt 17.589 2.000 8.794 .944 .402 
Lower-bound 17.589 1.000 17.589 .944 .349 
Duration * 
Oswestry 
Sphericity Assumed 34.515 2 17.258 1.853 .177 
Greenhouse-Geisser 34.515 1.651 20.902 1.853 .185 
Huynh-Feldt 34.515 2.000 17.258 1.853 .177 
Lower-bound 34.515 1.000 34.515 1.853 .197 
Error(Duration) 
Sphericity Assumed 242.107 26 9.312   
Greenhouse-Geisser 242.107 21.466 11.278   
Huynh-Feldt 242.107 26.000 9.312   
Lower-bound 242.107 13.000 18.624   
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 2.368 2 1.184 .115 .892 
Greenhouse-Geisser 2.368 1.566 1.512 .115 .844 
Huynh-Feldt 2.368 1.880 1.260 .115 .881 
Lower-bound 2.368 1.000 2.368 .115 .740 
Duration * Control 
Sphericity Assumed 8.792 2 4.396 .427 .657 
Greenhouse-Geisser 8.792 1.566 5.613 .427 .610 
Huynh-Feldt 8.792 1.880 4.677 .427 .645 
Lower-bound 8.792 1.000 8.792 .427 .525 
Error(Duration) 
Sphericity Assumed 267.831 26 10.301   
Greenhouse-Geisser 267.831 20.362 13.153   
Huynh-Feldt 267.831 24.439 10.959   
Lower-bound 267.831 13.000 20.602   
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 21.927 2 10.964 1.082 .354 
Greenhouse-Geisser 21.927 1.630 13.455 1.082 .344 
Huynh-Feldt 21.927 1.974 11.108 1.082 .353 
Lower-bound 21.927 1.000 21.927 1.082 .317 
Duration * disability 
Sphericity Assumed 13.158 2 6.579 .649 .531 
Greenhouse-Geisser 13.158 1.630 8.074 .649 .502 
Huynh-Feldt 13.158 1.974 6.666 .649 .529 
Lower-bound 13.158 1.000 13.158 .649 .435 
Error(Duration) 
Sphericity Assumed 263.464 26 10.133   
Greenhouse-Geisser 263.464 21.185 12.436   
Huynh-Feldt 263.464 25.661 10.267   
Lower-bound 263.464 13.000 20.266   
 
 
 
 
 
 
 
Tests of Within-Subjects Effects 
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Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 28.223 2 14.112 1.351 .277 
Greenhouse-Geisser 28.223 1.592 17.728 1.351 .276 
Huynh-Feldt 28.223 1.918 14.715 1.351 .277 
Lower-bound 28.223 1.000 28.223 1.351 .266 
Duration * Harm 
Sphericity Assumed 5.096 2 2.548 .244 .785 
Greenhouse-Geisser 5.096 1.592 3.201 .244 .736 
Huynh-Feldt 5.096 1.918 2.657 .244 .776 
Lower-bound 5.096 1.000 5.096 .244 .630 
Error(Duration) 
Sphericity Assumed 271.527 26 10.443   
Greenhouse-Geisser 271.527 20.696 13.120   
Huynh-Feldt 271.527 24.934 10.890   
Lower-bound 271.527 13.000 20.887   
 
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 64.150 2 32.075 3.241 .055 
Greenhouse-Geisser 64.150 1.666 38.514 3.241 .066 
Huynh-Feldt 64.150 2.000 32.075 3.241 .055 
Lower-bound 64.150 1.000 64.150 3.241 .095 
Duration * Emotion 
Sphericity Assumed 19.298 2 9.649 .975 .391 
Greenhouse-Geisser 19.298 1.666 11.586 .975 .379 
Huynh-Feldt 19.298 2.000 9.649 .975 .391 
Lower-bound 19.298 1.000 19.298 .975 .341 
Error(Duration) 
Sphericity Assumed 257.325 26 9.897   
Greenhouse-Geisser 257.325 21.653 11.884   
Huynh-Feldt 257.325 26.000 9.897   
Lower-bound 257.325 13.000 19.794   
 
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean Square F Sig. 
Duration 
Sphericity Assumed 40.704 2 20.352 1.956 .162 
Greenhouse-Geisser 40.704 1.626 25.028 1.956 .171 
Huynh-Feldt 40.704 1.969 20.672 1.956 .163 
Lower-bound 40.704 1.000 40.704 1.956 .185 
Duration * 
Medication 
Sphericity Assumed 6.066 2 3.033 .291 .750 
Greenhouse-Geisser 6.066 1.626 3.730 .291 .705 
Huynh-Feldt 6.066 1.969 3.081 .291 .746 
Lower-bound 6.066 1.000 6.066 .291 .598 
Error(Duration) 
Sphericity Assumed 270.556 26 10.406   
Greenhouse-Geisser 270.556 21.143 12.797   
Huynh-Feldt 270.556 25.598 10.570   
Lower-bound 270.556 13.000 20.812   
 
 
 
 
 
 
Tests of Within-Subjects Effects 
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Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 92.926 2 46.463 4.615 .019 
Greenhouse-Geisser 92.926 1.615 57.526 4.615 .028 
Huynh-Feldt 92.926 1.953 47.588 4.615 .020 
Lower-bound 92.926 1.000 92.926 4.615 .051 
Duration * 
Solicitude 
Sphericity Assumed 14.850 2 7.425 .737 .488 
Greenhouse-Geisser 14.850 1.615 9.193 .737 .463 
Huynh-Feldt 14.850 1.953 7.605 .737 .485 
Lower-bound 14.850 1.000 14.850 .737 .406 
Error(Duration) 
Sphericity Assumed 261.773 26 10.068   
Greenhouse-Geisser 261.773 21.000 12.465   
Huynh-Feldt 261.773 25.385 10.312   
Lower-bound 261.773 13.000 20.136   
 
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 28.474 2 14.237 1.447 .254 
Greenhouse-Geisser 28.474 1.639 17.370 1.447 .255 
Huynh-Feldt 28.474 1.988 14.321 1.447 .254 
Lower-bound 28.474 1.000 28.474 1.447 .250 
Duration * 
medcure 
Sphericity Assumed 20.838 2 10.419 1.059 .361 
Greenhouse-Geisser 20.838 1.639 12.712 1.059 .351 
Huynh-Feldt 20.838 1.988 10.481 1.059 .361 
Lower-bound 20.838 1.000 20.838 1.059 .322 
Error(Duration) 
Sphericity Assumed 255.784 26 9.838   
Greenhouse-Geisser 255.784 21.310 12.003   
Huynh-Feldt 255.784 25.848 9.896   
Lower-bound 255.784 13.000 19.676   
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Appendix 13 
 
ANOVA / ANCOVA Pain on PA force application 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 6.792 2 3.396 6.159 .006 
Greenhouse-Geisser 6.792 1.201 5.654 6.159 .019 
Huynh-Feldt 6.792 1.248 5.443 6.159 .018 
Lower-bound 6.792 1.000 6.792 6.159 .025 
Error(Duration) 
Sphericity Assumed 16.542 30 .551   
Greenhouse-Geisser 16.542 18.018 .918   
Huynh-Feldt 16.542 18.718 .884   
Lower-bound 16.542 15.000 1.103   
 
 
 
 
 
 
Pairwise Comparisons 
Measure: MEASURE_1 
(I) 
Duration 
(J) Duration Mean 
Difference 
(I-J) 
Std. Error Sig.a 95% Confidence Interval 
for Differencea 
Lower 
Bound 
Upper 
Bound 
1 
2 .688 .270 .067 -.039 1.414 
3 .875 .340 .064 -.041 1.791 
2 1 -.688 .270 .067 -1.414 .039 3 .188 .136 .564 -.179 .554 
3 
1 -.875 .340 .064 -1.791 .041 
2 -.188 .136 .564 -.554 .179 
 
 
 
 
 
ANCOVA Pain on PA force application 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 2.753 2 1.376 2.902 .074 
Greenhouse-Geisser 2.753 1.232 2.235 2.902 .104 
Huynh-Feldt 2.753 1.416 1.944 2.902 .096 
Lower-bound 2.753 1.000 2.753 2.902 .114 
Duration * GHQ 
Sphericity Assumed 1.426 2 .713 1.503 .243 
Greenhouse-Geisser 1.426 1.232 1.157 1.503 .246 
Huynh-Feldt 1.426 1.416 1.007 1.503 .246 
Lower-bound 1.426 1.000 1.426 1.503 .244 
Error(Duration) 
Sphericity Assumed 11.384 24 .474   
Greenhouse-Geisser 11.384 14.783 .770   
Huynh-Feldt 11.384 16.991 .670   
Lower-bound 11.384 12.000 .949   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 2.020 2 1.010 1.917 .167 
Greenhouse-Geisser 2.020 1.204 1.678 1.917 .186 
Huynh-Feldt 2.020 1.361 1.484 1.917 .183 
Lower-bound 2.020 1.000 2.020 1.917 .190 
Duration * 
Oswestry 
Sphericity Assumed .387 2 .194 .367 .696 
Greenhouse-Geisser .387 1.204 .322 .367 .592 
Huynh-Feldt .387 1.361 .284 .367 .617 
Lower-bound .387 1.000 .387 .367 .555 
Error(Duration) 
Sphericity Assumed 13.702 26 .527   
Greenhouse-Geisser 13.702 15.646 .876   
Huynh-Feldt 13.702 17.691 .775   
Lower-bound 13.702 13.000 1.054   
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 2.093 2 1.046 2.059 .148 
Greenhouse-Geisser 2.093 1.243 1.684 2.059 .169 
Huynh-Feldt 2.093 1.416 1.478 2.059 .165 
Lower-bound 2.093 1.000 2.093 2.059 .175 
Duration * 
Control 
Sphericity Assumed .876 2 .438 .862 .434 
Greenhouse-Geisser .876 1.243 .705 .862 .391 
Huynh-Feldt .876 1.416 .619 .862 .403 
Lower-bound .876 1.000 .876 .862 .370 
Error(Duration) 
Sphericity Assumed 13.213 26 .508   
Greenhouse-Geisser 13.213 16.158 .818   
Huynh-Feldt 13.213 18.404 .718   
Lower-bound 13.213 13.000 1.016   
 
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed .776 2 .388 .733 .490 
Greenhouse-Geisser .776 1.211 .641 .733 .430 
Huynh-Feldt .776 1.371 .566 .733 .445 
Lower-bound .776 1.000 .776 .733 .408 
Duration * 
disability 
Sphericity Assumed .324 2 .162 .306 .739 
Greenhouse-Geisser .324 1.211 .267 .306 .631 
Huynh-Feldt .324 1.371 .236 .306 .658 
Lower-bound .324 1.000 .324 .306 .590 
Error(Duration) 
Sphericity Assumed 13.765 26 .529   
Greenhouse-Geisser 13.765 15.742 .874   
Huynh-Feldt 13.765 17.824 .772   
Lower-bound 13.765 13.000 1.059   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed .777 2 .388 .755 .480 
Greenhouse-Geisser .777 1.185 .655 .755 .420 
Huynh-Feldt .777 1.335 .582 .755 .434 
Lower-bound .777 1.000 .777 .755 .401 
Duration * Harm 
Sphericity Assumed .711 2 .355 .691 .510 
Greenhouse-Geisser .711 1.185 .600 .691 .443 
Huynh-Feldt .711 1.335 .532 .691 .458 
Lower-bound .711 1.000 .711 .691 .421 
Error(Duration) 
Sphericity Assumed 13.378 26 .515   
Greenhouse-Geisser 13.378 15.407 .868   
Huynh-Feldt 13.378 17.359 .771   
Lower-bound 13.378 13.000 1.029   
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 1.037 2 .519 .987 .386 
Greenhouse-Geisser 1.037 1.226 .846 .987 .354 
Huynh-Feldt 1.037 1.392 .745 .987 .363 
Lower-bound 1.037 1.000 1.037 .987 .339 
Duration * 
Emotion 
Sphericity Assumed .433 2 .217 .413 .666 
Greenhouse-Geisser .433 1.226 .354 .413 .571 
Huynh-Feldt .433 1.392 .311 .413 .595 
Lower-bound .433 1.000 .433 .413 .532 
Error(Duration) 
Sphericity Assumed 13.655 26 .525   
Greenhouse-Geisser 13.655 15.935 .857   
Huynh-Feldt 13.655 18.093 .755   
Lower-bound 13.655 13.000 1.050   
 
 
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed .195 2 .097 .213 .809 
Greenhouse-Geisser .195 1.212 .160 .213 .697 
Huynh-Feldt .195 1.373 .142 .213 .726 
Lower-bound .195 1.000 .195 .213 .652 
Duration * 
Medication 
Sphericity Assumed 2.231 2 1.116 2.446 .106 
Greenhouse-Geisser 2.231 1.212 1.840 2.446 .134 
Huynh-Feldt 2.231 1.373 1.625 2.446 .128 
Lower-bound 2.231 1.000 2.231 2.446 .142 
Error(Duration) 
Sphericity Assumed 11.858 26 .456   
Greenhouse-Geisser 11.858 15.762 .752   
Huynh-Feldt 11.858 17.852 .664   
Lower-bound 11.858 13.000 .912   
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Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed 1.626 2 .813 1.501 .242 
Greenhouse-Geisser 1.626 1.226 1.326 1.501 .245 
Huynh-Feldt 1.626 1.392 1.168 1.501 .245 
Lower-bound 1.626 1.000 1.626 1.501 .242 
Duration * Solicitude 
Sphericity Assumed .005 2 .003 .005 .995 
Greenhouse-Geisser .005 1.226 .004 .005 .968 
Huynh-Feldt .005 1.392 .004 .005 .979 
Lower-bound .005 1.000 .005 .005 .945 
Error(Duration) 
Sphericity Assumed 14.083 26 .542   
Greenhouse-Geisser 14.083 15.940 .884   
Huynh-Feldt 14.083 18.099 .778   
Lower-bound 14.083 13.000 1.083   
 
 
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Duration 
Sphericity Assumed .026 2 .013 .024 .976 
Greenhouse-Geisser .026 1.229 .021 .024 .917 
Huynh-Feldt .026 1.396 .018 .024 .937 
Lower-bound .026 1.000 .026 .024 .878 
Duration * 
medcure 
Sphericity Assumed .432 2 .216 .411 .667 
Greenhouse-Geisser .432 1.229 .352 .411 .572 
Huynh-Feldt .432 1.396 .310 .411 .597 
Lower-bound .432 1.000 .432 .411 .532 
Error(Duration) 
Sphericity Assumed 13.657 26 .525   
Greenhouse-Geisser 13.657 15.973 .855   
Huynh-Feldt 13.657 18.145 .753   
Lower-bound 13.657 13.000 1.051   
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Appendix 14 
 
Correlations between PPT and VRS – single arm trial 
 
 
 
Correlations 
 VRSchange12 sympchange12 
VRSchange12 
Pearson Correlation 1 .057 
Sig. (2-tailed)  .834 
N 16 16 
sympchange12 
Pearson Correlation .057 1 
Sig. (2-tailed) .834  
N 16 16 
 
 
Correlations 
 VRSchange23 sympchang23 
VRSchange23 
Pearson Correlation 1 .141 
Sig. (2-tailed)  .603 
N 16 16 
sympchang23 
Pearson Correlation .141 1 
Sig. (2-tailed) .603  
N 16 16 
 
 
Correlations 
 VRSchange13 symptchnage13 
VRSchange13 
Pearson Correlation 1 -.325 
Sig. (2-tailed)  .219 
N 16 16 
symptchnage13 
Pearson Correlation -.325 1 
Sig. (2-tailed) .219  
N 16 16 
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Appendix 15 
 
Participant information sheet 
 
THE UNIVERSITY OF BRIGHTON 
School of Health Professions 
 
For a study in part fulfilment for a PhD entitled:  
 
The effects of lumbar mobilisations on pain sensitivity and pain levels in low back pain 
patients. 
 
Clair Hebron, Professor Ann Moore, Dr Anne Jackson, Dr Kambiz Saber-Sheikh,  
Dr Nikki Petty. 
 
 
PARTICIPANT INFORMATION SHEET  
 
 
1  Study title 
 
The perceived effects of different amounts of mobilisation for people with low back pain. 
 
2  Invitation paragraph 
 
You are being invited to take part in a research study. Before you decide it is important for you 
to understand why the research is being done and what it will involve. Please take time to read 
the following information carefully and discuss it with others if you wish. Ask if there is anything 
that is not clear or if you would like more information. Take time to decide whether or not you 
wish to take part. 
 
Thank you for reading this. 
  
3  What is the purpose of the study? 
 
The purpose of this study is to explore the perceived effects of different amounts of 
mobilisation for people with low back pain. 
 
   
4 Why have I been chosen? 
 
You have been chosen as you have experienced low back pain for three months or longer and 
experience this pain when you move. However you have not received treatment for these 
symptoms within the last 3 months. 
 
5 Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to take 
part you are still free to withdraw at any time without giving a reason. A decision to withdraw at 
any time, or a decision not to take part, will not affect you in any way. 
 
6  What will happen to me if I take part? 
 
If you agree to take part in this study you will be required to attend the human movement 
laboratory on three occasions, the first attendance will take approximately 60 minutes. The 
second and third attendance will each take approximately 40 minutes. On each occasion you 
will be asked to undress to shorts and for female participants’ shorts and bra. 
 
On the first occasion a physiotherapist will perform an examination of your spine to establish 
the area from which your symptoms are arising. This assessment would be typical of the 
assessment that you would receive on your first appointment with a physiotherapist. The 
assessment enables the physiotherapist to direct treatment to the level of your spine that is 
responsible for your symptoms.  During this examination you will be asked about your age and 
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medical history and your height and weight will be recorded. You will also be asked about 
where you feel your pain, what causes the pain to become worse and how and when it started. 
The physiotherapist will then look at and feel the movement of your back and your sensation, 
muscle strength and reflexes may also be tested. During these procedures there is likely to be 
some reproduction of your pain. It is necessary to reproduce some of your pain in order to 
understand the nature of your complaint and tailor treatment to your specific presentation. You 
will be asked to stop any movement that become too uncomfortable. This procedure is 
standard practice in physiotherapy assessment of patients with low back pain. You will also be 
asked to complete some questionnaires about your pain and your beliefs about pain, your 
cigarette and alcohol consumption and general health as it is thought that these may be factors 
that affect your response to treatment (the questionnaires will take approximately 20 minutes to 
complete). 
 
On the second occasion, you will be asked to bend forwards, backwards and bend and twist 
from side to side and asked to rate on a scale of 0-10 how much pain is produced on each 
movement. You will not be asked to move further into your pain than you are comfortable to. 
 
A machine with a contact area the size of a 5 pence piece will be applied to 5 points in your 
lower limb, a point in your upper arm and two points on your back. This machine is used to 
measure pressure pain threshold, which is the point at which sensation turns from pressure to 
pain. The machine will be used to gradually apply increasing pressure, you will be asked to 
press a button as soon as the sensation you are experiencing changes form pressure to 
discomfort or pain, at which point the pressure will be removed. 
 
You will then be required to lie on your front whilst a physiotherapist presses on your low back 
and you will be asked to rate on a scale of 0-10 how much pain is produced on each 
movement.  
 
The measurements of pain on movement, and pressure detailed above will be repeated on two 
further occasions after periods of rest and application of mobilisation to your back. You will also 
be asked to rate whether there has been any change in your pain following the mobilisations. 
 
You will receive mobilisation treatment that consists of repeated pressure applied through your 
back; this will be interspersed with rest periods. The mobilisation treatment will be tailored to 
your back pain, based on the findings from the physiotherapy assessment you received on 
your first assessment’ 
 
On your third attendance you will be asked to rate the pain you experience on movement and 
pressure and you will be asked to rate any change in your pain (the same as on your second 
attendance) for the final time. You will then be asked to complete a questionnaire on your 
expectations and experience of receiving a mobilisation technique (completion of the 
questionnaire will take approximately 15 minutes). The physiotherapist will advise you on the 
cause of, and best course of management for your back pain. 
 
7  What do I have to do? 
 
You will be asked to avoid undertaking strenuous exercise for at least 2 hours prior to each 
session. You will be asked to avoid taking pain-killing medication after 8pm the evening before 
each attendance.  
 
8 What are the possible disadvantages and risks of taking part? 
 
The intervention you will receive is safe and is of the type commonly used by physiotherapists 
in the assessment and treatment of the lumbar spine. It is normal for some of your back pain to 
be reproduced during mobilisations, the physiotherapist will monitor this throughout the 
procedure and if this should become unduly painful you should inform the physiotherapist and 
the procedure will be terminated. 
 
There is a chance that you will experience soreness in your low back for 24-48 hours after 
each session. If this should occur you could take the painkillers, which you would normally, 
take for your back pain.  
 
 
9  What are the possible benefits of taking part? 
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The examining physiotherapist will conduct an examination, and will be able to advise you of 
the possible cause of your symptoms and whether further treatment for your symptoms may be 
beneficial. However the physiotherapist will not be able to provide you with on-going treatment.  
 
The information from this study will help establish the pain relieving effect of using lumbar 
mobilisations.  
 
10 What if something goes wrong? 
 
If you experience undue discomfort during the intervention please tell the physiotherapist at the 
time and the procedure will be terminated. There is a chance that you will experience soreness 
in your low back for 24-48 hours after the treatment. If this should persist for longer period then  
you could take the painkillers that you would normally take for your back pain.  
We do not envisage any longer term complications as none have been reported to result from 
lumbar mobilisations, however if you should experience increased soreness for longer than 72 
hours after each session you should contact the principle researcher (Clair Hebron) on (01273) 
643878 or email C.L.Hebron@brighton.ac.uk. If you do require further treatment after the 
completion of this study you should contact your General Practitioner. 
 
If you have any issues or concerns about the procedures or how they are carried out, you may 
contact Dr Jane Morris who is Deputy Head of the School of Health Professions. Should you 
have any concerns regarding the conduct of the study, please contact Dr Morris on (01273) 
643651 or email JM309@bton.ac.uk. 
 
11 Will my taking part in this study be kept confidential? 
 
On entering the study you will be allocated with a subject number by which you will be referred 
for the remainder of the study. The code to your name will be kept on a password-protected 
computer; this will ensure your anonymity throughout.  
 
12 What will happen to the results of the research study? 
 
It is intended that the results from this study will be published in professional journals and 
presented at scientific conferences. You will not be identified in any publication. A summary of 
the results will be made available to you on your request once the study has been completed 
(by January 2014). 
 
13 Who has reviewed the study? 
 
This study has been reviewed and approved by the University of Brighton, Faculty of Health 
Research Ethics and Governance Committee 
 
14 Contact for Further Information 
 
If you require any further information you can contact Clair Hebron (the researcher) on 01273 
643878 or e-mail C.L.Hebron@brighton.ac.uk 
 
You will be given a copy of the information sheet and a signed consent form to keep for 
reference. 
 
Thank you for taking part in this study 
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Appendix 16 
 
Global rating of perceived effect 
 
 
Session two 
 
Global rating of perceived change scale 
 
 
With respect to your low back pain, how would you describe yourself now compared to immediately before the 
mobilisation treatment you have just received ? 
 
 
 
 
Global rating of perceived change scale 
 
With respect to your low back pain, how would you describe yourself now compared to immediately before the 
mobilisation treatment you have just received ? 
 
 
 
 
 
 
Session 3  
 
With respect to your low back pain, how would you describe yourself now compared to immediately before the 
mobilisation treatment you received yesterday? 
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Appendix 17 
 
 
 
 
 
 
 
 
 
 
 
 
The technique you received was a “mobilisation technique” involving pressure being applied to your lower 
back. This technique is often applied as part of treatment for low back pain. We would like to know more about 
what you expected from this technique and, what your experience was when the technique was applied. 
Please could you answer the following questions? 
 
 
 
 
 
Have you had previous experience of receiving this mobilisation technique?   Yes/ No (please circle). 
 
Please describe any previous experience of mobilisations that you have had. 
 
 
 
 
 
 
 
 
What were you expecting from having this ‘mobilisation technique’ applied on this occasion?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Was there anything that you didn’t expect about the mobilisation technique? If so, what happened that you 
didn’t expect? 
 
 
 
 
 
 
 
 
 
 
 
 
Participant expectations and experience 
of mobilisations questionnaire 
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What were you thinking and feeling when the mobilisation technique was applied? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
How comfortable was the mobilisation technique? 
 
  
 
 
 
 
 
 
 
 
 
 
 
What effect do you think the mobilisation technique had on your back? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Do you have any other comments? 
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Appendix 18 
 
Test of normality for the RCT 
 
Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
force .096 67 .200* .960 67 .032 
Age .077 67 .200* .958 67 .024 
Oswestry .134 67 .005 .964 67 .048 
McGill .124 67 .012 .948 67 .007 
Control .115 67 .029 .986 67 .632 
Disability .119 67 .019 .948 67 .008 
Harm .108 67 .051 .965 67 .058 
Emotion .192 67 .000 .873 67 .000 
medication .118 67 .021 .952 67 .012 
solicitude .108 67 .052 .933 67 .001 
medcure .114 67 .031 .963 67 .045 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
 
 
  
Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
PPB .292 71 .000 .733 71 .000 
PP1 .305 71 .000 .731 71 .000 
PP2 .258 71 .000 .718 71 .000 
PP24 .278 71 .000 .663 71 .000 
PAB .105 71 .052 .954 71 .012 
PA1 .099 71 .083 .971 71 .096 
PA2 .126 71 .007 .960 71 .022 
PA24 .125 71 .008 .949 71 .006 
GRPE1 .141 71 .001 .970 71 .084 
GRPE2 .118 71 .015 .972 71 .119 
GRPE24 .113 71 .025 .965 71 .045 
a. Lilliefors Significance Correction 
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Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
sympB .121 72 .011 .938 72 .002 
sympt1 .104 72 .053 .922 72 .000 
sympt2 .124 72 .008 .927 72 .000 
sympt24 .098 72 .083 .957 72 .014 
T10B .096 72 .098 .925 72 .000 
T101 .129 72 .005 .895 72 .000 
T102 .099 72 .077 .917 72 .000 
T1024 .142 72 .001 .934 72 .001 
DeltoidB .094 72 .191 .965 72 .043 
Deltoid1 .088 72 .200* .949 72 .006 
Deltoid2 .117 72 .017 .926 72 .000 
Deltoid2
4 
.130 72 .004 .917 72 .000 
S1B .094 72 .195 .968 72 .060 
S11 .079 72 .200* .956 72 .012 
S12 .134 72 .003 .924 72 .000 
S124 .112 72 .025 .916 72 .000 
L2B .114 72 .021 .950 72 .006 
L21 .095 72 .175 .950 72 .006 
L22 .110 72 .030 .953 72 .010 
L224 .075 72 .200* .976 72 .188 
L3B .117 72 .017 .941 72 .002 
L31 .101 72 .066 .909 72 .000 
L32 .137 72 .002 .910 72 .000 
L324 .127 72 .006 .911 72 .000 
L4B .099 72 .075 .961 72 .024 
L41 .096 72 .095 .946 72 .004 
L42 .102 72 .059 .955 72 .012 
L424 .105 72 .047 .935 72 .001 
L5B .147 72 .001 .918 72 .000 
L51 .115 72 .019 .927 72 .000 
L52 .115 72 .019 .947 72 .004 
L524 .087 72 .200* .918 72 .000 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
symptBtrans .078 71 .200* .983 71 .472 
sympt1trans .049 71 .200* .987 71 .698 
sympt2trans .103 71 .060 .970 71 .090 
sympt24trans .074 71 .200* .964 71 .041 
T10Btrans .065 71 .200* .989 71 .769 
T101trans .075 71 .200* .983 71 .461 
T102trans .071 71 .200* .987 71 .700 
T1024trans .081 71 .200* .983 71 .444 
DeltoidBtrans .093 71 .200* .978 71 .238 
Deltoid1trans .084 71 .200* .985 71 .575 
Deltoid2trans .054 71 .200* .986 71 .599 
Deltoid24trans .113 71 .024 .964 71 .042 
S1Btrans .073 71 .200* .978 71 .258 
S11trans .085 71 .200* .990 71 .831 
S12trans .071 71 .200* .987 71 .654 
S124trans .072 71 .200* .984 71 .530 
L2Btrans .072 71 .200* .983 71 .441 
L21trans .083 71 .200* .982 71 .391 
L22trans .117 71 .017 .976 71 .188 
L224trans .097 71 .094 .977 71 .223 
L3Btrans .057 71 .200* .993 71 .970 
L31trans .057 71 .200* .985 71 .587 
L32trans .085 71 .200* .977 71 .229 
L324trans .048 71 .200* .993 71 .961 
L4Btrans .052 71 .200* .989 71 .790 
L41trans .093 71 .200* .983 71 .464 
L42trans .095 71 .184 .985 71 .554 
L424trans .077 71 .200* .977 71 .206 
L5Btrans .063 71 .200* .993 71 .971 
L51trans .070 71 .200* .989 71 .777 
L52trans .054 71 .200* .984 71 .516 
L524trans .067 71 .200* .982 71 .424 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Appendix 19 
 
T-test for differences in PPT between groups at baseline. 
 
 
Independent Samples Test 
 Levene's Test for 
Equality of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence Interval 
of the Difference 
Lower Upper 
symptBtrans 
Equal variances assumed .000 .982 1.257 70 .213 .05936 .04721 -.03479 .15351 
Equal variances not assumed   1.260 68.611 .212 .05936 .04710 -.03461 .15332 
T10Btrans Equal variances assumed .324 .571 1.702 70 .093 .07608 .04469 -.01306 .16522 Equal variances not assumed   1.688 65.364 .096 .07608 .04506 -.01391 .16607 
DeltoidBtrans Equal variances assumed .274 .603 1.374 70 .174 .05592 .04069 -.02523 .13708 Equal variances not assumed   1.379 68.850 .172 .05592 .04055 -.02498 .13683 
S1Btrans Equal variances assumed .000 .990 .383 70 .703 .01351 .03531 -.05692 .08394 Equal variances not assumed   .380 65.582 .705 .01351 .03559 -.05755 .08456 
L2Btrans Equal variances assumed 9.202 .003 -.551 70 .584 -.02222 .04037 -.10274 .05829 Equal variances not assumed   -.568 67.213 .572 -.02222 .03915 -.10036 .05591 
L3Btrans Equal variances assumed .686 .410 .512 70 .610 .02347 .04584 -.06795 .11489 Equal variances not assumed   .519 69.977 .606 .02347 .04526 -.06680 .11374 
L4Btrans Equal variances assumed 3.674 .059 1.320 70 .191 .05145 .03899 -.02631 .12921 Equal variances not assumed   1.352 68.977 .181 .05145 .03806 -.02447 .12737 
L5Btrans 
Equal variances assumed .370 .545 -.423 70 .673 -.01808 .04269 -.10321 .06706 
Equal variances not assumed   -.425 69.016 .672 -.01808 .04250 -.10287 .06672 
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Mann-Whitney U test for difference between skewed questionnaire data 
sets between groups at baseline 
 
 
 
 
 
  
 281 
Test for baseline difference between responders and non-responders 
 
 
 
 
 
 282 
  
 283 
 
Appendix 20 
 
ANOVA/ ANCOVA for PPT - RCT 
 
ANOVA PPT Baseline to after treatment period 1. 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed 6.988 7 .998 54.610 .000 
Greenhouse-Geisser 6.988 5.383 1.298 54.610 .000 
Huynh-Feldt 6.988 5.967 1.171 54.610 .000 
Lower-bound 6.988 1.000 6.988 54.610 .000 
site * condition 
Sphericity Assumed .167 7 .024 1.308 .244 
Greenhouse-Geisser .167 5.383 .031 1.308 .257 
Huynh-Feldt .167 5.967 .028 1.308 .253 
Lower-bound .167 1.000 .167 1.308 .257 
Error(site) 
Sphericity Assumed 8.957 490 .018   
Greenhouse-Geisser 8.957 376.816 .024 
  
Huynh-Feldt 8.957 417.704 .021 
  
Lower-bound 8.957 70.000 .128   
time 
Sphericity Assumed .001 1 .001 .057 .812 
Greenhouse-Geisser .001 1.000 .001 .057 .812 
Huynh-Feldt .001 1.000 .001 .057 .812 
Lower-bound .001 1.000 .001 .057 .812 
time * condition 
Sphericity Assumed .032 1 .032 3.330 .072 
Greenhouse-Geisser .032 1.000 .032 3.330 .072 
Huynh-Feldt .032 1.000 .032 3.330 .072 
Lower-bound .032 1.000 .032 3.330 .072 
Error(time) 
Sphericity Assumed .666 70 .010   
Greenhouse-Geisser .666 70.000 .010   
Huynh-Feldt .666 70.000 .010   
Lower-bound .666 70.000 .010   
site * time 
Sphericity Assumed .023 7 .003 .964 .457 
Greenhouse-Geisser .023 5.774 .004 .964 .447 
Huynh-Feldt .023 6.442 .004 .964 .453 
Lower-bound .023 1.000 .023 .964 .329 
site * time * 
condition 
Sphericity Assumed .050 7 .007 2.100 .042 
Greenhouse-Geisser .050 5.774 .009 2.100 .055 
Huynh-Feldt .050 6.442 .008 2.100 .047 
Lower-bound .050 1.000 .050 2.100 .152 
Error(site*time) 
Sphericity Assumed 1.672 490 .003   
Greenhouse-Geisser 1.672 404.176 .004 
  
Huynh-Feldt 1.672 450.918 .004 
  
Lower-bound 1.672 70.000 .024   
 
 
Tests of Between-Subjects Effects 
Measure: MEASURE_1  
 Transformed Variable: Average 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Intercept 518.595 1 518.595 1358.134 .000 
condition .108 1 .108 .282 .597 
Error 26.729 70 .382   
 284 
ANOVA PPT Baseline to after treatment period 2. 
 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed 6.698 7 .957 52.410 .000 
Greenhouse-Geisser 6.698 5.552 1.206 52.410 .000 
Huynh-Feldt 6.698 6.172 1.085 52.410 .000 
Lower-bound 6.698 1.000 6.698 52.410 .000 
site * condition 
Sphericity Assumed .131 7 .019 1.028 .410 
Greenhouse-Geisser .131 5.552 .024 1.028 .404 
Huynh-Feldt .131 6.172 .021 1.028 .407 
Lower-bound .131 1.000 .131 1.028 .314 
Error(site) 
Sphericity Assumed 8.946 490 .018   
Greenhouse-Geisser 8.946 388.667 .023   
Huynh-Feldt 8.946 432.041 .021   
Lower-bound 8.946 70.000 .128   
time 
Sphericity Assumed .002 1 .002 .093 .761 
Greenhouse-Geisser .002 1.000 .002 .093 .761 
Huynh-Feldt .002 1.000 .002 .093 .761 
Lower-bound .002 1.000 .002 .093 .761 
time * condition 
Sphericity Assumed .051 1 .051 2.779 .100 
Greenhouse-Geisser .051 1.000 .051 2.779 .100 
Huynh-Feldt .051 1.000 .051 2.779 .100 
Lower-bound .051 1.000 .051 2.779 .100 
Error(time) 
Sphericity Assumed 1.277 70 .018   
Greenhouse-Geisser 1.277 70.000 .018   
Huynh-Feldt 1.277 70.000 .018   
Lower-bound 1.277 70.000 .018   
site * time 
Sphericity Assumed .029 7 .004 .924 .488 
Greenhouse-Geisser .029 5.110 .006 .924 .467 
Huynh-Feldt .029 5.639 .005 .924 .474 
Lower-bound .029 1.000 .029 .924 .340 
site * time * 
condition 
Sphericity Assumed .086 7 .012 2.705 .009 
Greenhouse-Geisser .086 5.110 .017 2.705 .020 
Huynh-Feldt .086 5.639 .015 2.705 .016 
Lower-bound .086 1.000 .086 2.705 .105 
Error(site*time) 
Sphericity Assumed 2.213 490 .005   
Greenhouse-Geisser 2.213 357.681 .006   
Huynh-Feldt 2.213 394.713 .006   
Lower-bound 2.213 70.000 .032   
 
 
  
Tests of Between-Subjects Effects 
Measure: MEASURE_1  
 Transformed Variable: Average 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Intercept 519.412 1 519.412 1365.215 .000 
condition .079 1 .079 .208 .650 
Error 26.632 70 .380   
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Pairwise Comparisons 
Measure: MEASURE_1 
site time (I) 
conditi
on 
(J) 
condition 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig.a 95% Confidence 
Interval for Differencea 
Lower 
Bound 
Upper 
Bound 
1 
1 
Short Long .059 .047 .213 -.035 .154 
Long Short -.059 .047 .213 -.154 .035 
2 
Short Long -.003 .057 .959 -.117 .111 
Long Short .003 .057 .959 -.111 .117 
2 
1 Short Long .076 .045 .093 -.013 .165 Long Short -.076 .045 .093 -.165 .013 
2 Short Long .023 .047 .626 -.071 .117 Long Short -.023 .047 .626 -.117 .071 
3 
1 Short Long .056 .041 .174 -.025 .137 Long Short -.056 .041 .174 -.137 .025 
2 Short Long .031 .050 .537 -.069 .132 Long Short -.031 .050 .537 -.132 .069 
4 
1 Short Long .014 .035 .703 -.057 .084 Long Short -.014 .035 .703 -.084 .057 
2 Short Long .011 .034 .742 -.056 .078 Long Short -.011 .034 .742 -.078 .056 
5 
1 Short Long -.022 .040 .584 -.103 .058 Long Short .022 .040 .584 -.058 .103 
2 Short Long -.014 .045 .748 -.104 .075 Long Short .014 .045 .748 -.075 .104 
6 
1 Short Long .023 .046 .610 -.068 .115 Long Short -.023 .046 .610 -.115 .068 
2 Short Long -.004 .045 .922 -.094 .085 Long Short .004 .045 .922 -.085 .094 
7 
1 Short Long .051 .039 .191 -.026 .129 Long Short -.051 .039 .191 -.129 .026 
2 Short Long -.028 .046 .545 -.119 .063 Long Short .028 .046 .545 -.063 .119 
8 
1 
Short Long -.018 .043 .673 -.103 .067 
Long Short .018 .043 .673 -.067 .103 
2 
Short Long .011 .042 .802 -.073 .094 
Long Short -.011 .042 .802 -.094 .073 
Based on estimated marginal means 
a. Adjustment for multiple comparisons: Least Significant Difference (equivalent to no 
adjustments). 
 
 
 
  
 286 
ANOVA PPT Baseline to after treatment at 24 hour follow-up 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
site 
Sphericity Assumed 7.040 7 1.006 52.202 .000 
Greenhouse-Geisser 7.040 5.560 1.266 52.202 .000 
Huynh-Feldt 7.040 6.191 1.137 52.202 .000 
Lower-bound 7.040 1.000 7.040 52.202 .000 
site * condition 
Sphericity Assumed .189 7 .027 1.403 .202 
Greenhouse-Geisser .189 5.560 .034 1.403 .217 
Huynh-Feldt .189 6.191 .031 1.403 .210 
Lower-bound .189 1.000 .189 1.403 .240 
Error(site) 
Sphericity Assumed 9.305 483 .019   
Greenhouse-Geisser 9.305 383.663 .024   
Huynh-Feldt 9.305 427.210 .022   
Lower-bound 9.305 69.000 .135   
time 
Sphericity Assumed .383 1 .383 16.687 .000 
Greenhouse-Geisser .383 1.000 .383 16.687 .000 
Huynh-Feldt .383 1.000 .383 16.687 .000 
Lower-bound .383 1.000 .383 16.687 .000 
time * 
condition 
Sphericity Assumed .174 1 .174 7.585 .008 
Greenhouse-Geisser .174 1.000 .174 7.585 .008 
Huynh-Feldt .174 1.000 .174 7.585 .008 
Lower-bound .174 1.000 .174 7.585 .008 
Error(time) 
Sphericity Assumed 1.583 69 .023   
Greenhouse-Geisser 1.583 69.000 .023   
Huynh-Feldt 1.583 69.000 .023   
Lower-bound 1.583 69.000 .023   
site * time 
Sphericity Assumed .049 7 .007 1.219 .291 
Greenhouse-Geisser .049 4.852 .010 1.219 .300 
Huynh-Feldt .049 5.339 .009 1.219 .298 
Lower-bound .049 1.000 .049 1.219 .273 
site * time * 
condition 
Sphericity Assumed .043 7 .006 1.062 .387 
Greenhouse-Geisser .043 4.852 .009 1.062 .381 
Huynh-Feldt .043 5.339 .008 1.062 .383 
Lower-bound .043 1.000 .043 1.062 .306 
Error(site*time) 
Sphericity Assumed 2.764 483 .006   
Greenhouse-Geisser 2.764 334.785 .008   
Huynh-Feldt 2.764 368.393 .008   
Lower-bound 2.764 69.000 .040   
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Tests of Between-Subjects Effects 
Measure: MEASURE_1  
 Transformed Variable: Average 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Intercept 482.814 1 482.814 1177.762 .000 
condition .012 1 .012 .028 .867 
Error 28.286 69 .410   
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Appendix 21 
 
Stratified analysis for mediating effect of force on PPT at the symptomatic 
paravertebral level after treatment period 2 
 
 
 
 
 
 
 
Model Summary 
Model R R 
Square 
Adjusted 
R Square 
Std. Error of the 
Estimate 
Change Statistics 
R Square 
Change 
F Change df1 df2 Sig. F 
Change 
1 .330a .109 .096 1.64493 .109 8.318 1 68 .005 
a. Predictors: (Constant), force 
 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 22.507 1 22.507 8.318 .005b 
Residual 183.993 68 2.706 
  
Total 206.501 69 
   
a. Dependent Variable: SymptchB2 
b. Predictors: (Constant), force 
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Stratified analysis for mediating effect of force on PPT at the symptomatic 
paravertebral level at 24 hour follow-up 
 
 
 
 
 
 
Model Summary 
Model R R 
Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
Change Statistics 
R Square 
Change 
F Change df1 df2 Sig. F 
Change 
1 .302a .091 .078 1.29292 .091 6.807 1 68 .011 
a. Predictors: (Constant), force 
 
 
 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 11.379 1 11.379 6.807 .011b 
Residual 113.671 68 1.672 
  
Total 125.051 69 
   
a. Dependent Variable: T10chB2 
b. Predictors: (Constant), force 
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Stratified analysis for mediating effect of force on PPT at the T10 
paravertebral level after treatment period 2 
 
 
 
 
 
Model Summary 
Model R R 
Square 
Adjusted 
R 
Square 
Std. Error of 
the Estimate 
Change Statistics 
R Square 
Change 
F Change df1 df2 Sig. F 
Change 
1 .052a .003 -.012 2.14888 .003 .188 1 68 .666 
a. Predictors: (Constant), force 
 
ANOVAa 
Model Sum of 
Squares 
df Mean Square F Sig. 
1 
Regression .867 1 .867 .188 .666b 
Residual 314.002 68 4.618 
  
Total 314.869 69 
   
a. Dependent Variable: SymptchB24 
b. Predictors: (Constant), force 
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Stratified analysis for mediating effect of force on PPT at the Deltoid muscle 
site after treatment period 2 
 
 
 
Model Summary 
Model R R 
Square 
Adjusted R 
Square 
Std. 
Error of 
the 
Estimate 
Change Statistics 
R Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 .124a .015 -.002 1.41325 .015 .881 1 56 .352 
a. Predictors: (Constant), force 
 
 
ANOVAa 
Model Sum of 
Squares 
df Mean Square F Sig. 
1 
Regression 1.760 1 1.760 .881 .352b 
Residual 111.847 56 1.997   
Total 113.606 57    
a. Dependent Variable: DeltchB2 
b. Predictors: (Constant), force 
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Stratified analysis for mediating effect of force on Verbal rating of pain on 
movement after treatment period 2 
 
 
 
 
 
Model Summary 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .364a .132 .120 9.61258 
a. Predictors: (Constant), force 
 
ANOVAa 
Model Sum of 
Squares 
df Mean Square F Sig. 
1 
Regression 959.499 1 959.499 10.384 .002b 
Residual 6283.320 68 92.402   
Total 7242.819 69    
a. Dependent Variable: ChangeVRSmvt 
b. Predictors: (Constant), force 
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Stratified analysis for mediating effect of force on Verbal rating of pain on 
movement at 24 hour follow-up 
 
Model Summary 
Model R R 
Square 
Adjusted 
R Square 
Std. Error of 
the Estimate 
Change Statistics 
R Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 .245a .060 .046 9.72957 .060 4.337 1 68 .041 
a. Predictors: (Constant), force 
 
 
ANOVAa 
Model Sum of 
Squares 
df Mean Square F Sig. 
1 
Regression 410.528 1 410.528 4.337 .041b 
Residual 6437.187 68 94.665   
Total 6847.714 69    
a. Dependent Variable: ChangeVRSmvt24 
b. Predictors: (Constant), force 
 
 
 
 
 
Stratified analysis for mediating effect of force on Verbal rating of pain on 
PA force application 
 
 
Model Summary 
Model R R 
Square 
Adjusted 
R Square 
Std. Error of 
the Estimate 
Change Statistics 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 .109a .012 -.003 1.58164 .012 .815 1 68 .370 
a. Predictors: (Constant), force 
 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 2.039 1 2.039 .815 .370b 
Residual 170.107 68 2.502   
Total 172.146 69    
a. Dependent Variable: ChangePA 
b. Predictors: (Constant), force 
 
 294 
 
Stratified analysis for mediating effect of force on Verbal rating of pain of 
resting pain 
 
Model Summary 
Model R R 
Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
1 .183a .033 .019 1.47303 
a. Predictors: (Constant), force 
 
 
ANOVAa 
Model Sum of 
Squares 
df Mean Square F Sig. 
1 
Regression 5.114 1 5.114 2.357 .129b 
Residual 147.548 68 2.170   
Total 152.662 69    
a. Dependent Variable: ChangeRP 
b. Predictors: (Constant), force 
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Appendix 22 
 
ANOVA - VRS of pain on movement between baseline and after treatment 
period 1 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean Square F Sig. 
time 
Sphericity Assumed .767 1 .767 31.448 .000 
Greenhouse-Geisser .767 1.000 .767 31.448 .000 
Huynh-Feldt .767 1.000 .767 31.448 .000 
Lower-bound .767 1.000 .767 31.448 .000 
time * 
Condition 
Sphericity Assumed .002 1 .002 .073 .788 
Greenhouse-Geisser .002 1.000 .002 .073 .788 
Huynh-Feldt .002 1.000 .002 .073 .788 
Lower-bound .002 1.000 .002 .073 .788 
Error(time) 
Sphericity Assumed 1.609 66 .024 
  
Greenhouse-Geisser 1.609 66.000 .024 
  
Huynh-Feldt 1.609 66.000 .024 
  
Lower-bound 1.609 66.000 .024 
  
 
Tests of Within-Subjects Contrasts 
Measure: MEASURE_1 
Source time Type III Sum of 
Squares 
df Mean 
Square 
F Sig. 
time Linear .767 1 .767 31.448 .000 
time * Condition Linear .002 1 .002 .073 .788 
Error(time) Linear 1.609 66 .024 
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VRS of pain on movement between baseline and after treatment period 2 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean Square F Sig. 
time 
Sphericity Assumed 1.632 1 1.632 38.802 .000 
Greenhouse-Geisser 1.632 1.000 1.632 38.802 .000 
Huynh-Feldt 1.632 1.000 1.632 38.802 .000 
Lower-bound 1.632 1.000 1.632 38.802 .000 
time * 
Condition 
Sphericity Assumed .056 1 .056 1.325 .254 
Greenhouse-Geisser .056 1.000 .056 1.325 .254 
Huynh-Feldt .056 1.000 .056 1.325 .254 
Lower-bound .056 1.000 .056 1.325 .254 
Error(time) 
Sphericity Assumed 2.777 66 .042 
  
Greenhouse-Geisser 2.777 66.000 .042 
  
Huynh-Feldt 2.777 66.000 .042 
  
Lower-bound 2.777 66.000 .042 
  
 
 
Tests of Within-Subjects Contrasts 
Measure: MEASURE_1 
Source time Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
time Linear 1.632 1 1.632 38.802 .000 
time * Condition Linear .056 1 .056 1.325 .254 
Error(time) Linear 2.777 66 .042 
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VRS of pain on movement between baseline and 24-hour follow-up 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
time 
Sphericity Assumed 1.517 1 1.517 48.266 .000 
Greenhouse-Geisser 1.517 1.000 1.517 48.266 .000 
Huynh-Feldt 1.517 1.000 1.517 48.266 .000 
Lower-bound 1.517 1.000 1.517 48.266 .000 
time * 
Condition 
Sphericity Assumed .003 1 .003 .098 .755 
Greenhouse-Geisser .003 1.000 .003 .098 .755 
Huynh-Feldt .003 1.000 .003 .098 .755 
Lower-bound .003 1.000 .003 .098 .755 
Error(time) 
Sphericity Assumed 1.949 62 .031 
  
Greenhouse-Geisser 1.949 62.000 .031 
  
Huynh-Feldt 1.949 62.000 .031 
  
Lower-bound 1.949 62.000 .031 
  
 
Tests of Within-Subjects Contrasts 
Measure: MEASURE_1 
Source time Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
time Linear 1.517 1 1.517 48.266 .000 
time * Condition Linear .003 1 .003 .098 .755 
Error(time) Linear 1.949 62 .031 
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Resting Pain 2-way mixed ANOVA between baseline and after treatment 
period 1 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
time 
Sphericity Assumed .255 1 .255 .296 .588 
Greenhouse-Geisser .255 1.000 .255 .296 .588 
Huynh-Feldt .255 1.000 .255 .296 .588 
Lower-bound .255 1.000 .255 .296 .588 
time * 
condition 
Sphericity Assumed .339 1 .339 .393 .533 
Greenhouse-Geisser .339 1.000 .339 .393 .533 
Huynh-Feldt .339 1.000 .339 .393 .533 
Lower-bound .339 1.000 .339 .393 .533 
Error(time) 
Sphericity Assumed 60.326 70 .862 
  
Greenhouse-Geisser 60.326 70.000 .862 
  
Huynh-Feldt 60.326 70.000 .862 
  
Lower-bound 60.326 70.000 .862 
  
 
  
Tests of Between-Subjects Effects 
Measure: MEASURE_1  
 Transformed Variable: Average 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Intercept 615.289 1 615.289 157.726 .000 
condition 4.803 1 4.803 1.231 .271 
Error 273.070 70 3.901 
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Resting Pain 2-way mixed ANOVA  between baseline and after treatment 
period 2 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
time 
Sphericity Assumed .083 1 .083 .076 .784 
Greenhouse-Geisser .083 1.000 .083 .076 .784 
Huynh-Feldt .083 1.000 .083 .076 .784 
Lower-bound .083 1.000 .083 .076 .784 
time * 
condition 
Sphericity Assumed .044 1 .044 .041 .841 
Greenhouse-Geisser .044 1.000 .044 .041 .841 
Huynh-Feldt .044 1.000 .044 .041 .841 
Lower-bound .044 1.000 .044 .041 .841 
Error(time) 
Sphericity Assumed 76.288 70 1.090 
  
Greenhouse-Geisser 76.288 70.000 1.090 
  
Huynh-Feldt 76.288 70.000 1.090 
  
Lower-bound 76.288 70.000 1.090 
  
 
 
Tests of Within-Subjects Contrasts 
Measure: MEASURE_1 
Source time Type III Sum of 
Squares 
df Mean Square F Sig. 
time Linear .083 1 .083 .076 .784 
time * condition Linear .044 1 .044 .041 .841 
Error(time) Linear 76.288 70 1.090 
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Resting Pain 2-way mixed ANOVA between baseline and 24-hour 
follow-up 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
time 
Sphericity Assumed 1.395 1 1.395 1.168 .284 
Greenhouse-Geisser 1.395 1.000 1.395 1.168 .284 
Huynh-Feldt 1.395 1.000 1.395 1.168 .284 
Lower-bound 1.395 1.000 1.395 1.168 .284 
time * 
condition 
Sphericity Assumed .598 1 .598 .501 .482 
Greenhouse-Geisser .598 1.000 .598 .501 .482 
Huynh-Feldt .598 1.000 .598 .501 .482 
Lower-bound .598 1.000 .598 .501 .482 
Error(time) 
Sphericity Assumed 83.652 70 1.195 
  
Greenhouse-Geisser 83.652 70.000 1.195 
  
Huynh-Feldt 83.652 70.000 1.195 
  
Lower-bound 83.652 70.000 1.195 
  
 
 
Tests of Within-Subjects Contrasts 
Measure: MEASURE_1 
Source time Type III Sum of 
Squares 
df Mean Square F Sig. 
time Linear 1.395 1 1.395 1.168 .284 
time * condition Linear .598 1 .598 .501 .482 
Error(time) Linear 83.652 70 1.195 
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Pain on PA force. 2-way mixed ANOVA between baseline to after treatment 
period 1. 
 
 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum of 
Squares 
df Mean 
Square 
F Sig. 
time 
Sphericity Assumed .004 1 .004 .127 .723 
Greenhouse-Geisser .004 1.000 .004 .127 .723 
Huynh-Feldt .004 1.000 .004 .127 .723 
Lower-bound .004 1.000 .004 .127 .723 
time * condition 
Sphericity Assumed .008 1 .008 .241 .625 
Greenhouse-Geisser .008 1.000 .008 .241 .625 
Huynh-Feldt .008 1.000 .008 .241 .625 
Lower-bound .008 1.000 .008 .241 .625 
Error(time) 
Sphericity Assumed 2.373 70 .034 
  
Greenhouse-Geisser 2.373 70.000 .034 
  
Huynh-Feldt 2.373 70.000 .034 
  
Lower-bound 2.373 70.000 .034 
  
 
 
Tests of Within-Subjects Contrasts 
Measure: MEASURE_1 
Source time Type III Sum of 
Squares 
df Mean Square F Sig. 
time Linear .004 1 .004 .127 .723 
time * condition Linear .008 1 .008 .241 .625 
Error(time) Linear 2.373 70 .034 
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Pain on PA force. 2-way mixed ANOVA between baseline to after 
treatment period 2. 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean Square F Sig. 
time 
Sphericity Assumed .001 1 .001 .014 .905 
Greenhouse-Geisser .001 1.000 .001 .014 .905 
Huynh-Feldt .001 1.000 .001 .014 .905 
Lower-bound .001 1.000 .001 .014 .905 
time * 
condition 
Sphericity Assumed .004 1 .004 .110 .741 
Greenhouse-Geisser .004 1.000 .004 .110 .741 
Huynh-Feldt .004 1.000 .004 .110 .741 
Lower-bound .004 1.000 .004 .110 .741 
Error(time) 
Sphericity Assumed 2.490 70 .036 
  
Greenhouse-Geisser 2.490 70.000 .036 
  
Huynh-Feldt 2.490 70.000 .036 
  
Lower-bound 2.490 70.000 .036 
  
 
 
Tests of Within-Subjects Contrasts 
Measure: MEASURE_1 
Source time Type III Sum of 
Squares 
df Mean Square F Sig. 
time Linear .001 1 .001 .014 .905 
time * condition Linear .004 1 .004 .110 .741 
Error(time) Linear 2.490 70 .036 
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Pain on PA force. 2-way mixed ANOVA between baseline to 24 hour follow-
up. 
 
 
Tests of Within-Subjects Effects 
Measure: MEASURE_1 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
time 
Sphericity Assumed .042 1 .042 1.145 .288 
Greenhouse-Geisser .042 1.000 .042 1.145 .288 
Huynh-Feldt .042 1.000 .042 1.145 .288 
Lower-bound .042 1.000 .042 1.145 .288 
time * 
condition 
Sphericity Assumed .001 1 .001 .025 .874 
Greenhouse-Geisser .001 1.000 .001 .025 .874 
Huynh-Feldt .001 1.000 .001 .025 .874 
Lower-bound .001 1.000 .001 .025 .874 
Error(time) 
Sphericity Assumed 2.596 70 .037 
  
Greenhouse-Geisser 2.596 70.000 .037 
  
Huynh-Feldt 2.596 70.000 .037 
  
Lower-bound 2.596 70.000 .037 
  
 
 
Tests of Within-Subjects Contrasts 
Measure: MEASURE_1 
Source time Type III Sum of 
Squares 
df Mean Square F Sig. 
time Linear .042 1 .042 1.145 .288 
time * condition Linear .001 1 .001 .025 .874 
Error(time) Linear 2.596 70 .037 
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Appendix 23  
Global rating of perceived effect 
 
Correlation between change in PPT at the symptomatic level and Global 
Rating of Perceived Effect after treatment period 1. 
 
Correlations 
 PPTchnage
baserx1 
GRPE 
Spearman's rho 
PPTchnage
baserx1 
Correlation Coefficient 1.000 .086 
Sig. (2-tailed) . .469 
N 73 73 
GRPE 
Correlation Coefficient .086 1.000 
Sig. (2-tailed) .469 . 
N 73 73 
 
Correlation between change in PPT at the symptomatic level and Global 
Rating of Perceived Effect after treatment period 2. 
 
Correlations 
 PPTChange
baseRx2 
GPRPE2 
Spearman's rho 
PPTChange
baseRx2 
Correlation Coefficient 1.000 .349** 
Sig. (2-tailed) . .002 
N 73 73 
GPRPE2 
Correlation Coefficient .349** 1.000 
Sig. (2-tailed) .002 . 
N 73 73 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Correlation between change in PPT at the symptomatic level and Global 
Rating of Perceived Effect at 24 hour follow-up. 
 
Correlations 
 PPTChange
base24 
GRPE24 
Spearman's rho 
PPTChange
base24 
Correlation Coefficient 1.000 .256* 
Sig. (2-tailed) . .030 
N 73 72 
GRPE24 
Correlation Coefficient .256* 1.000 
Sig. (2-tailed) .030 . 
N 72 72 
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Correlation between change in verbal rating of pain on movement 
and Global Rating of Perceived Effect after treatment period 1. 
 
Correlations 
 VRSDiffBrx1 GRPE 
Spearman's rho 
VRSDiffBrx1 
Correlation Coefficient 1.000 .083 
Sig. (2-tailed) . .489 
N 72 72 
GRPE 
Correlation Coefficient .083 1.000 
Sig. (2-tailed) .489 . 
N 72 73 
 
 
Correlation between change in verbal rating of pain on movement 
and Global Rating of Perceived Effect after treatment period 2. 
 
Correlations 
 VRmvtDiffbaseRx2 GPRPE2 
Spearman's rho 
VRmvtDiffbaseRx2 
Correlation 
Coefficient 
1.000 -.414** 
Sig. (2-tailed) . .000 
N 73 73 
GPRPE2 
Correlation 
Coefficient 
-.414** 1.000 
Sig. (2-tailed) .000 . 
N 73 73 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Correlation between change in verbal rating of pain on movement and 
Global Rating of Perceived Effect at 24 hour follow-up. 
 
Correlations 
 VRmvtDiff
base24 
GRPE24 
Spearman's rho 
VRmvtDif
fbase24 
Correlation Coefficient 1.000 -.534** 
Sig. (2-tailed) . .000 
N 73 72 
GRPE24 
Correlation Coefficient -.534** 1.000 
Sig. (2-tailed) .000 . 
N 72 72 
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Correlation between change in verbal rating of pain on application of PA 
force and Global Rating of Perceived Effect after treatment period 1. 
 
Correlations 
 GRPE ChangeP
AB1 
Spearman's rho 
GRPE 
Correlation Coefficient 1.000 -.269* 
Sig. (2-tailed) . .022 
N 73 73 
Change
PAB1 
Correlation Coefficient -.269* 1.000 
Sig. (2-tailed) .022 . 
N 73 73 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 
Correlation between change in verbal rating of pain on application of PA 
force and Global Rating of Perceived Effect after treatment period 2 
 
Correlations 
 VRPAchnage
baserx2 
GPRPE2 
Spearman's rho 
VRPAchnage
baserx2 
Correlation Coefficient 1.000 -.219 
Sig. (2-tailed) . .063 
N 73 73 
GPRPE2 
Correlation Coefficient -.219 1.000 
Sig. (2-tailed) .063 . 
N 73 73 
 
 
Correlation between change in verbal rating of pain on application of PA 
force and Global Rating of Perceived Effect at 24 hour follow-up 
 
Correlations 
 ChangePA
base24 
GRPE24 
Spearman's rho 
ChangePA
base24 
Correlation Coefficient 1.000 -.480** 
Sig. (2-tailed) . .000 
N 73 72 
GRPE24 
Correlation Coefficient -.480** 1.000 
Sig. (2-tailed) .000 . 
N 72 72 
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Correlation between change in verbal rating of resting pain and Global 
Rating of Perceived Effect after treatment period 1 
 
Correlations 
 Change
RPB1 
GRPE 
Spearman's rho 
Change
RPB1 
Correlation Coefficient 1.000 -.321** 
Sig. (2-tailed) . .006 
N 73 73 
GRPE 
Correlation Coefficient -.321** 1.000 
Sig. (2-tailed) .006 . 
N 73 73 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Correlation between change in verbal rating of resting pain and Global 
Rating of Perceived Effect after treatment period 2  
 
Correlation between change in verbal rating of resting pain and Global 
Rating of Perceived Effect at 24 hour follow-up 
 
Correlations 
 ChnageRP
B24 
GRPE24 
Spearman's rho 
ChnageRPB24 
Correlation Coefficient 1.000 -.235* 
Sig. (2-tailed) . .047 
N 73 72 
GRPE24 
Correlation Coefficient -.235* 1.000 
Sig. (2-tailed) .047 . 
N 72 72 
*. Correlation is significant at the 0.05 level (2-tailed). 
Correlations 
 RestingPcahnge
baseRx2 
GPRPE2 
Spearman's rho 
RestingPcahngeb
aseRx2 
Correlation Coefficient 1.000 -.341** 
Sig. (2-tailed) . .003 
N 73 73 
GPRPE2 
Correlation Coefficient -.341** 1.000 
Sig. (2-tailed) .003 . 
N 73 73 
**. Correlation is significant at the 0.01 level (2-tailed). 
308
 
30
8 
A
na
ly
si
s 
fo
r G
lo
ba
l R
at
in
g 
of
 P
er
ce
iv
ed
 C
ha
ng
e 
 
G
ro
up
 S
ta
tis
tic
s 
 
co
nd
iti
on
 
N
 
M
ea
n 
St
d.
 
D
ev
ia
tio
n 
St
d.
 E
rr
or
 M
ea
n 
G
R
PE
1 
1.
00
 
34
 
.6
76
5 
1.
74
02
6 
.2
98
45
 
2.
00
 
38
 
.5
13
2 
1.
72
61
4 
.2
80
02
 
G
R
PE
2 
1.
00
 
34
 
.6
10
3 
2.
22
17
9 
.3
81
03
 
2.
00
 
38
 
.8
28
9 
1.
69
76
8 
.2
75
40
 
G
R
PE
24
 
1.
00
 
34
 
1.
26
47
 
1.
93
54
6 
.3
31
93
 
2.
00
 
37
 
1.
17
57
 
1.
80
74
5 
.2
97
14
 
  
In
de
pe
nd
en
t S
am
pl
es
 T
es
t 
 
Le
ve
ne
's
 T
es
t f
or
 
Eq
ua
lit
y 
of
 
Va
ria
nc
es
 
t-t
es
t f
or
 E
qu
al
ity
 o
f M
ea
ns
 
F 
Si
g.
 
t 
df
 
Si
g.
 (2
-
ta
ile
d)
 
M
ea
n 
D
iff
er
en
ce
 
St
d.
 E
rr
or
 
D
iff
er
en
ce
 
95
%
 C
on
fid
en
ce
 In
te
rv
al
 
of
 th
e 
D
iff
er
en
ce
 
Lo
w
er
 
U
pp
er
 
G
R
PE
1 
Eq
ua
l v
ar
ia
nc
es
 a
ss
um
ed
 
.6
22
 
.4
33
 
.3
99
 
70
 
.6
91
 
.1
63
31
 
.4
09
06
 
-.6
52
53
 
.9
79
16
 
Eq
ua
l v
ar
ia
nc
es
 n
ot
 a
ss
um
ed
 
 
 
.3
99
 
68
.9
90
 
.6
91
 
.1
63
31
 
.4
09
25
 
-.6
53
12
 
.9
79
74
 
G
R
PE
2 
Eq
ua
l v
ar
ia
nc
es
 a
ss
um
ed
 
3.
86
4 
.0
53
 
-.4
72
 
70
 
.6
38
 
-.2
18
65
 
.4
63
23
 
-1
.1
42
53
 
.7
05
23
 
Eq
ua
l v
ar
ia
nc
es
 n
ot
 a
ss
um
ed
 
 
 
-.4
65
 
61
.5
12
 
.6
44
 
-.2
18
65
 
.4
70
14
 
-1
.1
58
60
 
.7
21
29
 
G
R
PE
24
 
Eq
ua
l v
ar
ia
nc
es
 a
ss
um
ed
 
.6
08
 
.4
38
 
.2
00
 
69
 
.8
42
 
.0
89
03
 
.4
44
20
 
-.7
97
12
 
.9
75
18
 
Eq
ua
l v
ar
ia
nc
es
 n
ot
 a
ss
um
ed
 
 
 
.2
00
 
67
.4
04
 
.8
42
 
.0
89
03
 
.4
45
50
 
-.8
00
09
 
.9
78
15
 
 309 
Correlations between GRPC and pain measures 
 
Correlation between change in PPT at the symptomatic level and Global 
Rating of Perceived Effect after treatment period 1. 
 
Correlations 
 PPTchnage
baserx1 
GRPE 
Spearman's rho 
PPTchnage
baserx1 
Correlation Coefficient 1.000 .271 
Sig. (2-tailed) . .121 
N 34 34 
GRPE 
Correlation Coefficient .271 1.000 
Sig. (2-tailed) .121 . 
N 34 34 
 
Correlation between change in verbal rating of pain on movement and 
Global Rating of Perceived Effect after treatment period 1. 
 
 
Correlations 
 GRPE VRSDiffBrx1 
Spearman's rho 
GRPE 
Correlation Coefficient 1.000 .057 
Sig. (2-tailed) . .748 
N 34 34 
VRSDiffBrx1 
Correlation Coefficient .057 1.000 
Sig. (2-tailed) .748 . 
N 34 34 
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Correlation between change in PPT at the symptomatic level and Global 
Rating of Perceived Effect after treatment period 2. 
 
 
Correlations 
 PPTchnage
baserx1 
GRPE 
Spearman's rho 
PPTchnage
baserx1 
Correlation Coefficient 1.000 -.065 
Sig. (2-tailed) . .692 
N 39 39 
GRPE 
Correlation Coefficient -.065 1.000 
Sig. (2-tailed) .692 . 
N 39 39 
 
Correlation between change in verbal rating of pain on 
movement and Global Rating of Perceived Effect after 
treatment period 2. 
 
 
Correlations 
 GRPE VRSDiffBrx1 
Spearman's rho 
GRPE 
Correlation Coefficient 1.000 .143 
Sig. (2-tailed) . .391 
N 39 38 
VRSDiffBrx1 
Correlation Coefficient .143 1.000 
Sig. (2-tailed) .391 . 
N 38 38 
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Correlation between change in PPT at the symptomatic level and Global 
Rating of Perceived Effect at 24 hour follow-up. 
 
Correlations 
 PPTChange
base24 
GRPE24 
Spearman's rho 
PPTChange
base24 
Correlation Coefficient 1.000 .256* 
Sig. (2-tailed) . .030 
N 73 72 
GRPE24 
Correlation Coefficient .256* 1.000 
Sig. (2-tailed) .030 . 
N 72 72 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
Correlation between change in verbal rating of pain on movement and 
Global Rating of Perceived Effect at 24 hour follow-up. 
 
Correlations 
 VRmvtDiff
base24 
GRPE24 
Spearman's rho 
VRmvtDif
fbase24 
Correlation Coefficient 1.000 -.534** 
Sig. (2-tailed) . .000 
N 73 72 
GRPE24 
Correlation Coefficient -.534** 1.000 
Sig. (2-tailed) .000 . 
N 72 72 
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Appendix 24 
Correlation between pain measures at baseline 
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Correlation between pain measures after treatment period 1 
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Correlation between pain measures after treatment period 2 
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Correlation between pain measures at 24-hour follow-up 
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Correlations between PPT and VRS in Treatment Responders 
 
 
Correlations 
 PPTChange
baseRx2 
VRmvtDiffbase
Rx2 
Spearman's 
rho 
PPTChangeb
aseRx2 
Correlation Coefficient 1.000 -.314 
Sig. (2-tailed) . .063 
N 36 36 
VRmvtDiffbas
eRx2 
Correlation Coefficient -.314 1.000 
Sig. (2-tailed) .063 . 
N 36 36 
Correlations 
 PPTChange
baseRx2 
RestingPcahng
ebaseRx2 
Spearman's rho 
PPTChangebase
Rx2 
Correlation Coefficient 1.000 -.084 
Sig. (2-tailed) . .627 
N 36 36 
RestingPcahngeb
aseRx2 
Correlation Coefficient -.084 1.000 
Sig. (2-tailed) .627 . 
N 36 36 
Correlations 
 PPTChange
baseRx2 
VRPAchnageb
aserx2 
Spearman's rho 
PPTChangebase
Rx2 
Correlation Coefficient 1.000 -.222 
Sig. (2-tailed) . .194 
N 36 36 
VRPAchnagebas
erx2 
Correlation Coefficient -.222 1.000 
Sig. (2-tailed) .194 . 
N 36 36 
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Appendix 25 
Chi –square analysis for PPT responders based on SEM/ MDC 
 
 
placebo v 2 minutes of treatment * Response to treatment 
Crosstabulation 
 Response to treatment Total 
responder non-responder 
placebo v 2 
minutes of 
treatment 
Placebo 
Count 7 26 33 
Expected Count 8.3 24.8 33.0 
Std. Residual -.4 .3  
2 minutes of 
treatment 
Count 11 28 39 
Expected Count 9.8 29.2 39.0 
Std. Residual .4 -.2  
Total 
Count 18 54 72 
Expected Count 18.0 54.0 72.0 
 
Chi-Square Tests 
 Value df Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .466a 1 .495   
Continuity Correctionb .168 1 .682   
Likelihood Ratio .470 1 .493   
Fisher's Exact Test    .590 .343 
Linear-by-Linear Association .460 1 .498   
N of Valid Cases 72     
 
 
 
 
1 minute v 6 minutes of treatment * Response to treatment 
Crosstabulation 
 Response to treatment Total 
responder non-responder 
1 minute v 6 
minutes of 
treatment 
short duration 
Count 5 28 33 
Expected Count 11.9 21.1 33.0 
Std. Residual -2.0 1.5  
long duration 
Count 21 18 39 
Expected Count 14.1 24.9 39.0 
Std. Residual 1.8 -1.4  
Total 
Count 26 46 72 
Expected Count 26.0 46.0 72.0 
 
 
 
hi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 11.601a 1 .001   
Continuity Correctionb 9.984 1 .002   
Likelihood Ratio 12.278 1 .000   
Fisher's Exact Test    .001 .001 
Linear-by-Linear Association 11.440 1 .001   
N of Valid Cases 72     
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Duration of treatment at 24 hours * Response to treatment 
Crosstabulation 
 Response to treatment Total 
responder non-responder 
Duration of 
treatment at 24 
hours 
short durationof 
treatment 
Count 5 28 33 
Expected Count 7.8 25.2 33.0 
Std. Residual -1.0 .6  
long duration of 
treatment 
Count 12 27 39 
Expected Count 9.2 29.8 39.0 
Std. Residual .9 -.5  
Total 
Count 17 55 72 
Expected Count 17.0 55.0 72.0 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. 
(2-sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 2.417a 1 .120   
Continuity Correctionb 1.629 1 .202   
Likelihood Ratio 2.487 1 .115   
Fisher's Exact Test    .166 .100 
Linear-by-Linear Association 2.384 1 .123   
N of Valid Cases 72     
 
 
 
 
Chi –square analysis for responders based on percentage change in PPT 
 
 
 
placebo v 2 minutes of treatment * Response to treatment Crosstabulation 
 Response to treatment Total 
responder non-responder 
placebo v 2 minutes of 
treatment 
Placebo 
Count 4 29 33 
Expected Count 6.4 26.6 33.0 
Std. Residual -1.0 .5  
2 minutes of 
treatment 
Count 10 29 39 
Expected Count 7.6 31.4 39.0 
Std. Residual .9 -.4  
Total 
Count 14 58 72 
Expected Count 14.0 58.0 72.0 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 2.086a 1 .149   
Continuity Correctionb 1.312 1 .252   
Likelihood Ratio 2.156 1 .142   
Fisher's Exact Test    .232 .126 
Linear-by-Linear Association 2.057 1 .152   
N of Valid Cases 72     
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1 minute v 6 minutes of treatment * Response to treatment 
Crosstabulation 
 Response to treatment Total 
responder non-responder 
1 minute v 6 
minutes of 
treatment 
short duration 
Count 4 29 33 
Expected Count 10.5 22.5 33.0 
Std. Residual -2.0 1.4  
long duration 
Count 19 20 39 
Expected Count 12.5 26.5 39.0 
Std. Residual 1.9 -1.3  
Total 
Count 23 49 72 
Expected Count 23.0 49.0 72.0 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. 
(2-sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 11.012a 1 .001   
Continuity Correctionb 9.393 1 .002   
Likelihood Ratio 11.793 1 .001   
Fisher's Exact Test    .001 .001 
Linear-by-Linear Association 10.859 1 .001   
N of Valid Cases 72     
 
 
 
 
 
 
 
Duration of treatment at 24 hours * Response to treatment 
Crosstabulation 
 Response to treatment Total 
responder non-
responder 
Duration of 
treatment at 
24 hours 
short duration of 
treatment 
Count 5 28 33 
Expected Count 8.3 24.8 33.0 
Std. Residual -1.1 .7  
long duration of 
treatment 
Count 13 26 39 
Expected Count 9.8 29.2 39.0 
Std. Residual 1.0 -.6  
Total 
Count 18 54 72 
Expected Count 18.0 54.0 72.0 
 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 3.152a 1 .076   
Continuity Correctionb 2.256 1 .133   
Likelihood Ratio 3.256 1 .071   
Fisher's Exact Test    .103 .065 
Linear-by-Linear Association 3.108 1 .078   
N of Valid Cases 72     
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Chi –square analysis for responders based on change in Verbal 
rating of pain on movement 
 
 
RespondVRS * Longshort Crosstabulation 
Count 
 Longshort Total 
1.00 2.00 
RespondVRS 
1.00 25 28 53 
2.00 8 9 17 
Total 33 37 70 
Chi-Square Tests 
 Value df Asymp. 
Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .000a 1 .994   
Continuity Correctionb .000 1 1.000   
Likelihood Ratio .000 1 .994   
Fisher's Exact Test    1.000 .608 
Linear-by-Linear 
Association 
.000 1 .994 
  
N of Valid Cases 70     
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
8.01. 
b. Computed only for a 2x2 table 
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Chi Square analysis of expectations of responders 
 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
respnonresp * 
expectations 
72 100.0% 0 0.0% 72 100.0% 
 
 
respnonresp * expectations Crosstabulation 
Count 
 expectations Total 
.00 1.00 2.00 
respnonresp 
1.00 16 16 3 35 
2.00 20 14 3 37 
Total 36 30 6 72 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square .523a 2 .770 
Likelihood Ratio .523 2 .770 
Linear-by-Linear Association .335 1 .562 
N of Valid Cases 72   
a. 2 cells (33.3%) have expected count less than 5. The minimum expected 
count is 2.92. 
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Appendix 26. Questionnaire analysis  
 
 
 
Expectations of treatment 
 
Reduce pain Increased ROM Reduced 
pressure/stiffness 
tension/ stretching 
Identify source of 
symptoms 
Short term 
effect 
10, 17, 18, 19, 21, 
24, 25, 27, 29, 30, 
32, 35, 38, 44, 47, 
58, 61, 66, 68, 73 
9, 10, 17, 24, 27,  
32, 36, 49 
4, 8, 20, 23, 29 3, 7, 21, 22, 33, 
35, 48, 54, 55 
1, 27, 44 
=20 =8 =5 =9 =3 
 
 
Expectations of Pain during treatment 
 
Low expect of 
outcome 
Expect to then 
improve 
Kill or cure 
37, 41, 69 49, 61 51, 54 
=3 =2 =2 
 
Expected more complex treatment – 5, 8, 50, 67,11,17, 25, 27, 41. 
 
 
 
Experience of mobilisation treatment 
 
Painful treatment Reducing 
pain during 
treatment 
Painful 
during 
better after 
Increased 
pain / 
tightness 
after 
Reduced 
pain 
Sore 
immediately 
after then 
better 
4, 5, 7, 14, 19, 
23, 24, 28, 32, 
38, 39, 46 
48, 52, 54, 65, 
68, 70, 71, 16 
14, 29, 36, 
44, 58, 61, 
64, 73 
4, 8, 14, 
27, 29, 36, 
88, 61, 65 
17, 23, 29, 
31, 33, 35, 
42, 43, 60, 
64 
1, 3, 7, 8, 
10, 11, 19, 
20, 21, 27, 
38, 44, 46, 
52, 
58, 61, 69, 
71, 72 
27, 28 
=20 =8 =9 =10 =19 =2 
 
 
 
 
 
 
 
 
 
  
Expectations of mobilisation treatment 
 
Positive neutral Low 
4, 9, 10, 17, 18, 19, 21, 23, 
24, 25, 27, 28, 29, 30, 32, 
35, 36, 38, 39, 44, 47, 49, 
53, 57, 61, 65, 66, 68, 72, 16 
2, 3, 4, 5, 6, 7, 8, 11, 12, 13, 
14,15, 20, 22, 26, 31, 33, 34, 
37, 40, 42, 43, 45, 46, 48, 50, 
51, 54, 55, 59, 60, 63, 64, 70, 
71 
1, 16, 37, 41, 52, 58, 67, 69 
=30 =34  =8 
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Perceived beneficial effects of mobilisation treatment 
 
Reduced 
stiffness 
Reduced 
pressure/ 
tightness 
Increased 
movement 
“improvement” 
effective 
7, 12, 19 3, 6, 8 1, 8, 10, 14, 
16, 20, 27, 
28, 49, 55, 
16 
1, 12, 13, 18, 25, 26, 34, 
36, 37, 39, 43, 44, 46, 63, 
67 
 
=3 =3 =11 =15 
 
 
Perceived effects of mobilisation treatment 
Minimal 
effect 
Short term 
relief 
Not sure None 
2, 5, 48, 
50, 66, 68 
22, 23, 24, 
32, 44, 45, 
47, 57 
29, 33, 46, 
50, 33, 58, 
65, 68, 70, 
72 
15, 18, 40,  
41, 52, 59 
=6 =8 =10 =6 
 
 
Comfortable 33, uncomfortable 13 
Relaxing: 4, 18, 25, 27, 28, 34, 36, 43, 50, 64, 65, 69 
Commented on PPT: 7, 9, 33, 40, 60,  
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Have you had previous experience of receiving this 
mobilisation technique. Please describe any previous 
mobilisations that you have had. 
 
No. But, I have had physio on my back using different 
techniques: ITB release, stretching programme and IR 
lamp. P1 
 
No P2 
No P3 
No P4 
No P5 
 
No. General massage at Physiotherapists P6 
 
No P7 
No P8 
 
Yes – Previous physiotherapy when my back has gone into 
spasm P9 
 
Yes: Osteopathy, chiropractor and Physiotherapy P10 
 
No – being pulled about by a chiropractor P11 
 
No P12 
No P13 
No P14 
No P15 
No P17 
No P18 
 
I had approximately 3 years of osteopathy P19 
 
No P20 
No P21 
No P22 
 
Yes, 2 years ago I went to a chiropractor for the first time 
for 3 sessions P23 
 
No P24 
 
No, Mobility drills pre exercise P25 
 
Yes, Kneading, needling of lower back from previous 
physio treatments, specific stretching to prevent pain P26 
 
No P26 
No P27 
No P28 
No. I have had some mobilisation on my upper back by an 
osteopath, but mostly manipulation of thoracic spine. As a 
physio student I have had other students practicing on me 
P29 
 
No Sacroiliac manipulation P30 
No, only with the osteopath, but not the same P31 
Similar mobilisations in lecture as Physio student P32 
No P33 
No – introduction to alexander technique P34 
No P35 
 
Yes, I had mobilisation technique on both lumbar and 
cervical spine, from prone, same as this one P36 
 
No P37 
No P38 
No P39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Previous Rx not mobilisations 
Stretching  
Electrotherapy 
 
 
 
 
 
Massage 
 
 
 
 
 
Mobilisations 
 
Mobilisations 
Chiro/osteo 
 
‘Pulled about’ 
chiro 
 
 
 
 
 
 
 
Osetopath 
 
 
 
 
 
Chiro did 
 
 
 
 
Home exercises 
 
Massage 
Acupuncture 
Stretching 
 
 
 
Mobilisation and manip 
Osteopath 
PT student experience 
 
 
Manip 
Osteopath 
PT student – not as patient 
 
Alexander technique 
 
 
 
Mobilisations 
 
 
 
 
 
 325 
Back manipulation through osteopath, massage and physio 
exercise stretching P40 
 
No. chiropractor intervention, osteopathic treatment P41 
No manipulation by osteopath P42 
No P43 
No P44 
Yes P45 
No P46 
No P47 
No P48 
Yes, have had previous treatment to neck and upper back 
P49 
No P50 
No P51 
No 52 when I had my car accident, manipulation on my 
back and top of my spine. In the early days of my back 
injury I was placed in certain positions and my body was 
pressed down on and my back creaked sometimes. 
P53 No 
No P54 
No P55 
Sports massage P57 
No P58 
 
No P59 
No P60 
Yes. I am a physiotherapist so I have had experience of 
mobilisation technique being applied to me. I never had 
any previous experience of receiving mobilisation 
technique as a treatment. P61 
 
No P63 
No P4 
Yes, massage to the sides of my back P65 
 
No P66 
No P67 
No P68 
NoP69 
NoP70 
No P71 
Yes. A physio applied pressure /massage to several 
specific points on my back (until it felt numbed) if not the 
mobilisation technique it was similar. P72 
 
NoP73 
Yes, I have had experience as a physiotherapist of 
applying mobilisations. I have also received treatment 
using mobilisations by another therapist. P74 
 
 
 
 
 
 
What were you expecting from having this 
‘mobilisation technique’ applied on this occasion? 
 
 
Low expectation due to previous treatment being either 
ineffective or only of short term benefit. P1 
 
I wasn’t sure what to expect, other than just measuring and 
assessing the level of pain rather than any treatment P2 
 
I expected that the pain/problem would be identified first. 
When this was done, I assumed the ‘mobilisation 
technique’ would then be applied to the specific targeted 
where the pain originates from. P3 
 
That it would release pressure and tension in my lower 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-ve 
 
 
 
neut 
 
 
 
Neut 
 
 
+ve 
Manip osteo 
Massage and stretching physio 
 
Chiro/oseto 
 
Osteo 
 
 
 
 
 
Mobilisations 
 
 
 
 
Mobilisations and manipulation 
 
 
 
 
Massage 
 
 
 
 
 
Is a Physio. Had mobs but not 
as a patient 
 
 
 
 
 
Massage 
 
 
 
 
 
 
 
Physio mobilisations 
 
 
 
 
Is a Physio has received mob as 
a patient 
 
 
 
 
 
 
 
 
 
 
 
Low expectation 
Previous Rx ineffective 
Short term  
 
Unformed expectations. 
Monitoring of pain expected 
 
ID location of pain. Rx targeted 
at problem area 
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back P4 
 
I did not expect it to cure my back pain, but understood 
that it was part of a scientific study. P5 
 
I expected maybe a little more twisting of my back P5 
 
No expectations, completely open-minded P6 
 
Expected to locate the location of the pain and to see what 
movements caused the pain to happen P7 
 
Was expecting a release of pressure and pain from my 
lower back. I was also expecting the mobilisation 
technique to be more complex (more involvement from the 
physio) as it seems quite a simple exercise (i.e. applying 
pressure to the sore point). P8 
 
To give me increased movement P9 
 
Reduction in discomfort and better movement and better 
strength P10 
 
No idea what to expect P11 
 
Not sure what I was expecting P12 
 
I really didn’t know as I wasn’t aware of which technique 
would be applied P13 
 
No expectations P14 
 
Was not expecting anything P15 
 
Relief from the pain and increase in movement in my 
lower back P17 
 
Hopefully relief from the discomfort P18 
 
Hopefully that it may help alleviate some of the 
discomfort I experience. Also to gain advice about 
strategies that may help in the future P19 
 
I was unsure exactly what to expect. I suppose a degree of 
stretching was expected, however, the technique used was 
different to anything I have had in previous treatments P20 
 
 
Find out where problem is and hopefully establish method 
for maintaining decreased pain P21 
 
Didn’t know what to expect really, thought it might be 
more like making my spine do a range of movements, 
rather than pushing on spine P22 
 
I wanted to see if this technique would give some release 
to the tightness of my lower back P23 
 
Ease in pain, enable movement to become more 
comfortable. Loosen my back which feels tight P24 
 
Pain relief P25 
 
Different techniques from what I experienced previously 
to treatment of lower back pain P26 
 
Perhaps relief of symptoms of LBP, with an increased 
range of movement. I did not expect full recovery given 
just one treatment and the fact the pain is intermittent at 
times P27. 
 
Ideally some level of pain relief or increased movement. 
 
 
neut 
 
 
neut 
 
neut 
 
neut 
 
 
 
Neut 
 
 
 
 
+ve 
 
+ve 
 
 
neut 
 
neut 
 
neut 
 
 
neut 
 
neut 
 
+ve 
 
 
+ve 
 
+ve 
 
 
 
Neut 
 
 
 
 
 
+ve 
 
 
Neut 
 
 
+ve 
 
 
+ve 
 
 
+ve 
 
neut 
 
 
 
+ve 
 
 
 
 
Reduce pressure/tension 
 
 
Not expected to help 
 
Expected more vigorous Rx 
 
Unformed expec 
 
Expected to ID location of pain 
 
 
 
Reduced pressure experienced 
 
Expected more complex rx 
 
 
Increased movement 
 
Increased movement 
Reduced pain 
 
Unformed 
 
Unformed 
 
Unformed 
 
 
Unformed 
 
Unformed 
 
Increased movement reduced 
pain 
 
Reduced pain 
 
Reduced pain 
Advice for the future 
 
 
Unformed 
Stretching 
 
 
 
Identify problem 
Reduced pain long term 
 
Expected more complex 
technique 
 
 
 
Reduced tightness 
 
Loosen back 
Reduce pain 
 
Reduced pain 
 
 
 
 
Reduced pain 
Increase movement 
Short term effect 
 
 
Reduced pain 
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To possibly learn more about how to manage my back 
pain/what therapy to pursue. P28 
 
That it would reduce the feelings of stiffness and 
discomfort in my lower back P29 
 
To reduce the symptoms of long term back pain P30 
 
Unsure P31 
 
Slight reduction in pain, slight increase in mobility P32 
 
I expected concentration on upper legs and gluts opposed 
to knee/foot. I expected to understand the source of my 
pain more and have it surface more prominently P33 
 
No expectations P34 
 
The reason for my pain to be identified. Treatment of my 
pain P35 
 
I’d like to start to move better and I think with 
mobilisations and my trying, I can achieve that P36 
 
Expecting to feel a lot of pain when pressure applied. 
Didn’t expect that it would have much effect P37 
 
I was expecting this technique to have some sort of heavy 
pressure been applied to my back. Overall I expected this 
technique to relieve some of the pain P38 
 
That it would help relieve some of my back pain P39 
 
Some analysis between previous results P40 
 
To experience pain. To help find causation of back 
troubles P41 
 
I didn’t have any expectations P42 
 
I wasn’t sure at all what it would be like P43 
 
Brief and mild alleviation of back pain. Not lasting, short 
term fix P44 
 
No expectations P45 
 
Don’t know P46 
 
Help with pain P47 
 
To find the area of the body that would help in identifying 
the problem of pain P48 
 
To expect some discomfort as pressure is applied but to 
hopefully achieve freer movement after P49 
 
I thought there might be more pressure involved P50 
 
No real expectations but I assumed it might either hurt a 
lot, make a boney noise or solve the situation, either kill or 
cure P51 
 
I was surprised at the technique. I have never had this done 
before. I did not quite know what to expect. I did expect 
pain to come at some threshold. P52 
 
Pain relief P53 
 
To find exactly where the point of the pain is and increase 
it or decrease it P54 
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Long term strategy 
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Reduced stiffness 
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Reduced pain 
Increased movement 
Low expect 
 
Understand s of s 
 
 
 
Understand reason for pain 
Reduced pain 
 
Increased movement 
 
 
Expecting to feel pain 
Low expectations 
 
 
Reduced pain 
 
 
Reduced pain 
 
 
 
Find s of s  
Expected treatment to be 
painful 
 
 
 
 
Reduced pain 
Short term 
 
 
 
 
 
Reduced pain 
 
Find s of s 
 
 
Painful Rx 
Increased movement 
 
More pressure 
 
Kill or cure 
Pain and clicking 
 
 
Expected painful Rx 
 
 
 
pain relief 
 
find s of s 
increase or decrease pain 
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To find the cause of my discomfort P55 
 
Less pain P57 
 
A degree of pain/tenderness in my lower back P58 
 
Wasn’t sure what to expect P59 
 
Not sure what to expect P60 
 
I was expecting to have reduction of my back pain. I was 
also expecting to experience some pain during the 
application of the technique P61 
 
I had no expectations regarding either the technique or the 
outcomes P63 
 
Didn’t really give it a thought, just thought it was part of 
the test P64 
 
In the beginning I expected to relax me or stop any pain, 
but when the technique was applied it felt uncomfortable 
like it was the cause of the pain P65 
 
Pain relief P66 
 
I couldn’t possibly imagine a simple movement could 
prevent the pains I have been sustaining P67 
 
I am hoping that the findings from this will help me with 
the pain in my back eventually going P68 
 
That I would not relax during the technique, therefore feel 
anxious about having pressure applied in the area. I was 
expecting the technique to increase the pain slightly P69 
 
I didn’t know what to expectP70 
 
The second time when asked to bend backwards I did not 
feel the pain in my low back P71 
 
For the muscle area to feel malleable (and warm) after a 
while P72 
 
Relief from pain P73 
 
I was expecting a force to be applied to a segment of my 
spine in a specified direction and for my pain to be 
replicated. I was then expecting this symptomatic segment 
to be repeatedly mobilised for a set duration P74 
 
 
 
 
Was there anything that you didn’t expect about the 
mobilisation technique? If so, what happened that you 
didn’t expect? 
 
 
I had no real preconceptions and an open mind, so nothing 
that I didn’t expect really. My only observations are that 
the treatments were shorter than I would expect. 30 
seconds of pressure. My only other slight surprise was that 
it worked (seemingly) so effectively! P1 
 
The amount of pressure applied was much stronger than 
I’d expected P2 
 
I felt the technique had an almost immediate “calming” 
effect on the specific painful area. I wasn’t expecting the 
procedure to ease the pain that quickly. P3 
 
Neut 
 
+ve 
 
-ve 
 
neut 
 
Neut 
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neut 
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+ve 
 
-ve 
 
 
+ve 
 
 
-ve 
 
 
 
neut 
 
neut 
 
 
+ve 
 
 
+ve 
 
 
neut 
 
 
find s of s 
decreased pain 
 
painful rx 
 
 
 
 
 
 
Reduced pain but pain during 
technique 
 
 
 
 
 
 
 
 
+ve expect / -ve experience. 
Didn’t expect painful rx 
 
 
Pain relief 
 
More complex technique 
 
 
Reduced pain 
 
 
To feel anxious 
Painful rx 
 
 
 
 
 
 
 
 
to feel warm 
 
Pain relief 
 
Physio known expectation 
 
 
 
 
 
 
 
 
 
 
 
 
Unformed expectations 
Expected more treatment 
Surprisingly effective 
 
 
Stronger pressure than  
expected 
Massage 
 
‘calming effect’ 
“I wasn’t expecting it to ease 
the pain that quickly’ 
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That it got more painful, opposite to what I thought as it 
was taking place P4 
 
No P5 
 
The use of the instrument to apply the pressure P6 
 
Didn’t expect to feel the lower back pain in my hip area 
when the source of the pain feels like it’s in a different 
place (towards lower spine). P7 
 
Didn’t expect the muscle around my lower spine to be so 
tight initially, but also to relax so much as they did after 
the mobilisation technique. P8 
 
Discomfort in the front pelvic area when maximum 
pressure (of the 3) was applied yesterday…a type of 
muscular pain/discomfort. P9 
 
Felt better, out of pain, and a lot more comfortable, 
healing hands P10 
 
Thought it might be more active and not so gentle P11 
 
Pressure testing was a new experience for me P12 
 
No as I was prepared for any technique to be applied, but I 
am pleasantly surprised about how effective they have 
been how quickly P13 
 
-P14 
 
No P15 
 
Thought there would be more involved in this technique 
P17 
 
No, I just went along with it P18 
 
It was short in time. I anticipated a technique may need 
longer time in application or duration over time P19 
 
No, again as I was unsure what would be involved. I 
certainly didn’t expect the technique to be centered on a 
few very precise areas across such a wide area P20 
 
No P21 
 
Didn’t expect pushing on spine P22 
 
I didn’t expect for the next day to be tight and tense. This 
however could be due to other factors (carrying heavy 
bags). P23 
 
I didn’t expect the pressure point on my legs, shoulder and 
feet. These points were just pressured until I felt anything 
other than pressure such as pain or discomfort P24 
 
How straight forwards it was P25 
 
Measurements of exact pressure being applied, esp to parts 
other than the back P26 
 
I had no expectations or previous experience in the 
technique. Perhaps thought it wouldn’t be so isolated. 
However this would be due to inexperience and the nature 
of the pain in the first place P27 
 
-P28 
 
I didn’t expect the ache and discomfort in my back to be as 
 
More painful than expected 
 
 
 
 
PPT measures 
 
Referral of pain to another area 
 
 
 
Didn’t expect muscle to relax 
as much 
 
 
 
Referral of pain to another area 
 
 
Less pain “healing hands’ 
 
Expected more vigorous 
technique 
 
PPT 
 
Surprised how effective how 
quickly. 
 
 
 
 
 
 
Expected more complex 
technique 
 
 
 
Expected longer treatment 
 
 
 
 
 
 
 
 
Didn’t expect pushing on spine 
 
Didn’t expect tightness the next 
day 
 
 
PPT 
 
 
Expected more complex 
technique 
 
PPT 
 
 
Didn’t expect such an isolated 
technique 
 
 
 
 
 
Didn’t expect ache immediately 
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strong in the immediate period afterwards P29 
 
No P30 
 
You wonder if/when the pain will kick in P31 
 
No P32 
 
I didn’t expect an immediate painless recovery – this 
didn’t happen. I didn’t expect to be stiffer today (D2) P33 
 
Repetitive Pressure point test a surprise P34 
 
No P35 
 
No P36 
 
No, I didn’t expect anything during the technique P38 
 
Didn’t really know what to expect but it was fine P39 
No P40 
 
Expected more manipulation P41 
 
I had no expectations P42 
 
After each session my back did feel a little easier P43 
 
Reduced discomfort for longer than was expecting P44 
 
No P45 
 
Changes to where and how much I felt the pain afterwards, 
including during and after exercises P46 
 
No P47 
 
Drawing the nerve points and applying pressure P48 
 
No P49 
 
Less invasive P50 
 
It was longer than anticipated and repetitive rather than 
one movement P51 
 
The sharp pain quite central when it did come. P52 
 
Pain increase P53 
 
I had no expectations P54 
 
Nothing I didn’t expect from this technique P55 
-P57 
 
Pain seemed to decrease with time spent applying this 
technique P58 
 
As above P59 
 
Not really as I didn’t know what to expect in the first place 
P60 
 
I didn’t expect to become painfree after the application of 
the technique for 2-3 minutes. I didn’t expect that the 
result would last until the next day. P61 
 
 
No P63 
-P64 
The technique made quite a change in the sense of pain 
P65 
after 
 
 
 
Anticipating pain 
 
 
Didn’t expect immediate 
recovery 
Didn’t expect stiffness the next 
day. 
 
PPT 
 
 
 
 
Unformed 
 
Unformed 
 
 
Expected more complex 
technique 
 
 
It did feel easier 
 
It reduced pain more than 
expected 
 
 
Helped more than expected 
 
 
 
 
PPT 
 
 
 
 
 
Longer than expected 
 
 
Pain 
 
Pain increase 
 
Unformed 
 
 
 
 
Reducing pain 
 
 
 
 
Unformed 
 
 
Didn’t expect relief of pain 
lasting until the next day 
 
 
 
 
Changed pain more than 
expected 
 
 331 
-P66 
To have so much improvement P67 
-P68 
 
I did relax, and did not worry about having the pressure 
applied. It did not expect the technique to be so 
concentrated and I enjoyed the release of the pressure in 
the area P69 
 
No P70 
 
The second time when asked to bend backwards I did not 
feel the pain in my low back. I did not expect this. P71 
 
I didn’t expect the lack of pressure, ie under the threshold 
of 1 on a pain scale P72 
 
Heat P73 
 
The duration of mobilisation P74 
 
 
What were you thinking and feeling when the 
mobilisation technique was applied? 
 
Thinking- nothing specific. 
Feeling – from an emotional perspective nothing of note.  
P1 
 
It felt like I was being squashed and was fairly 
uncomfortable P2 
 
I was trying to relax my muscles as much as possible when 
the technique was being applied. During the technique I 
felt a degree of pressure being applied to the area. P3 
 
Trying to understand how it works on the back P4 
It was quite relaxing but slightly painful P4 
 
I was feeling a bit of pain/discomfort, I wasn’t really 
thinking anything about it. P5 
 
Confidence in the operator P6 
 
I was mainly concentrating on when I felt the pressure 
changed to pain. I don’t remember having any particular 
feelings at the time P7  
 
I felt a release of pressure from the lower back region P8 
 
Wondering if it would increase the leg discomfort/ 
awareness in my right calf and toes P9 
 
Is this going to hurt? What clicks are going to happen? Am 
I going to get better or worse? P10 
 
That it seemed like a good way to ease the problem P11 
 
Was wondering what was going to be done. I was pleased 
it did not involve lots of manipulation P12 
 
I was just trying to stay relaxed and let the applications 
take place as I have a lot of trust and belief in 
physiotherapy P13 
 
When the pressure was applied at first I felt the pain I had 
been experiencing but after the second time I felt it release 
P14 
 
Nothing in particular P15 
 
The movement and pressure was quite light, thought it 
 
Didn’t expect so much 
improvement 
 
Enjoyed release of pressure 
 
 
 
 
 
 
Didn’t expect relief of pain on 
movement 
 
 
Expected more pain 
 
 
 
 
Duration  
 
 
 
 
 
 
 
 
Felt squashed and 
uncomfortable 
 
Pressure 
 
 
Relaxing but painful 
Trying to understand how it 
works 
 
Feeling pain 
 
 
Confidence in Physio 
 
PPT 
 
 
 
Reduced pressure 
 
PPT 
 
 
Is it going to hurt, am I going to 
get better or worse 
 
 
Pleased it did not involve 
manipulation 
 
 
Confidence and trust in physio 
 
 
 
Released pain 
 
 
 
 
 
Not complex 
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would be more involved P17 
 
I was feeling at ease and thinking about relieving he 
discomfort P18 
 
Feeling some slight increase in discomfort with one of the 
techniques. Have been interested in technique and how it 
may help P19 
 
I was feeling uncertain as to how the technique worked 
and what effects it would have. I was thinking that there 
would be more pain involved! P20 
 
Pleasant and decreasing pain and warm P21 
 
Wondering how this could help P22 
 
The pressure felt like it was pinning the point of pain and I 
thought that this technique would provide relief from 
present back issues P23 
 
The pressure and pain it was causing P24 
 
I was thinking I hope this works and feeling relaxed P25 
 
Where and when exactly the pain I experience occurs, and 
how to explain/feedback most accurately P26 
 
I tried to feel relaxed and clear my thoughts. I felt mild 
discomfort during application however with a satisfying 
‘massage’ sensation through the origin of the pain P27 
 
Relaxing sensation despite the pain that was generated P28 
 
I found that the pain decreased as the technique was 
applied and it was quite comfortable, pleasant experience 
by the end. Initially the pressure was uncomfortable P29 
 
I didn’t realize it was happening P30 
 
Comfortable P31 
 
Concentrating on type and level of pain and discomfort 
P32 
 
Sometimes drifting off the fact I was feeling any pressure. 
A change of mindset creates a gap in the sensation. 
Suddenly it reintroduces itself P33 
 
Trying to relax P34 
 
Was slightly painful, but was as expected thinking whether 
there is anything that can be done for the pain P35 
 
I was focused on the pain in the beginning. As the 
mobilisation was continued I felt somehow better and I 
was just relaxed. I didn’t have any thoughts P36 
 
Whilst pressure was being applied and increased I was 
thinking the pain would get worse, and when it didn’t, 
thought to myself the worst pain must be related to certain 
movements P37 
 
My back felt more relieved than normal and just felt as my 
back was in a relaxation mode P38 
 
It hurt slightly but felt good P39 
 
Pressure and discomfort threshold P40 
 
Focusing on back and levels of discomfort P41 
 
 
 
Relaxed thinking about pain 
relief 
 
Increased pain 
How the technique will work 
 
 
How the technique will work 
Expecting more pain 
 
 
Decreasing pain 
 
How the technique will work 
  
Pain relief 
 
 
Caused pain 
 
Hope it works 
Relaxed 
 
Concentrating on pain 
 
 
Relaxed 
Discomfort 
‘Satisfying massage’ 
 
relaxing despite pain 
 
painful initially, then quite 
comfortable 
 
 
 
 
Comfortable 
 
Concentrating on pain 
 
 
 
 
 
Trying to relax 
 
Painful 
Will this help 
 
 
Pain, decreasing pain as it 
continued 
Relaxed 
 
Pain 
 
 
 
 
Relaxed 
 
 
Painful 
 
PPT 
 
Concentrating on Pain 
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What will these tests show P42 
 
It was quite soothing and relaxing P43 
 
Was unsure how to react, but thought it was working even 
if only a little bit. Felt a bit more comfortable on last 
application of the technique than on the first P44 
 
Temporary relief P45 
 
Increase in pain sensation in affected area P46 
 
Concentrating on the process and feeling in my back P47 
 
Interested in the treatment and trying to concentrate on the 
exact point of pain P48 
 
That it was uncomfortable but that it would hopefully 
reduce pain and tension in lower back P49 
 
Quite relaxed P50 
 
I was hoping it would enable my back to heal P51 
 
I was concentrating on waiting for it to cause me pain. 
Quite focused. P52 
 
Nothing in particular P53 
 
How interesting it was to be able to find the exact point 
where my pain is P54 
 
I was thinking in a positive way that this technique would 
do some good. And feeling pretty upbeat about it P55 
 
Very gentle P57 
 
I thought that it wasn’t hurting particularly, that it wasn’t 
unpleasant P58 
 
This doesn’t hurt P59 
 
Was wondering how it could improve my back pain and 
also wondering how pressure to the lower leg/ foot area 
could help P60 
 
That is localized on the area where my most pain is. I was 
feeling the pain to be reduced during the application of the 
mobilisation technique P61 
 
It felt good and seemed to ease the pain a bit P63 
 
Playing golf. Just relaxing P64 
 
Sometimes relaxing but sometimes it was uncomfortable 
P65 
 
Fine P66 
 
How could this possibly work P67 
 
Just hoping all this is going to help me and did feel pain 
when pressure was applied P68 
 
I relaxed, actually felt calmer. I can’t recall many thoughts 
at the time of the technique, probably because I did relax. I 
concentrated on the pressure that was being applied and 
how this was making me feel, which was good, ie I felt my 
mood lift P69 
 
Whether the pain was increasing or decreasing P70 
 
 
Relaxing 
 
 
More comfortable as the 
technique continued 
 
Relief 
 
Pain 
 
Concentrating 
 
 
Interested in RX 
Concentrate on pain 
 
Uncomfortable 
Reduced pain and tension 
 
Relaxed 
 
 
 
Pain 
 
 
 
 
 
 
 
Thinking it would help 
 
 
 
 
 
 
 
 
How it would work 
 
PPT 
 
 
Reducing pain 
 
 
 
Reducing pain 
 
 
Relaxing 
 
Relaxing 
 
 
 
How it could work 
 
Pain 
 
 
 
Relaxed 
 
 
 
 
Pain 
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Thinking that I didn’t know the particular point in my 
lower back was sore as the pain is referred around my 
lower back P71 
 
I was thinking I could feel the pressure but it was very 
light, like I should be reacting, but there was nothing to 
react to P72 
 
Be careful !! P73 
 
That is was tolerable and to feedback to the therapist as 
accurately as possible P74 
 
How comfortable was the technique? 
 
It was painful but in a sort of nice way that makes you feel 
it is working. A good pain. Felt nice. P1 
 
Fairly uncomfortable but tolerable if it achieves a result. 
P2 
 
The technique I felt was comfortable enough and I never 
once felt as if the pain/tension became too much too take. 
P3 
 
Quite comfortable until the pressure was increased P4 
 
Fairly comfortable, it hurt though when the pressure 
increased P5 
 
Fine P6 
 
Fine. Positioning on the bed was comfortable. Didn’t feel 
anything until the pressure increased to the point when I 
pressed the button. My ankle point could hardly take any 
pressure. P7 
 
The mobilisation technique itself was fine, there was no 
discomfort during the application P8 
 
Gave a relieving feeling in my lower back whilst being 
applied. Laying prone was not comfortable as a starting 
position and neither was the face hole which distracts from 
relaxing P9 
 
Very comfortable and relaxing P10 
 
Very comfortable really P11 
 
It was not at all painful, was just a little uncomfortable P12 
 
Quite comfortable. I could feel the amount of pressure 
being applied but it didn’t cause me any concern at all and 
no discomfort P13 
 
Relieving P14 
 
Not uncomfortable P15 
 
Fine, felt comfortable P17 
 
Apart from the pressure reading, it was reasonably 
comfortable P18 
 
Only very minor discomfort, but not an issue P19 
 
Very comfortable in most cases, except the lower leg and 
toe, which I found to be quite painful. The effects wore off 
very quickly though P20 
 
Very P21 
 
 
Referral of pain 
 
 
 
 
 
 
e careful!! 
 
 
 
 
 
 
Nice pain 
Feels it’s working 
 
Tolerable if it works 
 
 
Comfortable 
 
 
 
Comfortable 
 
Comfortable 
 
 
 
 
PPT 
 
 
 
 
Comfortable 
 
 
Relieving in low back. But 
position on plinth 
uncomfortable. 
 
 
Comfortable/relaxing 
 
Comfortable 
 
A little uncomfortable 
 
 
Comfortable 
 
 
Relieving 
 
Comfortable 
 
Comfortable 
 
PPT 
Comfortable 
 
Minor discomfort 
 
Comfortable 
PPT’s 
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Little bit of increased pain, but final one was almost 
relaxing, felt a bit sleepy P22 
 
It was pressured but not uncomfortable during the session 
P23 
 
It was not comfortable when the pressure was applied 
because the area is sore and sensitive. However it felt 
somewhat relieving P24 
 
Very comfortable P25 
 
Comfortable mostly, except when large amounts of 
pressure is applied to local point where I experience pain 
P26 
 
Generally ok, slight/mild discomfort, particularly during 
the start P27 
 
As the treatment continued it became more comfortable 
and less painful (started off tender to the touch). Did 
however give pain down the thigh also P28 
 
Yes although initially it was uncomfortable P29 
 
Very P30 
 
Same, as was sore in the afternoon /evening after P31 
 
 
Very comfortable P32 
 
A little uncomfortable on some muscles P33 
 
Not particularly, but not painful P34 
 
Was comfortable to start with, but after a while it became 
relaxing. P35 
 
It was uncomfortable the first seconds but then it was ok 
P36 
 
Fairly comfortable. Pain never felt like it would be too 
much to handle P37 
 
From a scale 1-10 I would say 8 P38 
 
Slightly painful but nothing extreme P39 
 
Minimal discomfort P40 
 
Very comfortable P41 
 
Fine P42 
 
See above P43 
 
More comfortable towards the end. Some spikes of 
increase pain which subsided when pressure was reduced 
P44 
 
Comfortable P45 
 
Reasonable – although an increase in pain at the time, not 
excessively painful P46 
 
Very P47 
 
Not too bad bearable P48 
 
It was uncomfortable but not painful P49 
 
Bit of pain 
Sleepy 
 
Comfortable 
 
 
Comfortable relieving 
 
 
 
Comfortable 
 
 
Mostly comfortable 
 
 
Slight discomfort 
 
 
Comfortable 
 
 
 
Initially uncomfortable 
 
Very comfortable 
 
Sore in afternoon /evening 
 
 
Very comfortable 
 
PPT 
 
 
 
Comfortable/ relaxing 
 
 
Uncomfortable to start with 
 
 
Comfortable 
 
 
Slight pain 
 
Slight pain 
 
Minimal discomfort 
 
Comfortable 
 
 
 
 
 
Pain>comfort 
 
 
 
Comfort 
 
 
 
 
 
 
Bearable 
 
Uncomfortable but not painful 
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It was quite comfortable P50 
 
It was a bit uncomfortable at the beginning but this wore 
off the more it was applied P51 
 
Not very comfortable at all. P52 
 
OK P53 
 
It was not uncomfortable per say, but as it was a way to 
find my pain spot I would not  catagorise it as comfortable 
either, therefore all I can say is that it did it’s purpose P54 
 
The mobilisation technique was fairly comfortable P55 
 
Painless P57 
 
Quite comfortable and fairly pleasant P58 
 
Fine P59 
 
Reasonably comfortable P60 
 
Very (although it was partially reproducing my pain) P61 
 
Very comfortable P63 
 
The first session was a bit uncomfortable but as the 
pressure reduced it was relaxing P64 
 
On a scale of 1-10  I would say 6.5 although it was 
confortable sometimes it felt slightly painful P65 
 
Fine P66 
 
Reasonable. Getting both arms behind your back in not the 
easiest technique P67 
 
Completely bearable P68 
 
The technique felt comfortable P69 
 
Not uncomfortable P70 
 
It was fairly comfortable P71 
 
Yes P72 
 
At the beginning not very comfortable then the pain eased 
off P73 
 
Touching on pain but otherwise comfortable P74 
 
 
What effect do you think the mobilisation technique 
had on your back? 
 
Immediate benefit as illustrated by increased mobilisation 
during stretching and a major reduction in soreness. P1 
 
I don’t know what was intended by I assume it was 
loosening the muscles and the spine. P2 
 
Felt as if the tightness I experienced had been reduced and 
that movements which may have caused pain before 
became more bearable. P3 
 
It made it more painful to start with but it felt much better 
afterwards (later on). P4 
 
Minimal- would probably help as part of physio treatment 
P5 
 
 
Decreasing discomfort 
 
 
Uncomfortable 
 
 
 
 
Uncomfortable 
 
 
Comfortable 
 
Painless 
 
Comfortable 
 
 
Comfortable 
 
 
Comfortable though some pain 
 
Comfortable 
 
Uncomfortable but relaxing 
 
 
 
 
 
 
 
Positioning uncomfortable 
 
 
 
 
Comfortable 
 
Comfortable 
 
Comfortable 
 
Comfortable 
 
Initially uncomfortable 
 
comfortable 
 
 
 
 
 
 
Immediate benefit 
Decreased pain 
Increased movement 
 
 
 
Reduced tightness 
Reduced pain on mvt 
 
 
Increased pain 
initially then better 
 
Minimal 
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Possible release of muscle tension P6. 
 
The stiffness has eased since yesterday and the recovery 
from feeling pain (ie bending forwards) eases more 
quickly rather than feeling pain with every movement. P7 
 
Mobilisation technique improved my range of motion after 
application and also reduced my pain levels yesterday. 
Certainly improved my lower back pain and flexibility, 
however I wouldn’t say it has cured the issue but rather 
assisted in pain relief. Would need to be able to do 
something like this myself everyday as can’t go to the 
physio everytime I experience pain. P8 
 
Initially when I had just left the session it felt a bit 
‘vulnerable’ . This wore off quickly, no issues overnight/in 
the morning. P9 
 
Great improvement, better mobility, back felt stronger and 
no pain P10 
 
It seemed to ease it somewhat P11 
 
I feel a lot more comfortable and less stiff in my lower 
back P12 
 
It was a noticeable improvement over a short period of 
time P13 
 
I feel more free P14 
 
None P15 
 
Made it stiffer and sore today P17 
 
So far, improvement P18 
 
Difficult to know at this early stage? Some slight 
improvement in stiffness and level of discomfort today 
P19 
 
I seem to have more movement and less pain. I was able to 
stretch further with not as much discomfort on the second 
day P20. 
 
Reduced the pain P21  
 
Back felt a little sore (that afternoon/evening) BUT did 
seem to sleep better (I often wake at night with back ache). 
Today my back seems its usual self- just small amounts of 
background pain there P22. 
 
Up to eight hours after the technique my back felt very 
relaxed> However I woke up and it was once again 
tense/tight P23 
 
It was relieving shortly after receiving it and although it 
was uncomfortable at first, I felt it was doing my back 
some good. The relief was only short term P24 
 
Seems to be effective P25 
 
Improved symptoms, improved knowledge on how to 
prevent/ treat myself when/if pain occurs P26 
 
Some relief, particularly on the pain symptoms. Ranges of 
motion appear better 24 hours later despite feelings of 
slight stiffness on some actions, immediately after P27 
 
After a nights rest the back feels much more flexible and 
not so tight – greater range of movement without an 
 
Reduced tension 
 
Reduced pain on movement 
Reduced stiffness 
 
 
 
Increased movement 
Decreased pain 
Not cured 
Need to be able to do it myself 
 
 
 
Initially felt vulnerable 
 
 
 
Increased movement 
Felt stronger 
 
Felt eased 
 
More comfortable 
Less stiff 
 
Improved 
 
 
Free 
 
None 
 
Stiffer and sore 
 
None 
 
Slight decrease pain  
Increased movement 
 
 
Increased movement decreased 
pain 
 
 
 
Reduced pain 
 
 
Sore 
 
 
Short term relaxation 
 
 
 
Short term relief 
 
 
Effective 
 
 
Improved symptoms 
 
 
Reduced pain 
Stiff immediately then greater 
movement 
 
Reduced tightness 
Increased movement 
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increase in the pain. Pain was still present but markedly 
reduced and less bothersome P28 
 
I feel at this stage I can’t honestly say. I would have a 
better idea when the pain settles – at the moment it feels 
like I’ve done a hard session of exercise (DOM’s like feel, 
especially on movement). 
 
Difficult to say as I wasn’t in extreme pain before hand 
P30 
 
Slight relief of pain, but only temporary P32 
 
Not sure P33 
 
Slight improvement P34 
 
Made it feel better at the time, however, I ached slightly 
the following day. BUT this may have been due to ROM 
exercises P35 
 
I think that the next day after the mobilisation I woke up 
unusually better P36 
 
Getting up in the morning the pain wasn’t as bad as the 
previous morning (when it’s normally at its worst). Based 
on today I feel slight improvement and reduction in pain 
from yesterday P37 
 
I believed it had a positive effect on my back in the sense 
that the pain/uncomfortableness in my back was less 
severe and some occasions couldn’t feel any pain P38 
 
Its helped just when completing day to day activities P39 
 
No apparent change in back discomfort P40 
 
No discernable effect P41 
 
Increased the overall pain after an initial reduction P42 
 
After the mobilisation my back did feel easier and when I 
left it felt looser. However later on in the day my back did 
seem to ache more P43 
 
Hard to tell, relief from some of the pain for a few hours 
after. Not long lasting P44. 
 
Temporary (short term) relief P45 
 
Not sure. Was more aware of the pain sensation and more 
frequently afterwards, but at different times and different 
situations than previously i.e. usually during and after 
exercise the pain eases, but not this time, but other times 
eg when sitting in certain chairs when I would feel the 
pain, or in bed, there was more instances of no pain. P46 
 
Seemed to relieve the pain, at least in the short term P47 
 
I think it helped P48 
 
To relieve tension in the muscles and increase movement 
in the vertebrae P49 
 
It may have loosened it P50 
 
I think it is re injuring the joints to promote a healing 
response P51 
 
None to be honest P52 
 
Don’t know P53 
Decreased pain 
 
 
 
Not sure 
 
 
 
 
 
 
Short term relief 
 
Not sure 
 
 
 
Ached the following day 
 
 
 
Improved next day 
 
 
Improved next day 
 
 
 
 
Decreased pain 
 
 
 
 
None 
 
None 
 
 
Increased pain 
 
Initially decreased pain then 
increased 
 
 
Short term pain relief 
 
 
Short term relief 
 
 
 
unsure 
 
 
 
 
Short term relief 
 
unsure 
 
 
 
 
unsure 
 
 
 
 
None 
 
unsure 
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Find the pressure point where my pain originates, and 
increase it or decrease it according to need. Beneficial to 
be able to know where it is now P54 
 
The effect of the M/T was to loosen up my lower back in a 
similar way to excersie for example yoga P55 
 
Short term relief P57 
 
My back seemed a little lea painful and stiff today but I’m 
not sure of this is an effect of my swim this morning. P58 
 
Not sure no noticeable difference P59 
 
Felt a wee bit stiffer this morning but whether it was as a 
result of the technique or not I’m not sure P60 
 
Pain relief (placebo effect) P61. 
 
Gentle movement helps with my back and this had a 
similar effect P63 
 
Trying to bend forward after the massage was pretty 
uncomfortable P64 
 
I cannot justify if the technique had any positive effect or 
negative effect because sometimes I felt pain and 
sometimes I felt quite relaxed P65 
 
Slight relief P66 
 
Very good relief P67 
 
Hard to say presently, maybe I feel less stiff with it today 
P68 
 
I felt that the area where I experienced the technique began 
to feel less painful, almost like the numbness that I 
experienced had eased away P69 
 
Not too sore. I think the points became a little less painful. 
Definitely not more painful P70. 
 
It made it feel more relaxed P71 
 
Limbers area/? More flexible. Hard to tell P72 
 
Ease of pain. More movement around hip area P73. 
 
I felt as though pain replicated upon active movement was 
slightly better, but sensation of pressure pain thresholds I 
couldn’t determine a difference P74 
Any other comments: 
 
I quite enjoyed being a guinae pig and feel much better. 
The morning after session 2 was unusual for me in that I 
had less pain than has been typical for the last 2 months. 
P1 
 
No, other than it was interesting to be part of. P2 
 
I had heard a lot about the technique and it was interesting 
to experience it. P3 
 
No P4 
 
No P5 
 
No P6 
 
Slept on a different mattress last night to previous weeks 
 
 
 
 
 
Looser 
 
 
Short term relief 
 
Not sure 
 
 
None 
 
Stiffer 
 
 
Decreased pain 
 
 
 
 
More pain on movement 
 
 
Not sure 
 
 
 
Slight relief 
 
Good relief 
 
Not sure 
 
 
Decreased pain 
 
 
 
Unsure 
 
 
More relaxed 
 
Unsure 
 
Reduced pain 
 
PPT 
 
 
 
 
 
Less pain than last 2 months 
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P8. 
 
Has increased the awareness of my left leg issues and I’m 
left with a dull awareness in my lower (RH) back. P9 
 
I am aware I need to keep exercising and help long term 
support of my back. Thank you for helping P10 
 
Would be interested to see the effect of continuous 
treatment over a period of time P11 
 
This technique appears to have worked and improved my 
back P12 
 
I will recommend this technique and pursue this type of 
treatment if and when I need it P13 
  
No P14 
 
The whole experience was quite pleasant P18  
 
Its been an interesting experience and I am always 
welcome to new ideas to pain relief without painkillers 
P23 
 
No P24 
No P25 
 
Unfortunately, immediately before the mobilisation 
technique my back pain was low so any effects were 
difficult to determine. 
 
Pain and discomfort in my back has a history of being 
erratic with not always a reason for pain P32 
 
I liked the mobilisation but I find the pressure measures a 
bit weird P36 
Was the technique expected to have an impact? P40 
No P44 
No P45 
- P46 
No P47 
- P48 
- -P49 
- P50 
- -P51 
- P53 Having the pressure placed on the point 
today I probably felt some bruising from 
yesterday so may have reacted earlier to stimuli 
than yesterday. 
The pillow under my legs works wonders P54 
 
It remains to be seen if this has helped when I come to 
stress my lower back when for example I have been 
standing or gardening for any length of time. It would also 
be helpful to know the cause of my discomfort (whether I 
could do anything different in my day to day life) P55 
 
Can you make it more long term? P57 
-P58 
-P59 
 
Not at this stage P60 
 
I am extremely happy that such a small movement has 
given me the relief I require and a confidence in exercise 
P67 
 
-P68 
-P69 
-P70 
No P71 
 
 
 
 
 
 
 
 
Would be interested to see 
effect of multiple rx 
 
helped 
 
would recommend mobs and 
seek more treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Can you make it more long 
term? 
 
 
 
 
Extremely happy with relief 
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Purely preference. Would have preferred stronger 
massage/pressure P72 
-P73 
-P74 
 
 
 
 
 
